---
title: 'Medicine üçä‚≠ê'
date: 2023-01-03
permalink: /note/medicine
tags:
  - note
toc: true
---

Essences of clinical medicine.

{% include toc %}

# Cardiology / Âæ™Áí∞Âô®Áßë

## Ischemic Heart Disease and Heart Failure / ËôöË°ÄÊÄßÂøÉÁñæÊÇ£„ÉªÂøÉ‰∏çÂÖ®

### Effort Angina / Âä¥‰ΩúÊÄßÁã≠ÂøÉÁóá

* **Overview**
  * Transient myocardial ischemia due to coronary artery stenosis (from atherosclerosis) and increased oxygen demand (during exertion)
  * Risk factors: Hypertension, DM, dyslipidemia, smoking, aging
* **Presentation**
  * **Chest tightness/pressure during exertion (lasting 3-5 minutes)**: Temporary myocardial ischemia, rapid relief with nitroglycerin
* **Examination**
  * **[ECG] ST depression (during attack or exercise stress)**: Ischemia
  * **[Echocardiography] Wall motion abnormality**: Ischemia
  * **[Blood] No elevation in cardiac biomarkers**: Excludes myocardial necrosis
  * **[Myocardial perfusion SPECT] Reduced uptake during stress, improved at rest**: Reversible ischemia
* **Management**
  * **Nitroglycerin (sublingual)**: Rapid relief of acute attacks (relax coronary artery)
  * **Œ≤-blockers, calcium channel blockers**: Prevent attacks (decrease oxygen demand)
  * **Antiplatelet drugs, statins**: Prevent thrombosis, improve atherosclerosis
  * **Percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG)**: For severe cases
  * **Lifestyle modifications**
{: .notice--info}

### Vasospastic Angina / ÂÜ†Êî£Á∏ÆÊÄßÁã≠ÂøÉÁóá

* **Overview**
  * Transient myocardial ischemia caused by coronary artery spasm
  * Risk factors: Smoking, hypertension, DM, dyslipidemia
* **Presentation**
  * **Chest tightness/pressure at night to early morning or at rest (lasting several to 15 minutes)**: Coronary artery spasm, triggered by hyperventilation, alcohol, or early morning exercise
* **Examination**
  * **[ECG] ST elevation or depression (during attack)**: Ischemia due to spasm
  * **[Blood] No elevation in cardiac biomarkers**: Excludes myocardial infarction
  * **[Coronary angiography] Hyperventilation or drug-induced spasm**: Confirms diagnosis
* **Management**
  * **Nitroglycerin (sublingual)**: Rapid relief of acute attacks (relax coronary artery)
  * **Calcium channel blockers, nitrates**: Prevent attacks (relax coronary artery)
  * **Lifestyle modifications**
{: .notice--info}

### Acute Coronary Syndrome / ÊÄ•ÊÄßÂÜ†ÁóáÂÄôÁæ§

* **Overview**
  * Myocardial ischemia and necrosis due to rapid narrowing or obstruction of coronary artery by thrombosis formation, encompasses unstable angina, acute myocardial infarction, and sudden cardiac death due to ischemia
  * Classified as non-ST elevation ACS (NSTE-ACS) and ST elevation myocardial infarction (STEMI)
  * Risk factors: Hypertension, DM, dyslipidemia, smoking, aging
* **Presentation**
  * **Chest pain at rest or during exertion (lasting several to >15 minutes)**: Acute myocardial ischemia
* **Examination**
  * **[ECG] ST elevation (or depression for NSTE-ACS), hyperacute T, abnoraml Q**:  Infarction or ischemia
  * **[Blood] Elevated cardiac troponin**: Confirms myocardial injury
  * **[Echocardiography]**: Abnormal wall motions
* **Management**
  * **[Initial treatment] Morphine, oxygen, nitroglycerin, aspirin**: Stabilize general condition
  * **[Reperfusion therapy] Percutaneous coronary intervention (PCI), thrombolysis (t-PA), coronary artery bypass grafting (CABG)**: Reopen obstructed coronary artery (first choice: PCI)
  * **[Antiplatelet drugs] Aspirin, clopidogrel, prasugrel**: Prevent thrombosis
  * **[Anti-anginal drugs] Œ≤-blockers, nitrates, calcium channel blockers**: Reduce oxygen demant and relax coronary artery
  * **[Anti-hypertensive drugs] ACE inhibitors, ARBs, MRAs**: Reduce afterload
  * **[Anti-hyperlipidemic drugs] Statins**: Prevent recurrence
  * **[Complications management] Arrhythmias, heart failure, stroke, cardiac rehabilitation**
{: .notice--info}

### Heart Failure / ÂøÉ‰∏çÂÖ®

* **Overview**
  * Cardiac pump dysfunction leading to pulmonary and systemic congestion
  * Causes: Ischemic heart disease, valvular heart disease, cardiomyopathy, hypertension
* **Presentation**
  * **Dyspnea, tachypnea, orthopnea, paroxysmal nocturnal dyspnea**: Left-sided heart failure (pulmonary congestion)
  * **Leg edema, jugular vein distension**: Right-sided heart failure (systemic congestion)
* **Examination**
  * **[Auscultation] Coarse crackles, S3 or S4 gallop**: Pulmonary congestion, ventricular dysfunction
  * **[Chest X-ray] Cardiomegaly, pulmonary vascular markings, butterfly shadow, Kerley's lines, pleural effusion**: Cardiac enlargement and congestion
  * **[Blood] BNP‚Üë, NT-proBNP‚Üë**: Sensitive markers of heart failure
  * **[Echocardiography] Systolic dysfunction, diastolic dysfunction**: Cardiac function assessment
* **Management**
  * **Diuretics, vasodilators**: Improve hemodynamics and symptoms
  * **ACE inhibitors, ARBs, ARNI, MRAs, Œ≤-blockers, ivabradine**: Cardioprotective effects
  * **ICD, CRT, MitraClip, IABP, ECMO, IMPELLA, VAD**: Cardiac and circulatory support for severe cases
  * **Heart transplantation**: For end-stage heart failure
  * **Disease management**: Address underlying causes
{: .notice--info}

## Arrhythmia / ‰∏çÊï¥ËÑà

### Atrial Premature Contraction / ÂøÉÊàøÊúüÂ§ñÂèéÁ∏Æ

* **Overview**
  * Premature excitation from atria earlier than sinus node firing
* **Presentation**
  * **Asymptomatic, palpitations, chest discomfort**: Mostly asymptomatic
* **Examination**
  * **[ECG] Early P wave**: Premature atrial depolarization
* **Management**
  * **Observation**: For asymptomatic cases
  * **Œ≤-blockers , Na channel blockers**: For symptomatic cases
{: .notice--info}

### Paroxysmal Supraventricular Tachycardia / Áô∫‰ΩúÊÄß‰∏äÂÆ§È†ªÊãç

* **Overview**
  * Supraventricular tachycardia due to reentry involving AV node (AVNRT) or accessory pathway (AVRT)
* **Presentation**
  * **Palpitations (sudden onset and termination)**: Reentry mechanism
  * **Dizziness, syncope (in severe cases)**: Due to reduced cardiac output
* **Examination**
  * **[ECG] Regular narrow QRS complexes at 120-220 bpm**: Supraventricular origin of tachycardia
* **Management**
  * **Vagal maneuvers, ATP, calcium channel blockers**: For stable hemodynamics
  * **Cardioversion, overdrive pacing**: For unstable hemodynamics
  * **Catheter ablation**: Curative treatment
{: .notice--info}

### Wolff-Parkinson-White Syndrome / WPWÁóáÂÄôÁæ§

* **Overview**
  * Presence of accessory pathway directly connecting atria and ventricles, can cause AVRT or AF resembling VT
* **Presentation**
  * **Asymptomatic**: Mostly
  * **Palpitations, syncope**: During tachycardia episodes
* **Examination**
  * **[ECG] Delta wave, short PQ interval, wide QRS complex**: Ventricular pre-excitation through accessory pathway
  * **[ECG] AVRT or AF resembling VT (during episodes)**: Reentry or direct connection
* **Management**
  * **Observation**: For asymptomatic cases
  * **Vagal maneuvers, ATP, Ca channel blockers**: For AVRT
  * **Na channel blockers**: For AF resembling VT (digitalis and Ca channel blockers contraindicated)
  * **Cardioversion**: For hemodynamically unstable AVRT or AF
  * **Catheter ablation**: Curative treatment
{: .notice--info}

### Atrial Flutter / ÂøÉÊàøÁ≤óÂãï

* **Overview**
  * Regular reentrant circuit in atria with consistent conduction to ventricles
* **Presentation**
  * **Palpitations, dyspnea**: Due to rapid heart rate
* **Examination**
  * **[ECG] Regular RR intervals, narrow QRS complexes, regular flutter waves (~300/min)**: Regular tachycardia with consistent AV conduction ratio
* **Management**
  * **Na channel blockers, K channel blockers, Ca channel blockers, cardioversion**: Termination of episodes
  * **Catheter ablation**: Prevention of recurrence
  * **Anticoagulation**: For thromboembolic prevention
  * **Upstream therapy**: Treatment of underlying diseases
{: .notice--info}

### Atrial Fibrillation / ÂøÉÊàøÁ¥∞Âãï

* **Overview**
  * Rapid and disorganized electrical activity in atria leading to irregular ventricular conduction
  * Common in elderly, hypertension, valvular disease, heart failure, ischemic heart disease, hyperthyroidism
  * High risk of thromboembolism due to left atrial thrombus formation
* **Presentation**
  * **Palpitations, irregular pulse**: Due to irregular ventricular conduction
* **Examination**
  * **[ECG] Irregular RR intervals, narrow QRS complexes, absence of P waves with fine baseline oscillations**: Rapid atrial activation with irregular conduction to ventricles
* **Management**
  * **Anticoagulation (warfarin, DOAC)**: Thromboembolism prevention
  * **Œ≤-blockers, Ca channel blockers, digitalis**: Rate control
  * **Na channel blockers, K channel blockers, cardioversion**: Rhythm control
  * **Catheter ablation**: Prevention of recurrence
  * **Upstream therapy**: Treatment of underlying diseases
{: .notice--info}

### Ventricular Premature Contraction / ÂøÉÂÆ§ÊúüÂ§ñÂèéÁ∏Æ

* **Overview**
  * Premature ectopic excitation from ventricles, seen in patients with underlying heart diseases
* **Presentation**
  * **Asymptomatic, palpitations, chest discomfort**
* **Examination**
  * **[ECG] Wide QRS complex without preceding P wave**: Premature ventricular depolarization
* **Management**
  * **Observation**: For asymptomatic cases without risk factors
  * **Na channel blockers, K channel blockers, Œ≤-blockers**: For symptomatic cases or risk of VT/VF (myocardial infarction)
{: .notice--info}

### Ventricular Tachycardia / ÂøÉÂÆ§È†ªÊãç

* **Overview**
  * Consecutive VPCs causing tachycardia, dangerous arrhythmia with risk of pulselessness and VF
* **Presentation**
  * **Palpitations, shortness of breath**: Due to rapid heart rate
  * **Dizziness, syncope, loss of consciousness**: Due to reduced cardiac output
* **Examination**
  * **[ECG] Wide QRS complexes occurring regularly**: Regular ventricular tachycardia
* **Management**
  * **Amiodarone, nifekalant, procainamide**: Acute termination (hemodynamically stable)
  * **Cardioversion, electrical defibrillation**: Acute termination (hemodynamically unstable)
  * **Amiodarone, sotalol, bepridil, catheter ablation**: Prevention of recurrence (normal cardiac function)
  * **Implantable cardioverter-defibrillator (ICD)**: Prevention of recurrence (reduced cardiac function)
{: .notice--info}

### Ventricular Fibrillation / ÂøÉÂÆ§Á¥∞Âãï

* **Overview**
  * Completely disorganized ventricular excitation resulting in zero cardiac output, rapidly fatal without immediate treatment
  * Common in: STEMI, cardiomyopathy, Brugada syndrome, long QT syndrome, hypoxemia, hypothermia
* **Presentation**
  * **Dizziness followed by immediate syncope, absence of pulse**: Sudden loss of cardiac output
* **Examination**
  * **[ECG] Completely irregular waves with variable amplitude and frequency**: Chaotic ventricular activity
* **Management**
  * **Immediate electrical defibrillation**: First-line treatment
  * **CPR 2 minutes, IV adrenaline, defibrillation**: If above unsuccessful
  * **CPR 2 minutes, IV nifekalant or amiodarone, defibrillation**: If above unsuccessful
  * **CPR 2 minutes, IV Œ≤-blockers, left stellate ganglion block**: If above unsuccessful
  * **Treatment of underlying disease**: If defibrillation successful
{: .notice--info}

### Sick Sinus Syndrome / Ê¥û‰∏çÂÖ®ÁóáÂÄôÁæ§

* **Overview**
  * Dysfunction of sinoatrial node or surrounding tissue, leading to sinus bradycardia, sinoatrial block, or sinus arrest
* **Presentation**
  * **Dizziness, lightheadedness, syncope**: Cerebral hypoperfusion due to bradycardia
  * **Fatigue, shortness of breath**: Heart failure symptoms
* **Examination**
  * **[ECG] Sinus bradycardia (HR < 50 bpm), sinus arrest (absence of P waves)**: Dysfunction of sinoatrial node
* **Management**
  * **Observation**: For asymptomatic cases
  * **Pacemaker implantation**: For persistent symptomatic bradycardia
  * **Atropine, isoproterenol, theophylline, cilostazol**: For cases where pacemaker is not suitable
{: .notice--info}

### Atrioventricular Block / ÊàøÂÆ§„Éñ„É≠„ÉÉ„ÇØ

* **Overview**
  * Delayed or interrupted conduction from atria to ventricles at AV node or His bundle
* **Presentation**
  * **Syncope, heart failure**: Due to decreased cardiac output
* **Examination**
  * **[ECG] Prolonged PQ intervals**: 1st degree AV block
  * **[ECG] Progressive lengthing of PQ intervals with subsequent QRS drop**: Mobitz I 2nd degree AV block
  * **[ECG] Regular PQ intervals with random QRS drop**: Mobitz II 2nd degree AV block
  * **[ECG] P and QRS independently at regular intervals**: 3rd degree AV block
  * **[Auscultation] Cannon sound**: Loud S1 every few beats (3rd degree AV block)
* **Management**
  * **Observation**: For 1st degree and Mobitz I 2nd degree AV block
  * **Pacemaker implantation**: For Mobitz II 2nd degree and 3rd degree AV block
  * **Atropine, isoproterenol**: Bridge therapy before pacemaker implantation
{: .notice--info}

### Bundle Branch Block / ËÑö„Éñ„É≠„ÉÉ„ÇØ

* **Overview**
  * Impaired conduction in right or left bundle branch due to myocardial ischemia or degeneration
* **Presentation**
  * Asymptomatic
* **Examination**
  * **[ECG] Wide QRS, rSR' in V1, wide S in V6**: Right bundle branch block
  * **[ECG] Wide QRS, QS or rS in V1, absent septal Q and notched QRS in V6**: Left bundle branch block
* **Management**
  * **Observation**: Mostly
  * **Cardiac resynchronization therapy (CRT)**: For some left bundle branch block 
{: .notice--info}

### Brugada Syndrome / BrugadaÁóáÂÄôÁæ§

* **Overview**
  * Genetic disorder causing ventricular fibrillation during parasympathetic dominance
  * More common in young to middle-aged men, often associated with family history of sudden death
* **Presentation**
  * **Recurrent syncope, loss of consciousness**: Due to VF episodes
  * **Sudden cardiac death**: Especially during sleep or rest after meals
* **Examination**
  * **[ECG] Right bundle branch block pattern, characteristic ST elevation**: Diagnostic feature
* **Management**
  * **Implantable cardioverter defibrillator (ICD)**: Only effective prevention for sudden death
  * **Pharmacological therapy, catheter ablation**: Considered in some cases
{: .notice--info}

### Long QT Syndrome / QTÂª∂Èï∑ÁóáÂÄôÁæ§

* **Overview**
  * Prolongation of myocardial action potential leading to extended QT interval, can cause torsades de pointes (a type of polymorphic VT)
* **Presentation**
  * **Recurrent syncope**: Due to TdP episodes
  * **Sudden cardiac death**: In severe cases
* **Examination**
  * **[ECG] Corrected QT interval > 0.48 seconds**: Diagnostic feature
* **Management**
  * **Beta-blockers, temporary pacing**: For congenital LQTS
  * **Remove underlying cause**: For acquired LQTS
  * **Magnesium sulfate**: During TdP episodes
{: .notice--info}

## Endocardium and Valvular Disease / ÂøÉÂÜÖËÜú„ÉªÂºÅËÜúÁñæÊÇ£

### Mitral Stenosis / ÂÉßÂ∏ΩÂºÅÁã≠Á™ÑÁóá

* **Overview**
  * Narrowing of mitral valve, impeding blood flow from left atrium to left ventricle
  * Common in women over 40-50 years, often with history of rheumatic fever
* **Presentation**
  * **Dyspnea on exertion, palpitations, irregular pulse**: Due to pulmonary congestion and atrial fibrillation
  * **Embolism**: Thrombus formation in left atrium
* **Examination**
  * **[Auscultation] Accentuated S1, opening snap, diastolic rumble, presystolic murmur**: Mitral valve stenosis
  * **[ECG] Left atrial enlargement, atrial fibrillation**: Increase left atrium pressure
  * **[Chest X-ray] Prominent left 3rd arc**: Enlarged left atrium
  * **[Echocardiography] Reduced valve area, dome-shaped anterior mitral leaflet**: Confirms diagnosis
* **Management**
  * **Symptomatic treatment**: For heart failure
  * **Anticoagulation**: For patients with AF
  * **Percutaneous mitral commissurotomy (PTMC)**: Catheter-based valve opening
  * **Open mitral commissurotomy (OMC) or mitral valve replacement (MVR)**: Surgical options
{: .notice--info}

### Mitral Regurgitation / ÂÉßÂ∏ΩÂºÅÈñâÈéñ‰∏çÂÖ®Áóá

* **Overview**
  * Backflow of blood from left ventricle to left atrium during systole
  * Common causes: mitral valve prolapse, ischemic heart disease
* **Presentation**
  * **Dyspnea on exertion, palpitations, fatigue, paroxysmal nocturnal dyspnea, orthopnea**: Left heart failure symptoms
* **Examination**
  * **[Auscultation] Holosystolic murmur at apex, diminished S1, S3**: Mitral valve regurgitation
  * **[ECG] Left atrial enlargement, left ventricular hypertrophy, atrial fibrillation**: Increased volume load
  * **[Chest X-ray] Prominent left 3rd and 4th arcs**: Left atrial and ventricular enlargement
  * **[Echocardiography] Valve abnormalities, left heart enlargement, regurgitation**: Confirms diagnosis
* **Management**
  * **Symptomatic treatment**: For heart failure
  * **Mitral valve repair or replacement (MVR)**: Surgical options
{: .notice--info}

### Mitral Valve Prolapse / ÂÉßÂ∏ΩÂºÅÈÄ∏ËÑ±Áóá

* **Overview**
  * Syndrome characterized by prolapse of mitral valve leaflets into left atrium during systole
  * Often idiopathic, can be associated with Marfan syndrome
* **Presentation**
  * **Asymptomatic, chest pain, dizziness**: Mild cases
  * **Heart failure symptoms**: Severe mitral regurgitation
* **Examination**
  * **[Auscultation] Mid-systolic click or Holosystolic murmur**: Mitral valve prolapse or regurgitation
  * **[Echocardiography] Prolapse of mitral valve leaflets during systole**: Confirms diagnosis
* **Management**
  * **Œ≤ blockers**: For chest pain and dizziness
{: .notice--info}

### Aortic Stenosis / Â§ßÂãïËÑàÂºÅÁã≠Á™ÑÁóá

* **Overview**
  * Narrowing of aortic valve, impeding blood flow from left ventricle to aorta
  * Causes: Degeneration due to aging, abnormal number of valves
* **Presentation**
  * **Dyspnea, angina**: Left heart failure, myocardial ischemia due to ventricular hypertrophy
  * **Syncope, dizziness, slow and weak pulse, hypotension**: Reduced cardiac output
* **Examination**
  * **[Auscultation] Ejection click, systolic ejection murmur, diminished and paradoxical splitting of S2**: Aortic valve stenosis
  * **[ECG] Left ventricular hypertrophy**
  * **[Echocardiography] Restricted valve opening, reduced valve area, increased transvalvular gradient**: Confirms diagnosis
* **Management**
  * **Aortic valve replacement (AVR)**: Surgical option
  * **Transcatheter aortic valve implantation (TAVI)**: Less invasive option
{: .notice--info}

### Aortic Regurgitation / Â§ßÂãïËÑàÂºÅÈñâÈéñ‰∏çÂÖ®Áóá

* **Overview**
  * Backflow of blood from aorta to left ventricle during diastole
  * Causes left ventricular volume and pressure overload, leading to LV enlargement and hypertrophy
  * Can be compensated for long periods, but poor prognosis once heart failure develops
* **Presentation**
  * **Palpitations**: Increased stroke volume
  * **Dyspnea, angina**: Pulmonary congestion, decreased diastolic aortic pressure
  * **Strong and fast pulse, capillary pulsations of fingernail bed (Quincke's sign)**: Increased pulse pressure
* **Examination**
  * **[Auscultation] Diastolic decrescendo murmur, systolic ejection murmur, Austin-Flint murmur**: Aortic valve regurgitation, relative AS, functional MS
  * **[Chest X-ray] Prominent left 4th arc**: Left ventricular enlargement
  * **[ECG] Left ventricular hypertrophy**
  * **[Echocardiography] Valve abnormalities, left ventricular enlargement, regurgitation, fluttering of mitral valve**: Confirms diagnosis
* **Management**
  * **Aortic valve replacement (AVR) or aortic valvuloplasty (AVP)**: Surgical option
{: .notice--info}


### Tricuspid Stenosis / ‰∏âÂ∞ñÂºÅÁã≠Á™ÑÁóá

* **Overview**
  * Narrowing of tricuspid valve, impeding blood flow from right atrium to right ventricle
  * Mostly due to rheumatic fever
* **Presentation**
  * **Asymptomatic**
  * **Right heart failure symptoms**: In advanced cases
* **Examination**
  * **[Auscultation] Diastolic rumble**: Tricuspid valve stenosis
  * **[Echocardiography] Restricted tricuspid valve, increased transvalvular gradient**: Confirms diagnosis
* **Management**
  * **Symptomatic treatment**: For heart failure
  * **Tricuspid valve replacement**: Surgical options
{: .notice--info}

### Tricuspid Regurgitation / ‰∏âÂ∞ñÂºÅÈñâÈéñ‰∏çÂÖ®Áóá

* **Overview**
  * Backflow of blood from right ventricle to right atrium during systole
  * Common causes: Pulmonary hypertension due to left valvular heart disease
* **Presentation**
  * **Asymptomatic**
  * **Right heart failure symptoms**: In advanced cases
* **Examination**
  * **[Auscultation] Holosystolic murmur**: Tricuspid valve regurgitation
  * **[Echocardiography] Valve abnormalities, regurgitation**: Confirms diagnosis
* **Management**
  * **Symptomatic treatment**: For heart failure
  * **Tricuspid valve repair or replacement**: Surgical options
{: .notice--info}

### Infective Endocarditis / ÊÑüÊüìÊÄßÂøÉÂÜÖËÜúÁÇé

* **Overview**
  * Systemic septic disease with vegetation formation on heart valves or endocardium due to bacterial infection
  * Common cause: Dental intervention, with underlying congenital heart disease or valvular heart disease
* **Presentation**
  * **Fever, joint pain, muscle pain**: Systemic infection
  * **Petechiae, splinter hemorrhages, Osler nodes, Janeway lesions, Roth spots**: Peripheral embolism
  * **Stroke, renal infarction, splenic infarction**: Systemic embolism
  * **Congestive heart failure**: Valve destruction, regurgitation, or chordae tendineae rupture
* **Examination**
  * **[Auscultation] Heart murmur**: Valvular damage
  * **[Blood] WBC‚Üë, ESR‚Üë, CRP‚Üë, Œ≥-globulin‚Üë, fibrinogen‚Üë**: Inflammatory response
  * **[Blood culture] Pathogen detection**: Confirms causative microorganism
  * **[Echocardiography] Vegetation**: Confirms cardiac involvement
* **Management**
  * **High-dose, long-term intravenous antibiotics**: Based on causative microorganism
  * **Surgical intervention**: If antibiotics ineffective
{: .notice--info}

### Cardiac Myxoma / ÂøÉËáìÁ≤òÊ∂≤ËÖ´

* **Overview**
  * Most common primary cardiac tumor, mostly occur in the left atrium
* **Presentation**
  * **Fatigue, weight loss, fever, joint pain**: Systemic effects due to IL-6 secreted by tumor
* **Examination**
  * **[Auscultation] Variable diastolic murmur with position changes, tumor plop**: Tumor movement mimicking mitral stenosis
  * **[Blood] ESR‚Üë, WBC‚Üë, CRP‚Üë, Œ≥-globulin‚Üë**: Inflammation due to IL-6 secreted by tumor
  * **[Echocardiography] Mass in atrium**: Confirms diagnosis
* **Management**
  * **Surgical resection**: Prevents potentially fatal embolization
{: .notice--info}

## Myocardium Disease / ÂøÉÁ≠ãÁñæÊÇ£

### Dilated Cardiomyopathy / Êã°ÂºµÂûãÂøÉÁ≠ãÁóá

* **Overview**
  * Degenerative myocardial disease with left ventricular dilation and reduced contractility
  * More common in males aged 40-70, about 20-30% are familial
* **Presentation**
  * **Palpitations, dyspnea, pulsus alternans, edema**: Chronic progressive heart failure
* **Examination**
  * **[Auscultation] S3 or S4 (gallop rhythm), systolic murmur**: Heart failure, ventricular dilation leading to mitral regurgitation
  * **[ECG] Left ventricular high voltage, wide QRS**: Left ventricular hypertrophy
  * **[Chest X-ray] Cardiomegaly**: Heart failure
  * **[Echocardiography, MRI] Dilated left ventricle, diffuse hypokinesis**: Left ventricular dilation
  * **[Cardiac catheterization] LVEDP‚Üë, PAWP‚Üë**: Left heart failure
* **Management**
  * **Lifestyle modifications (restrict water and salt), medication (Œ≤-blockers, ACE inhibitors, ARBs, MRAs)**: For heart failure
  * **Cardiac resynchronization therapy (CRT), ventricular assist devices (VAD), heart transplantation**: For severe heart failure
  * **Anticoagulation**: For thromboembolism prevention
  * **Antiarrhythmic drugs, implantable cardioverter-defibrillator (ICD), pacemaker**: For arrhythmia management
{: .notice--info}

### Hypertrophic Cardiomyopathy / ËÇ•Â§ßÂûãÂøÉÁ≠ãÁóá

* **Overview**
  * Degenerative myocardial disease with asymmetric ventricular hypertrophy, with high risk of sudden death
  * 50% familial (autosomal dominant, mutation of sarcomere protein gene)
* **Presentation**
  * **Chest pain, dyspnea, palpitations**: Due to increased oxygen demand, pulmonary congestion, and arrhythmia
  * **Dizziness, syncope**: Due to left ventricular outflow tract obstruction or arrhythmia
* **Examination**
  * **[Auscultation] S4, S3, increased apical impulse**: Ventricular diastolic dysfunction
  * **[ECG] Left ventricular high voltage, ST depression, negative T waves**: Left ventricular hypertrophy, relative ischemia
  * **[Chest X-ray] Normal or mild cardiomegaly, upper lung field congestion**: Pulmonary congestion
  * **[Echocardiography, MRI] Asymmetric left ventricular wall hypertrophy (thickness ‚â•15 mm), diastolic dysfunction**: Left ventricular hypertrophy
  * **[Cardiac catheterization] LVEDP‚Üë**: Diastolic dysfunction
* **Management**
  * **Lifestyle modifications (Avoid strenuous exercise), implantable cardioverter-defibrillator (ICD)**: Prevent sudden death
  * **Medications (Œ≤-blockers, CCBs, diuretics, ACE inhibitors, ARBs)**: For heart failure
  * **Antiarrhythmic drugs, anticoagulants**: For arrhythmia management
{: .notice--info}

### Hypertrophic Obstructive Cardiomyopathy / ÈñâÂ°ûÊÄßËÇ•Â§ßÂûãÂøÉÁ≠ãÁóá

* **Overview**
  * Subset of HCM with left ventricular outflow tract obstruction (about 25% of HCM cases)
* **Presentation**
  * **Symptoms of HCM**
  * **Bifid pulse**: Due to dynamic obstruction
* **Examination**
  * **[Auscultation] Ejection systolic murmur**: Outflow obstruction
  * **[Echocardiography] Systolic anterior motion of mitral valve**: Due to increased outflow speed and Venturi phenomenon
  * **[Cardiac catheterization] Brockenbrough phenomenon**: Increased LV-aorta systolic pressure gradient after premature ventricular contraction
* **Management**
  * **Treatmnents of HCM**
  * **Medications (Œ≤-blockers, CCBs, antiarrhythmics)**: Decrease LV-aorta systolic pressure gradient
  * **Surgical myectomy, pacemaker implantation, percutaneous transluminal septal myocardial ablation (PTSMA)**: For refractory cases
{: .notice--info}

### Restrictive Cardiomyopathy / ÊãòÊùüÂûãÂøÉÁ≠ãÁóá

* **Overview**
  * Characterized by reduced left ventricular compliance and diastolic dysfunction
* **Presentation**
  * **Generalized edema, pulmonary congestion, pleural effusion**: Heart failure symptoms
* **Examination**
  * **[Cardiac catheterization] Dip and plateau pattern in ventricular pressure curve**: Diastolic restriction
* **Management**
  * **Symptom management (diuretics)**
{: .notice--info}

### Cardiac Sarcoidosis / ÂøÉËáì„Çµ„É´„Ç≥„Ç§„Éâ„Éº„Ç∑„Çπ

* **Overview**
  * Part of systemic sarcoidosis, forming non-caseating epithelioid granulomas in multiple organs
* **Presentation**
  * **Complete atrioventricular block, ventricular arrhythmias**: Damage to conduction pathways and cardiac muscles
* **Examination**
  * **[Ga scintigraphy, PET] Focal uptake in heart**: Inflammation
* **Management**
  * **Corticosteroid**: Control inflammation
{: .notice--info}

### Cardiac Amyloidosis / ÂøÉ„Ç¢„Éü„É≠„Ç§„Éâ„Éº„Ç∑„Çπ

* **Overview**
  * Systemic syndrome with amyloid protein deposition in various organs (AL amyloidosis or ATTR amyloidosis)
* **Presentation**
  * **Cardiac hypertrophy, diastolic dysfunction**: Deposition of amyloid protein
* **Examination**
  * **[ECG] Low voltage, conduction disorders**: Damage to conduction pathways
  * **[Echocardiography] Cardiac hypertrophy, diastolic dysfunction**: Deposition of amyloid protein
  * **[Cardiac biopsy] Amyloid deposition in myocardium**: Confirms diagnosis
* **Management**
  * **Symptomatic treatment**: For heart failure and arrhythmias
{: .notice--info}

### Acute Myocarditis / ÊÄ•ÊÄßÂøÉÁ≠ãÁÇé

* **Overview**
  * Acute myocardial necrosis and dysfunction due to infection (mostly virus) or idiopathic, may cause of sudden death but good prognosis if overcome acute phase
* **Presentation**
  * **Flu-like symptoms, gastrointestinal symptoms**: Prodromal phase of infection
  * **Heart failure symptoms, chest pain, fever**: Acute cardiac inflammation
* **Examination**
  * **[Auscultation] S3, crackles**: Heart failure signs
  * **[ECG] ST-T changes, arrhythmia**: Myocardial injury and conduction disturbances
  * **[Echocardiography] Diffuse wall thickening, hypokinesis, small cardiac chambers, pericardial effusion**: Myocardial inflammation and dysfunction
  * **[Blood] Troponin T‚Üë, CK-MB‚Üë, AST‚Üë, LDH‚Üë, CRP‚Üë**: Myocardial injury and inflammation
  * **[Endomyocardial biopsy] Inflammatory cell infiltration, myocyte necrosis, interstitial edema**: Confirms diagnosis
* **Management**
  * **Bed rest, hospitalization**: Supportive care
  * **Diuretics, catecholamines, IABP, ECMO**: For heart failure and cardiogenic shock
  * **Pacemaker, defibrillation**: For arrhythmia
{: .notice--info}

## Pericardium Disease / ÂøÉËÜúÁñæÊÇ£

### Acute Pericarditis / ÊÄ•ÊÄßÂøÉËÜúÁÇé

* **Overview**
  * Acute inflammation of the pericardium, mostly idiopathic (90%) or viral, generally good prognosis
* **Presentation**
  * **Chest pain worsening in supine position and during inspiration**: Pericardial irritation
  * **Fever**: Inflammatory response
* **Examination**
  * **[Auscultation] Pericardial friction rub**: Inflamed pericardial surfaces rubbing together
  * **[ECG] Diffuse concave ST elevation**: Pericardial inflammation
  * **[Blood] WBC‚Üë, ESR‚Üë, CRP‚Üë**: Inflammatory response
  * **[Echocardiography] Small pericardial effusion**: May be present
  * **[Chest X-ray] Usually normal**: Distinguishes from pleuritis
* **Management**
  * **Symptomatic treatment (NSAIDs)**: Often self-resolving
  * **Treat primary cause**: If secondary to underlying disease
{: .notice--info}

### Cardiac Tamponade / ÂøÉ„Çø„É≥„Éù„Éä„Éº„Éá

* **Overview**
  * Life-threatening condition where pericardial fluid accumulation impairs cardiac filling
  * Causes include aortic dissection, cardiac rupture after MI, trauma, malignancies invading pericardium
* **Presentation**
  * **Hypotension, jugular vein distension, muffled heart sounds**: Decreased cardiac output, increased venous pressure, pericardial fluid accumulation
  * **Hepatomegaly, ascites, leg edema**: Right heart failure signs
  * **Narrow pulse pressure, tachycardia, pulsus paradoxus (systolic BP drop during inspiration)**: Decreased cardiac output, exaggerated when increased venous return compress left ventricle
* **Examination**
  * **[Chest X-ray] Enlarged flask-shaped cardiac silhouette**: Pericardial effusion
  * **[Echocardiography] Echo-free space in pericardium, ventricular free wall collapse**: Confirmatory findings
* **Management**
  * **Pericardiocentesis**: Definitive treatment to drain fluid
  * **Treat underlying cause**
{: .notice--info}

### Constrictive Pericarditis / ÂèéÁ∏ÆÊÄßÂøÉËÜúÁÇé

* **Overview**
  * Chronic inflammation causing fibrotic thickening and calcification of pericardium, impairing cardiac filling
  * Causes include idiopathic, tuberculosis, viral, post-radiation, post-cardiac surgery
* **Presentation**
  * **Dyspnea on exertion, fatigue**: Decreased cardiac output
  * **Jugular vein distension (exaggerated during inspiration = Kussmaul's sign), ascites, edema, hepatomegaly, congestive cirrhosis**: Right heart failure signs
* **Examination**
  * **[Auscultation] Pericardial knock**: Abrupt cessation of ventricular filling
  * **[ECG] Low voltage, nonspecific ST-T changes**: Thickening of pericardium
  * **[Echocardiography, Chest X-ray, CT, MRI] Thickened or calcified pericardium**: Thickening of pericardium
  * **[Cardiac catheterization] M or W-shaped RAP curve, RVP dip and plateau pattern**: Impaired ventricular filling lead to increased pressure of RA, rapid filling and termination of RV
* **Management**
  * **Pericardiectomy**: Definitive treatment
{: .notice--info}

## Congenital Heart Disease / ÂÖàÂ§©ÊÄßÂøÉÁñæÊÇ£

### Atrial Septal Defect / ÂøÉÊàø‰∏≠ÈöîÊ¨†ÊêçÁóá

* **Overview**
  * Congenital defect in atrial septum causing left-to-right shunt
* **Presentation**
  * **Asymptomatic (childhood)**: Left-to-right shunt compensated
  * **Dyspnea on exertion, fatigue (adolescence/adulthood)**: Right heart volume overload
* **Examination**
  * **[Auscultation] Fixed splitting of S2, systolic ejection murmur, accentuated S1, tricuspid diastolic rumble**: Relative pulmonary stenosis and tricuspid stenosis due to right atrial volume overload
  * **[ECG] Right axis deviation, incomplete right bundle branch block, right ventricular hypertrophy, atrial fibrillation**: Right heart strain
  * **[Echocardiography] Left atrium to right atrium shunt**: Confirms diagnosis
  * **[Cardiac catheterization] O2 step-up in right atrium**: Quantifies shunt
* **Management**
  * **Observation**: For mild cases (pulmonary-to-systemic flow ratio <1.5)
  * **Surgical or catheter-based closure**: For significant shunts (ratio >1.5)
{: .notice--info}

### Ventricular Septal Defect / ÂøÉÂÆ§‰∏≠ÈöîÊ¨†ÊêçÁóá

* **Overview**
  * Congenital defect in ventricular septum causing left-to-right shunt
* **Presentation**
  * **Asymptomatic**: Left-to-right shunt compensated (small VSD)
  * **Tachypnea, feeding difficulties, poor weight gain, sweating**: Heart failure symptoms (large VSD)
* **Examination**
  * **[Auscultation] Holosystolic murmur, palpable thrill**: Shunt through defect (small VSD)
  * **[Auscultation] Accentuated S2, diastolic rumble**: Pulmonary hypertension, relative mitral stenosis (large VSD)
  * **[ECG] Biventricular hypertrophy, left atrial overload**: Pulmonary hypertension (large VSD)
  * **[Chest X-ray] Marked ventricular and atrial enlargement, prominent pulmonary artery, increased pulmonary vascularity**: Left-to-right shunt (large VSD)
  * **[Echocardiography, left ventriculography] Left ventricle to right ventricle shunt**: Confirms diagnosis
  * **[Cardiac catheterization] O2 step-up in right atrium to ventricle**: Quantifies shunt
* **Management**
  * **Observation**: Many small defects close spontaneously
  * **Diuretics, surgical closure**: For large VSD
{: .notice--info}

### Atrioventricular Septal Defect / ÊàøÂÆ§‰∏≠ÈöîÊ¨†ÊêçÁóá

* **Overview**
  * Developmental defect of atrioventricular septum, classified into incomplete and complete type based on existence of VSD
  * Associated with Down syndrome
* **Presentation**
  * **Asymptomatic, dyspnea**: Heart failure symptoms
* **Examination**
  * **[Auscultation] Systolic regurgitant murmur, systolic ejection murmur, diastolic rumble, fixed S2 splitting**: MR + ASD (imcomplete AVSD)
  * **[Auscultation] Systolic regurgitant murmur, diastolic rumble, accentuated S2**: MR + VSD (complete AVSD)
  * **[ECG] Left axis deviation, incomplete right bundle branch block, prolonged PQ interval, right ventricular hypertrophy**: Conduction abnormalities and right heart strain
  * **[Chest X-ray] Cardiomegaly, increased pulmonary vascularity**: Volume overload and increased pulmonary flow
  * **[Echocardiography] ASD, VSD (in complete type), left-to-right shunt, valve abnormalities**: Confirms diagnosis
  * **[Cardiac catheterization] O2 step-up in right heart chambers**: Quantifies shunt
  * **[Left ventriculography] Goose-neck sign**: Characteristic appearance of AVSD
* **Management**
  * **Surgical closure of defects, mitral valve repair**: For incomplete and complete AVSD
{: .notice--info}

### Patent Ductus Arteriosus / ÂãïËÑàÁÆ°ÈñãÂ≠òÁóá

* **Overview**
  * Persistence of fetal ductus arteriosus between aortic isthmus and pulmonary artery
  * Associated with congenital rubella syndrome
* **Presentation**
  * **Asymptomatic**: In mild cases
  * **Widened pulse pressure, bounding pulse, Quincke's sign**: Increased systolic and decreased diastolic pressures
* **Examination**
  * **[Auscultation] Continuous machinery murmur**: Aorta-to-pulmonary artery shunt
  * **[ECG] Left ventricular hypertrophy**: Increased pulmonary flow
  * **[Chest X-ray] Prominent left 1st/2nd/4th arches, increased pulmonary vascularity**: Volume overload and increased pulmonary flow
  * **[Echocardiography, aortography] Aorta-to-pulmonary artery shunt**: Confirms diagnosis
  * **[Cardiac catheterization] O2 step-up in pulmonary artery**: Quantifies shunt
* **Management**
  * **Coil embolization, Amplatzer duct occluder, PDA ligation**: If continuous murmur present
  * **Indomethacin or ibuprofen**: Pharmacological closure in premature infants
{: .notice--info}

### Pulmonary Stenosis / ËÇ∫ÂãïËÑàÁã≠Á™ÑÁóá

* **Overview**
  * Congenital narrowing of pulmonary artery (most commonly pulmonary valve)
* **Presentation**
  * **Asymptomatic**: Compensated right heart function
* **Examination**
  * **[Auscultation] Ejection click, systolic ejection murmur, weakened and pathological splitting of S2**: Obstruction in pulmonary outflow
  * **[ECG] Right ventricular hypertrophy**: Right heart pressure overload
  * **[Chest X-ray] Prominent left 2nd arc, rounded left 4th arc**: Post-stenotic dilatation of pulmonary artery
  * **[Echocardiography, right ventriculography] Stenotic valve, post-stenotic dilatation**: Confirms diagnosis
  * **[Cardiac catheterization] Pressure gradient between pulmonary artery and right ventricle, elevated right heart pressures**: Quantifies stenosis severity
* **Management**
  * **Observation**: For mild cases
  * **Percutaneous balloon pulmonary valvuloplasty (PTPV), surgical valvotomy**: For moderate to severe cases
{: .notice--info}

### Coarctation of the Aorta / Â§ßÂãïËÑàÁ∏ÆÁ™ÑÁóá

* **Overview**
  * Local narrowing of aortic isthmus or descending aorta, classified into simple and complex types based on existence of associated defects
* **Presentation**
  * **Asymptomatic**: Gradual development of collateral circulation (simple CoA)
  * **Dyspnea, pallor, oliguria, differential cyanosis**: Heart failure and upper-lower body perfusion difference (complex CoA)
  * **Weak/absent lower limb pulses, upper limb hypertension**: Aortic narrowing
* **Examination**
  * **[Auscultation] Accentuated S2, systolic murmur**: Increased flow velocity at coarctation
  * **[ECG] Left ventricular or biventricular hypertrophy**: Cardiac strain
  * **[Chest X-ray] 3-sign, rib notching, cardiomegaly, increased pulmonary vascularity**: Collateral circulation and heart failure
  * **[Echocardiography] Narrowing at aortic isthmus, associated defects**: Confirms diagnosis
* **Management**
  * **Balloon angioplasty, stent placement, aortic arch reconstruction**: Intervention for pressure gradient ‚â•20mmHg (simple CoA)
  * **Prostaglandin E1, aortic arch reconstruction with/without intracardiac repair**: Urgent surgery (complex CoA) 
{: .notice--info}

### Ruptured Aneurysm of the Sinus of Valsalva / ValsalvaÊ¥ûÂãïËÑàÁò§Á†¥Ë£Ç

* **Overview**
  * Sudden rupture of aneurysm in right or non-coronary sinus into right ventricle/atrium
* **Presentation**
  * **Sudden onset of palpitations, dyspnea, chest pain**: Aneurysm rupture
  * **Bounding pulse**: Increased stroke volume due to left-to-right shunt
* **Examination**
  * **[Auscultation] Continuous murmur**: Shunt from aorta to right heart
  * **[Chest X-ray] Prominence of left second arch, increased pulmonary vascularity**: Pulmonary volume overload
  * **[Echocardiography] Coronary sinus to right ventricle shunt**: Confirms diagnosis
* **Management**
  * **Aneurysm resection, fistula closure with patch**: Early surgical intervention
  * **VSD closure, aortic valve repair**: If necessary
{: .notice--info}

### Tetralogy of Fallot / FallotÂõõÂæ¥Áóá

* **Overview**
  * Congenital heart defect with four main features: pulmonary stenosis, ventricular septal defect, overriding aorta, right ventricular hypertrophy
* **Presentation**
  * **Cyanosis (from neonatal period)**: Right-to-left shunt
  * **Hypoxic spells (from 2-3 months)**: Right ventricular outflow tract spasm
  * **Squatting posture (after age 2)**: Increases systemic vascular resistance
* **Examination**
  * **[Auscultation] Systolic ejection murmur, single S2**: PS, weak pulmonary component
  * **[ECG] Right ventricular hypertrophy, right axis deviation**: Right heart overload
  * **[Chest X-ray] Boot-shaped heart, decreased pulmonary vascular markings**: Characteristic findings
  * **[Echocardiography] Pulmonary stenosis, ventricular septal defect, overriding aorta, right ventricular hypertrophy**: Confirms diagnosis
* **Management**
  * **Blalock-Taussig shunt**: Subclavian artery to pulmonary artery shunt (palliative surgery)
  * **VSD closure, right ventricular outflow tract reconstruction**: Complete repair (after 6 months of age)
  * **Sedation, oxygen, knee-chest position, Œ≤-blockers, Œ±-agonists**: Hypoxic spell management
{: .notice--info}

### Complete Transposition of the Great Arteries / ÂÆåÂÖ®Â§ßË°ÄÁÆ°Ëª¢‰ΩçÁóá

* **Overview**
  * Aorta from right ventricle, pulmonary artery from left ventricle, classified into Types I-III based on associated defects
* **Presentation**
  * **Cyanosis, tachypnea, respiratory distress**: Separation of systemic and pulmonary circulations
* **Examination**
  * **[Auscultation] Single and accentuated S2**: Anterior displacement of aorta
  * **[ECG] Right ventricular hypertrophy, right axis deviation**: Right heart overlaod due to high resistance
  * **[Chest X-ray] Egg-shaped cardiac silhouette**: Characteristic findings
  * **[Echocardiography] Aorta from right ventricle (anterior), pulmonary artery from left ventricle**: Confirms diagnosis
* **Management**
  * **PGE1 infusion, balloon atrial septostomy, diuretics**: Emergency measures
  * **Jatene procedure**: Arterial switch operation (type I, II)
  * **Rastelli procedure**: Creates intracardiac tunnel to redirect blood flow (type III)
{: .notice--info}

### Total Anomalous Pulmonary Venous Return / Á∑èËÇ∫ÈùôËÑàÈÇÑÊµÅÁï∞Â∏∏Áóá

* **Overview**
  * All four pulmonary veins drain into the right heart system
* **Presentation**
  * **Respiratory distress, right heart failure symptoms, cyanosis**: Abnormal pulmonary venous return
* **Examination**
  * **[Auscultation] Accentuated S2**: Pulmonary hypertension
  * **[ECG] Right ventricular hypertrophy, right axis deviation**: Right heart strain
  * **[Chest X-ray] Cardiomegaly, increased pulmonary vascular markings, snowman appearance (Type Ia)**: Right heart volume overload and pulmonary congestion
  * **[Echocardiography, MDCT] Enlarged right atrium and ventricle, abnormal pulmonary vein course**: Confirms diagnosis
* **Management**
  * **Anastomosis of common pulmonary vein to left atrium, ASD closure**: Urgent intracardiac repair
{: .notice--info}

### Tricuspid Atresia / ‰∏âÂ∞ñÂºÅÈñâÈéñÁóá

* **Overview**
  * Absent tricuspid valve blocking right atrium-ventricle communication, always with ASD
* **Presentation**
  * **Cyanosis, heart failure symptoms**: Right-to-left shunt
* **Examination**
  * **[ECG] Left ventricular hypertrophy, left axis deviation**: Right-to-left shunt through ASD
  * **[Chest X-ray] Prominent left 4th arc**: Left ventricular enlargement
  * **[Echocardiography] Absence of right atrium-right ventricle communication**: Confirms diagnosis
* **Management**
  * **PGE1 administration, Blalock-Taussig shunt**: For decreased pulmonary flow type (palliative treatment)
  * **Pulmonary artery banding**: For increased pulmonary flow type (palliative treatment)
  * **Bidirectional Glenn procedure, Fontan procedure**: Connect SVC and IVC to pulmonary artery
{: .notice--info}

### Ebstein's Anomaly / EbsteinÁóÖ

* **Overview**
  * Malformation of right ventricle and tricuspid valve causing tricuspid regurgitation
* **Presentation**
  * **Cyanosis, heart failure symptoms**: Severity varies widely
* **Examination**
  * **[Auscultation] Holosystolic murmur, S3, S4**: TR, heart failure
  * **[ECG] Right atrial P waves, prolonged PQ interval, right bundle branch block, WPW syndrome**: Conduction abnormalities
  * **[Chest X-ray] Prominent right second arc**: Enlarged right atrium
  * **[Echocardiography] Tricuspid valve displaced towards right ventricle, tricuspid regurgitation**: Confirms diagnosis
* **Management**
  * **Observation**: For mild cyanosis and heart failure symptoms
  * **Tricuspid valve repair (Carpentier procedure), ASD closure if needed**: For severe cyanosis or heart failure
  * **Starnes procedure, Fontan operation**: For severe neonatal cases
{: .notice--info}

## Arterial Disorder / ÂãïËÑàÁñæÊÇ£

### Aortic Aneurysm / Â§ßÂãïËÑàÁò§

* **Overview**
  * Abnormal dilation of aorta due to atherosclerosis, potentially fatal if ruptured
  * More common in middle-aged and elderly men
* **Presentation**
  * **Asymptomatic**: Most common
  * **Hoarseness, Horner's syndrome**: Compression of recurrent laryngeal nerve or sympathetic nerves
  * **Dysphagia, nausea, vomiting**: Compression of esophagus
  * **Cough, hemoptysis, dyspnea**: Compression of trachea or lungs
  * **Altered consciousness, abdominal pain, leg numbness**: Organ ischemia
* **Examination**
  * **[Physical] Pulsatile abdominal mass**: Expansion of abdominal aorta
  * **[Chest X-ray] Widened mediastinal shadow**: Expansion of thoracic aorta
  * **[CT, MRI, Ultrasound] Aneurysm**: Confirmation of size and location
* **Management**
  * **Lifestyle modification, blood pressure control**: Conservative management
  * **Artificial graft replacement, endovascular stent grafting**: If aneurysm >5-6 cm or rapid expansion
{: .notice--info}

### Ruptured Aortic Aneurysm / Â§ßÂãïËÑàÁò§Á†¥Ë£Ç

* **Overview**
  * Life-threatening complication of aortic aneurysm
* **Presentation**
  * **Sudden severe chest/back/lumbar pain, anemia, shock**: Rupture and rapid blood loss
  * **Hemoptysis, hematemesis**: Blood leaking into adjacent structures
* **Examination**
  * **[CT, Ultrasound] Aneurysm and hematoma**: Confirmation of rupture
* **Management**
  * **Artificial graft replacement, endovascular stent grafting, open stent grafting**: Immediate intervention required
{: .notice--info}

### Aortic Dissection / Â§ßÂãïËÑàËß£Èõ¢

* **Overview**
  * Tear in aortic intima leads to blood flow separating the medial layer and forming a false lumen, high mortality rate
  * Risk factors: Chronic hypertension, congenital connective tissue disorders
* **Presentation**
  * **Sudden severe chest/back pain**: Aortic wall disruption
  * **Hypertension, blood pressure difference between arms**: Organ ischemia
* **Examination**
  * **[ECG] No specific findings**: Rules out myocardial infarction
  * **[Blood] Elevated D-dimer**: Indicates thrombosis
  * **[Chest X-ray] Widened mediastinal shadow**: Aortic dilatation
  * **[CT] Intimal flap, true and false lumens**: Confirms diagnosis
  * **[Echocardiography] Aortic regurgitation, pericardial effusion**: Complications
* **Management**
  * **[Stanford Type A] Emergency surgical graft replacement**: Involving ascending aorta
  * **[Stanford Type B] Blood pressure and heart rate control, pain management**: Not involving ascending aorta 
  * **[Stanford Type B] Endovascular stent graft**: For complications or refractory cases
{: .notice--info}

### Takayasu's Arteritis / È´òÂÆâÂãïËÑàÁÇé

* **Overview**
  * Chronic vasculitis affecting aorta and its major branches
  * More common in young women
* **Presentation**
  * **Fever, fatigue**: Systemic inflammation
  * **Dizziness, syncope**: Common carotid artery stenosis
  * **Upper limb numbness/coldness**: Subclavian artery stenosis
  * **Heart murmur**: Often due to aortic regurgitation
* **Examination**
  * **[Physical] Weak/absent pulses, BP differences, bruits**: Vascular stenosis
  * **[Blood] ESR‚Üë, CRP‚Üë, WBC‚Üë, Œ≥-globulin‚Üë**: Inflammatory markers
  * **[DSA, CT, MRA, FDG-PET] Vessel wall calcification, stenosis/occlusion/dilation**: Confirms diagnosis
* **Management**
  * **Corticosteroids, immunosuppressants**: Suppress inflammation
  * **Surgery**: For cardiac or aortic lesions
{: .notice--info}

### Arteriosclerosis Obliterans / ÈñâÂ°ûÊÄßÂãïËÑàÁ°¨ÂåñÁóá

* **Overview**
  * Chronic occlusive disease of arteries in lower limbs due to arteriosclerosis
  * Common in males over 50 with risk factors of atherosclerosis
* **Presentation**
  * **Intermittent claudication, rest pain, ulcers/necrosis**: Chronic lower limb ischemia
* **Examination**
  * **[Physical] Weakened or absent arterial sounds, ankle-brachial index (ABI) ‚â§ 0.9**: Reduced blood flow
  * **[Angiography, ultrasound, MRA, CTA] Arterial stenosis or occlusion**: Confirms diagnosis
* **Management**
  * **Exercise therapy, antiplatelet drugs (cilostazol), vasodilators**: For intermittent claudication
  * **Percutaneous transluminal angioplasty (PTA), stenting, bypass surgery, thromboembolectomy**: For severe ischemia
{: .notice--info}

### Thromboangiitis Obliterans / ÈñâÂ°ûÊÄßË°ÄÊ†ìË°ÄÁÆ°ÁÇé

* **Overview**
  * Inflammatory occlusive disease of arteries in distal extremities
  * Affects male smokers under 50
* **Presentation**
  * **Cold sensation, numbness, Raynaud's phenomenon in extremities**: Reduced blood flow
  * **Intermittent claudication, painful ulcers/necrosis in fingers or toes**: Progressive vascular occlusion
* **Examination**
  * **[Doppler] Decreased ankle blood pressure, low ankle-brachial index (ABI)**: Reduced distal blood flow
  * **[Angiography] Abrupt vessel cutoffs, corkscrew collaterals**: Characteristic vascular changes
* **Management**
  * **Smoking cessation**: Essential for disease control
  * **Antiplatelet drugs (cilostazol), vasodilators**: Improve blood flow
  * **Sympathectomy, bypass surgery, amputation**: Surgical interventions
{: .notice--info}

### Acute Arterial Occlusive Disease / ÊÄ•ÊÄßÂãïËÑàÈñâÂ°ûÁóá

* **Overview**
  * Sudden occlusion of peripheral arteries due to embolism or thrombosis, high mortality rate if not treated
  * Risk factors: Atrial fibrillation, cardiac myxoma, hypercoagulability, atherosclerosis
* **Presentation**
  * **Pain, pulselessness, pallor, paralysis, paresthesia (5P)**: Acute limb ischemia
* **Examination**
  * **[Physical] Absent peripheral pulses, decreased ankle-brachial index (ABI)**: Signs of arterial occlusion
  * **[Ultrasound, angiography, MDCT, MRA] Arterial occlusion**: Confirms diagnosis
* **Management**
  * **Urgent thromboembolectomy, catheter-directed thrombolysis, bypass surgery**: Revascularization
  * **Anticoagulants (heparin)**: Conservative treatment
{: .notice--info}

## Venous Disorder / ÈùôËÑàÁñæÊÇ£

### Varicose Vein of the Lower Extremity / ‰∏ãËÇ¢ÈùôËÑàÁò§

* **Overview**
  * Dilated and tortuous superficial veins in lower limbs due to venous valve incompetence
  * More common in women over 30, influenced by pregnancy, prolonged standing, obesity, aging
* **Presentation**
  * **Dilated and tortuous veins**: Venous reflux and stasis
  * **Dull pain, heaviness, itching, eczema, skin pigmentation**: Chronic blood stasis
* **Examination**
  * **[Ultrasound] Reflux and valve incompetence in superficial veins**: Confirms diagnosis
* **Management**
  * **Compression stockings, leg elevation**: Conservative therapy to improve venous return
  * **Endovenous ablation, stripping, varicectomy, sclerotherapy**: Occlusion or removal of incompetent veins
{: .notice--info}

### Deep Vein Thrombosis / Ê∑±ÈÉ®ÈùôËÑàË°ÄÊ†ìÁóá

* **Overview**
  * Thrombosis in deep veins of lower limbs, can lead to pulmonary thromboembolism
  * Risk factors: Surgery, trauma, prolonged bed rest, intravenous catheterization, pregnancy, malignancy
* **Presentation**
  * **Unilateral leg swelling, superficial vein dilation, color changes**: Venous obstruction and congestion
  * **Leg tension, pain, Homans' sign**: Vascular inflammation
* **Examination**
  * **[Blood] D-dimer‚Üë, FDP‚Üë**: Fibrin degradation products
  * **[Ultrasound] Reduced blood flow**: Venous obstruction
  * **[Contrast CT] Confirmation of thrombus**: Definitive diagnosis
* **Management**
  * **Anticoagulation (heparin, warfarin, DOACs)**: Prevent clot propagation
  * **Thrombolysis (urokinase)**: Dissolve existing clots
  * **Catheter-directed therapy, surgical thrombectomy**: For severe cases
  * **Early ambulation, compression stockings, intermittent compression**: Reduce risk in high-risk situations
{: .notice--info}

### Superior Vena Cava Syndrome / ‰∏äÂ§ßÈùôËÑàÁóáÂÄôÁæ§

* **Overview**
  * Obstruction of venous return through superior vena cava, often caused by malignant tumors or aortic aneurysms
* **Presentation**
  * **Edema of head/face/unilateral arm, headache, dyspnea**: Upper body congestion
  * **Distended neck and upper body superficial veins**: Impaired venous return
* **Examination**
  * **[Chest X-ray] Widened upper mediastinum**: Mass effect
  * **[CT, MRI] Stenosis or occlusion of superior vena cava**: Definitive diagnosis
* **Management**
  * **Treatment of underlying cause**: Malignant tumors, benign mediastinal tumors, thoracic aortic aneurysm
  * **Stent placement, bypass surgery**: Endovascular or surgical treatment
{: .notice--info}

### Lymphedema / „É™„É≥„ÉëÊµÆËÖ´

* **Overview**
  * Impaired lymphatic drainage causing tissue swelling, 
  * Primary (rare) or secondary (often due to cancer treatment)
* **Presentation**
  * **Unilateral or bilateral limb swelling**: Impaired lymph drainage
* **Examination**
  * **[Physical] Asymmetric limb swelling, skin changes**: Visual and tactile assessment
* **Management**
  * **Limb elevation, compression stockings, massage, infection prevention**: Complex decongestive therapy
  * **Lymphaticovenous anastomosis**: For refractory cases
{: .notice--info}

## Blood Pressure Disorder / Ë°ÄÂúßÁï∞Â∏∏

### Essential Hypertension / Êú¨ÊÖãÊÄßÈ´òË°ÄÂúß

* **Overview**
  * High blood pressure without identifiable cause
  * Accounts for about 90% of hypertension cases
* **Presentation**
  * **Asymptomatic**: Gradual onset and progression
* **Examination**
  * **[Blood Pressure] ‚â•140/90 mmHg**: Persistent elevation of blood pressure
* **Management**
  * **Salt reduction, weight loss, exercise, smoking cessation, alcohol moderation**: Lifestyle modifications
  * **CCBs, ARBs, ACE inhibitors, MRAs, diuretics, Œ≤-blockers**: Vasodilation, fluid excretion, cardiac output reduction
{: .notice--info}

### Malignant Hypertension / Âä†ÈÄüÂûãÊÇ™ÊÄßÈ´òË°ÄÂúß

* **Overview**
  * Severe hypertension with rapid progression of organ damage
  * More common in males 40-50 years old
* **Presentation**
  * **Headache, visual disturbances**: Hypertensive encephalopathy
  * **Oliguria, uremia**: Rapidly progressing renal dysfunction
  * **Heart failure symptoms**: Cardiac overload
* **Examination**
  * **[Blood pressure] Diastolic BP ‚â•120-130 mmHg**: Severe elevation of blood pressure
  * **[Fundoscopy] Retinal hemorrhages, papilledema**: Hypertensive retinopathy
* **Management**
  * **Immediate IV or oral antihypertensives**: Hypertensive emergency
  * **Dialysis**: For severe renal dysfunction
{: .notice--info}

### Renovascular Hypertension / ËÖéË°ÄÁÆ°ÊÄßÈ´òË°ÄÂúß

* **Overview**
  * Hypertension caused by renal artery stenosis and increased RAA system activity
  * Common in patients <30 or >60 years old
* **Presentation**
  * **Treatment-resistant or malignant hypertension**: Due to persistent RAAS activation
  * **Worsening renal function after ACE inhibitors or ARBs**: Impaired glomerular filtration
* **Examination**
  * **[Auscultation] Abdominal bruit**: Severe vascular stenosis
  * **[Ultrasound, MR/CT angiography] Renal artery stenosis**: Primary screening method
  * **[Blood] Elevated plasma renin activity (PRA)**: RAAS activation
* **Management**
  * **Combination of antihypertensives**: ACE inhibitors/ARBs contraindicated in bilateral cases
  * **Percutaneous transluminal renal angioplasty (PTRA)**: For significant stenosis
{: .notice--info}

### Hypotension / ‰ΩéË°ÄÂúß

* **Overview**
  * Low blood pressure due to various causes, including essential hypotension, orthostatic hypotension, postprandial hypotension
* **Presentation**
  * **Asymptomatic**: Especially in essential hypotension
  * **Dizziness, fatigue, syncope**: Inadequate cerebral perfusion
* **Examination**
  * **[Blood pressure] Systolic BP <100 mmHg**: Basic diagnostic criteria
  * **[Orthostatic test] BP drop after standing (‚â•20 mmHg systolic or ‚â•10 mmHg diastolic)**: Diagnoses orthostatic hypotension
* **Management**
  * **Improve sleep, diet, exercise habits**: Lifestyle modifications
  * **Sympathomimetics, mineralocorticoids**: Vasoconstriction, increase plasma volume
{: .notice--info}

<!-- ## Introduction / Á∑èË´ñ

### Cardiovascular Drugs / Âæ™Áí∞Âô®ÁñæÊÇ£Ê≤ªÁôÇËñ¨

* **Calcium channel blocker (DHP)**
  * **Drugs**: Amlodipine, nifedipine
  * **Mechanism**: Decrease intracellular calcium, relax smooth muscle
  * **Indication**: Hypertension, angina pectoris
  * **Adverse effect**: Tachycardia, flush
* **Calcium channel blocker (non-DHP)**
  * **Drugs**: Verapamil, diltiazem, bepridil
  * **Mechanism**: Decrease intracellular calcium, inhibit SA node and AV node
  * **Indication**: Supraventribular tachycardia
  * **Adverse effect**: Bradycardia
* **Œ≤ blockers**
* **Œ±Œ≤ blockers**
{: .notice--info}


### Adrenergic Agonist / „Ç¢„Éâ„É¨„Éä„É™„É≥‰ΩúÂãïËñ¨

* **Œ±Œ≤ agonist**
  * **Drugs**: Epinephrine, norepinephrine, dopamine
  * **Mechanism**: Œ±Œ≤ agonist (epinephrine: Œ≤>Œ±, norepinephrine: Œ±>Œ≤, dopamine: D>Œ≤>Œ±)
  * **Indication**: Shock (dopamine preserve renal blood flow), glaucoma (epinephrine)
* **Œ±1 agonist**
  * **Drugs**: Oxymetazoline, phenylephrine, midodrine
  * **Mechanism**: Œ±1 agonist
  * **Indication**: Nasal congestion (Oxymetazoline, phenylephrine), midodrine (orthostatic hypotension)
* **Œ±2 agonist**
  * **Drugs**: Clonidine, methyldopa, brimonidine
  * **Mechanism**: Œ±2 agonist
  * **Indication**: Hypertension (methyldopa: for pregnant women), glaucoma (brimonidine)
* **Œ≤ agonist**
  * **Drugs**: Isoproterenol
  * **Mechanism**: Œ≤1-Œ≤2 agonist
  * **Indication**: Bradycardia
* **Œ≤1 agonist**
  * **Drugs**: Dobutamine
  * **Mechanism**: Œ≤1 agonist
  * **Indication**: Heart failure
* **Œ≤2 agonist**
  * **Drugs**: Albuterol (salbutamol), terbutaline, fenoterol, metaproterol, procaterol, salmeterol, formoterol, ritodrine
  * **Mechanism**: Œ≤2 agonist
  * **Indication**: Asthma, COPD, tocolytic (ritodrine)
* **Œ≤3 agonist**
  * **Drugs**: Mirabegron
  * **Mechanism**: Œ≤3 agonist
  * **Indication**: Overactive bladder
* **Indirect agonist**
  * **Drugs**: Amphetamine, methylphenidate, modafinil, cocaine, amitryptiline
  * **Mechanism**: Increase catecholamine release (amphetamine), inhibit catecholamine reuptake (others)
  * **Indication**: ADHD, narcolepsy
* **Mixed agonist**
  * **Drugs**: Ephedrine, pseudoephedrine
  * **Mechanism**: Direct and indirect agonist
  * **Indication**: Nasal congestion, nocturnal neuresis
{: .notice--info}

### Adrenergic Antagonist / „Ç¢„Éâ„É¨„Éä„É™„É≥ÊãÆÊäóËñ¨

* **Œ± antagonist**
  * **Drugs**: Phentolamine, phenoxybenzamine
  * **Mechanism**: Non-selective Œ± antagonist
  * **Indication**: Pheochromocytoma diagnosis (Phentolamine), pheochromocytoma treatment (phenoxybenzamine)
* **Œ±1 antagonist**
  * **Drugs**: Prazosin, doxazosin, terazosin, tamsulosin, indoramin, urapidil
  * **Mechanism**: Œ±1 antagonist
  * **Indication**: Hypertension, BPH
* **Œ±2 antagonist**
  * **Drugs**: Mirtazapine
  * **Mechanism**: Œ±2 antagonist
  * **Indication**: Depression
* **Œ≤ antagonist**
  * **Drugs**: Nadolol, pindolol, propranolol, timolol
  * **Mechanism**: Non-selective Œ≤ antagonist
  * **Indication**: Hypertension, arrhythmia, heart failure, glaucoma (timolol)
* **Œ≤1 antagonist**
  * **Drugs**: Acebutolol, atenolol, betaxolol, bisoprolol, esmolol, metoprolol
  * **Mechanism**: Œ≤1 antagonist
  * **Indication**: Same as Œ≤ antagonist
* **Œ±Œ≤ antagonist**
  * **Drugs**: Labetalol, carvedilol
  * **Mechanism**: Œ±Œ≤ antagonist
  * **Indication**: Hypertension, heart failure
* **Indirect antagonist**
  * **Drugs**: Reserpine, guanethidene, bretylium, metyrosine
  * **Mechanism**: Deplete neurotransmitter in vesicle (reserpine), inhibit vesicle release (guanethidine, bretylium), inhibit tyrosine hydroxylase (metyrosine)
  * **Indication**: Hypertension, heart failure
{: .notice--info}

### Cholinergic Agonist / „Ç≥„É™„É≥‰ΩúÂãïËñ¨

* **Direct agonist**
  * **Drugs**: Acetylcholine, bethanechol, carbachol, methacholine, pilocarpine, cevimeline
  * **Mechanism**: Muscarinic agonist (+ nicotinic agonist: acetylcholine, carbachol)
  * **Indication**: Ileus and urinary retension, asthma diagnosis (methacholine), glaucoma (pilocarpine), Sjogren syndrome (cevimeline)
* **Indirect agonist (anti-cholinesterase)**
  * **Drugs**: Physostigmine, neostigmine, pyridostigmine, edrophonium, ambenonium
  * **Mechanism**: Inhibit cholinesterase to increase acetylcholine
  * **Indication**: Myasthenia gravis, ileus and urinary retension, glaucoma (physostigmine)
  * **Organic phosphate**: Irreversible anti-cholinesterase (treatment: pyridostigmine, atropine, pralidoxime)
{: .notice--info}

### Cholinergic Antagonist / „Ç≥„É™„É≥ÊãÆÊäóËñ¨

* **Muscarinic antagonist**
  * **Drugs and indication**
    * Reduce exocrine: Atropine
    * Ophthalmoscopic examination: Homatropine, cyclopentolate, tropicamide
    * Motion sickness: Scopolamine
    * Gastric ulcer: Pirenzepine, propantheline
    * Diarrhea and IBS: Dicyclomine, clidinium
    * Asthama and COPD: Ipratropium, tiotropium
    * Overactive bladder: Oxybutynin
    * Parkinson disease: Trihexyphenidyl, bentropine, biperidin
  * **Mechanism**: Muscarinic antagonist
* **Nitotinic antagonist (ganglion blocker)**
  * **Drugs**: Mecamylamine, trimethaphan, hexamethonium
  * **Mechanism**: Nitotinic antagonist at autonomic ganglion
  * **Indication**: Hypertension
* **Nitotinic antagonist (muscle relaxant)**
  * **Drugs**: Tubocurarine, mivacurium, atracurium, cisatracurium, pancuronium, vecuronium, rocuronium, succinylcholine, decamothonium
  * **Mechanism**: Nitotinic antagonist at neuromuscular junction (non-depolarizing: tubocurarine ~ rocuronium, depolarizing: succinylcholine, decamothonium)
  * **Indication**: Anesthesia
* **Other muscle relaxant**
  * **Drugs**: Diazepam, baclofen, tizanidine, dantroline, hemicholinium, botulinum toxin, tetrodotoxin
  * **Mechanism**: GABA-A agonist (diazepam), GABA-B agonist (baclofen), Œ±2 agonist (tizanidine), ryodine receptor blocker (dantroline), inhibit cholien uptake (hemicholinium), inhibit vesicle release (botulinum toxin), inhibit Na+ channel (tetrodotoxin)
  * **Indication**: Spasmolytic
{: .notice--info}

### Antihypertensive Drug / ÈôçÂúßËñ¨

* **ACE inhibitor**
  * **Drugs**: Captopril, enalapril, lisinopril
  * **Mechanism**: Angiotensin converting enzyme inhibitor
  * **Indication**: Hypertension (heart failure, diabetes)
  * **Adverse effect**: Nonproductive cough, angioadema
* **Angiotensin II receptor blocker**
  * **Drugs**: Losartan, valsartan, candesartan
  * **Mechanism**: Angiotensin II receptor blocker
  * **Indication**: Hypertension
* **Renin inhibitor**
  * **Drugs**: Aliskiren
  * **Mechanism**: Renin inhibitor
  * **Indication**: Hypertension
* **Œ≤-blocker**
  * **Drugs**: Acebutolol, atenolol, carvedilol, esmolol, labetalol, metoprolol, pindolol, propranolol
  * **Mechanism**: Œ≤1-blocker (reduce cardial output, inhibit renin secretion)
  * **Indication**: Hypertension
  * **Adverse effect**: Asthma
* **Calcium channel blocker**
  * **Drugs**: DHP: Amlodipine, nifedipine, felodipine / Non-DHP: verapamil, diltiazem, bepridil
  * **Mechanism**: Calcium channel blocker (vessel: DHP, heart: non-DHP)
  * **Indication**: Hypertension
* **Vasodilator**
  * **Drugs**: Minoxidil, diazoxide, hydralazine, nitroprusside
  * **Mechanism**: Activate K channel (minoxidil, diazoxide), increase cGMP (hydralazine, nitroprusside)
  * **Indication**: Hypertension
  * **Adverse effect**: Hirsutism (minoxidil), hyperglycemia (diazoxide), lupus-like syndrome (hydralazine), nitroprusside (cyanide toxicity)
* **Œ±1 antagonist**
  * **Drugs**: Prazosin, doxazosin, terazosin
  * **Mechanism**: Œ±1 antagonist 
  * **Indication**: Hypertension (with BPH)
* **Œ±2 agonist**
  * **Drugs**: Clonidine, methyldopa
  * **Mechanism**: Œ±2 agonist 
  * **Indication**: Hypertension (pregnancy)
* **D1 agonist**
  * **Drugs**: Fenoldopam
  * **Mechanism**: D1 agonist
  * **Indication**: Malignant hypertension
* **PDE5 inhibitor**
  * **Drugs**: Sildenafil, vardenafil
  * **Mechanism**: PDE5 inhibitor, increase cGMP
  * **Indication**: Pulmonary hypertension, erectile dysfunction
* **Diuretics**
  * See diuretics
{: .notice--info}

### Heart Failure Drug / ÂøÉ‰∏çÂÖ®„ÅÆËñ¨

* **Cardiac glycoside**
  * **Drugs**: Digoxin, digitoxin
  * **Mechanism**: Inhibit Na/K ATPase, elevate intreacellular Ca
  * **Indication**: Congestive heart failure
  * **Adverse effect**: GI distress, visual disturbance, digoxin toxicity (treat with potassium and antibody)
* **PDE3 inhibitor**
  * **Drugs**: Melrinone, amrinone
  * **Mechanism**: Inhibit PDE3, increase cAMP
  * **Indication**: Heart failure
* **Adrenergic agonist**
  * **Drugs**: Dobutamine
  * **Mechanism**: Œ≤1 agonist
  * **Indication**: Heart failure
* **BNP agonist**
  * **Drugs**: Nesiritide, sacubitril
  * **Mechanism**: BNP agonist (nersiritide), increase BNP (sacubitril)
  * **Indication**: Heart failure
{: .notice--info}

### Antianginal Drug / ÊäóÁã≠ÂøÉÁóáËñ¨

* **Nitrates**
  * **Drugs**: Nitroglycerin, isosorbide mononitrate, isosorbide dinitrate
  * **Mechanism**: Increase cGMP
  * **Indication**: Angina pectoris
  * **Adverse effect**: Headache, flushing
* **Ranolazine**
  * **Drugs**: Ranolazine
  * **Mechanism**: Inhibit Na current, decrease intracellular Ca
  * **Indication**: Angina pectoris
  * **Adverse effect**: QT prolongation
{: .notice--info}

### Antiarrhythmic Drug / Êäó‰∏çÊï¥ËÑàËñ¨

* **Class IA**
  * **Drugs**: Quinidine, procainamide, disopyramide
  * **Mechanism**: Na (and K) channel blocker (prolong QRS)
  * **Indication**: Arrythmia
  * **Adverse effect**: Torsade de pointes, cinchonism (quinidine), lupus-like syndrome (procainamide)
* **Class IB**
  * **Drugs**: Mexiletine, lidocaine, phenytoin
  * **Mechanism**: Na channel blocker (prolong QRS)
  * **Indication**: Arrythmia
* **Class IC**
  * **Drugs**: Flecanide, propafenone
  * **Mechanism**: Na channel blocker (prolong QRS)
  * **Indication**: Arrythmia
* **Class II**
  * **Drugs**: Propranolol, metoprolol, pindolol, esmolol
  * **Mechanism**: Œ≤ blocker (prolong PR)
  * **Indication**: Tachycardia, Post-MI
* **Class III**
  * **Drugs**: Amiodarone, dronedarone, sotalol, ibutilide, dofetilide
  * **Mechanism**: K channel blocker (prolong QT)
  * **Indication**: Arrythmia
  * **Adverse effect**: Torsade de pointes, thyroid dysfunction (amiodarone), liver dysfunction (amiodarone), pulmonary fibrosis (amiodarone)
* **Class IV**
  * **Drugs**: Verapamil, diltiazem, bepridil
  * **Mechanism**: Ca channel blocker (prolong PR)
  * **Indication**: Tachycardia
* **Class V**
  * **Drugs**: Adenosine, MgSO4
  * **Mechanism**: Gi (adenosine)
  * **Indication**: PSVT (adenosine), torsade de pointes (MgSO4)
{: .notice--info} -->

<!-- ## Heart Failure / ÂøÉ‰∏çÂÖ®

### Left-Sided Heart Failure / Â∑¶ÂøÉ‰∏çÂÖ®
### Right-Sided Heart Failure / Âè≥ÂøÉ‰∏çÂÖ®

## Arrhythmia / ‰∏çÊï¥ËÑà

### Sinus Tachycardia / Ê¥ûÊÄßÈ†ªËÑà
### Paroxysmal Supraventricular Tachycardia / Áô∫‰ΩúÊÄß‰∏äÂÆ§È†ªÊãç
### Wolff-Parkinson-White Syndrome / WPWÁóáÂÄôÁæ§
### Atrial Flutter / ÂøÉÊàøÁ≤óÂãï
### Atrial Fibrillation / ÂøÉÊàøÁ¥∞Âãï
### Atrial Premature Contraction / ÂøÉÊàøÊúüÂ§ñÂèéÁ∏Æ
### Ventricular Premature Contraction / ÂøÉÂÆ§ÊúüÂ§ñÂèéÁ∏Æ
### Ventricular Tachycardia / ÂøÉÂÆ§È†ªÊãç
### Ventricular Fibrillation / ÂøÉÂÆ§Á¥∞Âãï
### Long QT Syndrome / QTÂª∂Èï∑ÁóáÂÄôÁæ§
### Brugada Syndrome / BrugadaÁóáÂÄôÁæ§
### Sick Sinus Syndrome / Ê¥û‰∏çÂÖ®ÁóáÂÄôÁæ§
### Atrioventricular Block / ÊàøÂÆ§„Éñ„É≠„ÉÉ„ÇØ
### Bundle Branch Block / ËÑö„Éñ„É≠„ÉÉ„ÇØ

## Ischemic Heart Disease / ËôöË°ÄÊÄßÂøÉÁñæÊÇ£

### Effort Angina Pectoris / Âä¥‰ΩúÊÄßÁã≠ÂøÉÁóá
### Vasospastic Angina Pectoris / ÂÜ†Êî£Á∏ÆÊÄßÁã≠ÂøÉÁóá
### Unstable Angina Pectoris / ‰∏çÂÆâÂÆöÁã≠ÂøÉÁóá
### Acute Myocardial Infarction / ÊÄ•ÊÄßÂøÉÁ≠ãÊ¢óÂ°û
### Complication of Myocardial Infarction / ÂøÉÁ≠ãÊ¢óÂ°û„ÅÆÂêà‰ΩµÁóá

## Valvular Heart Disease / ÂøÉËáìÂºÅËÜúÁóá

### Mitral Stenosis / ÂÉßÂ∏ΩÂºÅÁã≠Á™ÑÁóá
### Mitral Regurgitation / ÂÉßÂ∏ΩÂºÅÈñâÈéñ‰∏çÂÖ®Áóá
### Mitral Valve Prolapse / ÂÉßÂ∏ΩÂºÅÈÄ∏ËÑ±Áóá
### Aortic Stenosis / Â§ßÂãïËÑàÂºÅÁã≠Á™ÑÁóá
### Aortic Regurgitation / Â§ßÂãïËÑàÂºÅÈñâÈéñ‰∏çÂÖ®Áóá
### Tricuspid Stenosis / ‰∏âÂ∞ñÂºÅÁã≠Á™ÑÁóá
### Tricuspid Regurgitation / ‰∏âÂ∞ñÂºÅÈñâÈéñ‰∏çÂÖ®Áóá

## Endocardium, Myocardium and Pericardium Disease / ÂøÉÂÜÖËÜú„ÉªÂøÉÁ≠ã„ÉªÂøÉËÜúÁñæÊÇ£

### Infectious Endocarditis / ÊÑüÊüìÊÄßÂøÉÂÜÖËÜúÁÇé
### Cardiac Myxoma / ÂøÉËáìÁ≤òÊ∂≤ËÖ´
### Dilated Cardiomyopathy / Êã°ÂºµÂûãÂøÉÁ≠ãÁóá
### Hypertrophic Cardiomyopathy / ËÇ•Â§ßÂûãÂøÉÁ≠ãÁóá
### Restrictive Cardiomyopathy / ÊãòÊùüÂûãÂøÉÁ≠ãÁóá
### Takotsubo-Type Cardiomyopathy / „Åü„Åì„Å§„ÅºÂûãÂøÉÁ≠ãÁóá
### Myocarditis / ÂøÉÁ≠ãÁÇé
### Acute Pericarditis / ÊÄ•ÊÄßÂøÉËÜúÁÇé
### Cardiac Tamponade / ÂøÉ„Çø„É≥„Éù„Éä„Éº„Éá
### Constrictive Pericarditis / ÂèéÁ∏ÆÊÄßÂøÉËÜúÁÇé

## Arterial Disease / ÂãïËÑàÁñæÊÇ£

### Arteriosclerosis / ÂãïËÑàÁ°¨Âåñ
### Aortic Aneurysm / Â§ßÂãïËÑàÁò§
### Aortic Dissection / Â§ßÂãïËÑàËß£Èõ¢
### Arterio-Venous Fistula / ÂãïÈùôËÑàÁòª
### Acute Arterial Occlusive Disease / ÊÄ•ÊÄßÂãïËÑàÈñâÂ°ûÁóá
### Arteriosclerosis Obliterans / ÈñâÂ°ûÊÄßÂãïËÑàÁ°¨ÂåñÁóá
### Thromboangiitis Obliterans / ÈñâÂ°ûÊÄßË°ÄÊ†ìË°ÄÁÆ°ÁÇé
### Raynaud Disease / RaynaudÁóÖ

## Venous Disease / ÈùôËÑàÁñæÊÇ£

### Deep Vein Thrombosis / Ê∑±ÈÉ®ÈùôËÑàË°ÄÊ†ìÁóá
### Varicose Vein / ‰∏ãËÇ¢ÈùôËÑàÁò§
### SVC Syndrome / ‰∏äÂ§ßÈùôËÑàÁóáÂÄôÁæ§
### Lymphedema / „É™„É≥„ÉëÊµÆËÖ´

## Blood Pressure Disorder / Ë°ÄÂúßÁï∞Â∏∏

### Essential Hypertension / Êú¨ÊÖãÊÄßÈ´òË°ÄÂúßÁóá
### Secondary Hypertension / ‰∫åÊ¨°ÊÄßÈ´òË°ÄÂúßÁóá
### Malignant Hypertension / ÊÇ™ÊÄßÈ´òË°ÄÂúßÁóá
### Hypotension / ‰ΩéË°ÄÂúß -->

# Pulmonology/ ÂëºÂê∏Âô®Áßë

## Infectious Disorder / ÊÑüÊüìÊÄßÁñæÊÇ£

### Common Cold Syndrome / „Åã„ÅúÁóáÂÄôÁæ§

* **Overview**
  * Most common respiratory infection affecting upper respiratory tract mucosa, mostly caused by viruses
  * Transmitted through droplets and contact
* **Presentation**
  * **Rhinorrhea, nasal congestion, sneezing**: Nasal inflammation
  * **Sore throat, dry throat, hoarseness**: Upper respiratory tract inflammation
  * **Cough, sputum**: Lower respiratory tract inflammation
  * **Mild fever, headache, fatigue**: Systemic inflammatory response
* **Examination**
  * **Clinical**
* **Management**
  * **Rest, warmth, gargling, hand washing**: Supportive care
  * **Traditional medicines (Kakkonto, Maoto), acetaminophen, NSAID, antihistamine**: Symptom relief
{: .notice--info}

### Acute Bronchiolitis / ÊÄ•ÊÄßÁ¥∞Ê∞óÁÆ°ÊîØÁÇé

* **Overview**
  * Acute inflammation of bronchioles causing airway narrowing and obstruction, mainly caused by RSV and parainfluenza virus
  * Most common in infants under 1 year
* **Presentation**
  * **Fever, cough, rhinorrhea**: Initial cold-like symptoms
  * **Expiratory wheezing**: Bronchiolar narrowing
  * **Nasal flaring, chest retractions, tachypnea**: Respiratory distress
* **Examination**
  * **[Antigen test] Positive for RSV**: Confirm diagnosis
* **Management**
  * **Oxygen therapy, nebulizer humidification, IV fluids**: Supportive care
{: .notice--info}

### Influenza / „Ç§„É≥„Éï„É´„Ç®„É≥„Ç∂

* **Overview**
  * Infectious disease with seasonal epidemic caused by influenza virus, more severe than common cold and can be fatal
  * Transmitted through droplets and contact, common in winter to spring
* **Presentation**
  * **High fever (>38¬∞C), chills, headache, muscle/joint pain, fatigue**: Rapid onset systemic symptoms
  * **Cough, sore throat, rhinorrhea**: Respiratory symptoms
* **Examination**
  * **[Antigen test]] Positive for influenza virus**: Confirm diagnosis
* **Management**
  * **Neuraminidase inhibitor (Oseltamivir, Zanamivir), RNA polymerase inhibitor (Favipiravir)**: Shorten fever duration, prevent severe complications
{: .notice--info}

### COVID-19 / Êñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá

* **Overview**
  * Novel infectious disease caused by SARS-CoV-2, can be severe and fatal especially in elderly or immunocompromised patients
  * Transmitted through droplets and contact 
* **Presentation**
  * **Fever, fatigue, dry cough, shortness of breath**: Systemic and respiratory symptoms
  * **Loss of smell/taste**: Characteristic symptoms
  * **Acute respiratory distress syndrome, thrombotic events, shock, organ failure**: Complications in severe cases
* **Examination**
  * **[PCR, Antigen test] Positive for SARS-CoV-2**: Confirm diagnosis
  * **[Blood] Lymphopenia**: Indicates disease severity
  * **[Blood] D-dimer elevation**: Suggests thromboembolism/DIC
* **Management**
  * **Remdesivir, Molnupiravir, Nirmatrelvir, Ritonavir**: Antiviral treatment
  * **Dexamethasone, Baricitinib, Tocilizumab (severe case)**: Anti-inflammatory treatment
  * **Mechanical ventilation (severe case)**: Respiratory support
{: .notice--info}

### Bacterial Pneumonia / Á¥∞ËèåÊÄßËÇ∫ÁÇé

* **Overview**
  * Acute purulent inflammation of lung caused by bacterial infection
  * [Streptococcus pneumoniae] 1st common
  * [Haemophilus influenzae] 2nd common
  * [Klebsiella pneumoniae] Often serious in underlying diseases
  * [Staphylococcus aureus] Often with local destruction
  * [Moraxella catarrhalis] Often cause deterioration of COPD
  * [Pseudomonas aeruginosa] Often in immunocompromised or ventilator-associated 
* **Presentation**
  * **Cough, purulent sputum, chest pain, dyspnea**: Local inflammation of lung
  * **Fever, fatigue, loss of appetite**: Systemic inflammatory response
* **Examination**
  * **[Physical] Dullness on percussion, decreased breath sounds, coarse crackles**: Consolidation of lung tissue
  * **[Blood] WBC‚Üë, CRP‚Üë, ESR‚Üë, hypoxemia**: Inflammatory response
  * **[Chest X-ray, CT] Infiltrative shadows, air bronchogram**: Alveolar filling
  * **[Sputum] Gram stain, culture, rapid antigen test**: Identify causative bacteria
* **Management**
  * **Antibiotics based on pathogen**: Target causative bacteria
  * **Rest, temperature/fluid/electrolyte control**: Supportive care
  * **Oxygen therapy, mechanical ventilation**: Treat respiratory failure
{: .notice--info}

### Aspiration Pneumonia / Ë™§Âö•ÊÄßËÇ∫ÁÇé

* **Overview**
  * Pneumonia caused by aspiration due to swallowing dysfunction, aspiration often silent
  * Common in elderly, major cause of healthcare-associated pneumonia
* **Presentation**
  * **Decreased ADL, appetite loss, incontinence**: Atypical symptoms in elderly
  * **Less fever, cough, or sputum**: May lack typical pneumonia symptoms
* **Examination**
  * **[Physical] Respiratory rate‚Üë, SpO2‚Üì**: Impaired gas exchange
  * **[Blood] WBC‚Üë, CRP‚Üë, ESR‚Üë**: Inflammatory response
  * **[Chest X-ray] Infiltrative shadows**: Alveolar filling
* **Management**
  * **Empiric antibiotics**: Cover anaerobes and streptococci
  * **Prevention**: Swallowing rehabilitation, oral care, proper positioning
{: .notice--info}

### Chlamydial Pneumonia / „ÇØ„É©„Éü„Ç∏„Ç¢ËÇ∫ÁÇé

* **Overview**
  * Atypical pneumonia caused by C. pneumoniae, C. trachomatis, C. psittaci (psittacosis)
  * Common in young adults and elderly, bird exposure (psittacosis)
* **Presentation**
  * **Persistent dry cough, mild fever**: Atypical pneumonia pattern
  * **[Psittacosis] Dry cough, high fever >39‚ÑÉ, headache, relative bradycardia, hepatosplenomegaly**: More severe systemic symptoms
* **Examination**
  * **[Clinical] No response to Œ≤-lactams**: Characteristic of atypical bacteria
  * **[Antibody/Gene test] Positive for chlamydia**: Confirm diagnosis
* **Management**
  * **Tetracyclines, macrolides, fluoroquinolones**: Target atypical bacteria
{: .notice--info}

### Mycoplasma Pneumonia / „Éû„Ç§„Ç≥„Éó„É©„Ç∫„ÉûËÇ∫ÁÇé

* **Overview**
  * Atypical pneumonia caused by Mycoplasma pneumoniae, transmitted by contact/droplets
  * Common in healthy young people
* **Presentation**
  * **Persistent dry cough, minimal physical findings**: Atypical pneumonia pattern
  * **Fever, headache, fatigue**: Systemic symptoms
* **Examination**
  * **[Clinical] No response to Œ≤-lactams**: Characteristic of atypical bacteria
  * **[Blood] WBC‚Üí, ESR‚Üë, CRP‚Üë, cold agglutinin(+)**: Non-specific inflammation
  * **[Antibody/Gene test] Positive for mycoplasma**: Confirm diagnosis
* **Management**
  * **Macrolides, tetracyclines, fluoroquinolones**: Target atypical bacteria
{: .notice--info}

### Legionella Pneumonia / „É¨„Ç∏„Ç™„Éç„É©ËÇ∫ÁÇé

* **Overview**
  * Pneumonia caused by inhaling aerosols containing Legionella
  * Common in middle-aged adults with exposure to water systems (hot springs, circulating baths)
* **Presentation**
  * **High fever, cough, chest pain**: Inflammation of lungs
  * **Relative bradycardia, neuropsychiatric symptoms, diarrhea**: Characteristic of Legionella pneumonia
* **Examination**
  * **[Blood] Na‚Üì, CK‚Üë**: Characteristic laboratory findings
  * **[Chest X-ray] Infiltrates, pleural effusion**: Lung involvement
  * **[Clinical] No response to Œ≤-lactams**: Characteristic of atypical bacteria
  * **[Urine antigen] Positive for Legionella**: Rapid diagnosis
  * **[Sputum] Culture on BCYEŒ± agar**: Confirmatory tests
* **Management**
  * **Fluoroquinolones, macrolides (IV)**: First-line treatment
  * **Rifampicin, tetracyclines**: Alternative options
{: .notice--info} 

### Cytomegalovirus Pneumonia / „Çµ„Ç§„Éà„É°„Ç¨„É≠„Ç¶„Ç§„É´„ÇπËÇ∫ÁÇé

* **Overview**
  * CMV acquired in childhood and remains latent, reactivates in immunocompromised patients
  * Common in patients on steroids/immunosuppressants, malignancy, HIV/AIDS
* **Presentation**
  * **Fever, dyspnea, dry cough**: Inflammation of lungs
* **Examination**
  * **[Chest X-ray] Bilateral diffuse ground-glass opacities**: Interstitial pneumonia
  * **[Sputum, Lung biopsy] Giant cells with nuclear inclusions**: Characteristic finding
  * **[Gene/Antigen test] Positive for CMV**: Confirmatory test
* **Management**
  * **Ganciclovir, valganciclovir**: First-line antiviral treatment
  * **Foscarnet**: For drug-resistant cases
{: .notice--info} 

### Lung Abscess / ËÇ∫ËÜøÁòç

* **Overview**
  * Severe complication of pneumonia with destruction of lung tissue forming pus-filled cavity
  * Common in alcoholics, diabetics
* **Presentation**
  * **Fever, cough, foul-smelling sputum, hemoptysis**: Purulent inflammation and tissue destruction
  * **Chest pain**: When lesion reaches pleura
* **Examination**
  * **[Blood] WBC‚Üë, CRP‚Üë**: Infection
  * **[CT] Well-defined mass, air-fluid level (niveau)**: Abscess formation
* **Management**
  * **Combination antibiotics**: Target multiple bacterial species
  * **Drainage**: For persistent cases
{: .notice--info}

### Pulmonary Tuberculosis / ËÇ∫ÁµêÊ†∏Áóá

* **Overview**
  * Respiratory infection caused by Mycobacterium tuberculosis, classified as primary (initial infection) and secondary (reactivation)
* **Presentation**
  * **Cough >2 weeks, sputum, hemoptysis**: Active infection in airways
  * **Fever, fatigue, night sweat**: Systemic inflammatory response
* **Examination**
  * **[Chest X-ray] Hilar lymphadenopathy, nodular shadows, cavitary lesions**: Different stages of infection
  * **[CT] Bronchiolar nodules (tree-in-bud sign)**: Bronchiolar spread of infection
  * **[Sputum smear] Fluorescent or red-stained bacilli with Ziehl-Neelsen stain**: Acid-fast bacteria
  * **[Culture, PCR] Identification of M. tuberculosis**: Confirmatory test
* **Management**
  * **Multi-drug therapy with RFP, INH, PZA, EB/SM**: Different mechanisms to prevent drug resistance
{: .notice--info}

### Miliary Tuberculosis / Á≤üÁ≤íÁµêÊ†∏

* **Overview**
  * Hematogenous spread of tuberculosis forming multiple tubercles in various organs
  * Common in children, elderly, immunocompromised patients
* **Presentation**
  * **Persistent high fever, headache, fatigue**: Systemic infection
* **Examination**
  * **[Blood] ESR‚Üë, CRP‚Üë**: Systemic inflammation
  * **[Tuberculin test] Sometimes negative**: Anergic state due to overwhelming infection
  * **[Chest X-ray] Diffuse miliary nodules in both lungs**: Disseminated infection
  * **[Biopsy, Culture] Identification of M. tuberculosis**: Confirmatory test
* **Management**
  * **Multi-drug therapy with RFP, INH, PZA, EB/SM**: Different mechanisms to prevent drug resistance
{: .notice--info}

### MAC Disease / ÈùûÁµêÊ†∏ÊÄßÊäóÈÖ∏ËèåÁóá

* **Overview**
  * Caused by Mycobacterium avium complex, environmental organism without human-to-human transmission
  * Common in patients without underlying disease (nodular/bronchiectatic), patients with previous TB or COPD (fibrocavitary), younger patients (hypersensitivity)
* **Presentation**
  * **Cough, sputum, hemoptysis**: Airway infection
* **Examination**
  * **[Chest X-ray, CT] Multiple nodules with bronchiectasis, upper lobe cavities, diffuse ground-glass opacities**: Nodular/bronchiectatic, fibrocavitary, or hypersensitivity type
  * **[Sputum culture] Positive MAC cultures**: Confirmatory test
* **Management**
  * **Multi-drug therapy with CAM, RFP, EB**: Different mechanisms to prevent drug resistance
  * **Lobectomy**: Surgical option for localized disease
{: .notice--info}

### Simple Pulmonary Aspergilloma / ÂçòÁ¥îÊÄßËÇ∫„Ç¢„Çπ„Éö„É´„ÇÆ„É≠„Éº„Éû

* **Overview**
  * Aspergillus colonization in pre-existing lung cavity forming fungus ball
  * Common in patients with previous tuberculosis, fibrosis, emphysema
* **Presentation**
  * **Asymptomatic**
  * **Fever, cough, hemoptysis**: Local inflammation
* **Examination**
  * **[Chest X-ray, CT] Fungus ball, meniscus sign, thickened cavity wall and pleura**: Characteristic findings
  * **[Blood] Anti-aspergillus precipitating antibodies (+)**: Immune response to infection
  * **[Sputum, BALF, TBLB] Fungal hyphae, positive culture**: Confirms diagnosis
* **Management**
  * **Surgical resection**: Curative treatment
  * **Voriconazole, itraconazole**: For inoperable cases
{: .notice--info}

### Chronic Progressive Pulmonary Aspergillosis / ÊÖ¢ÊÄßÈÄ≤Ë°åÊÄßËÇ∫„Ç¢„Çπ„Éö„É´„ÇÆ„É´„ÇπÁóá

* **Overview**
  * Progressive Aspergillus infection with cavity expansion and infiltrates
  * Common in patients with pre-existing lung cavities or immunocompromised states
* **Presentation**
  * **Persistent cough, sputum/hemoptysis, fever, weight loss**: Chronic inflammation
* **Examination**
  * **[Chest X-ray] New/expanding cavities, thickened cavity walls, air-fluid levels**: Progressive nature of disease
  * **[Blood] WBC‚Üë, CRP‚Üë, ESR‚Üë**: Chronic inflammation
  * **[Blood] Anti-aspergillus precipitating antibodies (+), galactomannan antigen (+)**: Fungal infection markers
  * **[Sputum, BALF, TBLB] Fungal hyphae, positive culture**: Confirms diagnosis
* **Management**
  * **Micafungin, voriconazole, caspofungin, amphotericin B**: Target fungal cells
{: .notice--info}

### Invasive Pulmonary Aspergillosis / ‰æµË•≤ÊÄßËÇ∫„Ç¢„Çπ„Éö„É´„ÇÆ„É´„ÇπÁóá

* **Overview**
  * Severe Aspergillus infection with tissue invasion
  * Common in immunocompromised patients (neutropenia, leukemia, GVHD, steroid, immunosuppressant)
* **Presentation**
  * **Sudden fever, cough, hemoptysis**: Aggressive fungal invasion
* **Examination**
  * **[Chest X-ray] Rapidly progressing wedge-shaped shadows**: Vascular invasion
  * **[CT] Halo sign, air crescent sign**: Characteristic findings
  * **[Blood] Œ≤-D-glucan‚Üë, galactomannan antigen (+)**: Fungal infection markers
  * **[Sputum, BALF, TBLB] Fungal hyphae, positive culture**: Confirms diagnosis
* **Management**
  * **Voriconazole, amphotericin B, itraconazole, micafungin, caspofungin** Target fungal cell
{: .notice--info}

### Pulmonary Cryptococcosis / ËÇ∫„ÇØ„É™„Éó„Éà„Ç≥„ÉÉ„ÇØ„ÇπÁóá

* **Overview**
  * Infection by Cryptococcus neoformans through inhalation from soil contaminated with bird droppings
  * Occurs in both immunocompetent and immunocompromised patients
* **Presentation**
  * **[Immunocompetent] Asymptomatic, mild fever, cough**: Limited immune response
  * **[Immunocompromised] Fever, fatigue, chest pain, dyspnea,  cough, hemoptysis**: More severe symptoms due to poor immune function
* **Examination**
  * **[Chest X-ray, CT] Solitary/multiple nodules, cavitation, infiltrates**: Different patterns based on immune status
  * **[Blood] GXM antigen (+)**: Confirms diagnosis
* **Management**
  * **Fluconazole ,itraconazole, voriconazole, amphotericin B,**:  Target fungal cells
{: .notice--info}

### Pneumocystis Pneumonia / „Éã„É•„Éº„É¢„Ç∑„Çπ„ÉÅ„ÇπËÇ∫ÁÇé

* **Overview**
  * Severe pneumonia caused by Pneumocystis jirovecii in immunocompromised patients
  * Common in patents with AIDS, malignancy, autoimmune disease, steroid, immunosuppressant
* **Presentation**
  * **Sudden fever, dry cough, dyspnea**: Acute inflammatory response
* **Examination**
  * **[Blood] LDH‚Üë, KL-6‚Üë, Œ≤-D-glucan‚Üë, PaO2‚Üì**: Lung damage and fungal infection markers
  * **[Chest X-ray, CT] Diffuse ground-glass opacity, multiple cystic shadows**: Characteristic radiological findings
  * **[Sputum, BALF, TBLB] Detection of pneumocystis**: Confirms diagnosis
* **Management**
  * **Trimethoprim-sulfamethoxazole, pentamidine, atovaquone**: Target fungal cells
  * **Steroids**: For severe respiratory compromise
{: .notice--info}

## Immune and Allergic Disorder / ÂÖçÁñ´„Éª„Ç¢„É¨„É´„ÇÆ„ÉºÊÄßÁñæÊÇ£

### Acute Eosinophilic Pneumonia / ÊÄ•ÊÄßÂ•ΩÈÖ∏ÁêÉÊÄßËÇ∫ÁÇé

* **Overview**
  * Rapidly progressive diffuse eosinophilic lung infiltration
  * Common in young males within 1 month of starting smoking
* **Presentation**
  * **Fever, dyspnea, dry cough, chest pain**: Acute inflammatory response and lung infiltration
  * **Severe hypoxemia**: Rapid onset respiratory failure
* **Examination**
  * **[Chest X-ray] Diffuse ground-glass opacity/infiltrates, Kerley B lines, pleural effusion**: Lung inflammation and edema
  * **[Blood] CRP‚Üë**: Acute inflammation
  * **[BALF] Eosinophils‚Üë**: Diagnostic criteria
* **Management**
  * **High-dose steroids**: Good prognosis
{: .notice--info}

### Chronic Eosinophilic Pneumonia / ÊÖ¢ÊÄßÂ•ΩÈÖ∏ÁêÉÊÄßËÇ∫ÁÇé

* **Overview**
  * Subacute to chronic eosinophilic lung infiltration
  * Common in middle-aged women with allergic history
* **Presentation**
  * **Fever, cough, sputum, dyspnea,**: Chronic inflammatory response and lung infiltration
  * **Weight loss, general fatigue**: Chronic inflammatory condition
* **Examination**
  * **[Chest X-ray] Migratory peripheral infiltrates**: Characteristic findings
  * **[Blood] Eosinophils‚Üë, CRP‚Üë**: Eosinophilic inflammation
  * **[BALF, Lung biopsy] Eosinophils‚Üë**: Confirms diagnosis
* **Management**
  * **High-dose steroids followed by gradual reduction**: Good prognosis but high relapse rate
{: .notice--info}

### Allergic Bronchopulmonary Aspergillosis / „Ç¢„É¨„É´„ÇÆ„ÉºÊÄßÊ∞óÁÆ°ÊîØËÇ∫„Ç¢„Çπ„Éö„É´„ÇÆ„É´„ÇπÁóá

* **Overview**
  * Allergic respiratory disease caused by Aspergillus species
  * Common in patients with atopic predisposition
* **Presentation**
  * **Fever, cough, paroxysmal dyspnea**: Allergic bronchial response
  * **Thick brownish sputum**: Mucoid impaction
* **Examination**
  * **[Blood] Eosinophils‚Üë, IgE‚Üë, specific IgE to Aspergillus**: Allergic response
  * **[PFT] FEV1%‚Üì, %VC‚Üíor‚Üì**: Obstructive or mixed ventilatory disorder
  * **[Chest X-ray, CT] Recurrent transient infiltrates, central bronchiectasis, mucoid plugging**: Characteristic findings
  * **[Skin test] Immediate reaction to Aspergillus antigen**: Type I allergy
* **Management**
  * **Systemic steroids**: Control asthma
  * **Itraconazole**: Antifungal therapy
{: .notice--info}

### Hypersensitivity Pneumonitis / ÈÅéÊïèÊÄßËÇ∫ËáìÁÇé

* **Overview**
  * Diffuse granulomatous interstitial pneumonia caused by repeated inhalation of antigens
  * Commonly improves with environment change but relapses with re-exposure
* **Presentation**
  * **Fever, dry cough, dyspnea on exertion, fine crackles**: Interstitial inflammation
* **Examination**
  * **[Blood] WBC‚Üë, ESR‚Üë, CRP‚Üë, IgE‚Üí, eosinophils‚Üí, specific antibody**: Inflammatory response
  * **[PFT] %VC‚Üì, FEV1%‚Üí, PaO2‚Üì, DLCO‚Üì**: Restrictive ventilatory disorder with diffusion impairment
  * **[Chest X-ray, HRCT] Bilateral diffuse ground-glass opacities, nodular shadows**: Interstitial inflammation
  * **[BALF] T-cells‚Üë, CD4/CD8 ratio varies by type**: Immunological abnormality
  * **[Inhalation test] Positive inhalation challenge test**: Confirm diagnosis
* **Management**
  * **Antigen avoidance**: Primary treatment
  * **Corticosteroids**: For severe or persistent cases
{: .notice--info}

### Sarcoidosis / „Çµ„É´„Ç≥„Ç§„Éâ„Éº„Ç∑„Çπ

* **Overview**
  * Non-caseating epithelioid granulomatous disease involving multiple organs
  * Common in young adults and middle-aged women
* **Presentation**
  * **Fatigue, fever, joint pain**: Systemic inflammation
  * **Cough, exertional dyspnea**: Pulmonary involvement
  * **Visual disturbance, photophobia, floaters**: Ocular involvement
  * **Erythema nodosum, scar infiltration**: Cutaneous involvement
  * **Facial nerve palsy, diabetes insipidus**: Neurological involvement
  * **Advanced AV block**: Cardiac involvement
  * **Hypercalcemia**: Renal involvement
* **Examination**
  * **[Chest X-ray] Bilateral hilar lymphadenopathy, Ga-67 increased uptake**: Active inflammation
  * **[Blood] Lymphocytes‚Üì, Œ≥-globulin‚Üë, ACE‚Üë, Ca‚Üë**: Systemic inflammation
  * **[BALF] Lymphocytes‚Üë, CD4/CD8 ratio‚Üë**: Local inflammation
  * **[Tuberculin test] Negative conversion**: Decreased cellular immunity
  * **[Biopsy] Non-caseating epithelioid granuloma**: Diagnostic finding
* **Management**
  * **Observation**: Often resolve spontaneously
  * **Corticosteroids**: For serious cases
{: .notice--info}

### Microscopic Polyangiitis / È°ïÂæÆÈè°ÁöÑÂ§öÁô∫Ë°ÄÁÆ°ÁÇé

* **Overview**
  * Necrotizing vasculitis affecting lungs and kidneys
  * Common in 50-70s
* **Presentation**
  * **Alveolar hemorrhage, interstitial pneumonia**: Pulmonary involvement
  * **Hematuria, proteinuria, casts, rapidly progressive glomerulonephritis**: Renal involvement
  * **Fever, weight loss, fatigue, myalgia, arthralgia**: Systemic inflammation
  * **Purpura, GI bleeding, mononeuritis multiplex**: Multi-organ involvement
* **Examination**
  * **[Blood] CRP‚Üë, WBC‚Üë, MPO-ACNA(+)**: Systemic inflammation
  * **[Blood] BUN‚Üë, Cr‚Üë**: Renal damage
* **Management**
  * **Steroids, high-dose steroids + cyclophosphamide pulse**: Induction therapy
  * **Low-dose steroids + immunosuppressants**: Maintenance therapy
{: .notice--info}

### Eosinophilic Granulomatosis with Polyangiitis / Â•ΩÈÖ∏ÁêÉÊÄßÂ§öÁô∫Ë°ÄÁÆ°ÁÇéÊÄßËÇâËäΩËÖ´Áóá

* **Overview**
  * Granulomatous necrotizing vasculitis with eosinophilic infiltration affecting upper airways and peripheral nerves
  * Common in 40-60s
* **Presentation**
  * **Asthma, eosinophilic sinusitis**: Respiratory tract involvement
  * **Numbness, muscle weakness**: Neurological involvement
  * **Fever, weight loss**: Systemic inflammation
  * **GI bleeding, purpura, arthralgia, myalgia**: Multi-organ involvement
* **Examination**
  * **[Blood] CRP‚Üë, WBC‚Üë (eosinophilia), platelets‚Üë, IgE‚Üë, RF(+), MPO-ANCA(+)**: Systemic inflammation
  * **[Chest X-ray] Migratory infiltrates**: Eosinophilic pneumonia
  * **[Biopsy] Granulomatous necrotizing vasculitis with eosinophilic infiltration**: Confirms diagnosis
* **Management**
  * **Moderate-dose steroids**: Control inflammation
  * **High-dose steroids + cyclophosphamide pulse, IVIG, anti-IL-5**: For severe or resistant cases
{: .notice--info}

### Granulomatosis with Polyangiitis / Â§öÁô∫Ë°ÄÁÆ°ÁÇéÊÄßËÇâËäΩËÖ´Áóá

* **Overview**
  * Necrotizing granulomatous vasculitis affecting upper airways, lungs, and kidneys
  * Common in 40-50s
* **Presentation**
  * **Otitis media, chronic sinusitis, oral ulcers, exophthalmos**: Upper airway involvement
  * **Hemoptysis, cough, dyspnea**: Pulmonary involvement
  * **Hematuria, proteinuria, edema, hypertension**: Renal involvement
  * **Fever, weight loss**: Systemic inflammation
  * **Purpura, arthritis, episcleritis, mononeuritis multiplex**: Multi-organ involvement
* **Examination**
  * **[Blood] CRP‚Üë, WBC‚Üë, PR3-ANCA or MPO-ANCA(+)**: Systemic inflammation
  * **[Blood] BUN‚Üë, Cr‚Üë**: Renal damage
  * **[Chest X-ray/CT] Multiple nodules with cavitation**: Granulomatous inflammation
  * **[Biopsy] Necrotizing granulomas with giant cells**: Confirms diagnosis
* **Management**
  * **High-dose steroids + cyclophosphamide pulse**: Induction therapy
  * **Low-dose steroids + immunosuppressants**: Maintenance therapy
{: .notice--info}

### Goodpasture Syndrome / GoodpastureÁóáÂÄôÁæ§

* **Overview**
  * Autoimmune disease caused by anti-GBM antibodies targeting basement membranes in lungs and kidneys
* **Presentation**
  * **Cough, hemoptysis, dyspnea**: Pulmonary involvement
  * **Hematuria, proteinuria, oliguria/anuria**: Renal involvement
* **Examination**
  * **[Sputum] Hemosiderin-laden macrophages**: Alveolar hemorrhage
  * **[Chest X-ray] Diffuse reticulonodular infiltrates**: Alveolar damage
  * **[PFT] Restrictive pattern, DLCO‚Üë**: Alveolar damage
  * **[Urine] Proteinuria, hematuria**: Glomerular damage
  * **[Blood] Anti-GBM antibodies(+)**: Confirms diagnosis
  * **[Biopsy] Linear IgG deposits along basement membranes**: Definitive diagnosis
* **Management**
  * **High-dose steroids + immunosuppressants**: Control inflammation
  * **Plasma exchange**: Remove anti-GBM antibodies
  * **Dialysis**: For severe renal dysfunction
{: .notice--info}

## Interstitial Lung Disease / ÈñìË≥™ÊÄßËÇ∫ÁñæÊÇ£

### Idiopathic Pulmonary Fibrosis / ÁâπÁô∫ÊÄßËÇ∫Á∑öÁ∂≠Áóá

* **Overview**
  * Progressive lung fibrosis and honeycomb formation
  * Common in male smokers over 50
* **Presentation**
  * **Dry cough, exertional dyspnea, fine crackles**: Progressive lung fibrosis
  * **Clubbing**: Chronic hypoxemia
* **Examination**
  * **[Blood] LDH‚Üë, ESR‚Üë, CRP‚Üë, WBC‚Üë, IgG‚Üë, KL-6‚Üë, SP-A‚Üë, SP-D‚Üë**: Inflammation and tissue damage
  * **[PFT] VC‚Üì, DLCO‚Üì, PaO2‚Üì, A-aDO2‚Üë**: Restrictive ventilatory disorder and diffusion impairment
  * **[HRCT, X-ray] Honeycomb pattern with reticular shadows**: Characteristic fibrotic changes
* **Management**
  * **Pirfenidone, nintedanib**: Anti-fibrotic effect
  * **N-acetylcysteine inhalation**: Antioxidant effect
  * **Steroids, immunosuppressants**: For acute exacerbations
{: .notice--info}

### Pneumoconiosis / „Åò„ÇìËÇ∫

* **Overview**
  * Fibroproliferative lung disease caused by inhalation of dust particles
  * Common in patients with history of long-term dust inhalation
* **Presentation**
  * **Dry cough, dyspnea, fine crackles**: Progressive lung fibrosis
* **Examination**
  * **[PFT] %VC‚Üì, DLCO‚Üì**: Restrictive ventilatory disorder and diffusion impairment
  * **[X-ray, CT] Diffuse or merged nodular shadows**: Silicosis
  * **[X-ray, CT] Reticular shadows, pleural plaques**: Asbestosis
  * **[Pathology] Silicotic nodules**: Silicosis
  * **[Pathology] Asbestos bodies**: Asbestosis
* **Management**
  * **Antitussives, expectorants**: Symptomatic treatment
  * **Smoking cessation, respiratory rehabilitation**: Preservation of remaining lung function
{: .notice--info}

### Radiation Pneumonitis / ÊîæÂ∞ÑÁ∑öËÇ∫ÁÇé

* **Overview**
  * Interstitial lung disease caused by radiation therapy
  * Common complication of chest radiation for lung or breast cancer
* **Presentation**
  * **Dry cough, dyspnea**: Focal lung fibrosis
* **Examination**
  * **[CT] Infiltrates corresponding to radiation field**: Characteristic radiation-induced changes
* **Management**
  * **Supportive care**: For mild cases
  * **Corticosteroids**: For severe cases
{: .notice--info}

### Drug-induced Lung Injury / Ëñ¨Ââ§ÊÄßËÇ∫ÈöúÂÆ≥

* **Overview**
  * Interstitial lung disease caused by drugs
  * Causative drugs include chemotherapy or immunosuppressive drugs
* **Presentation**
  * **Dry cough, dyspnea**: Lung fibrosis
* **Examination**
  * **[CT] Infiltrates, irregular shadows**: Interstitial pneumonitis and fibrosis 
* **Management**
  * **Discontinuation of suspected drug**: Primary treatment
  * **Corticosteroids**: For severe cases
{: .notice--info}

### Pulmonary Langerhans Cell Histiocytosis / ËÇ∫LangerhansÁ¥∞ËÉûÁµÑÁπîÁêÉÁóá

* **Overview**
  * Proliferation and infiltration of Langerhans cells in lungs
  * Common 20-40s smokers
* **Presentation**
  * **Asymptomatic**: 10-20% cases
  * **Dry cough, exertional dyspnea, sputum**: Lung infiltration
  * **Chest pain, pneumothorax**: Cyst rupture
* **Examination**
  * **[CT] Multiple nodules and cysts**: Disease progression pattern
  * **[Pathology] Langerhans cell infiltration with eosinophils**: Diagnostic finding
* **Management**
  * **Smoking cessation**: Primary treatment for smokers
  * **Corticosteroids**: For progressive or symptomatic cases
{: .notice--info}

## Obstructive Lung Disease / ÈñâÂ°ûÊÄßËÇ∫ÁñæÊÇ£

### Bronchial Asthma / Ê∞óÁÆ°ÊîØÂñòÊÅØ

* **Overview**
  * Chronic airway inflammation causing variable obstructive ventilatory impairment
* **Presentation**
  * **Recurrent dyspnea, wheezing, cough (often nocturnal or early morning)**: Bronchial narrowing
* **Examination**
  * **[Auscultation] Wheezes**: High-pitched sounds from narrowed airways
  * **[Spirometry] Decreased FEV1 and FEV1%, obstructive pattern on flow-volume curve**: Airway obstruction
  * **[Bronchial test] FEV1 increase after Œ≤2-agonist, FEV1 decrease after bronchoconstrictor**: Airflow limitation reversibility
  * **[Blood, Sputum] Eosinophils‚Üë, ECP‚Üë**: Eosinophilic inflammation
* **Management**
  * **[Long-term control] Inhaled corticosteroids (ICS), leukotriene receptor antagonists (LTRA), sustained-release theophylline (SRT), long-acting Œ≤2-agonists (LABA) , long-acting muscarinic antagonists (LAMA)**: Suppress airway inflammation and bronchodilation
  * **[Long-term control] Bronchial thermoplasty**: Reduce bronchial smooth muscle
  * **[Acute exacerbation] Short-acting Œ≤2-agonists (SABA), systemic steroids, aminophylline, epinephrine, short-acting muscarinic antagonists (SAMA)**: Rapid bronchodilation
  * **[Acute exacerbation] Oxygen therapy, intubation**: For life-threatening cases
{: .notice--info}

### Aspirin-Exacerbated Respiratory Disease / „Ç¢„Çπ„Éî„É™„É≥ÂñòÊÅØ

* **Overview**
  * Asthma triggered by NSAIDs with COX-1 inhibitory action
  * Common in non-atopic refractory asthma
* **Presentation**
  * **Nasal congestion, dyspnea, wheezing, cough after NSAIDs intake**: Bronchial constriction triggered by COX-1 inhibition
  * **Chronic rhinosinusitis with nasal polyps**: Associated upper airway inflammation
* **Examination**
  * **[Spirometry] Decreased FEV1, reversible airway obstruction**: Confirms asthma
* **Management**
  * **Inhaled Œ≤2 agonists, IV aminophylline, SC epinephrine**: Rapid bronchodilation
  * **Intubation, oxygen, mechanical ventilation**: For life-threatening cases
{: .notice--info}

### Chronic Obstructive Pulmonary Disease / ÊÖ¢ÊÄßÈñâÂ°ûÊÄßËÇ∫ÁñæÊÇ£

* **Overview**
  * Irreversible airflow limitation due to long-term exposure to harmful substances mainly tobacco
  * Common in smokers >40s
* **Presentation**
  * **Chronic cough, sputum production, exertional dyspnea**: Airway inflammation and obstruction
* **Examination**
  * **[Spirometry] Post-bronchodilator FEV1% < 70%**: Irreversible obstructive ventilatory impairment
  * **[Chest X-ray, CT] Hyperinflation, emphysematous changes**: Air trapping and tissue destruction
* **Management**
  * **[Stable] Smoking cessation, vaccinations, pulmonary rehabilitation**: Conservative treatment
  * **[Stable] Bronchodilators (anticholinergics, Œ≤2-agonists, methylxanthines), inhaled steroids**: Reduce airway obstruction
  * **[Exacerbation] Antibiotics, bronchodilators, corticosteroids**: Treat infection and inflammation
  * **[Exacerbation] Oxygen therapy, ventilation support**: Manage respiratory failure
{: .notice--info}

### Diffuse Panbronchiolitis / „Å≥„Åæ„ÇìÊÄßÊ±éÁ¥∞Ê∞óÁÆ°ÊîØÁÇé

* **Overview**
  * Chronic inflammation of respiratory bronchioles in both lungs
  * Common in patients with chronic sinusitis, associated with HLA-B54
* **Presentation**
  * **Chronic purulent sputum, cough, exertional dyspnea**: Airway inflammation and obstruction
  * **Coarse crackles**: Sputum retention in airways
* **Examination**
  * **[Chest X-ray] Diffuse nodular shadows, hyperinflation**: Bronchiolar inflammation and remodeling
  * **[Chest CT] Centrilobular nodules, bronchiectasis**: Bronchiolar inflammation and remodeling
  * **[Spirometry] FEV1% < 70%**: Obstructive ventilatory impairment
* **Management**
  * **Low-dose long-term erythromycin**: Immunomodulatory effects
{: .notice--info}

## Lung Tumor / ËÇ∫ËÖ´Áòç

### Pulmonary Hamartoma / ËÇ∫ÈÅéË™§ËÖ´

* **Overview**
  * Benign tumor with abnormal proliferation of normal lung tissue components
* **Presentation**
  * **Asymptomatic**: Incidental finding
  * **Obstructive pneumonia**: Due to bronchial obstruction
* **Examination**
  * **[CT] Well-defined shadow, popcorn-like calcification**: Characteristic radiological finding
  * **[Biopsy] Mixed mesenchymal and epithelial components**: Hamartoma nature
* **Management**
  * **Observation**: For asymptomatic cases
  * **Surgical resection**: Rule out malignancy
{: .notice--info}

### Squamous Cell Carcinoma / ÊâÅÂπ≥‰∏äÁöÆÁôå

* **Overview**
  * Type of non-small cell lung cancer showing keratinization and intercellular bridges
  * Common in males over 50 with smoking history
* **Presentation**
  * **Cough, sputum, hemoptysis**: Due to bronchial invasion
  * **Clubbing**: Paraneoplastic manifestation
  * **Hypercalcemia**: Due to PTHrP production
* **Examination**
  * **[Chest X-ray, CT] Mass shadow, atelectasis**: Due to airway obstruction
  * **[Sputum cytology] Orange-stained cells on Papanicolaou stain**: Shows keratinized cancer cells
  * **[Blood] Elevated SCC antigen, CYFRA, CEA**: Tumor markers
  * **[Biopsy] Keratinization, intercellular bridges**: Diagnostic features
* **Management**
  * **Surgery + adjuvant chemotherapy**: Stage IA-IIIA
  * **Radiation therapy alone**: Stage I-III (inoperable)
  * **Chemoradiotherapy**: Stage IIIB-IIIC
  * **Systemic therapy**: Stage III (inoperable), Stage IV (metastatic)
{: .notice--info}

### Adenocarcinoma / ËÖ∫Áôå

* **Overview**
  * Type of non-small cell lung cancer showing glandular differentiation
  * Common in both genders including non-smokers
* **Presentation**
  * **Asymptomatic**: Peripheral location of tumor
  * **Chest pain, cough, sputum**: Due to tumor growth and invasion
* **Examination**
  * **[Chest X-ray, CT] Spicula, vessel convergence, pleural indentation**: Due to fibrosis and contraction of tumor
  * **[Sputum cytology] Clusters of abnormal cells**: Shows adenocarcinoma cells
  * **[Blood] Elevated CEA, SLX**: Tumor markers
  * **[Biopsy] Glandular differentiation, mucin production**: Diagnostic features
* **Management**
  * **Surgery + adjuvant chemotherapy**: Stage IA-IIIA
  * **Radiation therapy alone**: Stage I-III (inoperable)
  * **Chemoradiotherapy**: Stage IIIB-IIIC
  * **Systemic therapy**: Stage III (inoperable), Stage IV (metastatic)
{: .notice--info}

### Small Cell Lung Cancer / Â∞èÁ¥∞ËÉûËÇ∫Áôå

* **Overview**
  * Malignant neuroendocrine tumor with small cancer cells, rapid progression and poor prognosis
  * Common in male with smoking history
* **Presentation**
  * **Cough, sputum, hemoptysis**: Due to bronchial invasion
  * **SIADH, Cushing syndrome, Lambert-Eaton syndrome**: Paraneoplastic syndromes due to hormone production
* **Examination**
  * **[Chest X-ray, CT] Hilar mass, lymphadenopathy**: Central location with lymph node metastasis
  * **[Sputum cytology] Small cells with scant cytoplasm**: Characteristic appearance
  * **[Blood] Elevated NSE, Pro-GRP**: Tumor markers
  * **[Biopsy] Small undifferentiated cells, neuroendocrine markers**: Diagnostic features
* **Management**
  * **Chemoradiotherapy**: Limited Disease
  * **Systemic therapy**: Extensive Disease
  * **Prophylactic cranial irradiation**: Prevent brain metastasis
{: .notice--info}

### Metastatic Lung Tumor / Ëª¢ÁßªÊÄßËÇ∫ËÖ´Áòç

* **Overview**
  * Malignant tumors from other organs metastasizing to lungs
* **Presentation**
  * **Symptoms of primary tumor**: Varies by origin
* **Examination**
  * **[Chest X-ray, CT] Single or multiple nodules**: Various radiological patterns
  * **[Biopsy] Histology matching primary tumor**: Confirms diagnosis and origin
* **Management**
  * **Systemic therapy**: Based on primary tumor sensitivity
  * **Radiation therapy**: For symptom palliation
  * **Surgery**: Selected cases with controlled primary and resectable metastases
{: .notice--info}

## Circulatory Disorder / Âæ™Áí∞ÈöúÂÆ≥

### Idiopathic Pulmonary Arterial Hypertension / ÁâπÁô∫ÊÄßËÇ∫ÂãïËÑàÊÄßËÇ∫È´òË°ÄÂúßÁóá

* **Overview**
  * Elevated pulmonary arterial pressure due to narrowing of small pulmonary arteries without identifiable cause
  * Common in women aged 20-40s
* **Presentation**
  * **Exertional dyspnea, fatigue, chest pain, cyanosis, syncope**: Reduced pulmonary blood flow and cardiac output
  * **Jugular vein distention, leg edema, hepatomegaly**: Right heart failure
* **Examination**
  * **[Physical] Accentuated P2, Graham Steell murmur**: Pulmonary hypertension
  * **[ECG] Right axis deviation, right ventricular hypertrophy, P pulmonale**: Right heart strain
  * **[Chest X-ray, CT] Enlarged pulmonary trunk, right heart enlargement**: Pulmonary hypertension
  * **[Echocardiogram] Right heart dilation, septal flattening**: Right ventricular pressure overload
  * **[Right heart catheterization] PAP ‚â•25mmHg, PAWP ‚â§15mmHg**: Confirms diagnosis
* **Management**
  * **Prostacyclin derivatives, endothelin antagonists, PDE5 inhibitors, continuous IV prostacyclin**:  Relax pulmonary arteries
  * **Anticoagulation**: Prevent thrombosis
  * **Oxygen therapy, diuretics**: For right heart failure
  * **Lung transplantation**: For refractory cases
{: .notice--info}

### Cardiogenic Pulmonary Edema / ÂøÉÂéüÊÄßËÇ∫Ê∞¥ËÖ´

* **Overview**
  * Pulmonary edema due to left heart failure
  * Common causes: Myocardial infarction, valvular disease, cardiomyopathy, hypertensive heart disease
* **Presentation**
  * **Exertional dyspnea, orthopnea, paroxysmal nocturnal dyspnea, cyanosis, pink frothy sputum**: Pulmonary congestion due to left heart failure
* **Examination**
  * **[Physical] Bilateral coarse crackles**: Fluid in alveoli
  * **[Blood gas] PaO2‚Üì, PaCO2‚Üì**: Type I respiratory failure
  * **[Blood] BNP‚Üë**: Heart failure
  * **[Chest X-ray] Enlarged cardiac silhouette, butterfly shadow, Kerley lines, vanishing tumor**: Pulmonary edema
  * **[Echocardiogram] Left ventricular enlargement, reduced wall motion**: Left heart failure
* **Management**
  * **Oxygen therapy**: Treat hypoxemia
  * **Diuretics, inotropes, vasodilators, morphine**: Treat heart failure
{: .notice--info}

### Acute Respiratory Distress Syndrome / ÊÄ•ÊÄßÂëºÂê∏Á™ÆËø´ÁóáÂÄôÁæ§

* **Overview**
  * Acute onset of increased permeability pulmonary edema with severe hypoxemia
  * Common causes: Sepsis, trauma, severe burns, pneumonia, aspiration
* **Presentation**
  * **Rapidly progressive dyspnea, tachypnea, cyanosis**: Acute respiratory failure
* **Examination**
  * **[Physical] Bilateral coarse crackles**: Pulmonary edema
  * **[Blood gas] PaO2‚Üì, PaCO2‚Üì, A-aDO2‚Üë**: Type I respiratory failure
  * **[Chest X-ray] Bilateral infiltrates**: Pulmonary edema
  * **[Echocardiogram] Normal cardiac function**: Rules out cardiogenic pulmonary edema
* **Management**
  * **Oxygen therapy, mechanical ventilation**: Treat hypoxemia
  * **Antibiotics, diuretics**: Treat sepsis/pneumonia, prevent fluid overload
{: .notice--info}

### Acute Pulmonary Thromboembolism / ÊÄ•ÊÄßËÇ∫Ë°ÄÊ†ìÂ°ûÊ†ìÁóá

* **Overview**
  * Acute blockage of pulmonary arteries by blood clots from deep vein thrombosis
  * Common after surgery, prolonged bed rest, long flights
* **Presentation**
  * **Sudden dyspnea, tachypnea, chest pain**: Acute pulmonary arterial obstruction
* **Examination**
  * **[Blood gas] PaO2‚Üì, PaCO2‚Üì, A-aDO2‚Üë**: Type I respiratory failure
  * **[Blood] D-dimer‚Üë, FDP‚Üë**: Evidence of thrombosis
  * **[Chest X-ray] Enlarged cardiac silhouette, dilated pulmonary arteries**: Pulmonary hypertension
  * **[Echocardiogram] Right ventricular dilation and dysfunction**: Right ventricular pressure overload
  * **[Leg ultrasound] Deep vein thrombosis**: Source of embolism
  * **[Contrast CT] Filling defects in pulmonary arteries**: Confirms diagnosis
* **Management**
  * **Oxygen therapy**: Treat hypoxemia
  * **Heparin followed by warfarin/DOAC**: Remove and prevent thrombosis
  * **Thrombolysis, catheter thrombectomy**: For severe or refractory cases
{: .notice--info}

### Chronic Thromboembolic Pulmonary Hypertension / ÊÖ¢ÊÄßË°ÄÊ†ìÂ°ûÊ†ìÊÄßËÇ∫È´òË°ÄÂúßÁóá

* **Overview**
  * Pulmonary hypertension caused by organized thrombi in pulmonary arteries
* **Presentation**
  * **Exertional dyspnea**: Reduced pulmonary blood flow
  * **Leg edema**: Right heart failure
* **Examination**
  * **[Right heart catheterization] Elevated pulmonary arterial pressure**: Confirms pulmonary hypertension
  * **[V/Q scan] Mismatched perfusion defects**: Characteristic finding
* **Management**
  * **Pulmonary endarterectomy**: Remove thrombi
  * **Balloon pulmonary angioplasty, pulmonary vasodilators**: Relax pulmonary arteries
  * **Lung transplantation**: For severe cases
{: .notice--info}

### Pulmonary Arteriovenous Fistula / ËÇ∫ÂãïÈùôËÑàÁòª

* **Overview**
  * Vascular malformation with direct shunt between pulmonary artery and vein
* **Presentation**
  * **Exertional dyspnea, cyanosis, clubbing**: Reduced gas exchange efficiency
  * **Polycythemia (RBC‚Üë, Hb‚Üë, Ht‚Üë)**: Compensatory response to chronic hypoxemia
* **Examination**
  * **[Blood gas] PaO2‚Üì**: Type I respiratory failure
  * **[Chest X-ray] Well-defined nodular shadow**: Vascular malformation
  * **[Contrast CT] Homogeneously enhanced nodule**: Diagnostic finding
* **Management**
  * **Transcatheter embolization**: Treat fistula
  * **Surgical resection**: Alternative option
{: .notice--info}

## Functional Disorder / Ê©üËÉΩÈöúÂÆ≥

### Obstructive Sleep Apnea Syndrome / ÈñâÂ°ûÊÄßÁù°Áú†ÊôÇÁÑ°ÂëºÂê∏ÁóáÂÄôÁæ§

* **Overview**
  * Recurrent upper airway obstruction during sleep leading to apnea or hypopnea
  * Common in middle-aged obese men and postmenopausal women
* **Presentation**
  * **Snoring, breathing pauses during sleep**: Upper airway obstruction
  * **Daytime sleepiness, reduced concentration**: Sleep fragmentation
* **Examination**
  * **[Polysomnography] Obstructive apnea, AHI ‚â•5**: Confirms diagnosis
* **Management**
  * **Weight reduction**: Lifestyle modification
  * **Nasal CPAP**: Maintains airway patency
{: .notice--info}

### Hyperventilation Syndrome / ÈÅéÊèõÊ∞óÁóáÂÄôÁæ§

* **Overview**
  * Episodic hyperventilation triggered by psychological factors
  * Common in young women
* **Presentation**
  * **Tachypnea, dyspnea, palpitations, chest pain**: Triggered by stress or anxiety
  * **Dizziness, altered consciousness, numbness, spasm**: Respiratory alkalosis and hypocalcemia
* **Examination**
  * **[Blood gas] PaCO2‚Üì, pH‚Üë**: Respiratory alkalosis
* **Management**
  * **Calm patient, guide slow breathing**: Normalize respiratory rate
{: .notice--info}

### CO2 Narcosis / CO2„Éä„É´„Ç≥„Éº„Ç∑„Çπ

* **Overview**
  * Severe accumulation of CO2 leading to central nervous system dysfunction
* **Presentation**
  * **Drowsiness, confusion, coma**: High CO2 levels affecting brain function
  * **Decreased respiratory rate**: Respiratory center depression
* **Examination**
  * **[Blood gas] PaCO2‚Üë, HCO3-‚Üë**: Severe CO2 retention
* **Management**
  * **Reduce O2 concentration**: High-concentration O2 suppress respiration
  * **NPPV, intubation**: For persistent hypoxemia
{: .notice--info}

## Pleural Disorder / ËÉ∏ËÜúÁñæÊÇ£

### Pleuritis / ËÉ∏ËÜúÁÇé

* **Overview**
  * Inflammation of pleura due to malignancy or infection
* **Presentation**
  * **Chest pain (worsening with deep breathing or coughing), dyspnea**: Inflammation of pleural membrane
  * **Cough, fever**: Underlying infection or inflammation
* **Examination**
  * **[Physical] Dullness to percussion, pleural friction rub, decreased breath sounds, egophony**: Pleural effusion
  * **[Chest X-ray] Blunting of costophrenic angle, band-like opacity**: Pleural effusion
  * **[Pleural fluid] Exudative effusion**: Identify malignant, tuberculous, or parapneumonic causes
* **Management**
  * **Treat underlying cause**: Primary management
  * **Thoracentesis, chest tube drainage**: Remove pleural fluid
{: .notice--info}

### Empyema / ËÜøËÉ∏

* **Overview**
  * Collection of purulent fluid in pleural space due to infection, classified into acute or chronic forms
* **Presentation**
  * **Chest pain, dyspnea, fever**: Infection and inflammation of pleural space
* **Examination**
  * **[Chest X-ray] Pleural opacity, possible air-fluid level**: Purulent effusion
  * **[Pleural fluid] Purulent fluid, bacterial culture positive**: Confirms diagnosis
* **Management**
  * **[Acute] Antibiotics, chest tube drainage**: Treat infection and remove pus
  * **[Chronic] Decortication**: Remove thickened pleura
{: .notice--info}

### Spontaneous Pneumothorax / Ëá™ÁÑ∂Ê∞óËÉ∏

* **Overview**
  * Air in pleural space without obvious cause
  * Common in males (20s, tall, thin) and patients with underlying lung diseases (COPD, interstitial pneumonia, tuberculosis)
* **Presentation**
  * **Sudden onset dyspnea, chest pain**: Lung collapse due to air entrance
* **Examination**
  * **[Physical] Hyperresonance to percussion, decreased breath sounds**: Air in pleural space
  * **[Chest X-ray] Transparency without lung markings, collapsed lung**: Pneumothorax with lung collapse
* **Management**
  * **Observation, needle aspiration**: For small pneumothorax
  * **Chest tube drainage**: For larger pneumothorax
{: .notice--info}

### Tension Pneumothorax / Á∑äÂºµÊÄßÊ∞óËÉ∏

* **Overview**
  * Air continuously enters pleural space, medical emergency due to rapid respiratory and circulatory deterioration
  * Occurs in spontaneous pneumothorax, chest trauma, or mechanical ventilation
* **Presentation**
  * **Chest pain, dry cough, tachypnea, dyspnea, cyanosis**: Ventilation impairment
  * **Sudden hypotension, tachycardia, jugular vein distention**: Circulatory shock due to mediastinal compression
* **Examination**
  * **[Physical] Hyperresonance to percussion, decreased breath sounds**: Air in pleural space
  * **[Chest X-ray] Severe lung collapse, mediastinal shift to opposite side, depressed hemidiaphragm**: High pressure pneumothorax
* **Management**
  * **Immediate needle decompression, chest tube drainage**: Emergent treatment
{: .notice--info}

### Pleural Mesothelioma / ËÉ∏ËÜú‰∏≠ÁöÆËÖ´

* **Overview**
  * Malignant tumor arising from pleural mesothelial cells
  * Strong association with asbestos exposure, 20-40 years latency period
* **Presentation**
  * **Chest pain, exertional dyspnea**: Tumor invasion and pleural effusion
* **Examination**
  * **[Chest X-ray, CT] Pleural masses, irregular pleural thickening, pleural effusion**: Tumor invasion and pleural effusion
  * **[Pleural fluid] Elevated hyaluronic acid**: Characteristic finding
  * **[Biopsy] Pleural malignant cells**: Confirm diagnosis
* **Management**
  * **Extrapleural pneumonectomy, pleurectomy**: For resectable cases
  * **Chemotherapy, radiation therapy**: Combined or palliative treatment
{: .notice--info}

## Mediastinal Disorder / Á∏¶ÈöîÁñæÊÇ£

### Mediastinitis / Á∏¶ÈöîÁÇé

* **Overview**
  * Inflammation of mediastinum due to descending infection, trauma, or esophageal perforation
* **Presentation**
  * **Fever, chest pain, dyspnea, neck swelling**: Severe inflammation in mediastinum
* **Examination**
  * **[Blood] WBC‚Üë, CRP‚Üë**: Active inflammation
  * **[Chest X-ray] Widened mediastinum**: Inflammatory changes and edema
* **Management**
  * **Antibiotics, drainage**: Control infection
{: .notice--info}

### Thymoma / ËÉ∏ËÖ∫ËÖ´

* **Overview**
  * Mediastinal tumor arising from thymic epithelial cells, commonly in anterior mediastinum
 * Common in adults over 40s
* **Presentation**
  * **Asymptomatic, chest pressure, dyspnea, cough**: Mass effect in mediastinum
  * **Muscle weakness, ptosis, diplopia**: Associated myasthenia gravis
* **Examination**
  * **[Chest X-ray, CT, MRI] Mass in anterior mediastinum**: Evaluate tumor extent and characteristics
  * **[Biopsy] Proliferation of epithelial cells and lymphocytes**: Confirm diagnosis
* **Management**
  * **Thymectomy, radiation therapy**: Complete resection
  * **Chemotherapy**: For metastatic cases
{: .notice--info}

### Germ Cell Tumor / ËÉöÁ¥∞ËÉûÊÄßËÖ´Áòç

* **Overview**
  * Mediastinal tumor derived from primitive germ cells, commonly in anterior mediastinum
  * Common in young adults
* **Presentation**
  * **Asymptomatic, chest pain, dyspnea**: Mass effect in mediastinum
* **Examination**
  * **[Chest X-ray, CT, MRI] Mass in anterior mediastinum**: Evaluate tumor extent and characteristics
  * **[Biopsy] Teratoma, seminoma, nonseminoma**: Confirm diagnosis
* **Management**
  * **[Mature teratoma] Surgery**: Complete resection
  * **[Seminoma, non-seminoma] Chemotherapy, combined with other therapies**: Multimodal therapy
{: .notice--info}

### Neurogenic Tumor / Á•ûÁµåÂéüÊÄßËÖ´Áòç

* **Overview**
  * Mediastinal tumor derived from peripheral nerve tissues, commonly in posterior mediastinum
* **Presentation**
  * **Asymptomatic, Horner's syndrome**: Tumor compressing adjacent nerves
* **Examination**
  * **[Chest X-ray, CT, MRI] Mass in posterior mediastinum**: Evaluate tumor extent and characteristics
  * **[Pathology] Diagnosis after resection**: Difficult location for biopsy
* **Management**
  * **Surgical resection**: Complete resection
{: .notice--info}

## Miscellaneous Respiratory Disorder / „Åù„ÅÆ‰ªñ„ÅÆÂëºÂê∏Âô®ÁñæÊÇ£

### Bronchiectasis / Ê∞óÁÆ°ÊîØÊã°ÂºµÁóá

* **Overview**
  * Irreversible dilation of peripheral airways due to recurrent infection or inflammation
* **Presentation**
  * **Chronic cough, substantial sputum, hemoptysis, recurrent fever**: Chronic airway infection
* **Examination**
  * **[Physical] Coarse crackles**: Airway secretions
  * **[Chest X-ray] Tram lines**: Thickened bronchial walls
  * **[Chest CT] Dilated bronchi**: Confirms diagnosis
* **Management**
  * **Postural drainage, respiratory rehabilitation, expectorants**: Remove airway secretions
  * **Long-term low-dose macrolide**: Anti-inflammatory effect
  * **Hemostatic drugs, bronchoscopic hemostasis, bronchial artery embolization**: Treat hemoptysis
  * **Antibiotics**: Treat secondary bacterial infection during acute exacerbation
{: .notice--info}

### Pulmonary Sequestration / ËÇ∫ÂàÜÁîªÁóá

* **Overview**
  * Abnormal lung tissue receiving blood supply directly from aorta without normal airway connection, classified as intralobar or extralobar
  * Common in young adults (intralobar) and infants (extralobar)
* **Presentation**
  * **[Intralobar] Cough, sputum, fever**: Recurrent infection
  * **[Extralobar] Dyspnea, cyanosis**: Developmental abnormality
* **Examination**
  * **[Chest X-ray] Mass or cystic shadow in left lower lung**: Abnormal lung tissue
  * **[CTA, MRA] Aberrant artery from descending aorta**: Diagnostic finding
* **Management**
  * **Surgical resection**: Prevent infection
{: .notice--info}

### Pulmonary Cyst Disease / ËÇ∫ÂõäËÉûÁóá

* **Overview**
  * Formation of sac-like structures in lungs, including bullae/blebs (air-filled) and bronchogenic cysts (mucus-filled)
* **Presentation**
  * **[Bullae/Blebs] Asymptomatic, occasionally pneumothorax**: Rupture of subpleural bullae/blebs
  * **[Bronchogenic cysts] Asymptomatic, occasionally dyspnea**: Airway compression
* **Examination**
  * **[Bullae/Blebs, CT] Air-filled spaces in subpleural region**: Confirm bullae/blebs
  * **[Bronchogenic cysts, CT] Mucus-filled cyst in middle mediastinum**: Confirm bronchogenic cysts
* **Management**
  * **[Bullae/Blebs] Surgical resection**: For recurrent pneumothorax
  * **[Bronchogenic cysts] Surgical resection**: For symptomatic cases
{: .notice--info}

### Autoimmune Pulmonary Alveolar Proteinosis / Ëá™Â∑±ÂÖçÁñ´ÊÄßËÇ∫ËÉûËõãÁôΩÁóá

* **Overview**
  * Abnormal accumulation of surfactant-derived lipoprotein in alveoli and terminal bronchioles, mostly associated with anti-GM-CSF antibodies
  * Common in 30-50s smoking males
* **Presentation**
  * **Cough, exertional dyspnea**: Accumulation of surfactant material
* **Examination**
  * **[Blood] LDH‚Üë, KL-6‚Üë, CEA‚Üë, SP-A‚Üë, SP-D‚Üë**: Markers of alveolar damage and surfactant accumulation
  * **[Chest X-ray] Bilateral ground-glass opacities**: Surfactant accumulation
  * **[CT] Crazy-paving pattern**: Combined ground-glass and septal thickening
  * **[BAL] Milky-white lavage fluid**: Surfactant accumulation
  * **[Blood] Anti-GM-CSF antibody positive**: Confirms autoimmune nature
* **Management**
  * **Whole lung or segmental lavage**: Remove accumulated material
{: .notice--info}

### Lymphangioleiomyomatosis / „É™„É≥„ÉëËÑàÁÆ°Á≠ãËÖ´Áóá

* **Overview**
  * Proliferation of smooth muscle-like cells (LAM cells) in lungs, kidneys, and lymphatics, associated with tuberous sclerosis
  * Common in 20-40s women
* **Presentation**
  * **Exertional dyspnea, cough, bloody sputum**: Lung destruction 
  * **Recurrent pneumothorax**: Rupture of lung cysts
* **Examination**
  * **[Blood] VEGF-D‚Üë**: Marker for LAM
  * **[PFT] Diffusion impairment, obstructive pattern**: Airway obstruction and parenchymal destruction
  * **[Chest X-ray] Reticular shadows, hyperinflation**: Formation of multiple cysts
  * **[CT] Multiple thin-walled cysts**: Characteristic finding
  * **[Biopsy] LAM cell proliferation**: Confirms diagnosis
* **Management**
  * **Sirolimus (mTor inhibitors)**: Inhibit LAM cells proliferation
  * **Bronchodilators**: For obstructive symptoms
  * **Surgery**: For recurrent pneumothorax
  * **Oxygen therapy, lung transplantation**: For respiratory failure
{: .notice--info}

### Airway Foreign Bodies / Ê∞óÈÅìÁï∞Áâ©

* **Overview**
  * Foreign objects obstructing or narrowing airways
  * Common in children and elderly with history of aspiration 
* **Presentation**
  * **Cough, wheezing, dyspnea, cyanosis**: Airway obstruction
* **Examination**
  * **[Chest X-ray] Visible foreign body, Holzknecht sign**: Identify foreign body
* **Management**
  * **Heimlich maneuver**: Immediate intervention for complete obstruction
  * **Bronchoscopic removal**: For accessible foreign bodies
{: .notice--info}

### Flail Chest / „Éï„É¨„Ç§„É´„ÉÅ„Çß„Çπ„Éà

* **Overview**
  * Multiple rib fractures cause chest wall segment to lose continuity
  * Commonly due to severe chest trauma
* **Presentation**
  * **Paradoxical chest wall movement**: Affected segment moves inward during inspiration, outward during expiration
* **Examination**
  * **[Physical] Chest wall instability on palpation**: Loss of normal thoracic cage rigidity
  * **[Imaging] Multiple rib fractures**: Confirms diagnosis
* **Management**
  * **Chest tube drainage**: For pneumothorax or hemothorax
  * **Positive pressure ventilation**: For respiratory failure
  * **Analgesics**: Pain control
  * **Surgical fixation**: For refractory cases
{: .notice--info}


<!-- ### Inferior Respiratory Tract / ‰∏ãÊ∞óÈÅì

* **Bronchial tree**
  * **Structure**: Trachea, main bronchus, lobar bronchus, segmental bronchus, terminal bronchus (conduction) \| (respiratory) respiratory bronchus, alveolar duct, alveolus
  * **Trachea and broncus**: Smooth muscle, cartilage, gland, globet cell, pseudostratified columnar
  * **Bronchiole**: Smooth muscle, simple columnar to cuboid, Clara cell (surfactant)
  * **Alveoli**: Simple squamous, type I pneumocyte (septum), type II pneumocyte (surfactant), alveolar macrophate
* **Lung**
  * **Structure**: 2 left lobe (9 segment), 3 right lobe (10 segment), horizontal fissure, oblique fissure
  * **Root**: Main bronchus, pulmonary artery and vein, bronchiolar artery and vein, phrenic nerve (anterior), vagus nerve (posterior)
  * **Hilum**: Left (heart, aortic arch, thoracic aorta, aorta-bronchus-vein), right (vena cava, azygos vein, bronchus-aorta-vein)
  * **Artery**: Pulmonary artery (exchange), bronchial artery (nutrition)
  * **Nerve**: Sympathetic nerve (bronchodilation, vasoconstriction), Parasympathetic nerve (bronchoconstriction, vasodilation, sensation)
  * **Pleura**: Visceral pleura (autonomic nerve), parietal pleura (intercostal nerve, phrenic nerve), pleural cavity
  * **Inferior**: Lung (R6-R8-R10), pleura (R8-R10-R12)
{: .notice--info} -->

<!-- ## Infectious Disease / ÊÑüÊüìÊÄßÁñæÊÇ£

### Acute Bronchiolitis / ÊÄ•ÊÄßÁ¥∞Ê∞óÁÆ°ÊîØÁÇé
### Community-Acquired Pneumonia / Â∏Ç‰∏≠ËÇ∫ÁÇé
### Hospital-Acquired Pneumonia / Èô¢ÂÜÖËÇ∫ÁÇé
### Aspiration Pneumonia / Ë™§Âö•ÊÄßËÇ∫ÁÇé
### Streptococcus Penumoniae Pneumonia / ËÇ∫ÁÇéÁêÉËèåËÇ∫ÁÇé
### Haemophilus Influenzae Pneumonia / „Ç§„É≥„Éï„É´„Ç®„É≥„Ç∂ËèåËÇ∫ÁÇé
### Klebsiella Pneumoniae Pneumonia / „ÇØ„É¨„Éñ„Ç∑„Ç®„É©ËÇ∫ÁÇé
### Staphylococcus Aureus Pneumonia / ÈªÑËâ≤„Éñ„Éâ„Ç¶ÁêÉËèåËÇ∫ÁÇé
### Moraxella Catarrhalis Pneumonia / „É¢„É©„ÇØ„Çª„É©ËÇ∫ÁÇé
### Pseudomonas Aeruginosa Pneumonia / Á∑ëËÜøËèåËÇ∫ÁÇé
### Legionella Pneumophila Pneumonia / „É¨„Ç∏„Ç™„Éç„É©ËÇ∫ÁÇé
### Mycoplasma Pneumoniae Pneumonia / „Éû„Ç§„Ç≥„Éó„É©„Ç∫„ÉûËÇ∫ÁÇé
### Chlamydophila Pneumoniae Pneumonia / „ÇØ„É©„Éü„Ç∏„Ç¢ËÇ∫ÁÇé
### Psittacosis / „Ç™„Ç¶„É†ÁóÖ
### Viral Pneumonia / „Ç¶„Ç§„É´„ÇπÊÄßËÇ∫ÁÇé
### Lung Abscess / ËÇ∫ËÜøÁòç
### Pulmonary Tuberculosis / ËÇ∫ÁµêÊ†∏
### Miliary Tuberculosis / Á≤üÁ≤íÁµêÊ†∏
### Nontuberculous Mycobacteriosis / ÈùûÁµêÊ†∏ÊÄßÊäóÈÖ∏ËèåÁóá
### Simple Pulmonary Aspergilloma / ÂçòÁ¥îÊÄßËÇ∫„Ç¢„Çπ„Éö„É´„ÇÆ„É≠„Éº„Éû
### Chronic Progressive Pulmonary Aspergillosis / ÊÖ¢ÊÄßÈÄ≤Ë°åÊÄßËÇ∫„Ç¢„Çπ„Éö„É´„ÇÆ„É´„ÇπÁóá
### Invasive Pulmonary Aspergillosis / ‰æµË•≤ÊÄßËÇ∫„Ç¢„Çπ„Éö„É´„ÇÆ„É´„ÇπÁóá
### Pulmonary Cryptococcosis / ËÇ∫„ÇØ„É™„Éó„Éà„Ç≥„ÉÉ„Ç´„ÇπÁóá

## Obstructive Lung Disease / ÈñâÂ°ûÊÄßËÇ∫ÁñæÊÇ£

### Chronic Obstructive Pulmonary Disease / ÊÖ¢ÊÄßÈñâÂ°ûÊÄßËÇ∫ÁñæÊÇ£
### Diffuse Panbronchiolitis / „Å≥„Åæ„ÇìÊÄßÊ±éÁ¥∞Ê∞óÁÆ°ÊîØÁÇé
### Lymphangioleiomyomatosis / „É™„É≥„ÉëËÑàÁÆ°Á≠ãËÖ´Áóá

## Interstitial Lung Disease / ÈñìË≥™ÊÄßËÇ∫ÁñæÊÇ£

### Idiopathic Pulmonary Fibrosis / ÁâπÁô∫ÊÄßËÇ∫Á∑öÁ∂≠Áóá
### Non-Specific Interstitial Pneumonia / ÈùûÁâπÁï∞ÊÄßÈñìË≥™ÊÄßËÇ∫ÁÇé
### Cryptogenic Organizing Pneumonia / ÁâπÁô∫ÊÄßÂô®Ë≥™ÂåñËÇ∫ÁÇé
### Asbestosis / Áü≥Á∂øËÇ∫
### Silicosis / Áè™ËÇ∫
### Radiation Pneumonitis / ÊîæÂ∞ÑÁ∑öËÇ∫ÁÇé
### Drug-Induced Pneumonia / Ëñ¨Ââ§ÊÄßËÇ∫ÁÇé

## Immune and Allergic Lung Disease / ÂÖçÁñ´„Éª„Ç¢„É¨„É´„ÇÆ„ÉºÊÄßËÇ∫ÁñæÊÇ£

### Bronchial Asthma / Ê∞óÁÆ°ÊîØÂñòÊÅØ
### Aspirin-Induced Asthma / „Ç¢„Çπ„Éî„É™„É≥ÂñòÊÅØ
### Acute Eosinophilic Pneumonia / ÊÄ•ÊÄßÂ•ΩÈÖ∏ÁêÉÊÄßËÇ∫ÁÇé
### Chronic Eosinophilic Pneumonia / ÊÖ¢ÊÄßÂ•ΩÈÖ∏ÁêÉÊÄßËÇ∫ÁÇé
### Allergic Bronchopulmonary Aspergillosis / „Ç¢„É¨„É´„ÇÆ„ÉºÊÄßÊ∞óÁÆ°ÊîØËÇ∫„Ç¢„Çπ„Éö„É´„ÇÆ„É´„ÇπÁóá
### Hypersensitivity Pneumonitis / ÈÅéÊïèÊÄßËÇ∫ÁÇé

## Lung and Bronchus Malformation / ËÇ∫„ÉªÊ∞óÁÆ°ÊîØ„ÅÆÂΩ¢ÊÖãÁï∞Â∏∏
### Bronchiectasis / Ê∞óÁÆ°ÊîØÊã°ÂºµÁóá
### Atelectasis / ÁÑ°Ê∞óËÇ∫
### Pulmonary Sequestration / ËÇ∫ÂàÜÁîªÁóá
### Pulmonary Cystic Disease / ËÇ∫Âö¢ËÉûÁóá
### Pulmonary Alveolar Proteinosis / ËÇ∫ËÉûËõãÁôΩÁóá

## Lung Tumor / ËÇ∫ËÖ´Áòç

### Pulmonary Hamartoma / ËÇ∫ÈÅéË™§ËÖ´
### Squamous Cell Carcinoma / ÊâÅÂπ≥‰∏äÁöÆÁôå
### Adenocarcinoma / ËÖ∫Áôå
### Small Cell Lung Carcinoma / Â∞èÁ¥∞ËÉûËÇ∫Áôå
### Metastatic Lung Tumor / Ëª¢ÁßªÊÄßËÇ∫ËÖ´Áòç

## Pulmonary Circulation Disorder / ËÇ∫Âæ™Áí∞ÈöúÂÆ≥

### Pulmonary Thromboembolism / ËÇ∫Ë°ÄÊ†ìÂ°ûÊ†ìÁóá
### Idiopathic Pulmonary Arterial Hypertension / ÁâπÁô∫ÊÄßËÇ∫ÂãïËÑàÊÄßËÇ∫È´òË°ÄÂúßÁóá
### Cor Pulmonale / ËÇ∫ÊÄßÂøÉ
### Pulmonary Arteriovenous Fistula / ËÇ∫ÂãïÈùôËÑàÁòª
### Pulmonary Edema / ËÇ∫Ê∞¥ËÖ´
### Acute Respiratory Distress Syndrome / ÊÄ•ÊÄßÂëºÂê∏Á™ÆËø´ÁóáÂÄôÁæ§

## Functional Respiratory Disease / Ê©üËÉΩÁöÑÂëºÂê∏ÈöúÂÆ≥

### Hyperventilation Syndrome / ÈÅéÊèõÊ∞óÁóáÂÄôÁæ§
### CO2 Narcosis / CO2„Éä„É´„Ç≥„Éº„Ç∑„Çπ
### Sleep Apnea Syndrome / Áù°Áú†ÊôÇÁÑ°ÂëºÂê∏ÁóáÂÄôÁæ§

## Pleural Disease / ËÉ∏ËÜúÁñæÊÇ£

### Pneumothorax / Ê∞óËÉ∏
### Pleuritis / ËÉ∏ËÜúÁÇé
### Pyothorax / ËÜøËÉ∏
### Chylothorax / ‰π≥„Å≥ËÉ∏
### Pleural Mesothelioma / ËÉ∏ËÜú‰∏≠ÁöÆËÖ´

## Mediastinal Disease / Á∏¶ÈöîÁñæÊÇ£

### Acute Mediastinitis / ÊÄ•ÊÄßÁ∏¶ÈöîÁÇé
### Mediastinal Emphysema / Á∏¶ÈöîÊ∞óËÖ´
### Thymoma / ËÉ∏ËÖ∫ËÖ´
### Neurogenic Tumor / Á•ûÁµåÂéüÊÄßËÖ´Áòç
### Germ Cell Tumor / ËÉöÁ¥∞ËÉûËÖ´Áòç -->

# Gastroenterology / Ê∂àÂåñÂô®Áßë

## Esophagus Disorder / È£üÈÅìÁñæÊÇ£

### Esophageal Achalasia / È£üÈÅì„Ç¢„Ç´„É©„Ç∑„Ç¢

* **Overview**
  * Functional disease due to degeneration of Auerbach's plexus in lower esophageal muscle layer
  * Common in 20-60s adults
* **Presentation**
  * **Dysphagia, chest pain, food regurgitation**: Impaired esophageal peristalsis and lower esophageal sphincter relaxation
* **Examination**
  * **[Barium swallow] Beak-like narrowing of lower esophagus, dilated proximal esophagus**: Impaired LES relaxation and esophageal motility
  * **[Endoscopy] Fluid/food retention, dilated esophagus, wrap-around at cardia**: Impaired esophageal emptying
  * **[Manometry] Elevated LES pressure, absent esophageal peristalsis**: Confirms diagnosis
* **Management**
  * **Calcium channel blockers, nitrates**: Relax LES
  * **Balloon dilation**: Extend LES
  * **Per-Oral Endoscopic Myotomy (POEM), Heller-Dor procedure**: Endoscopic or laparoscopic myotomy
{: .notice--info}

### Mallory-Weiss Syndrome / Mallory-WeissÁóáÂÄôÁæ§

* **Overview**
  * Mucosal tear at gastroesophageal junction due to sudden increase in intra-abdominal pressure (vomiting)
  * Common causes: Excessive alcohol intake, hyperemesis gravidarum, chemotherapy, endoscopy
* **Presentation**
  * **Hematemesis after forceful vomiting**: Bleeding from mucosal tear
* **Examination**
  * **[Endoscopy] Longitudinal mucosal tear at gastroesophageal junction**: Confirms diagnosis
* **Management**
  * **Conservative treatment (NPO, IV fluids, hemostatic drugs)**: If bleeding stopped
  * **Endoscopic hemostasis (clipping, hemostatic forceps, injection therapy)**: If active bleeding
{: .notice--info}

### Spontaneous Esophageal Rupture / ÁâπÁô∫ÊÄßÈ£üÈÅìÁ†¥Ë£Ç

* **Overview**
  * Full-thickness rupture of esophageal wall due to sudden increase in intra-abdominal pressure (vomiting)
* **Presentation**
  * **Severe chest pain, dyspnea, shock**: Full-thickness rupture with mediastinal involvement
* **Examination**
  * **[X-ray, CT] Pleural effusion, mediastinal emphysema, pneumothorax**: Air and fluid in mediastinum
  * **[Contrast CT] Contrast leakage into mediastinum**: Confirm diagnosis
* **Management**
  * **Emergency surgery**: Surgical closure and drainage
 {: .notice--info}

### Esophageal Hiatal Hernia / È£üÈÅìË£ÇÂ≠î„Éò„É´„Éã„Ç¢

* **Overview**
  * Protrusion of stomach through esophageal hiatus into mediastinum
  * Common in obese middle-aged men and elderly women
* **Presentation**
  * **Heartburn, chest pain, epigastric pain, dysphagia**: Due to associated GERD
* **Examination**
  * **[Barium swallow] Protrusion of stomach into mediastinum**: Confirm diagnosis
  * **[Endoscopy] Gastric mucosa extending above diaphragm**: Confirm diagnosis
* **Management**
  * **Observation**: For asymptomatic cases
  * **Weight loss, elevation of upper body during sleep, acid suppressants**: For GERD cases
  * **Surgical repair (Nissen fundoplication)**: For incarceration cases
{: .notice--info}

### Gastroesophageal Reflux Disease / ËÉÉÈ£üÈÅìÈÄÜÊµÅÁóá

* **Overview**
  * Reflux of gastric contents into esophagus causing symptoms, risk factor for Barrett's esophagus and adenocarcinoma
* **Presentation**
  * **Heartburn, acid regurgitation (worse after meals, at night, bending forward)**: Typical symptoms from acid reflux
  * **Chest pain, cough, wheezing, throat discomfort, ear pain, hoarseness**: Extra-esophageal symptoms
* **Examination**
  * **[Endoscopy] Mucosal redness, erosions, ulcers**: Erosive GERD
  * **[Endoscopy, 24h pH monitoring] No visible lesions + abnormal acid exposure**: Non-erosive GERD (NERD)
* **Management**
  * **Lifestyle modifications**: Avoid late meals, elevate head of bed, weight loss, discontinue causative drugs
  * **PPI/P-CAB, H2RAs, antacids, prokinetics**: Reduce acid secretion, improve gastric motility
  * **Endoscopic or surgical treatment (Nissen fundoplication)**: For refractory cases
{: .notice--info}

### Esophageal Cancer / È£üÈÅìÁôå

* **Overview**
  * Malignant epithelial tumor of esophagus, mainly squamous cell carcinoma but also adenocarcinoma
  * Common in 60-70s men, risk factors include alcohol, smoking, achalasia, Barrett's esophagus (adenocarcinoma)
* **Presentation**
  * **[Early] Asymptomatic, mild burning sensation during swallowing**: Early mucosal changes
  * **[Advanced] Dysphagia, weight loss, chest discomfort, hoarseness, cough**: Local invasion and obstruction
* **Examination**
  * **[Endoscopy] Subtle redness, elevation/depression, iodine-unstained areas, brownish areas on NBI**: Mucosal changes in early stage
  * **[Endoscopy] Irregular ulcers, masses, strictures**: Tumor growth in advanced stage
* **Management**
  * **[Stage 0] EMR, ESD**: Remove early mucosal lesions
  * **[Stage I-III] Surgery, lymph node dissection, reconstruction**: Curative resection
  * **[Stage IV] Chemotherapy (5-FU + cisplatin), radiation**: For unresectable cases
  * **[Palliative] Stenting, bypass surgery, gastrostomy**: Relieve obstruction and fistulas
{: .notice--info}

### Esophagogastric Varices / È£üÈÅì„ÉªËÉÉÈùôËÑàÁò§

* **Overview**
  * Dilated submucosal veins in esophagus and stomach due to portal hypertension, asymptomatic but life-threatening if ruptured
  * Common in liver cirrhosis
* **Presentation**
  * **Asymptomatic**: Found during screening
* **Examination**
  * **[Endoscopy, esophagogram] Dilated submucosal veins**: Assess risk of bleeding
  * **[Contrast CT] Dilated vessels in esophagus and stomach**: Confirm diagnosis and extent
* **Management**
  * **[Endoscopic] Endoscopic injection sclerotherapy (EIS), endoscopic variceal ligation (EVL)**: First choice for esophageal varices
  * **[Interventional] B-RTO, TIPS**: For gastric varices resistant to endoscopic treatment
  * **[Medical] Œ≤-blockers, nitrates**: Prevent bleeding and recurrence
  * **[Surgical] Hassab operation, esophageal transection**: Less common
{: .notice--info}

### Rupture of Esophagogastric Varices / È£üÈÅì„ÉªËÉÉÈùôËÑàÁò§Á†¥Ë£Ç

* **Overview**
  * Life-threatening bleeding from esophagogastric varices
* **Presentation**
  * **Sudden hematemesis, melena**: Massive bleeding from ruptured varices
  * **Shock**: Blood loss leading to circulatory failure
* **Examination**
  * **[Physical] Vital signs**: Assess severity
* **Management**
  * **[Initial] IV fluids, blood transfusion**: Stabilize hemodynamics
  * **[Endoscopic] Endoscopic variceal ligation (EVL), cyanoacrylate injection (CA)**: Hemostasis of esophageal or gastric bleeding
  * **[Temporary] Balloon tamponade (SB tube)**: Hemostasis when endoscopic treatment fails
  * **[Medical] Vasopressin, nitroglycerin**: Reduce portal pressure
{: .notice--info}

## Stomach Disorder / ËÉÉÁñæÊÇ£

### Functional Dyspepsia / Ê©üËÉΩÊÄß„Éá„Ç£„Çπ„Éö„Éó„Ç∑„Ç¢

* **Overview**
  * Functional gastrointestinal disorder without organic, systemic, or metabolic causes, associated with stress
* **Presentation**
  * **Postprandial fullness, early satiety**: Postprandial distress syndrome
  * **Epigastric pain, burning**: Epigastric pain syndrome
* **Examination**
  * **[Endoscopy, blood tests] Normal**: Rules out organic or systemic disease
* **Management**
  * **Patient education, lifestyle modification, cognitive behavior therapy**: Stress management, regular meals
  * **Prokinetics (acotiamide), acid suppressants**: Improve gastric motility, reduce acid secretion
{: .notice--info}

### Acute Gastric Mucosal Lesion / ÊÄ•ÊÄßËÉÉÁ≤òËÜúÁóÖÂ§â

* **Overview**
  * Acute epigastric pain with multiple erosions and bleeding in gastric mucosa
  * Causes: NSAIDs, alcohol, stress, H. pylori, Anisakis infection
* **Presentation**
  * **Sudden epigastric pain, nausea, vomiting, hematemesis**: Acute mucosal inflammation
* **Examination**
  * **[Endoscopy] Multiple erosions, ulcers, edema, bleeding in gastric mucosa**: Acute mucosal damage
* **Management**
  * **Remove causative factors**: Stop NSAIDs, remove Anisakis
  * **Acid suppressants (PPI, H2-receptor antagonist)**: Reduce acid secretion
  * **Endoscopic hemostasis (clipping, injection therapy)**: For bleeding cases
{: .notice--info}

### H. pylori Gastritis / H. pyloriÊÑüÊüìËÉÉÁÇé

* **Overview**
  * Chronic gastritis caused by H. pylori infection, may progress to intestinal metaplasia and gastric cancer
* **Presentation**
  * **Epigastric pain, bloating, nausea, vomiting, loss of appetite**: Chronic gastritis
* **Examination**
  * **[Endoscopy] Atrophic changes, diffuse redness, enlarged folds**: Chronic inflammation
  * **[Endoscopy] Nodular gastritis, xanthoma, intestinal metaplasia**: Advanced changes
  * **[H. pylori tests] Rapid urease test, urea breath test**: Detect active infection
  * **[Biopsy] Inflammatory cell infiltration, atrophic changes**: Histological confirmation
* **Management**
  * **PPI/P-CAB + Amoxicillin + Clarithromycin (or metronidazole)**: Eradication of H. pylori
{: .notice--info}

### Gastroduodenal Ulcer / ËÉÉ„ÉªÂçÅ‰∫åÊåáËÖ∏ÊΩ∞Áòç

* **Overview**
  * Deep mucosal defect extending beyond muscularis mucosae
  * Causes: H. pylori infection, NSAIDs use
* **Presentation**
  * **Epigastric pain, bloating, nausea, vomiting, loss of appetite**: Chronic mucosal damage
  * **Coffee-ground vomiting, melena, anemia, shock (severe cases)**: Gastrointestinal bleeding
* **Examination**
  * **[Endoscopy] Smooth-edged ulcer**: Direct visualization of ulcer
  * **[Upper GI series] Niche sign, converging folds**: Radiological signs of ulcer
* **Management**
  * **H. pylori eradication, discontinue NSAIDs**: Remove underlying cause
  * **PPI/P-CAB, H2-blockers, mucosal protective agents, anticholinergics**: Acid suppression, enhance mucosal defense
  * **[Bleeding] Stabilize vital signs (if shock) , endoscopic hemostasis (clipping, injection therapy)**: Emergent hemostasis
  * **[Stenosis] Endoscopic balloon dilation, surgery**: Resolve stenosis
{: .notice--info}

### Perforated Gastroduodenal Ulcer / ËÉÉ„ÉªÂçÅ‰∫åÊåáËÖ∏ÊΩ∞ÁòçÁ©øÂ≠î

* **Overview**
  * Deep ulcer penetrating through stomach/duodenal wall into peritoneal cavity, leads to peritonitis and requires urgent treatment
  * Common in patients with gastroduodenal ulcer history
* **Presentation**
  * **Sudden severe epigastric pain, muscle guarding, rebound tenderness**: Peritoneal irritation from gastric contents
  * **Decreased bowel sounds, loss of liver dullness**: Paralytic ileus, free air
* **Examination**
  * **[Chest/Abdominal X-ray] Free air under diaphragm**: Perforation sign
  * **[CT] Free air around liver surface**: Perforation sign
* **Management**
  * **[Mild] NPO, IV fluids, antibiotics, acid suppression, nasogastric tube**: Conservative treatment
  * **[Severe] Laparoscopic surgery (peritoneal lavage and drainage, perforation repair, omental patch)**: Repair surgery
{: .notice--info}

### Gastric Polyps / ËÉÉ„Éù„É™„Éº„Éó

* **Overview**
  * Localized mucosal protrusions into gastric lumen excluding tumors
  * Classified as fundic gland polyps (associated with PPI use) and hyperplastic polyps (associated with H. pylori)
* **Presentation**
  * **Asymptomatic**: Mostly
  * **Anemia**: Due to polyp bleeding
* **Examination**
  * **[Endoscopy] Mucosal color polyp in fundic gland area**: Fundic gland polyps
  * **[Endoscopy] Reddish color polyp in atrophic mucosa**: Hyperplastic polyps
* **Management**
  * **Remove causative factors**: Reduce PPI use, H. pylori eradication
{: .notice--info}

### Gastric Adenoma / ËÉÉËÖ∫ËÖ´

* **Overview**
  * Benign epithelial tumor of stomach with risk of malignant transformation, associated with H. pylori infection
* **Presentation**
  * **Asymptomatic**: Mostly
  * **Anemia**: Due to bleeding
* **Examination**
  * **[Endoscopy] Whitish elevated lesion with uniform granular surface**: Differentiates from early gastric cancer
* **Management**
  * **Endoscopic resection**: For lesions showing growth or >2cm
{: .notice--info}

### Gastrointestinal Stromal Tumor / Ê∂àÂåñÁÆ°ÈñìË≥™ËÖ´Áòç

* **Overview**
  * Mesenchymal tumor from interstitial cells of Cajal, with c-kit gene mutation and KIT constitutive activation
  * Common in 50-60s
* **Presentation**
  * **Asymptomatic**: Mostly
  * **Abdominal discomfort, pain, palpable mass**: Tumor growth
  * **Melena, anemia**: Tumor bleeding
* **Examination**
  * **[Endoscopy, GI series, EUS] Smooth submucosal elevation, bridging fold, delle**: Submucosal tumor features
  * **[Pathology] KIT(+), CD34(+), DOG1(+)**: Confirms Cajal cell origin
* **Management**
  * **Surgical resection**: Risk of malignant transformation
  * **Imatinib, sunitinib, regorafenib**: For unresectable or recurrent cases
{: .notice--info}

### Gastric Cancer / ËÉÉÁôå

* **Overview**
  * Malignant tumor of gastric mucosa ,mostly adenocarcinoma
  * Risk factors: H. pylori infection, atrophic gastritis, high salt intake, smoking
* **Presentation**
  * **Asymptomatic**: Found during screening
  * **Epigastric discomfort, weight loss, appetite loss, nausea**: Tumor growth
  * **Black stool, fatigue**: Gastrointestinal bleeding
* **Examination**
  * **[Endoscopy, Upper GI series, EUS] Irregular depressed lesions, converging folds**: Early gastric cancer (‚â§submucosal invasion)
  * **[Endoscopy, Upper GI series, EUS] Irregular ulcers with raised margins**: Advanced gastric cancer (‚â•muscularis propria invasion)
* **Management**
  * **[Early] EMR, ESD, partial gastrectomy + lymph node dissection**: Endoscopic or limited surgery
  * **[Advanced] Extended gastrectomy + lymph node dissection**: Standard surgery
  * **[Unresectable] S-1 + cisplatin, capecitabine + cisplatin + trastuzumab**: Various combination of chemotherapy 
{: .notice--info}

### Dumping Syndrome / „ÉÄ„É≥„Éî„É≥„Ç∞ÁóáÂÄôÁæ§

* **Overview**
  * Post-gastrectomy condition with food rapidly entering small intestine
  * Classified as early (within 30 min) and late (2-3 hours after meals)
* **Presentation**
  * **[Early] Abdominal pain, diarrhea, nausea**: Rapid intestinal distension
  * **[Early] Palpitations, sweating, dizziness, syncope**: Vasomotor symptoms
  * **[Late] Palpitations, cold sweat, tremor, weakness**: Reactive hypoglycemia
* **Examination**
  * **Clinical**
* **Management**
  * **Dietary modification**: Small frequent meals, high protein/fat and low carb diet
  * **[Early] Antihistamines, antiserotonin drugs**: Relieve vasomotor symptoms
  * **[Late] Œ±-glucosidase inhibitors**: Prevent postprandial hyperglycemia
{: .notice--info}

## Intestine Disorder / ËÖ∏ÁñæÊÇ£

### Irritable Bowel Syndrome / ÈÅéÊïèÊÄßËÖ∏ÁóáÂÄôÁæ§

* **Overview**
  * Functional gastrointestinal disorder with chronic abdominal symptoms, stress-related but exact cause unknown
  * Common disease in adults
* **Presentation**
  * **Abdominal pain/discomfort, diarrhea, constipation**: Chronic symptoms lasting several months
  * **No alarm symptoms (fever, bloody stool, weight loss)**: Distinguishes from organic diseases
* **Examination**
  * **[Endoscopy] Normal**: Distinguishes from organic diseases
* **Management**
  * **Patient education, lifestyle modification, relaxation, cognitive behavioral therapy**: Benign nature of condition
  * **Probiotics, polycarboxylate calcium, trimebutine**: Improve gut function
  * **Lubiprostone, linaclotide, mosapride**: For constipation-predominant cases
  * **Ramosetron, loperamide**: For diarrhea-predominant cases
{: .notice--info}

### Simple Intestinal Obstruction / ÂçòÁ¥îÊÄßËÖ∏ÈñâÂ°û

* **Overview**
  * Mechanical bowel obstruction without vascular compromise
  * Most commonly due to postoperative adhesions, also due to colon cancer
* **Presentation**
  * **Intermittent abdominal pain, distension, vomiting, absence of defecation**: Gradual progression of obstruction
* **Examination**
  * **[Physical] Increased bowel sounds, metallic sounds, tympanic sound, visible peristalsis**: Signs of obstruction
  * **[Blood] Hemoconcentration, metabolic alkalosis**: Due to dehydration and vomiting
  * **[X-ray] Dilated bowel loops, niveau**: Gas and fluid accumulation in lumen
* **Management**
  * **NPO, IV fluids**: Correct dehydration and electrolyte imbalance
  * **Nasogastric/ileus tube**: Decompress bowel
  * **Antibiotics**: Prevent sepsis from bacterial overgrowth
  * **Surgery**: For resistant cases
{: .notice--info}

### Complex Intestinal Obstruction / Ë§áÈõëÊÄßËÖ∏ÈñâÂ°û

* **Overview**
  * Mechanical bowel obstruction with vascular compromise
  * Causes include adhesions, intussusception, volvulus, incarcerated hernia
* **Presentation**
  * **Sudden onset severe abdominal pain, vomiting, distension, shock**: Rapid progression
* **Examination**
  * **[Physical] Severe tenderness, decreased bowel sounds, muscle guarding, rebound tenderness**: Peritoneal irritation
  * **[Blood] Hemoconcentration, WBC‚Üë, CK‚Üë, LDH‚Üë, metabolic acidosis**: Indicates bowel necrosis
  * **[X-ray] Gasless abdomen, niveau**: Fluid accumulation in lumen
  * **[Contrast CT] Severe bowel wall edema, poor enhancement, ascites**: Confirms strangulation
* **Management**
  * **IV fluids, antibiotics**: Initial stabilization
  * **Surgery (release strangulation, resect necrotic bowel)**: Emergency surgery
{: .notice--info}

### Paralytic Ileus / È∫ªÁó∫ÊÄß„Ç§„É¨„Ç¶„Çπ

* **Overview**
  * Functional ileus due to impaired intestinal nerve and muscle function
  * Causes include post-surgery, acute peritonitis, acute mesenteric artery occlusion, diabetes, medications
* **Presentation**
  * **Minimal pain, abdominal distension**: Due to intestinal paralysis
* **Examination**
  * **[Physical] Decreased bowel sounds**: Intestinal paralysis
  * **[X-ray] Dilated bowel loops, air-fluid levels**: Gas and fluid accumulation in lumen
* **Management**
  * **Treat underlying cause**: Primary treatment
  * **Metoclopramide, neostigmine**: Improve intestinal motility
  * **Nasogastric/ileus tube**: Decompress bowel
{: .notice--info}

### Superior Mesenteric Artery Syndrome / ‰∏äËÖ∏ÈñìËÜúÂãïËÑàÁóáÂÄôÁæ§

* **Overview**
  * Compression of horizontal part of duodenum between superior mesenteric artery and aorta/vertebrae
  * Common in thin females
* **Presentation**
  * **Nausea, vomiting, loss of appetite, upper abdominal pain**: Due to duodenal obstruction
* **Examination**
  * **[Upper GI series] Dilated proximal duodenum, cutoff at SMA crossing**: Duodenal compression
  * **[CT] Narrow aortomesenteric angle**: Confirms diagnosis
* **Management**
  * **Weight gain, positional changes**: Conservative treatment
  * **Duodenojejunostomy**: For resistant cases
{: .notice--info}

### Crohn's Disease / CrohnÁóÖ

* **Overview**
  * Granulomatous inflammatory disease with skip lesions affecting all layers of digestive tract wall
  * Common in 10-20s adults
* **Presentation**
  * **Abdominal pain, diarrhea**: Transmural inflammation of intestinal wall
  * **Fever, weight loss**: Systemic inflammation
  * **Perianal abscess/fistula, oral aphthae, arthritis**: Extra-intestinal manifestations
* **Examination**
  * **[Blood] Anemia, WBC‚Üë, CRP‚Üë, ESR‚Üë, hypoproteinemia**: Chronic inflammation
  * **[Endoscopy] Skip lesions, longitudinal ulcers, cobblestone appearance, strictures, fistulas**: Non-continuous inflammation
  * **[Biopsy] Non-caseating epithelioid granulomas**: Chronic granulomatous inflammation
* **Management**
  * **Nutritional therapy (enteral nutrition, TPN)**: Rest bowel and eliminate dietary allergens
  * **Corticosteroids, 5-ASA (mesalazine, sulfasalazine)**: Anti-inflammatory drugs for remission induction
  * **5-ASA, biologics (anti-TNF-Œ±, anti-IL-12/23, anti-integrin), immunomodulators (azathioprine, mercaptopurine)**: Anti-inflammatory drugs for remission maintenance
  * **Surgery**: For strictures, fistula, bleeding
{: .notice--info}

### Ulcerative Colitis / ÊΩ∞ÁòçÊÄßÂ§ßËÖ∏ÁÇé

* **Overview**
  * Diffuse inflammatory disease with continuous lesions affecting colonic mucosa
  * Common in 10-30s adults
* **Presentation**
  * **Bloody diarrhea, abdominal pain, tenesmus**: Mucosal inflammation and ulceration
  * **Fever, weight loss**: Systemic inflammation
* **Examination**
  * **[Blood] Anemia, CRP‚Üë, ESR‚Üë, hypoproteinemia**: Chronic inflammation
  * **[Endoscopy] Continuous lesions, loss of vascular pattern, erosions/ulcers, pseudopolyps, loss of haustra**: Continuous inflammation from rectum
  * **[Biopsy] Diffuse inflammatory cell infiltration, crypt abscess, reduced goblet cells**: Chronic mucosal inflammation
* **Management**
  * **5-ASA (mesalazine, sulfasalazine), corticosteroids, calcineurin inhibitors (tacrolimus, cyclosporine)**: Anti-inflammatory drugs for remission induction
  * **5-ASA, immunomodulators (azathioprine, mercaptopurine) , biologics (anti-TNF-Œ±, anti-integrin), JAK inhibitors**: Anti-inflammatory drugs for remission maintenance
  * **Surgery (total colectomy)**: For refractory cases, cancer, toxic megacolon
{: .notice--info}

### Intestinal Tuberculosis / ËÖ∏ÁµêÊ†∏

* **Overview**
  * Tuberculosis infection of intestinal tract causing ulcers and scarring
* **Presentation**
  * **Abdominal pain, diarrhea, bloody stool**: Intestinal inflammation and ulceration
  * **Fever, weight loss**: Systemic effects of TB infection
* **Examination**
  * **[Endoscopy] Deformed ileocecal valve, ulcers**: Characteristic TB changes
  * **[Biopsy] Granulomas, caseous necrosis**: Confirms TB infection
* **Management**
  * **Anti-tuberculosis drugs**: Standard TB treatment
{: .notice--info}

### Pseudomembranous Colitis / ÂÅΩËÜúÊÄßÂ§ßËÖ∏ÁÇé

* **Overview**
  * Caused by Clostridioides difficile overgrowth after antibiotic use
  * Common in elderly and patients with underlying diseases
* **Presentation**
  * **Watery diarrhea, abdominal pain, fever (after antibiotic use)**: CD toxin damage colonic mucosa
* **Examination**
  * **[Blood] WBC‚Üë, CRP‚Üë**: Inflammatory response
  * **[Stool] CD toxin A/B positive, GDH antigen positive, culture positive**: Confirms C. difficile infection
  * **[Endoscopy] Multiple yellow-white pseudomembranes**: Lesions due to CD toxin
* **Management**
  * **Discontinue causative antibiotics**: Primary intervention
  * **Metronidazole, vancomycin**: Treat C. difficile infection
  * **Fidaxomicin, anti-toxin B antibody, fecal transplantation**: For refractory cases
{: .notice--info}

### Ischemic Colitis / ËôöË°ÄÊÄßÂ§ßËÖ∏ÁÇé

* **Overview**
  * Small vessel ischemia leading to localized mucosal damage in colon
  * Common in elderly with atherosclerotic risk factors
* **Presentation**
  * **Sudden left lower abdominal pain**: Ischemia primarily affects left colon
  * **Diarrhea, bloody stool**: Mucosal damage and inflammation
* **Examination**
  * **[Endoscopy] Mucosal edema, erosions, submucosal hemorrhage, longitudinal ulcers**: Mucosal damage in left colon
  * **[Barium enema] Thumb printing sign, longitudinal ulcers**: Mucosal edema in left colon
* **Management**
  * **Rest, fasting, fluid therapy**: Conservative treatment
  * **Balloon dilation, emergency surgery**: For stricture or gangrenous type
{: .notice--info} 

### Acute Mesenteric Artery Occlusion / ÊÄ•ÊÄßËÖ∏ÈñìËÜúÂãïËÑàÈñâÂ°ûÁóá

* **Overview**
  * Acute occlusion of mesenteric artery (mainly SMA) leading to bowel necrosis, peritonitis, and sepsis
  * Common in patients with atrial fibrillation, valvular diseases, or atherosclerosis
* **Presentation**
  * **Sudden severe abdominal pain, nausea, vomiting**: Visceral ischemia
  * **Peritoneal signs, paralytic ileus, shock**: Bowel necrosis and peritonitis
* **Examination**
  * **[Contrast CT] Filling defect in SMA, poor bowel wall enhancement**: Arterial occlusion and bowel ischemia
* **Management**
  * **Emergency laparotomy**: Remove thrombus and resect necrotic bowel
  * **Thrombolytic, vasodilator drugs**: Catheter infusion before surgery
{: .notice--info}

### Acute Appendicitis / ÊÄ•ÊÄßËô´ÂûÇÁÇé

* **Overview**
  * Acute inflammation of appendix due to obstruction by fecalith, food debris, or lymphoid hyperplasia
  * Common in 10-20s children and adults
* **Presentation**
  * **Initial epigastric/periumbilical pain, anorexia, nausea, vomiting**: Visceral pain from appendiceal distention
  * **Later right lower quadrant pain, low-grade fever**: Somatic pain due to peritoneal inflammation
* **Examination**
  * **[Physical] McBurney's point tenderness, rebound tenderness (Blumberg sign), muscle guarding**: Peritoneal irritation
  * **[Blood] WBC‚Üë, CRP‚Üë**: Acute inflammation
  * **[Ultrasound, CT] Enlarged appendix, fecalith, surrounding exudate**: Confirms appendiceal inflammation
* **Management**
  * **Appendectomy**: Remove inflamed appendix
  * **Antibiotics, fasting**: Conservative treatment
{: .notice--info}

### Colonic Diverticulitis / Â§ßËÖ∏ÊÜ©ÂÆ§ÁÇé

* **Overview**
  * Inflammation of colonic diverticula due to fecal impaction and bacterial overgrowth
  * Common in middle-aged to elderly adults with chronic constipation
* **Presentation**
  * **Lower abdominal pain and tenderness, low-grade fever**: Local inflammation around diverticulum
* **Examination**
  * **[Blood] WBC‚Üë, CRP‚Üë**: Acute inflammation
  * **[CT] Thickened bowel wall, surrounding inflammation**: Inflammation around diverticulum
  * **[Colonoscopy, Barium enema] Diverticula at tender points**: Visualization of diverticulum
* **Management**
  * **Fasting, IV fluids, antibiotics**: Conservative treatment
  * **Abscess drainage, colectomy**: For abscess or perforation
{: .notice--info}

### Colonic Diverticular Hemorrhage / Â§ßËÖ∏ÊÜ©ÂÆ§Âá∫Ë°Ä

* **Overview**
  * Bleeding of colonic diverticula
  * Common in elderly
* **Presentation**
  * **Painless bleeding, bloody stool**: Direct bleeding from diverticular vessels
* **Examination**
  * **[Endoscopy] Active bleeding from diverticula**: Confirms diagnosis
  * **[Contrast CT] Identifies bleeding site**: Localization of bleeding
* **Management**
  * **Rest, fasting, IV fluids**: Conservative treatment
  * **Endoscopic hemostasis (clipping, ligation)**: For active bleeding with identified source
  * **Transcatheter arterial embolization (TAE)**: For massive bleeding
{: .notice--info}

### Gastrointestinal Neuroendocrine Neoplasm / Ê∂àÂåñÁÆ°Á•ûÁµåÂÜÖÂàÜÊ≥åËÖ´Áòç

* **Overview**
  * Slow-growing but malignant submucosal tumors, classified as well-differentiated NET or poorly-differentiated NEC
* **Presentation**
  * **Asymptomatic, GI bleeding, abdominal pain**: Due to local tumor growth
  * **Flushing, wheezing, diarrhea**: Carcinoid syndrome due to hormone secretion
* **Examination**
  * **[Endoscopy] Smooth elevated lesion, bridging fold, delle**: Submucosal tumor
  * **[Urine, Blood] 5-HIAA‚Üë, Serotonin‚Üë**: Hormone production by tumor
  * **[Biopsy] Small uniform cells in cord/ribbon/rosette pattern, chromogranin A(+), silver stain(+)**: Confirms diagnosis
* **Management**
  * **Surgical resection, EMR**: For resectable cases
  * **Octreotide, lanreotide, everolimus, streptozocin**: For unresectable cases and carcinoid syndrome
{: .notice--info}

### Colonic Polyps / Â§ßËÖ∏„Éù„É™„Éº„Éó

* **Overview**
  * Protruding lesions from colonic mucosa into lumen, most commonly adenomas (neoplastic) or hyperplastic polyps (non-neoplastic)
* **Presentation**
  * **Asymptomatic, positive fecal occult blood test**: Found during screening
  * **Bloody stool**: With larger polyps
* **Examination**
  * **[Endoscopy] Protruding lesions, pit pattern analysis**: Determines polyp type and risk
  * **[Pathology] Adenoma, hyperplastic, serrated lesions**: Confirm polyp type
* **Management**
  * **Observation**: Small hyperplastic polyps
  * **Polypectomy, EMR**: For large symptomatic polyps or suspected cancer
{: .notice--info}

### Colorectal Cancer / Â§ßËÖ∏Áôå

* **Overview**
  * Malignant tumor arising from colon/rectal mucosa, mostly adenocarcinoma
  * Common in 50-70s adults
* **Presentation**
  * **Asymptomatic, positive fecal occult blood test**: Found during screening
  * **Constipation, diarrhea, bloody stool, thin stools, abdominal pain**: Due to tumor growth and obstruction
* **Examination**
  * **[Endoscopy] Elevated or depressed lesions, pit pattern analysis**: Early colorectal cancer (‚â§submucosal invasion)
  * **[Endoscopy] Ulcerative lesions with raised edges**: Advanced colorectal cancer (‚â•muscularis propria invasion)
  * **[Barium enema] Irregular filling defects, apple core sign**: Tumor causing luminal narrowing
  * **[Blood] Anemia, CEA‚Üë, CA19-9‚Üë**: Tumor markers (especially with liver metastasis)
  * **[CT] Multiple low-density areas in liver**: Common site of metastasis
* **Management**
  * **[Early] Polypectomy, EMR, ESD**: For early tumor
  * **[Advanced] Surgical resection + lymph node dissection**: For advanced tumor
  * **[Metastasis] Chemotherapy (FOLFOX/FOLFIRI), surgical resection**: For metastatic tumor
{: .notice--info}

### Familial Adenomatous Polyposis / ÂÆ∂ÊóèÊÄßÂ§ßËÖ∏ËÖ∫ËÖ´Áóá

* **Overview**
  * Multiple adenomatous polyps throughout colon with risk of developing cancer, autosomal dominant disorder caused by APC gene mutation
  * Common in 15-40s adults with familial history
* **Presentation**
  * **Bloody stools, diarrhea, abdominal pain**: Due to numerous polyps
* **Examination**
  * **[Endoscopy, Barium enema] Numerous polyps throughout colon**
  * **[Biopsy] Adenomatous polyps**: Confirm polyps type
  * **[Genetic testing] APC gene mutation**: Confirms diagnosis
* **Management**
  * **Total colectomy**: Prevent development of colon cancer
  * **Endoscopic polypectomy, aspirin**: For cases with fewer polyps
{: .notice--info}

### Peutz-Jeghers Syndrome / Peutz-JeghersÁóáÂÄôÁæ§

* **Overview**
  * Multiple hamartomatous polyps throughout GI tract, autosomal dominant disorder caused by STK11/LKB1 gene mutation
* **Presentation**
  * **Mucocutaneous pigmentation around lips**: Resembling freckles/moles
  * **Abdominal pain, bloody stools**: GI symptoms due to polyps
* **Examination**
  * **[Endoscopy] Hamartomatous polyps**: Confirm polyps type
  * **[Genetic testing] STK11/LKB1 mutation**: Confirms diagnosis
* **Management**
  * **Endoscopic polypectomy**: For symptomatic or large polyps
{: .notice--info}

## Peritoneum Disorder / ËÖπËÜúÁñæÊÇ£

### Acute Peritonitis / ÊÄ•ÊÄßËÖπËÜúÁÇé

* **Overview**
  * Acute inflammation of peritoneum, may progress to septic shock or SIRS
  * Commonly secondary to GI perforation or appendicitis
* **Presentation**
  * **Severe abdominal pain, nausea, vomiting**: Peritoneal inflammation
  * **Fever, shallow breathing, tachycardia**: Systemic response
* **Examination**
  * **[Physical] Tenderness, muscle guarding, rebound tenderness, rigidity, reduced bowel sounds**: Peritoneal irritation
  * **[Blood] WBC‚Üë, CRP‚Üë**: Inflammatory response
  * **[X-ray, CT, Ultrasound] Free fluid, free air, abscess**: Identify cause and complications
  * **[Paracentesis] Fluid analysis**: Determine nature of inflammation
* **Management**
  * **IV fluids, antibiotics**: Stabilization and infection control
  * **Emergency surgery**: Treat underlying cause
{: .notice--info}

### Pseudomyxoma Peritonei / ËÖπËÜúÂÅΩÁ≤òÊ∂≤ËÖ´

* **Overview**
  * Low-grade mucin-producing tumors spreading in peritoneal cavity, usually originates from appendix or ovary
* **Presentation**
  * **Asymptomatic, abdominal distension, abdominal pain**: Accumulation of mucinous material
* **Examination**
  * **[CT] Jelly-like masses, septated fluid collections**: Mucinous deposits in peritoneal cavity
  * **[Pathology] Low-grade epithelial cells in mucin pools**: Characteristic finding
* **Management**
  * **Cytoreductive surgery**: Remove tumor and mucinous deposits
{: .notice--info}

### Inguinal Hernia / Èº†ÂæÑÈÉ®„Éò„É´„Éã„Ç¢

* **Overview**
  * Protrusion of abdominal contents through defects in inguinal area, divided into indirect inguinal (most common), direct inguinal, and femoral hernias
* **Presentation**
  * **[Indirect inguinal] Bulge above inguinal ligament, lateral to inferior epigastric vessels**: Common in male infants and adults
  * **[Direct inguinal] Bulge above inguinal ligament, medial to inferior epigastric vessels**: Common in middle-aged obese men
  * **[Femoral] Bulge below inguinal ligament**: Common in middle-aged women
* **Examination**
  * **[Physical] Location of bulge**: Distinguishes between types
  * **[Physical] Tenderness, redness**: Signs of incarceration
* **Management**
  * **[Children] High ligation of hernia sac**: Remove hernia sac
  * **[Adults] Mesh repair**: Strengthen weakened area
  * **[Incarcerated hernia] Manual reduction, emergency surgery**: Prevent complications
{: .notice--info}

## Anus Disorder / ËÇõÈñÄÁñæÊÇ£

### Hemorrhoids / ÁóîÊ†∏

* **Overview**
  * Enlargement of anal cushions due to weakening of supporting tissue and venous congestion, classified as grade I to IV
* **Presentation**
  * **Prolapse, bleeding during defecation**: Enlargement and congestion of hemorrhoidal tissue
  * **Severe pain in acute state**: Incarcerated internal hemorrhoids, thrombosed external hemorrhoids
* **Examination**
  * **[Physical] Digital rectal exam, anoscopy**: Assess location and severity
* **Management**
  * **Suppositories, ointments**: Conservative treatment
  * **ALTA injection**: Sclerotherapy for internal hemorrhoids
  * **Surgical ligation and excision**: For Grade III-IV hemorrhoids
{: .notice--info}

### Perianal Abscess and Anal Fistula / ËÇõÈñÄÂë®Âõ≤ËÜøÁòç„ÉªÁóîÁòª

* **Overview**
  * Bacterial infection of anal glands leads to perianal abscess, can develop into chronic fistula
  * Common in males aged 30-40s, associated with Crohn's disease
* **Presentation**
  * **[Perianal Abscess] Severe anal pain, fever, perianal mass and redness**: Acute bacterial infection
  * **[Anal Fistula] Persistent pus drainage, intermittent swelling and tenderness**: Chronic infection with fistula formation
* **Examination**
  * **[Physical] Primary and secondary opening**: Identifies fistula
* **Management**
  * **[Perianal Abscess] Drainage, antibiotics**: Treat acute infection
  * **[Anal Fistula] Surgery**: Open fistula
{: .notice--info}

### Anal Fissure / Ë£ÇËÇõ

* **Overview**
  * Linear tear in anal canal epithelium caused by passage of hard stools
  * Common in young women, associated with constipation
* **Presentation**
  * **Pain during and after defecation, bleeding**: Tear in anal canal
  * **Anal stenosis**: Chronic inflammation and scarring
* **Examination**
  * **[Physical] Tear, sentinel pile, polyp**: Chronic inflammation leads to tissue changes
* **Management**
  * **Conservative treatment**: Primary treatment
  * **Surgery**: For severe cases
{: .notice--info}

## Liver Disorder / ËÇùÁñæÊÇ£

### Acute Viral Hepatitis / ÊÄ•ÊÄß„Ç¶„Ç§„É´„ÇπÊÄßËÇùÁÇé

* **Overview**
  * Acute liver inflammation caused by hepatitis viruses (A-E), generally self-limiting but risk of fulminant hepatitis or chronicity
  * Transmitted through fecal-oral route (HAV, HEV) or blood/body fluids (HBV, HCV, HDV)
* **Presentation**
  * **Fatigue, anorexia, nausea, vomiting, fever, muscle pain**: Systemic inflammatory response
  * **Jaundice, dark urine, hepatomegaly, abdominal pain**: Liver inflammation and dysfunction
* **Examination**
  * **[Blood] AST‚Üë, ALT‚Üë, bilirubin‚Üë, PT prolonged**: Hepatocyte damage and liver dysfunction
  * **[Blood] IgM-HA-Ab, HBs-Ag, IgM-HBc-Ab, HCV-RNA, HCV-Ab**: Acute viral infection
* **Management**
  * **Bed rest**: Increase hepatic blood flow
  * **Diet therapy**: Carbohydrate-rich diet, protein restriction
  * **[HBV] Lamivudine**: For HBV severe cases
  * **[HCV] Direct-acting antivirals**: For HCV chronic cases
{: .notice--info}

### Chronic Viral Hepatitis / ÊÖ¢ÊÄßËÇùÁÇé

* **Overview**
  * Chronic liver inflammation >6 months, can progress to liver cirrhosis and hepatocellular carcinoma
  * Mainly caused by chronic infection of HBV or HCV
* **Presentation**
  * **Asymptomatic, general fatigue, poor appetite**: Chronic liver inflammation
* **Examination**
  * **[Blood] AST‚Üë, ALT‚Üë**: Liver cell damage
  * **[Blood] HBs-Ag , IgG-HBc-Ab, HCV-RNA, HCV-Ab**: Chronic viral infection
  * **[Liver biopsy] Bridging fibrosis, piecemeal necrosis**: Chronic inflammation and fibrosis
* **Management**
  * **[HBV] Pegylated interferon, entecavir, tenofovir**: Suppress HBV replication
  * **[HCV] Direct acting antivirals**: Suppress HCV replication
  * **UDCA, glycyrrhizin**: Liver protection
{: .notice--info}

### Fulminant Hepatitis / ÂäáÁóáËÇùÁÇé

* **Overview**
  * Acute liver failure with hepatic encephalopathy within 8 weeks of symptom onset
  * Commonly after acute hepatitis (viral, metabolic, autoimmune)
* **Presentation**
  * **High fever, tachycardia, anorexia, nausea, vomiting**: Systemic inflammatory response
  * **Jaundice, ascites, edema**: Liver dysfunction
  * **Hepatic encephalopathy**: Ammonia toxicity and cerebral edema
* **Examination**
  * **[Blood] AST‚Üë, ALT‚Üë, bilirubin‚Üë, LDH‚Üë**: Severe hepatocellular damage
  * **[Blood] PT<40%, INR>1.5, albumin‚Üì, ChE‚Üì**: Impaired liver synthesis
  * **[Blood] Fischer ratio‚Üì, NH3‚Üë**: Impaired liver metabolism
  * **[Imaging] Liver atrophy, ascites**: Advanced liver damage
* **Management**
  * **Glucose-based fluids, respiratory control, antibiotics**: Support vital functions
  * **Hemodiafiltration + plasma exchange**: Remove toxins artificially
  * **Lactulose (hepatic encephalopathy), mannitol (cerebral edema), FFP (coagulation dysfunction)**: Treat complications
  * **Antiviral therapy (HBV), steroids (autoimmune)**: Treat underlying cause
  * **Liver transplantation**: Definitive treatment
{: .notice--info}

### Liver Cirrhosis / ËÇùÁ°¨Â§â

* **Overview**
  * End-stage liver disease with fibrosis and regenerative nodules, leading to liver failure and hepatocellular carcinoma
  * Common in chronic viral hepatitis or alcoholism
* **Presentation**
  * **Asymptomatic, fatigue, anorexia, ascites, edema, jaundice**: Liver dysfunction
  * **Spider angiomas, palmar erythema, gynecomastia**: Estrogen excess due to impaired metabolism
  * **Esophageal varices, GI bleeding**: Portal hypertension
  * **Altered consciousness, flapping tremor**: Hepatic encephalopathy
  * **Fever, abdominal pain, peritoneal irritation**: Spontaneous bacterial peritonitis
* **Examination**
  * **[Blood] Pancytopenia (especially platelets)**: Hypersplenism
  * **[Blood] AST‚Üë, bilirubin‚Üë, Œ≥-GT‚Üë, ALP‚Üë**: Liver damage and cholestasis
  * **[Blood] PT prolonged, albumin‚Üì, ChE‚Üì**: Decreased synthetic function
  * **[Blood] Type IV collagen‚Üë, hyaluronic acid‚Üë**: Fibrosis markers
  * **[Imaging] Irregular liver surface, blunt edge, splenomegaly, ascites**: Chronic liver disease
* **Management**
  * **Direct-acting antivirals, nucleoside analogues**: Treat underlying cause
  * **High-energy low-salt diet, glycyrrhizin, UDCA**: Liver protection
  * **[Ascites] Salt restriction, diuretics, albumin**: Manage fluid
  * **[Varices] Endoscopic treatment**: Prevent bleeding
  * **[Encephalopathy] Low-protein diet, lactulose, branched-chain amino acids**: Maintain consciousness 
  * **[Peritonitis] Antibiotics**: Control infection
  * **Liver transplantation**: Ultimate treatment
{: .notice--info}

### Liver Abscess / ËÇùËÜøÁòç

* **Overview**
  * Infectious collection in liver caused by bacteria (gram-negative rods) or amebae
  * Infection routes include biliary tract, portal vein, hepatic artery, direct spread
* **Presentation**
  * **Fever, general fatigue**: Systemic inflammatory response
  * **RUQ pain, hepatomegaly, liver tenderness**: Enlarged inflamed liver
* **Examination**
  * **[Blood] WBC‚Üë, ESR‚Üë, CRP‚Üë**: Infection
  * **[Blood] ALP‚Üë, Œ≥-GT‚Üë**: Cholestasis
  * **[Ultrasound] Heterogeneous hypoechoic lesion**: Abscess formation
  * **[CT] Ring-enhancing hypodense lesion**: Confirms abscess
  * **[Aspiration] Yellow malodorous pus (bacterial) or chocolate-colored viscous pus (amebic)**: Identifies causative pathogen
* **Management**
  * **[Bacterial] Antibiotics, percutaneous drainage**: Treat infection and remove pus
  * **[Amebic] Metronidazole**: Eliminate amebae
  * **Surgical drainage**: For failed percutaneous drainage or rupture
{: .notice--info}

### Fatty Liver / ËÑÇËÇ™ËÇù

* **Overview**
  * Abnormal accumulation of triglycerides in liver
  * Major causes include alcohol, obesity, diabetes mellitus
* **Presentation**
  * **Asymptomatic, RUQ heaviness/pain**: Enlarged liver
* **Examination**
  * **[Ultrasound] Bright liver, increased hepatorenal contrast, deep echo attenuation, blurred vessels**: Fat accumulation
  * **[CT] Low density liver**: Fat accumulation
  * **[Liver biopsy] Fat deposits**: Confirms diagnosis
* **Management**
  * **Alcohol cessation**: Treat alcoholism 
  * **Calorie restriction, diet modification, exercise**: Treat obesity
{: .notice--info}

### Alcoholic Hepatitis / „Ç¢„É´„Ç≥„Éº„É´ÊÄßËÇùÁÇé

* **Overview**
  * Acute alcoholic liver injury triggered by sudden increase in alcohol consumption
  * Common in chronic heavy drinkers
* **Presentation**
  * **Abdominal pain, fever, vomiting, diarrhea**: Acute liver inflammation
  * **Jaundice, altered consciousness, hepatomegaly**: Liver dysfunction
* **Examination**
  * **[Blood] AST‚Üë (AST>ALT), WBC‚Üë, Œ≥-GT‚Üë, ALP‚Üë**: Liver damage and cholestasis
  * **[Liver biopsy] Hepatocyte ballooning, Mallory-Denk bodies, neutrophil infiltration**: Confirms diagnosis
* **Management**
  * **Alcohol cessation**: Treat alcoholism
  * **Vitamin B1, hydration, balanced diet**: Nutritional support
  * **Glycyrrhizin, UDCA**: Liver protection
  * **Corticosteroids, plasma exchange, hemodiafiltration**: Treatment for severe inflammation
{: .notice--info}

### Non-alcoholic Steatohepatitis / Èùû„Ç¢„É´„Ç≥„Éº„É´ÊÄßËÑÇËÇ™ËÇùÁÇé

* **Overview**
  * Advanced non-alcoholic fatty liver disease with hepatocyte inflammation
  * Common in obesity, diabetes mellitus, hypertension
* **Presentation**
  * **Fatigue, insomnia, hepatomegaly**: Liver dysfunction
* **Examination**
  * **[Blood] AST‚Üë, Œ≥-GT‚Üë, platelets‚Üì, hyaluronic acid‚Üë, ferritin‚Üë, TG‚Üë, T.Cho‚Üë**: Liver dysfunction with metabolic abnormalities
  * **[Ultrasound] Bright liver, increased hepatorenal contrast, deep echo attenuation**: Fat accumulation
  * **[CT] Low liver density**: Fat accumulation
  * **[Liver biopsy] Steatosis, hepatocyte ballooning, inflammation**: Confirms diagnosis
* **Management**
  * **Diet, exercise therapy**: Treat obesity
  * **Pioglitazone (diabetes), statins (hyperlipidemia), ARBs (hypertension)**: Treat underlying disease
  * **Vitamin E**: Liver protection
{: .notice--info}

### Drug-Induced Liver Injury / Ëñ¨Áâ©ÊÄßËÇùÈöúÂÆ≥

* **Overview**
  * Hepatocellular injury or cholestasis due to drug toxicity
  * Common causes include antibiotics, antipyretic analgesics, herbal medicines, supplements
* **Presentation**
  * **Asymptomatic, fatigue, fever, rash, jaundice, pruritus**: Liver injury with various severity
* **Examination**
  * **[Blood]ALT‚Üë, AST‚Üë**: Liver cell damage
  * **[Blood] ALP‚Üë, Œ≥-GT‚Üë, T.Bil‚Üë**: Bile stasis
  * **[Blood] Eosinophils‚Üë**: Allergic reaction
* **Management**
  * **Drug discontinuation**: Improvement in most cases
  * **Glycyrrhizin, UDCA, corticosteroids**: Liver protection
  * **N-acetylcysteine**: For acetaminophen toxicity
{: .notice--info}

### Autoimmune Hepatitis / Ëá™Â∑±ÂÖçÁñ´ÊÄßËÇùÁÇé

* **Overview**
  * Chronic progressive liver disease of autoimmune origin
  * Common in middle-aged women, often associated with other autoimmune diseases
* **Presentation**
  * **Asymptomatic, fatigue, jaundice, poor appetite**: Chronic liver inflammation
  * **Fever, joint pain, rash**: Systemic autoimmune manifestations
* **Examination**
  * **[Blood] ALT‚Üë (ALT>AST), bilirubin‚Üë**: Liver cell damage
  * **[Blood] Œ≥-globulin‚Üë, IgG‚Üë, ESR‚Üë, CRP‚Üë**: Inflammatory response
  * **[Blood] ANA(+), anti-smooth muscle antibody(+)**: Autoimmune nature
  * **[Liver biopsy] Interface hepatitis, liver cell necrosis**: Confirms diagnosis
* **Management**
  * **Corticosteroids, azathioprine**: Anti-inflammatory and immunosuppressive
  * **UDCA**: Liver protection
  * **Liver transplantation**: For advanced cases
{: .notice--info}

### Primary Biliary Cholangitis / ÂéüÁô∫ÊÄßËÉÜÊ±ÅÊÄßËÉÜÁÆ°ÁÇé

* **Overview**
  * Chronic intrahepatic cholestasis characterized by chronic nonsuppurative destructive cholangitis
  * Common in middle-aged women, often associated with other autoimmune diseases
* **Presentation**
  * **Asymptomatic, pruritus, jaundice**: Bile stasis
* **Examination**
  * **[Blood] ALP‚Üë, Œ≥-GT‚Üë, T.Cho‚Üë, bilirubin‚Üë**: Cholestasis
  * **[Blood] Eosinophils‚Üë, ESR‚Üë, IgM‚Üë**: Inflammatory response
  * **[Blood] Anti-mitochondrial antibody(+)**: Autoimmune nature
  * **[Liver biopsy] Chronic nonsuppurative destructive cholangitis**: Confirms diagnosis
* **Management**
  * **UDCA, bezafibrate**: Improve bile flow
  * **Cholestyramine, antihistamines**: For pruritus
  * **Liver transplantation**: For advanced cases
{: .notice--info}

### Idiopathic Portal Hypertension / ÁâπÁô∫ÊÄßÈñÄËÑàÂúß‰∫¢ÈÄ≤Áóá

* **Overview**
  * Portal hypertension without cirrhosis or portal/hepatic vein obstruction
  * Common in middle-aged women, often associated with autoimmune diseases
* **Presentation**
  * **Esophageal varices, splenomegaly, pancytopenia**: Due to portal hypertension
* **Examination**
  * **[Blood] Œ≥-globulin‚Üë, autoantibodies**: Suggests autoimmune background
* **Management**
  * **Endoscopic treatment**: For esophageal varices
  * **Partial splenic embolization, splenectomy**: For hypersplenism
{: .notice--info}

### Budd-Chiari Syndrome / Budd-ChiariÁóáÂÄôÁæ§

* **Overview**
  * Obstruction/stenosis of hepatic veins or inferior vena cava, causing post-hepatic portal hypertension
  * Primary (coagulation disorders, myeloproliferative disorders) or secondary (liver cancer, thrombosis, heart failure)
* **Presentation**
  * **[Acute] Abdominal pain, ascites, fever**: Rapid development of hepatic congestion
  * **[Chronic] Asymptomatic, progressive portal hypertension**: Gradual hepatic congestion
* **Examination**
  * **[Blood] AST‚Üë, ALT‚Üë**: Liver cell damage
  * **[Imaging] Obstruction/stenosis of hepatic veins or IVC**: Direct visualization of blockage
* **Management**
  * **Balloon angioplasty, surgical shunting**: Widen or bypass obstructed vessels
{: .notice--info}

### Hepatic Cyst / ËÇùÂõäËÉû

* **Overview**
  * Fluid-filled sacs in liver, mostly benign but can be polycystic liver disease or echinococcus
* **Presentation**
  * **Asymptomatic**: In most cases
  * **Abdominal discomfort , obstructive jaundice**: In large cysts
* **Examination**
  * **[Ultrasound] Anechoic lesion, posterior acoustic enhancement**: Fluid-filled cyst
  * **[CT, MRI] Well-defined fluid-density lesion**: Confirms cyst
* **Management**
  * **Observation**: For asymptomatic cases
  * **Aspiration, surgical resection**: For symptomatic cases
{: .notice--info}

### Hepatic Hemangioma / ËÇùË°ÄÁÆ°ËÖ´

* **Overview**
  * Most common benign primary liver tumor
  * Common in middle-aged women
* **Presentation**
  * **Asymptomatic**: In most cases
  * **Abdominal discomfort, bleeding tendency**: In large tumors or consumption coagulopathy
* **Examination**
  * **[Ultrasound] Hyperechoic lesion**: Endothelium-rich tumor
  * **[CT, MRI] Peripheral nodular enhancement, centripetal filling**: Characteristic vascular pattern
* **Management**
  * **Observation**: For asymptomatic cases
  * **Surgical resection**: For symptomatic cases
{: .notice--info}

### Hepatocellular Carcinoma / ËÇùÁ¥∞ËÉûÁôå

* **Overview**
  * Malignant tumor from hepatocytes, characterized by multistep and multicentric carcinogenesis
  * Common in patients with chronic liver diseases (viral hepatitis B/C, NASH)
* **Presentation**
  * **Asymptomatic**: Often found during screening
* **Examination**
  * **[Blood] AFP‚Üë, PIVKA-II‚Üë, AFP-L3‚Üë**: Tumor markers
  * **[Ultrasound] Well-defined nodule with halo, mosaic pattern**: Tumor with capsule and septum
  * **[Contrast CT/MRI] Hyperenhancement in arterial phase, washout in portal/delayed phase**: Hypervascular tumor
* **Management**
  * **[Child-Pugh A/B, local] Resection, ablation, chemoembolization**: For local compensated tumor
  * **[Child-Pugh A/B, metastatic] Targeted therapy**: For metastatic compensated tumor
  * **[Child-Pugh C] Liver transplantation, palliative care**: For uncompensated tumor
{: .notice--info}

### Intrahepatic Cholangiocarcinoma / ËÇùÂÜÖËÉÜÁÆ°Áôå

* **Overview**
  * Malignant tumor from intrahepatic bile duct epithelium
* **Presentation**
  * **Asymptomatic, obstructive jaundice**: Depend on hilar or peripheral types
* **Examination**
  * **[Blood] ALP‚Üë, Œ≥-GT‚Üë, bilirubin‚Üë**: Bile duct obstruction
  * **[Blood] CA19-9‚Üë, CEA‚Üë**: Tumor markers
  * **[CT/MRI] Delayed enhancement, bile duct dilatation**: Differentiate from HCC
* **Management**
  * **Surgical resection**: For local tumor
  * **Gemcitabine + Cisplatin**: For metastatic tumor
{: .notice--info}

### Metastatic Liver Cancer / Ëª¢ÁßªÊÄßËÇùÁôå

* **Overview**
  * Metastatic tumor from other organ, more common than primary liver cancer
  * Common primary sites: colorectal, pancreatic, gastric, biliary tract, lung, breast, ovarian cancer
* **Presentation**
  * **Asymptomatic**: Often found during screening
  * **Abdominal distension, jaundice, ascites, anorexia**: Liver dysfunction in advanced disease
* **Examination**
  * **[Blood] CEA‚Üë (colorectal), CA19-9‚Üë (pancreatic/biliary)**: Primary tumor markers
  * **[Blood] ALP‚Üë, Œ≥-GT‚Üë, LDH‚Üë**: Cholestasis
  * **[Ultrasound] Bull's eye sign**: Tumor with capsule and central necrosis
  * **[CT] Ring enhancement of hypodense lesions**: Tumor with capsule and central necrosis
* **Management**
  * **Surgical resection**: For colorectal cancer and GIST
  * **Chemotherapy**: For most cancer
{: .notice--info}

## Biliary Tract Disorder / ËÉÜÈÅìÁñæÊÇ£

### Cholelithiasis / ËÉÜÁü≥Áóá

* **Overview**
  * Stones in biliary system (gallbladder, common bile duct, intrahepatic)
  * Common in middle-aged and older adults
* **Presentation**
  * **Asymptomatic, RUQ/epigastric pain after meals, radiate to right shoulder/back, nausea, vomiting**: Gallstone temporarily obstructs bile duct
* **Examination**
  * **[Blood] Œ≥-GT‚Üë, ALP‚Üë, bilirubin‚Üë**: Biliary obstruction
  * **[Ultrasound] High-echoic image, acoustic shadow**: Stone reflects sound waves
  * **[CT] High-density stone**: Visualize stones
  * **[MRCP, ERCP] Filling defects**: Visualize stones
* **Management**
  * **[Gallbladder stone] Observation, (asymptomatic), laparoscopic/open cholecystectomy (symptomatic), NSAID/anticholinergics**: Remove gallbladder with stones and control pain
  * **[CBD stone] Endoscopic sphincterotomy (EST), endoscopic papillary balloon dilatation (EPBD)**: Remove CBD stones
  * **[Intrahepatic stone] Percutaneous transhepatic cholangioscopy (PTCS), hepatectomy (atrophy, cancer)**: Remove intrahepatic stones or liver
{: .notice--info}

### Acute Cholecystitis / ÊÄ•ÊÄßËÉÜÂõäÁÇé

* **Overview**
  * Acute inflammation of gallbladder caused by gallstones impaction and bacterial infection
  * Common in middle-aged and older adults with gallstone history
* **Presentation**
  * **RUQ pain, fever, nausea, vomiting**: Gallbladder infection
  * **Tenderness, muscle guarding, Murphy's sign**: Local peritoneal irritation
* **Examination**
  * **[Blood] WBC‚Üë, CRP‚Üë**: Active infection
  * **[Blood] ALP‚Üë, Œ≥-GT‚Üë, bilirubin‚Üë**: Biliary obstruction
  * **[Ultrasound, CT] Gallbladder wall thickening, enlargement, debris, impacted stones, sonographic Murphy‚Äôs sign**: Gallbladder inflammation
* **Management**
  * **Fasting, IV fluids, antibiotics, analgesics**: Treat infection and pain
  * **Percutaneous transhepatic gallbladder drainage/aspiration (PTGBD)**: Reduce gallbladder pressure if unstable
  * **Laparoscopic cholecystectomy**: Remove gallbladder if stable
{: .notice--info}

### Acute Cholangitis / ÊÄ•ÊÄßËÉÜÁÆ°ÁÇé

* **Overview**
  * Acute inflammation of bile ducts caused by obstruction and bacterial infection, leading to sepsis in severe cases
  * Common in middle-aged and older adults with gallstone history
* **Presentation**
  * **Abdominal pain, fever with chills, jaundice (Charcot's triad)**: Bile duct infection and obstruction
  * **Shock, altered consciousness (Reynolds' pentad)**: Endotoxin and bacteria enter bloodstream in severe cases
* **Examination**
  * **[Blood] WBC‚Üë, CRP‚Üë**: Active infection
  * **[Blood] ALP‚Üë, Œ≥-GT‚Üë, bilirubin‚Üë**: Biliary obstruction
  * **[Blood] AST‚Üë, ALT‚Üë**: Liver damage
  * **[Ultrasound, CT] Dilated bile ducts, CBD stones**: CBD obstruction
* **Management**
  * **Fasting, IV fluids, antibiotics, analgesics**: Treat infection and pain
  * **Endoscopic biliary drainage (EBD), percutaneous transhepatic biliary drainage (PTBD)**: Reduce biliary tract pressure if unstable
  * **Endoscopic sphincterotomy (EST), endoscopic papillary balloon dilatation (EPBD)**: Remove stones if stable
{: .notice--info}

### Primary Sclerosing Cholangitis / ÂéüÁô∫ÊÄßÁ°¨ÂåñÊÄßËÉÜÁÆ°ÁÇé

* **Overview**
  * Progressive chronic inflammation of intra/extrahepatic bile ducts causing fibrous stenosis
  * Common in 20s and 60s adults, often associated with ulcerative colitis
* **Presentation**
  * **Asymptomatic, fluctuating jaundice, pruritus**: Cholestasis
* **Examination**
  * **[Blood] Œ≥-GT‚Üë, ALP‚Üë, bilirubin‚Üë**: Biliary obstruction
  * **[Blood] AST‚Üë, ALT‚Üë**: Liver damage
  * **[Blood] P-ANCA(+)**: Autoimmune nature
  * **[ERCP, MRCP] Intra/extrahepatic bile duct strictures (beaded appearance)**: Bile duct stenosis
* **Management**
  * **UDCA, bezafibrate, cholestyramine, antihistamines**: Improve bile flow and relieve pruritus
  * **Biliary drainage**: Control cholangitis and reduce jaundice
  * **Liver transplantation**: Only curative treatment for advanced cases
{: .notice--info}

### Congenital Biliary Dilatation / ÂÖàÂ§©ÊÄßËÉÜÈÅìÊã°ÂºµÁóá

* **Overview**
  * Congenital malformation with localized dilatation of extrahepatic bile ducts and pancreaticobiliary maljunction, high risk of biliary tract cancer
  * Common in children and young adults
* **Presentation**
  * **Asymptomatic, abdominal pain, jaundice, abdominal mass**: Biliary dilatation and bile stasis
* **Examination**
  * **[Blood] Œ≥-GT‚Üë, ALP‚Üë, amylase‚Üë**: Bile stasis and pancreatic enzyme reflux
  * **[CT, Ultrasound] Dilatation of CBD**: Biliary dilatation
  * **[MRCP, ERCP] Cystic/fusiform dilatation of CBD**: Biliary dilatation
  * **[MRCP, ERCP] Abnormal junction of pancreatic duct and CBD outside duodenal wall**: Pancreaticobiliary maljunction
* **Management**
  * **Extrahepatic bile duct resection, cholecystectomy, biliary reconstruction**: Prevent biliary tract cancer
{: .notice--info}

### Biliary Atresia / ËÉÜÈÅìÈñâÈéñÁóá

* **Overview**
  * Congenital obstruction of extrahepatic bile ducts
  * Common in female infants
* **Presentation**
  * **Prolonged jaundice, clay-colored stool**: Bile duct obstruction
  * **Bleeding tendency, bone abnormalities**: Fat-soluble vitamin malabsorption
* **Examination**
  * **[Blood] Œ≥-GT‚Üë, ALP‚Üë, bilirubin‚Üë**: Bile duct obstruction
  * **[CT, Ultrasound] Absent gallbladder or bile ducts**: Biliary atresia
* **Management**
  * **Kasai portoenterostomy**: Bypass biliary atresia
  * **Liver transplantation**: If Kasai procedure fails
{: .notice--info}

### Gallbladder Polyp / ËÉÜÂõä„Éù„É™„Éº„Éó

* **Overview**
  * Localized protruding lesions on gallbladder mucosa
* **Presentation**
  * **Asymptomatic**: Most cases
* **Examination**
  * **[Ultrasound] Protruding lesion in gallbladder**: Often found during screening
* **Management**
  * **Observation**: For typical polyps
  * **Cholecystectomy**: For polyp with cancer risk (>10mmm, broad-based)
{: .notice--info}

### Gallbladder Adenomyomatosis / ËÉÜÂõäËÖ∫Á≠ãËÖ´Áóá

* **Overview**
  * Excessive proliferation of Rokitansky-Aschoff sinuses, hyperplasia of gallbladder epithelium and smooth muscle
* **Presentation**
  * **Asymptomatic**: Most cases
* **Examination**
  * **[Ultrasound] Thickened gallbladder wall, comet-like echo**: Proliferated Rokitansky-Aschoff sinuses
  * **[MRCP] Pearl necklace appearance**: Proliferated Rokitansky-Aschoff sinuses
* **Management**
  * **Observation**: For asymptomatic cases
  * **Laparoscopic cholecystectomy**: For symptomatic cases or lesion with cancer risk
{: .notice--info}

### Gallbladder Cancer / ËÉÜÂõäÁôå

* **Overview**
  * Malignant tumor arising in gallbladder, poor prognosis due to late detection
  * Common in elderly females, risk factors include pancreaticobiliary maljunction and gallbladder dysplasia
* **Presentation**
  * **Asymptomatic, RUQ pain, nausea, vomiting, weight loss**: Local tumor effects
  * **Jaundice, pruritus**: Bile duct obstruction in advanced tumor
* **Examination**
  * **[Blood] ALP‚Üë, Œ≥-GT‚Üë**: Bile duct obstruction
  * **[Blood] CA19-9‚Üë, CEA‚Üë**: Tumor markers
  * **[Ultrasound] Irregular mass, wall thickening**: Suspicious lesions 
  * **[EUS, CT, MRCP, ERCP] Mass lesion, filling defect**: Assess extent of disease
* **Management**
  * **[Resectable] Cholecystectomy + gallbladder bed resection + lymph node dissection**: For local tumor 
  * **[Unresectable] Gemcitabine + cisplatin/S-1**: For metastatic tumor
  * **[Symptomatic] Biliary drainage (ENBD, stent)**: Relieve obstructive jaundice
{: .notice--info}

### Cholangiocarcinoma / ËÉÜÁÆ°Áôå

* **Overview**
  * Malignant tumor arising in extrehepatic bile duct, poor prognosis due to late detection
  * Common in elderly males, risk factors include pancreaticobiliary maljunction and primary sclerosing cholangitis
* **Presentation**
  * **Jaundice, pruritus, painless gallbladder enlargement (Courvoisier's sign)**: Bile duct obstruction
  * **Upper abdominal pain, weight loss, fever**: Local tumor effects
* **Examination**
  * **[Blood] ALP‚Üë, Œ≥-GT‚Üë**: Bile duct obstruction
  * **[Blood] CA19-9‚Üë, CEA‚Üë**: Tumor markers
  * **[Ultrasound] Dilated bile ducts, mass lesion**: Tumor obstruction
  * **[EUS, CT, MRCP, ERCP] Mass lesion, filling defect**: Assess extent of disease
* **Management**
  * **[Resectable] Hepatectomy + bile duct resection + lymph node dissection**: For local tumor in hilar region
  * **[Resectable] Pancreaticoduodenectomy + lymph node dissection**: For local tumor in distal region
  * **[Unresectable] Gemcitabine + cisplatin/S-1**: For metastatic tumor
  * **[Symptomatic] Biliary drainage (ENBD, stent, PTBD)**: Relieve obstructive jaundice
{: .notice--info}

### Peripapillary Carcinoma / ‰π≥È†≠ÈÉ®Áôå

* **Overview**
  * Malignant tumor arising in ampulla of Vater
  * Common in 60s males
* **Presentation**
  * **Fluctuating jaundice, dark urine, painless gallbladder enlargement (Courvoisier's sign)**: Bile duct obstruction
  * **Fever, abdominal pain**: Local tumor effects
* **Examination**
  * **[Blood] ALP‚Üë, Œ≥-GT‚Üë**: Bile duct obstruction
  * **[Blood] CA19-9‚Üë, CEA‚Üë**: Tumor markers
  * **[Ultrasound] Dilated pancreatic and bile ducts, mass lesion**: Tumor obstruction
  * **[Endoscopy] Irregular mass at duodenal papilla**: Direct visualization
  * **[EUS, CT, MRCP] Mass lesion, filling defect**: Assess extent of disease
* **Management**
  * **[Resectable] Pancreaticoduodenectomy + lymph node dissection**: For local tumor
  * **[Unresectable] Chemotherapy**: For metastatic tumor
  * **[Symptomatic] Biliary drainage (ENBD, stent, PTBD)**: Relieve obstructive jaundice
{: .notice--info}

## Pancreas Disorder / ËÜµÁñæÊÇ£

### Acute Pancreatitis / ÊÄ•ÊÄßËÜµÁÇé

* **Overview**
  * Self-digestion of pancreas by activated pancreatic enzymes, leading to multi-organ failure in severe cases
  * Common causes include alcohol and gallstones
* **Presentation**
  * **Epigastric/back pain, fever, nausea, vomiting**: Pancreatic inflammation, improves in knee-chest position
  * **Abdominal tenderness, muscle guarding, decreased bowel sounds**: Peritoneal irritation
  * **Shock, respiratory failure, oliguria, altered consciousness**: Cytokine storm due to pancreas self-digestion in severe cases
* **Examination**
  * **[Blood] Amylase‚Üë, lipase‚Üë**: Pancreatic enzyme activation
  * **[Blood] Platelets‚Üì, Ca‚Üì, CRP‚Üë, BUN‚Üë, Cr‚Üë, coagulation disorders**: Multi-organ dysfunction in severe cases
  * **[CT/MRI/US] Pancreatic swelling, blurred outline, fluid collection**: Pancreatic self-digestion
* **Management**
  * **NPO, IV fluids, pain control**: Conservative treatment in mild cases
  * **Antibiotics, protease inhibitors, enteral nutrition**: Prevent complications in severe cases
  * **ERCP, EST**: Resolve obstruction if gallstone present
  * **Drainage, necrosectomy**: Remove necrotic tissue
{: .notice--info}

### Chronic Pancreatitis / ÊÖ¢ÊÄßËÜµÁÇé

* **Overview**
  * Progressive and irreversible pancreatic damage with fibrosis and calcification
  * Common in middle-aged men with long-term alcohol use
* **Presentation**
  * **Recurrent epigastric/back pain**: Pancreatic inflammation, worsens with alcohol/fat intake
  * **Steatorrhea, diarrhea**: Exocrine insufficiency in decompensated stage
  * **Diabetes symptoms, weight loss**: Endocrine insufficiency in decompensated stage
* **Examination**
  * **[Blood] Amylase/lipase‚Üë or ‚Üì**: Compensated or decompensated pancreatic function
  * **[US/CT] Pancreatic duct dilation, pancreatic stones**: Pancreatic duct obstruction by stones
  * **[MRCP/ERCP] Pancreatic duct dilation, filling defects**: Pancreatic duct obstruction by stones
  * **[BT-PABA test] PABA excretion‚Üì**: Exocrine insufficiency
* **Management**
  * **Alcohol/smoking cessation, low-fat diet**: Prevent progression
  * **NSAIDs, anticholinergics, enzyme inhibitors**: Relieve symptoms
  * **ESWL, endoscopic treatment**: Remove stones
  * **Pancreatic enzymes, insulin**: For exocrine and endocrine insufficiency
{: .notice--info}

### Autoimmune Pancreatitis / Ëá™Â∑±ÂÖçÁñ´ÊÄßËÜµÁÇé

* **Overview**
  * Chronic progressive pancreatitis with autoimmune nature
  * Common in elderly males
* **Presentation**
  * **Jaundice, epigastric discomfort**: Pancreatic inflammation
  * **Diabetes mellitus**: Pancreatic endocrine dysfunction
* **Examination**
  * **[Blood] Œ≥-globulin‚Üë, IgG‚Üë, IgG4‚Üë, ANA(+), RF(+)**: Autoimmune nature
  * **[Blood] Amylase‚Üë, lipase‚Üë, Œ≥-GT‚Üë, ALP‚Üë**: Pancreatic inflammation and biliary obstruction
  * **[CT/MRI/US] Pancreatic enlargement**: Pancreatic inflammation
  * **[ERCP/MRCP] Pancreatic duct narrowing**: Pancreas chronic inflammation
  * **[Biopsy] IgG4-positive plasma cell infiltration, fibrosis**: Confirms diagnosis
* **Management**
  * **Corticosteroids**: Suppress inflammation
{: .notice--info}

### Pancreatic Cancer / ËÜµÁôå

* **Overview**
  * Malignant tumor arising from pancreatic ductal epithelium, poor prognosis due to late detection
  * Common in elderly, risk factors include chronic pancreatitis, diabetes, smoking
* **Presentation**
  * **Abdominal/back pain**: Local tumor invasion
  * **Jaundice**: Biliary tract obstruction
  * **Weight loss, indigestion, diabetes**: Impaired pancreatic function
* **Examination**
  * **[Blood] Amylase‚Üë, lipase‚Üë**: Pancreatic damage
  * **[Blood] CA19-9‚Üë, SPAN-1‚Üë, DUPAN-2‚Üë, CEA‚Üë**: Tumor markers
  * **[CT, US] Hypovascular pancreatic mass, dilated pancreatic duct**: Tumor obstruction
  * **[MRCP, ERCP] Stenosis/obstruction of pancreatic/bile duct**: Tumor obstruction
  * **[EUS-FNA] Malignant ductal cells**: Confirmatory diagnosis
* **Management**
  * **[Resectable] Pancreaticoduodenectomy, distal pancreatectomy (with/without neoadjuvant/adjuvant therapy)**: For tumors without major vessel invasion
  * **[Unresectable] Chemotherapy (FOLFIRINOX, gemcitabine+nab-paclitaxel)**: For tumor with major vessel invasion or metastasis
  * **[Paliative] Biliary stenting, gastric bypass, pain control**: Symptom management
{: .notice--info}

### Pancreatic Pseudocyst / ËÜµ‰ªÆÊÄßÂõäËÉû

* **Overview**
  * Non-epithelial-lined pancreatic cyst formed by encapsulation of leaked pancreatic fluid and necrotic material
  * Commonly from pancreatitis or trauma
* **Presentation**
  * **Asymptomatic, abdominal discomfort, nausea, vomiting**: Compression by cysts
* **Examination**
  * **[CT, US] Unilocular cyst**: Confirms diagnosis
* **Management**
  * **Observation**: May resolve spontaneously
  * **Drainage (endoscopic, percutaneous, surgical)**: For persistent symptoms or complications
{: .notice--info}

### Intraductal Papillary Mucinous Neoplasm / ËÜµÁÆ°ÂÜÖ‰π≥È†≠Á≤òÊ∂≤ÊÄßËÖ´Áòç

* **Overview**
  * Papillary tumor growing within pancreatic ducts with mucin production, may progress to malignant tumor
  * Common in elderly males, mostly in pancreatic head
* **Presentation**
  * **Asymptomatic, abdominal discomfort, acute pancreatitis**: Tumor compression and duct obstruction
* **Examination**
  * **[US/CT/MRI] Dilated pancreatic duct (main duct type), grape-like multicystic lesions (branch duct type)**: Different patterns of ductal involvement
* **Management**
  * **Observation**: For low malignant risk cases
  * **Pancreaticoduodenectomy**: For high malignant risk cases
{: .notice--info}

### Mucinous Cystic Neoplasm / Á≤òÊ∂≤ÊÄßÂõäËÉûËÖ´Áòç

* **Overview**
  * Cystic tumor with mucin-producing epithelium and ovarian-like stroma, may be malignant
  * Common in middle-aged women, mostly in pancreatic body/tail
* **Presentation**
  * **Asymptomatic, abdominal discomfort**: Tumor compression
* **Examination**
  * **[US/CT/MRI] Huge multilocular cyst**: Orange-like appearance
* **Management**
  * **Distal pancreatectomy**: Due to malignant potential
{: .notice--info}

### Serous Cystic Neoplasm / ÊºøÊ∂≤ÊÄßÂõäËÉûËÖ´Áòç

* **Overview**
  * Cystic tumor with serous fluid-filled cysts, mostly benign
  * Common in elderly women, mostly in pancreatic body/tail
* **Presentation**
  * **Asymptomatic**: Smaller tumor
* **Examination**
  * **[US/CT/MRI] Clustered microcysts**: Honeycomb appearance
* **Management**
  * **Observation**: Due to low malignant potential
{: .notice--info}

<!-- 
## Esophageal Disease / È£üÈÅìÁñæÊÇ£

### Achalasia / È£üÈÅì„Ç¢„Ç´„É©„Ç∑„Ç¢
### Gastroesophageal Reflux Disease / ËÉÉÈ£üÈÅìÈÄÜÊµÅÁóá
### Eosinophilic Esophagitis / Â•ΩÈÖ∏ÁêÉÊÄßÈ£üÈÅìÁÇé
### Esophageal Candidiasis / È£üÈÅì„Ç´„É≥„Ç∏„ÉÄÁóá
### Mallory-Weiss Syndrome / Mallory-WeissÁóáÂÄôÁæ§
### Spontaneous Rupture of the Esophagus / ÁâπÁô∫ÊÄßÈ£üÈÅìÁ†¥Ë£Ç
### Esophageal Cancer / È£üÈÅìÁôå
### Esophagogastric Varices / È£üÈÅì„ÉªËÉÉÈùôËÑàÁò§
### Esophageal Diverticulum / È£üÈÅìÊÜ©ÂÆ§

## Gastric and Duodenal Disease / ËÉÉ„ÉªÂçÅ‰∫åÊåáËÖ∏ÁñæÊÇ£

### Acute Gastric Mucosal Lesion / ÊÄ•ÊÄßËÉÉÁ≤òËÜúÁóÖÂ§â
### Chronic Gastritis / ÊÖ¢ÊÄßËÉÉÁÇé
### Functional Dyspepsia / Ê©üËÉΩÊÄß„Éá„Ç£„Çπ„Éö„Éó„Ç∑„Ç¢
### Gastro-Duodenal Ulcer / ËÉÉ„ÉªÂçÅ‰∫åÊåáËÖ∏ÊΩ∞Áòç
### Gastro-Duodenal Ulcer Perforation / ËÉÉ„ÉªÂçÅ‰∫åÊåáËÖ∏ÊΩ∞ÁòçÁ©øÂ≠î
### Gastric Polyp / ËÉÉ„Éù„É™„Éº„Éó
### GIST / Ê∂àÂåñÁÆ°ÈñìË≥™ËÖ´Áòç
### Gastrointestinal Malignant Lymphoma / Ê∂àÂåñÁÆ°ÊÇ™ÊÄß„É™„É≥„ÉëËÖ´
### Gastric Cancer / ËÉÉÁôå
### Dumping Syndrome / „ÉÄ„É≥„Éî„É≥„Ç∞ÁóáÂÄôÁæ§
### Gastro-Duodenal Diverticulum / ËÉÉ„ÉªÂçÅ‰∫åÊåáËÖ∏ÊÜ©ÂÆ§
### Superior Mesenteric Artery Syndrome / ‰∏äËÖ∏ÈñìËÜúÂãïËÑàÁóáÂÄôÁæ§
### M√©n√©trier's Disease / M√©n√©trierÁóÖ

## Intestinal and Colonic Disease / Â∞èËÖ∏„ÉªÂ§ßËÖ∏ÁñæÊÇ£

### Crohn's Disease / CrohnÁóÖ
### Ulcerative Colitis / ÊΩ∞ÁòçÊÄßÂ§ßËÖ∏ÁÇé
### Intestinal Tuberculosis / ËÖ∏ÁµêÊ†∏
### Infectious Enterocolitis / ÊÑüÊüìÊÄßËÖ∏ÁÇé
### Pseudomembranous Colitis / ÂÅΩËÜúÊÄßÂ§ßËÖ∏ÁÇé
### Antibiotic-Associated Hemorrhagic Colitis / ÊäóËèåËñ¨Èñ¢ÈÄ£Âá∫Ë°ÄÊÄßÂ§ßËÖ∏ÁÇé
### MRSA Enteritis / MRSAËÖ∏ÁÇé
### Irritable Bowel Syndrome / ÈÅéÊïèÊÄßËÖ∏ÁóáÂÄôÁæ§
### Colonic Polyp / Â§ßËÖ∏„Éù„É™„Éº„Éó
### Colorectal Cancer / Â§ßËÖ∏Áôå
### Lynch Syndrome / LynchÁóáÂÄôÁæ§
### Small Intestine Tumor / Â∞èËÖ∏ËÖ´Áòç
### Gastrointestinal Neuroendocrine Neoplasm / Ê∂àÂåñÁÆ°Á•ûÁµåÂÜÖÂàÜÊ≥åËÖ´Áòç
### Familial Adenomatous Polyposis / ÂÆ∂ÊóèÊÄßËÖ∫ËÖ´ÊÄß„Éù„É™„Éù„Éº„Ç∑„Çπ
### Peutz-Jeghers Syndrome / Peutz-JeghersÁóáÂÄôÁæ§
### Malabsorption Syndrome / Âê∏Âèé‰∏çËâØÁóáÂÄôÁæ§
### Protein-Losing Gastroenteropathy / ËõãÁôΩÊºèÂá∫ÊÄßËÉÉËÖ∏Áóá
### Ischemic Colitis / ËôöË°ÄÊÄßÂ§ßËÖ∏ÁÇé
### Acute Mesenteric Artery Occlusion / ÊÄ•ÊÄßËÖ∏ÈñìËÜúÂãïËÑàÈñâÂ°ûÁóá
### Occlusive Ileus / ÈñâÂ°ûÊÄßËÖ∏ÈñâÂ°û
### Strangulation Ileus / ÁµûÊâºÊÄßËÖ∏ÈñâÂ°û
### Paralytic Ileus / È∫ªÁó∫ÊÄß„Ç§„É¨„Ç¶„Çπ
### Colonic Diverticulum / Â§ßËÖ∏ÊÜ©ÂÆ§
### Acute Appendicitis / ÊÄ•ÊÄßËô´ÂûÇÁÇé

## Anal Disease / ËÇõÈñÄÁñæÊÇ£

### Hemorrhoids / ÁóîÊ†∏
### Anal Fissure / Ë£ÇËÇõ
### Perianal Abscess / ËÇõÈñÄÂë®Âõ≤ËÜøÁòç
### Anal Fistula / ÁóîÁòª
### Rectal Prolapse / Áõ¥ËÖ∏ËÑ±

## Peritoneal Disease / ËÖπËÜúÁñæÊÇ£

### Inguinal Hernia / Èº†ÂæÑ„Éò„É´„Éã„Ç¢
### Femoral Hernia / Â§ßËÖø„Éò„É´„Éã„Ç¢
### Obturator Hernia / ÈñâÈéñÂ≠î„Éò„É´„Éã„Ç¢
### Abdominal Incisional Hernia / ËÖπÂ£ÅÁò¢Áóï„Éò„É´„Éã„Ç¢
### Umbilical Hernia / Ëáç„Éò„É´„Éã„Ç¢
### Esophageal Hiatal Hernia / È£üÈÅìË£ÇÂ≠î„Éò„É´„Éã„Ç¢
### Acute Peritonitis / ÊÄ•ÊÄßËÖπËÜúÁÇé
### Spontaneous Bacterial Peritonitis / ÁâπÁô∫ÊÄßÁ¥∞ËèåÊÄßËÖπËÜúÁÇé
### Cancerous Peritonitis / ÁôåÊÄßËÖπËÜúÁÇé
### Pseudomyxoma Peritonei / ËÖπËÜúÂÅΩÁ≤òÊ∂≤ËÖ´

## Liver Disease / ËÇùÁñæÊÇ£

### Hepatitis A / AÂûãËÇùÁÇé
### Hepatitis B / BÂûãËÇùÁÇé
### Hepatitis C / CÂûãËÇùÁÇé
### Hepatitis D / DÂûãËÇùÁÇé
### Hepatitis E / EÂûãËÇùÁÇé
### Acute Viral Hepatitis / ÊÄ•ÊÄß„Ç¶„Ç§„É´„ÇπÊÄßËÇùÁÇé
### Chronic Viral Hepatitis / ÊÖ¢ÊÄß„Ç¶„Ç§„É´„ÇπÊÄßËÇùÁÇé
### Drug-Induced Liver Injury / Ëñ¨Ââ§ÊÄßËÇùÈöúÂÆ≥
### Acute Liver Failure / ÊÄ•ÊÄßËÇù‰∏çÂÖ®
### Fatty Liver / ËÑÇËÇ™ËÇù
### Nonalcoholic Steatohepatitis / Èùû„Ç¢„É´„Ç≥„Éº„É´ÊÄßËÑÇËÇ™ÊÄßËÇùÁÇé
### Alcoholic Liver Disease / „Ç¢„É´„Ç≥„Éº„É´ÊÄßËÇùÈöúÂÆ≥
### Autoimmune Hepatitis / Ëá™Â∑±ÂÖçÁñ´ÊÄßËÇùÁÇé
### Primary Biliary Cholangitis / ÂéüÁô∫ÊÄßËÉÜÊ±ÅÊÄßËÉÜÁÆ°ÁÇé
### Primary Sclerosing Cholangitis / ÂéüÁô∫ÊÄßÁ°¨ÂåñÊÄßËÉÜÁÆ°ÁÇé
### Liver Cirrhosis / ËÇùÁ°¨Â§â
### Hepatocellular Carcinoma / ËÇùÁ¥∞ËÉûÁôå
### Intrahepatic Cholangiocarcinoma / ËÇùÂÜÖËÉÜÁÆ°Áôå
### Metastatic Liver Tumor / Ëª¢ÁßªÊÄßËÇùÁôå
### Hepatic Hemangioma / ËÇùË°ÄÁÆ°ËÖ´
### Hepatic Cyst / ËÇùÂö¢ËÉû
### Liver Abscess / ËÇùËÜøÁòç
### Idiopathic Portal Hypertension / ÁâπÁô∫ÊÄßÈñÄËÑàÂúß‰∫¢ÈÄ≤Áóá
### Budd-Chiari Syndrome / Budd-ChiariÁóáÂÄôÁæ§

## Biliary Disease / ËÉÜÈÅìÁñæÊÇ£

### Cholelithiasis / ËÉÜÁü≥Áóá
### Acute Cholecystitis / ÊÄ•ÊÄßËÉÜÂö¢ÁÇé
### Acute Cholangitis / ÊÄ•ÊÄßËÉÜÁÆ°ÁÇé
### Gallbladder Adenomyomatosis / ËÉÜÂö¢ËÖ∫Á≠ãËÖ´Áóá
### Gallbladder Cancer / ËÉÜÂö¢Áôå
### Bile Duct Cancer / ËÉÜÁÆ°Áôå
### Cancer of Pipilla of Vator / ‰π≥È†≠ÈÉ®Áôå

## Pancreatic Disease / ËÜµÁñæÊÇ£

### Acute Pancreatitis / ÊÄ•ÊÄßËÜµÁÇé
### Chronic Pancreatitis / ÊÖ¢ÊÄßËÜµÁÇé
### Autoimmune Pancreatitis / Ëá™Â∑±ÂÖçÁñ´ÊÄßËÜµÁÇé
### Pancreatic Carcinoma / ËÜµÁôå
### Pancreatic Psuedocyst / ËÜµ‰ªÆÊÄßÂö¢ËÉû
### Intraductal Papillary Mucinous Neoplasm / ËÜµÁÆ°ÂÜÖ‰π≥È†≠Á≤òÊ∂≤ÊÄßËÖ´Áòç
### Mucinous Cystic Neoplasm / Á≤òÊ∂≤ÊÄßÂö¢ËÉûËÖ´Áòç
### Serous Cystic Neoplasm / ÊºøÊ∂≤ÊÄßÂö¢ËÉûËÖ´Áòç
### Pancreatic Neuroendocrine Neoplasm / ËÜµÁ•ûÁµåÂÜÖÂàÜÊ≥åËÖ´Áòç -->

# Endocrinology / ÂÜÖÂàÜÊ≥åÁßë

## Pituitary Gland Disorder / ‰∏ãÂûÇ‰ΩìÁñæÊÇ£

### Acromegaly & Pituitary Gigantism / ÂÖàÁ´ØÂ∑®Â§ßÁóá„Éª‰∏ãÂûÇ‰ΩìÊÄßÂ∑®‰∫∫Áóá

* **Overview**
  * Excess growth hormone secretion from pituitary adenoma
* **Presentation**
  * **Prominent brow, enlarged nose/lips, protruding jaw, enlarged hands/feet, macroglossia**: High GH causes bone and soft tissue overgrowth
  * **Headache, visual disturbance**: Pituitary tumor compressing optic chiasm
* **Examination**
  * **[Blood] GH‚Üë (not suppressed by glucose load), IGF-1‚Üë**: Excess GH secretion
  * **[MRI/CT] Pituitary adenoma**: Identify tumor
  * **[X-ray] Sella turcica ballooning/double floor, enlarged sinuses, cauliflower-like terminal phalanges, enlarged sesamoid bones, thick heel pad**: Bone and soft tissue overgrowth
* **Management**
  * **Transsphenoidal surgery**: Remove pituitary adenoma
  * **Somatostatin analogs (octreotide, lanreotide, pasireotide), GH receptor antagonist (pegvisomant)**: Suppress GH secretion/action
  * **Radiation therapy**: For recurrent or inoperable cases
{: .notice--info}

### Hyperprolactinemia / È´ò„Éó„É≠„É©„ÇØ„ÉÅ„É≥Ë°ÄÁóá

* **Overview**
  * Excessive prolactin secretion from pituitary adenoma or due to medication
* **Presentation**
  * **Galactorrhea, menstrual irregularities, infertility (women)**: High prolactin suppresses LH/FSH
  * **Decreased libido, penile atrophy (men)**: High prolactin suppresses testosterone
  * **Headache, visual disturbance**: Pituitary tumor compressing optic chiasm
* **Examination**
  * **[Blood] Prolactin‚Üë, FT4‚Üì (in some cases)**: Excess prolactin secretion
  * **[MRI/CT] Pituitary/hypothalamic lesions**: Identify tumor
* **Management**
  * **Dopamine agonists (bromocriptine, cabergoline)**: Suppress prolactin secretion
  * **Transsphenoidal surgery**: Remove pituitary adenoma or hypothalamic lesions
  * **Radiation therapy**: For recurrent or inoperable cases
  * **Discontinue causative medication, thyroid hormone replacement**: Treat other possible causes 
{: .notice--info}

### Cushing's Disease / CushingÁóÖ

* **Overview**
  * Excessive ACTH secretion from pituitary adenoma
* **Presentation**
  * **Moon face, central obesity, buffalo hump, purple striae, thin skin**: High cortisol causes abnormal fat distribution and skin
  * **Hypertension, edema, glucose intolerance, osteoporosis, easy bruising**: High cortisol causes metabolic effects
  * **Acne, menstrual irregularities, hirsutism**: High androgens causes reproductive effects
* **Examination**
  * **[Blood] ACTH‚Üë, cortisol‚Üë, DHEA-S‚Üë**: ACTH-dependent hypercortisolism
  * **[Blood] Na‚Üë, K‚Üì, pH‚Üë**: Mineralocorticoid effects
  * **[Endocrine tests] Cortisol circadian rhythm loss, absence low-dose dexamethasone suppression**: Autonomous ACTH secretion
  * **[MRI/CT] Pituitary adenoma**: Identify tumor
  * **[Inferior petrosal sinus sampling] ACTH‚Üë**: Confirm pituitary source
* **Management**
  * **Transsphenoidal surgery**: Remove pituitary adenoma
  * **Pasireotide, cabergoline, metyrapone, trilostane, mitotane**: Suppress ACTH/cortisol secretion
  * **Radiation therapy**: For recurrent or inoperable cases
{: .notice--info}

### Panhypopituitarism / Ê±é‰∏ãÂûÇ‰ΩìÊ©üËÉΩ‰Ωé‰∏ãÁóá

* **Overview**
  * Deficiency of multiple anterior pituitary hormones
  * Causes include supresellar/pituitary tumor, lymphocytic hypophysitis, Sheehan syndrome
* **Presentation**
  * **Amenorrhea, breast/genital atrophy (women), decreased libido, testicular atrophy (men)**: LH/FSH deficiency
  * **Decreased muscle mass, increased body fat**: GH deficiency
  * **Cold intolerance, dry skin, constipation, bradycardia**: TSH deficiency
  * **Fatigue, anorexia, hypotension, hypoglycemia**: ACTH deficiency
* **Examination**
  * **[Blood] Hormone levels‚Üì (LH/FSH, GH, TSH, ACTH)**: Pituitary dysfunction
  * **[Blood] Target organ hormones‚Üì (sex hormones , IGF-I, FT4/FT3, cortisol)**: End-organ hormone deficiency
  * **[CT/MRI] Pituitary/hypothalamic lesions**: Identify causes
* **Management**
  * **Sex hormones, levothyroxine, hydrocortisone**: Hormone replacement
  * **Surgery, medication, radiation**: Treatment of underlying cause
{: .notice--info}

### Growth Hormone Deficiency / ÊàêÈï∑„Éõ„É´„É¢„É≥ÂàÜÊ≥å‰∏çÂÖ®ÊÄß‰ΩéË∫´Èï∑Áóá

* **Overview**
  * Insufficient GH secretion leading to decreased growth velocity
  * Causes include idiopathic (peripartum events) or tumor
* **Presentation**
  * **Height < -2.0 SD, growth velocity < -1.5 SD, proportionate stature**: Decreased growth velocity
  * **Hypoglycemia in infants**: Due to GH deficiency
  * **Other pituitary hormone deficiency**: In cases of combined deficiency
* **Examination**
  * **[Stimulation tests] GH peak‚Üì with insulin/arginine/L-dopa/clonidine/glucagon/GHRP-2**: Confirms GH deficiency
  * **[CT/MRI] Pituitary hypoplasia or tumor**: Identify organic causes
* **Management**
  * **GH replacement**: Hormone replacement therapy
{: .notice--info}

### Hypogonadotropic Hypogonadism / „Ç¥„Éä„Éâ„Éà„É≠„Éî„É≥ÂçòÁã¨Ê¨†ÊêçÁóá

* **Overview**
  * Insufficient LH/FSH secretion leading to decreased gonadal function
  * Causes include congenital (Kallmann syndrome, Laurence-Moon-Biedl syndrome, Prader-Willi syndrome) or acquired (tumor, inflammation)
* **Presentation**
  * **Genital atrophy, absent secondary sexual development**: Incomplete sexual development
  * **Amenorrhea, decreased libido, infertility**: Decreased gonadal function
  * **[Kallmann syndrome] Anosmia**: Olfactory nerve hypoplasia
  * **[Prader-Willi syndrome] Hypotonia, hypogonadism, hypomentia, obesity**: Chromosomal loss or inactivation
* **Examination**
  * **[Blood] LH/FSH‚Üì, androgens/estrogens‚Üì**: Confirms gonadotropin deficiency
* **Management**
  * **Testosterone/estrogen replacement**: For secondary sexual development
  * **Gonadotropin therapy, Holmstrom/Kaufmann therapy**: For fertility treatment
{: .notice--info}

### Isolated ACTH Deficiency / ACTHÂçòÁã¨Ê¨†ÊêçÁóá

* **Overview**
  * Insufficient ACTH secretion leading to adrenal insufficiency
  * Causes include autoimmune or immune checkpoint inhibitors
* **Presentation**
  * **Fatigue, weight loss, anorexia, hypotension, hypoglycemia, hyponatremia**: Cortisol deficiency
* **Examination**
  * **[Blood] ACTH‚Üì, cortisol‚Üì**: Confirms ACTH deficiency
* **Management**
  * **Hydrocortisone replacement**: Hormone replacement therapy
{: .notice--info}

### SIADH / „Éê„ÇΩ„Éó„É¨„Ç∑„É≥ÂàÜÊ≥åÈÅéÂâ∞Áóá

* **Overview**
  * Water retention and hyponatremia due to inappropriate continuous AVP secretion
  * Causes include malignancies (SCLC), medications (vincristine), CNS diseases, thoracic diseases
* **Presentation**
  * **Fatigue, decreased appetite, altered consciousness**: Brain edema due to dilutional hyponatremia
* **Examination**
  * **[Blood] AVP‚Üë**: Inappropriate AVP secretion
  * **[Blood] Osmolality‚Üì, Na‚Üì, BUN‚Üì, uric acid‚Üì**: Water retention and increased GFR
  * **[Urine] Osmolality‚Üë, Na‚Üë**: Highly-concentrated urine
* **Management**
  * **[Mild] Water restriction, salt supplementation**: Correct hyponatremia
  * **[Severe] Furosemide + 3% saline**: Rapid correction of severe hyponatremia
  * **[Ectopic] V2 receptor antagonist (mozavaptan), demeclocycline**: Block AVP effect
  * **Treat underlying disease**: Address primary cause
{: .notice--info}

### Diabetes Insipidus / Â∞øÂ¥©Áóá

* **Overview**
  * Excessive dilute urine due to insufficient secretion of AVP (central DI) or kidney resistance to AVP (nephrogenic DI)
* **Presentation**
  * **Polyuria, thirst, polydipsia**: Inability to concentrate urine
* **Examination**
  * **[Urine] Osmolality‚Üì, specific gravity‚Üì**: Impaired water reabsorption
  * **[Diagnostic test] No response to hypertonic saline test / water deprivation test**: Differentiate DI from psychogenic polydipsia
  * **[DDAVP test] Response to vasopressin**: Differentiate central DI from nephrogenic DI
* **Management**
  * **[Central] Desmopressin acetate (DDAVP)**: Replaces AVP
  * **[Nephrogenic DI] Thiazide diuretics**: Reduces urine output
{: .notice--info}

## Thyroid Gland Disorder / Áî≤Áä∂ËÖ∫ÁñæÊÇ£

### Graves' Disease / BasedowÁóÖ

* **Overview**
  * Diffuse goiter and hyperthyroidism due to TSH receptor antibodies
  * Common in women aged 20-40 years
* **Presentation**
  * **Diffuse goiter, exophthalmos**: Antibodies attack thyroid gland and retrobulbar fat
  * **Tachycardia, palpitations, dyspnea, systolic hypertension**: Cardiovascular system activation
  * **Increased appetite, weight loss, fatigue, frequent bowel movements**: Increased metabolism
  * **Tremor, sweating**: Sympathetic nervous system activation
* **Examination**
  * **[Blood] FT4‚Üë, FT3‚Üë, TSH‚Üì**: Thyroid hormone excess
  * **[Blood] TRAb/TSAb positive**: Autoimmune nature
  * **[Ultrasound] Diffuse thyroid enlargement**: Thyroid inflammation
  * **[Scintigraphy] Radioiodine/technetium uptake‚Üë**: Hyperactive thyroid
* **Management**
  * **Thiamazole, propylthiouracil**: Inhibit thyroid hormone synthesis (stop if agranulocytosis)
  * **Œ≤ blockers**: Control tachycardia
  * **Thyroidectomy, radioactive iodine**: For refractory cases
{: .notice--info}

### Plummer's Disease / PlummerÁóÖ

* **Overview**
  * Hyperthyroidism due to functioning thyroid nodule
* **Presentation**
  * **Hyperthyroidism symptoms, no exophthalmos**: Excess thyroid hormone without autoimmune nature
* **Examination**
  * **[Blood] FT3‚Üë, FT4‚Üë, TSH‚Üì**: Thyroid hormone excess
  * **[Blood] TRAb negative**: Without autoimmune nature
  * **[Scintigraphy] Radioiodine/technetium uptake‚Üë (hot nodule)**: Autonomous nodule produces hormone
* **Management**
  * **Surgical removal, radioactive iodine therapy**: Remove autonomous nodule
{: .notice--info}

### Subacute Thyroiditis / ‰∫úÊÄ•ÊÄßÁî≤Áä∂ËÖ∫ÁÇé

* **Overview**
  * Follicular destruction and transient thyrotoxicosis with unknown cause (likely viral infection)
  * Common in women aged 30-50
* **Presentation**
  * **Upper respiratory infection-like symptoms**: Viral infection
  * **Painful thyroid swelling**: Thyroid inflammation
  * **High fever, fatigue, palpitations, sweating, tremor, weight loss**: Thyrotoxicosis due to excessive hormone release
* **Examination**
  * **[Blood] ESR‚Üë, CRP‚Üë**: Thyroid inflammation
  * **[Blood] FT4‚Üë, TSH‚Üì**: Thyrotoxicosis
  * **[Ultresound] Ill-defined hypoechoic areas**: Thyroid inflammation
  * **[Scintigraphy] Radioiodine/technetium uptake‚Üì**: Destroyed follicular cells
* **Management**
  * **NSAIDs**: Mostly self-limiting
  * **Corticosteroids**: For severe inflammation
  * **Beta blockers**: For thyrotoxicosis symptoms
{: .notice--info}

### Painless Thyroiditis / ÁÑ°ÁóõÊÄßÁî≤Áä∂ËÖ∫ÁÇé

* **Overview**
  * Follicular destruction and transient thyrotoxicosis, often developing from chronic thyroiditis
  * Common in women aged 20-40 with chronic thyroiditis
* **Presentation**
  * **Palpitations, tachycardia, sweating, tremor, fatigue, weight loss**: Thyrotoxicosis due to excessive hormone release
  * **No thyroid pain or fever**: Distinguishes from subacute thyroiditis
* **Examination**
  * **[Blood] FT4‚Üë, TSH‚Üì**: Thyrotoxicosis
  * **[Ultrasound] Decreased thyroid blood flow**: Distinguishes from Graves' disease
  * **[Scintigraphy] Radioiodine/technetium uptake‚Üì**: Destroyed follicular cells
* **Management**
  * **Observation**: Mostly self-limiting
  * **Beta blockers**: For thyrotoxicosis symptoms
{: .notice--info}

### Chronic Thyroiditis / ÊÖ¢ÊÄßÁî≤Áä∂ËÖ∫ÁÇéÔºàÊ©ãÊú¨ÁóÖÔºâ

* **Overview**
  * Chronic thyroiditis and hypothyroidism due to auto-antibodies
  * Common in middle-aged women
* **Presentation**
  * **Cold intolerance, dry skin, reduced sweating, non-pitting edema, weight gain, muscle weakness**: Decreased metabolism due to hypothyroidism
  * **Cardiomegaly, bradycardia, hypotension, pericardial effusion**: Cardiovascular effects of hypothyroidism
  * **Constipation, somnolence, slow movement, hoarseness, menorrhagia**: Multiple system effects of hypothyroidism
  * **Delayed tendon reflexes**: Especially delayed Achilles tendon relaxation phase
* **Examination**
  * **[Blood] FT4‚Üì, TC‚Üë**: Hypothyroidism
  * **[Blood] Anti-Tg antibody(+), Anti-TPO antibody(+)**: Autoimmune nature
  * **[Ultrasound] Diffuse thyroid enlargement**: Thyroid inflammation
  * **[FNA] Lymphocytic infiltration**: Confirms diagnosis
* **Management**
  * **Observation**: For euthyroid cases
  * **T4 replacement**: For hypothyroid cases
{: .notice--info}

### Adenomatous Nodule or Goiter / ËÖ∫ËÖ´ÊßòÁµêÁØÄ„ÉªÁî≤Áä∂ËÖ∫ËÖ´

* **Overview**
  * Hyperplastic lesions of thyroid gland with single or multiple nodules
* **Presentation**
  * **Palpable thyroid nodules**: Nodular enlargement of thyroid gland
* **Examination**
  * **[Ultrasound] Multiple nodules and cysts**: Hyperplastic changes
* **Management**
  * **Observation**: If no suspicious features
{: .notice--info}

### Follicular Adenoma / ÊøæËÉûËÖ∫ËÖ´

* **Overview**
  * Benign tumor from thyroid follicular epithelium, without capsular/vascular invasion or metastasis
* **Presentation**
  * **Asymptomatic, thyroid nodule**: Nodular enlargement of thyroid gland
* **Examination**
  * **[FNA] Follicular cell clusters**: Cannot differentiate from follicular carcinoma
  * **[Pathology] No capsular/vascular invasion**: Definitive diagnosis after lobectomy
* **Management**
  * **Thyroid lobectomy**: For both diagnosis and treatment
{: .notice--info}

### Papillary Thyroid Carcinoma / Áî≤Áä∂ËÖ∫‰π≥È†≠Áôå

* **Overview**
  * Malignant tumor from thyroid follicular epithelium, good prognosis
  * Commonly in 30-50 years old females
* **Presentation**
  * **Asymptomatic, neck lymph node swelling**: Commonly lymphatic spread
* **Examination**
  * **[Ultrasound] Ill-defined irregular mass, microcalcification**: Characteristic imaging findings
  * **[Pathology, FNA] Papillary structure, ground glass nuclei, nuclear grooves, intranuclear inclusions**: Definite diagnosis
  * **[Blood] Thyroglobulin‚Üë**: Can be used as tumor marker
* **Management**
  * **Lobectomy, total thyroidectomy**: Primary treatment
  * **Radioactive iodine therapy**: For distant metastasis
{: .notice--info}

### Follicular Thyroid Carcinoma / Áî≤Áä∂ËÖ∫ÊøæËÉûÁôå

* **Overview**
  * Malignant tumor from thyroid follicular epithelium, good prognosis
  * Commonly in 30-50 years old females
* **Presentation**
  * **Asymptomatic, distant metastasis**: Commonly hematogenous spread
* **Examination**
  * **[Pathology, FNA] Follicular structure, capsular/vascular invasion**: Definitive diagnosis requires surgical specimen
  * **[Blood] Thyroglobulin‚Üë**: Can be used as tumor marker
* **Management**
  * **Lobectomy, total thyroidectomy**: Primary treatment
  * **Radioactive iodine therapy**: For distant metastasis
{: .notice--info}

### Anaplastic Thyroid Carcinoma / Áî≤Áä∂ËÖ∫Êú™ÂàÜÂåñÁôå

* **Overview**
  * Malignant tumor transformed from highly-differentiated thyroid cancer, worse prognosis
* **Presentation**
  * **Rapidly growing neck mass, fever, pain**: Aggressive growth with inflammation
  * **Hoarseness, dyspnea, dysphagia**: Invasion of surrounding tissues
* **Examination**
  * **[Blood] WBC‚Üë, ESR‚Üë, CRP‚Üë**: Marked inflammation
  * **[Pathology, FNA] Large atypical cells, giant/multiple nuclei**: Definite diagnosis
* **Management**
  * **Radiation therapy, chemotherapy, targeted therapy**: Primary treatment
{: .notice--info}

### Medullary Thyroid Carcinoma / Áî≤Áä∂ËÖ∫È´ÑÊßòÁôå

* **Overview**
  * Malignant tumor from thyroid parafollicular C-cells
  * Commonly hereditary and associated with MEN2
* **Presentation**
  * **Thyroid mass**: Common in upper thyroid
  * **Pheochromocytoma, hyperparathyroidism**: In MEN2 cases
* **Examination**
  * **[Pathology, FNA] Amyloid deposits, medullary structure**: Definite diagnosis
  * **[Blood] CEA‚Üë, calcitonin‚Üë**: Diagnostic and useful as tumor markers
  * **[Genetic testing] RET mutation**: For hereditary (MEN2) cases
* **Management**
  * **Lobectomy, total thyroidectomy**: Primary treatment
  * **Remove pheochromocytoma first**: For MEN2 cases
{: .notice--info}

### Malignant Lymphoma / ÊÇ™ÊÄß„É™„É≥„ÉëËÖ´

* **Overview**
  * Malignant lymphoma develops in elderly patients with Hashimoto's thyroiditis
* **Presentation**
  * **Rapidly growing neck mass**: May mimic anaplastic carcinoma
  * **Local compression symptoms**: Often without B symptoms
* **Examination**
  * **[Pathology, FNA] Diffuse large cell proliferation (DLBCL), diffuse/nodular growth with mixed B-cells (MALT)**: Definitive diagnosis
* **Management**
  * **Radiation therapy, chemotherapy (R-CHOP)**: Primary treatment
{: .notice--info}

## Parathyroid Gland Disorder / ÂâØÁî≤Áä∂ËÖ∫ÁñæÊÇ£

## Adrenal Gland Disorder / ÂâØËÖéÁñæÊÇ£

## Neuroendocrine Tumor / Á•ûÁµåÂÜÖÂàÜÊ≥åËÖ´Áòç

## Carbohydrate and Lipid Metabolism Disorder / Á≥ñ„ÉªËÑÇË≥™‰ª£Ë¨ùÁï∞Â∏∏

## Uric Acid and Bone Metabolism Disorder / Â∞øÈÖ∏„ÉªÈ™®‰ª£Ë¨ùÁï∞Â∏∏

## Congenital Metabolism Disorder / ÂÖàÂ§©‰ª£Ë¨ùÁï∞Â∏∏

## Nutritional Disorder / Ê†ÑÈ§äÁï∞Â∏∏

<!-- ### Endocrine Organ / ÂÜÖÂàÜÊ≥åÂô®

* **Pituitary gland**
  * **Structure**: Anterior lobe (adenophysis), posterior lobe (neurophysis)
  * **Artery**: Superior hypophyseal artery (anterior lobe, hypophyseal portal system), inferior hypophyseal artery (posterior lobe)
  * **Cell (anterior)**: Acidophil (GH, PRL), basophil (TSH, FSL, LH, ACTH), chromophobe
  * **Cell (posterior)**: Nerve fiber (ADH, oxytocin from hypothalamus), pituicyte
* **Thyroid gland**
  * **Structure**: 2 lobes, isthmus
  * **Artery**: Superior thyroid artery (external carotid artery), inferior thyroid artery (thyrocervical trunk)
  * **Vein**: Superior thyroid vein (internal carotid vein), middle thyroid vein (internal carotid vein), inferior thyroid vein (brachiocephalic vein)
  * **Cell**: Follicular cell (thyroid hormone), parafollicular cell (calcitonin)
* **Parathyroid gland**
  * **Structure**: 2 upper glands, 2 lower glands
  * **Cell**: Chief cell (parathyroid hormone), oxyphil cell
* **Adrenal gland**
  * **Structure**: Adrenal cortex, adrenal medulla
  * **Artery**: Superior suprarenal artery (inferior phrenic artery), middle suprarenal artery (abdominal aorta), inferior suprarenal artery (renal artery)
  * **Vein**: Right suprarenal vein (inferior vena cava), left suprarenal vein (left renal vein)
  * **Adrenal cortex**: Zona glomerulosa (mineralcorticoid), zona fasciculata (glucocorticoid), zona reticulata (sex hormone)
  * **Adrenal medulla**: Chromaffin cell (epinephrine, norepinephrine), sympathetic presynaptic fiber
{: .notice--info} -->

<!-- ### Hypothalamus and Pituitary Hormone / Ë¶ñÂ∫ä‰∏ãÈÉ®„Éª‰∏ãÂûÇ‰Ωì„Éõ„É´„É¢„É≥

* **Somatostatin analog**
  * **Drugs**: Octreotide, lantreotide
  * **Mechanism**: Somatostatin analog (decrease GH)
  * **Indication**: Acromegaly, esophageal variceal bleeding
* **GH agonist**
  * **Drugs**: Somatropin, somatrem, mecasermin
  * **Mechanism**: recombinant GH (somatropin, somatrem), recombinant IGF-1 (mecasermin)
  * **Indication**: Acromegaly, variceal bleeding
* **GH antagonist**
  * **Drugs**: Pegvisomant
  * **Mechanism**: GH antagonist
  * **Indication**: Acromegaly
* **Dopamine analog**
  * **Drugs**: Bromocriptine, cabergoline
  * **Mechanism**: Dopamine analog (decrease prolactin)
  * **Indication**: Hyperprolactenemia
* **GnRH agonist**
  * **Drugs**: Leuprolide, goserelin
  * **Mechanism**: GnRH agonist (pulsatile: increase FSH and LH, chronic: decrease FSH and LH)
  * **Indication**: Prostate cancer, endometriosis
* **GnRH antagonist**
  * **Drugs**: Abarelix, ganirelix
  * **Mechanism**: GnRH antagonist (decrease FSH and LH)
  * **Indication**: Prostate cancer, controlled ovarian stimulation
* **ADH agonist**
  * **Drugs**: Desmopressin
  * **Mechanism**: ADH V2 agonist
  * **Indication**: Central diabetes indipidus, hemophilia A
* **ADH antagonist**
  * **Drugs**: Conivaptan, tolvaptan, demeclocycline
  * **Mechanism**: ADH V1/2 antagonist
  * **Indication**: SIADH
{: .notice--info}

### Thyroid Hormone / Áî≤Áä∂ËÖ∫„Éõ„É´„É¢„É≥

* **Thyroid hormone**
  * **Drugs**: Liothyronine (T3), levothyroxine (T4), liotrix (mix)
  * **Mechanism**: Thyroid hormone
  * **Indication**: Hypothyroidism
* **Thioamide**
  * **Drugs**: Propylthiouracil, methimazole, carbimazole
  * **Mechanism**: Inhibit T4/T3 synthesis and conversion
  * **Indication**: Hyperthyroidism
  * **Adverse effect**: Agranulocytosis
* **Iodide**
  * **Drugs**: Iodide, lithium
  * **Mechanism**: Inhibit T4/T3 release, decrease thyroid vascularity
  * **Indication**: Before thyroid surgery 
* **Radioactive iodide**
  * **Drugs**: I-131
  * **Mechanism**: Destruct thyroid gland
  * **Indication**: Hyperthyroidism, thyroid carcinoma
* **Anion inhibitor**
  * **Drugs**: Perchlorate, pertechnetate, thriocyanate
  * **Mechanism**: Inhibit iodide entry
  * **Indication**: Hyperthyroidism
* **Other therapy**
  * **Drugs**: Œ≤-blocker, hydrocortisone
  * **Mechanism**: Inhibit T4/T3 conversion, release symptom
{: .notice--info}

### Adrenal Cortical Hormone / ÂâØËÖéÈ´ÑË≥™„Éõ„É´„É¢„É≥

* **Glucocorticoid**
  * **Drugs**: Short-acting: Cortisol, cortisone / Intermediate-acting: Prednisone, prednisolone, methylprednisolone, triamcinolone / Long-acting: Betamethasone, dexamethasone
  * **Mechanism**: GR receptor agonist
  * **Indication**: Inflammation, replacement therapy, Cushing syndrome diagnosis (dexamethasone)
  * **Adverse effect**: Adrenal suppression, hyperglycemia, osteoporosis, peptic ulcer
* **Mineralcorticoid**
  * **Drugs**: Desoxycorticosterone, fludrocortisone
  * **Mechanism**: MR receptor agonist
  * **Indication**: Replacement therapy
* **Synthesis inhibitor**
  * **Drugs**: Ketoconazole, metyrapone, aminoglutethimide
  * **Mechanism**: 17Œ±-hydroxylase inhibitor (ketoconazole), 11Œ≤-hydroxylase inhibitor (metyrapone), cholesterol side chain cleaving enzyme inhibitor (aminoglutethimide)
  * **Indication**: Cushing syndrome, pituitary function test (metyrapone)
{: .notice--info}

### Sex Hormone / ÊÄß„Éõ„É´„É¢„É≥

* **Estrogen**
  * **Drugs**: Estradiol, mestranol
  * **Mechanism**: Estrogen
  * **Indication**: Menopausal therapy, contraception
  * **Adverse effect**: Endometrial cancer, breast cancer
* **SERM**
  * **Drugs**: Clomiphene, raloxifene, tamoxifen
  * **Mechanism**: Selective estrogen receptor modulator
  * **Indication**: Ovary dysfunction infertility (clomiphene), osteoporosis (raloxifene), breast cancer (tamoxifen)
* **Estrogen antagonist**
  * **Drugs**: Fulvestrant
  * **Mechanism**: Estrogen antagonist
  * **Indication**: Breast cancer
* **Aromatase inhibitor**
  * **Drugs**: Letrozole, anastrolzole, exemestane
  * **Mechanism**: Aromatase inhibitor (decrease estrogen)
  * **Indication**: Breast cancer
* **Progestin**
  * **Drugs**: Norgestrel, desogestrol
  * **Mechanism**: Progestin
  * **Indication**: Endometriosis, contraception (with estrogen)
* **Progestin antagonist**
  * **Drugs**: Mifepristone
  * **Mechanism**: Progestin antagonist
  * **Indication**: Abortion
* **Androgen**
  * **Drugs**: Testosterone, oxandrolone, danazol
  * **Mechanism**: Androgen
  * **Indication**: Hypogonadism, endometriosis (danazol)
  * **Adverse effect**: Decreased testicular function
* **Androgen antagonist**
  * **Drugs**: Cyproterone, flutamide, bicalutamide, spironolactone
  * **Mechanism**: Androgen antagonist
  * **Indication**: Prostate cancer
* **5Œ±-reductase inhibitor**
  * **Drugs**: Finasteride
  * **Mechanism**: 5Œ±-reductase inhibitor (decrease DHT)
  * **Indication**: BPH, male-pattern baldness
{: .notice--info}

### Glucose Homeostasis / Á≥ñ‰ª£Ë¨ù„ÅÆËñ¨

* **Insulin**
  * **Drugs**: Rapid-acting: insulin lispro, insulin aspart / Short-acting: Regular insulin / Intermediate-acting: NPH / Long-acting: insulin glargine, insulin detemir, insulin degludec
  * **Mechanism**: Insulin
  * **Indication**: Diabetes mellitus
* **Sulfonylurea**
  * **Drugs**: Glyburide, glipizide, glimepiride, tolbutamide
  * **Mechanism**: Inhibit ATP-dependent K channel (increase insulin secretion)
  * **Indication**: Diabetes mellitus
* **Meglitinide**
  * **Drugs**: Rapaglinide, nateglinide
  * **Mechanism**: Inhibit ATP-dependent K channel (increase insulin secretion)
  * **Indication**: Diabetes mellitus
* **GLP-1 agonist**
  * **Drugs**: Exenatide, liraglutide
  * **Mechanism**: GLP-1 analog (increase insulin secretion)
  * **Indication**: Diabetes mellitus
* **DPP-4 inhibitor**
  * **Drugs**: Sitagliptin, saxagliptin
  * **Mechanism**: DPP-4 inhibitor (increase GLP-1, increase insulin secretion)
  * **Indication**: Diabetes mellitus
* **Biguanide**
  * **Drugs**: Metformin
  * **Mechanism**: Reduce hepatic gluconeogenesis
  * **Indication**: Diabetes mellitus
* **Thiazolidinedione**
  * **Drugs**: Troglitazone, rosiglitazone
  * **Mechanism**: Activate PPARŒ≥ (decrease insulin resistance)
  * **Indication**: Diabetes mellitus
* **Œ±-glucosidase inhibitor**
  * **Drugs**: Acarbose
  * **Mechanism**: Œ±-glucosidase inhibitor (decrease intestinal glucose absorption)
  * **Indication**: Diabetes mellitus
* **SGLT2 inhibitor**
  * **Drugs**: Canagliflozin, empagliflozin
  * **Mechanism**: SGLT2 inhibitor (decrease renal glucose reabsorption)
  * **Indication**: Diabetes mellitus
* **Amylin analog**
  * **Drugs**: Pramlintide
  * **Mechanism**: Amylin analog
  * **Indication**: Diabetes mellitus
{: .notice--info}

### Calcium Homeostasis Drug / „Ç´„É´„Ç∑„Ç¶„É†‰ª£Ë¨ù„ÅÆËñ¨

* **Bisphosphonate**
  * **Drugs**: Alendronate, risedronate, pamidronate
  * **Mechanism**: Inhibit osteoclast
  * **Indication**: Osteoporosis
* **Anti-RANKL antibody**
  * **Drugs**: Denosumab
  * **Mechanism**: Anti-RANKL antibody (inhibit osteoclast)
  * **Indication**: Osteoporosis
* **Parathyroid hormone**
  * **Drugs**: Teriparatide
  * **Mechanism**: Stimulate osteoblast
  * **Indication**: Osteoporosis
* **Calcitonin**
  * **Drugs**: Calcitonin
  * **Mechanism**: Inhibit osteoclast
  * **Indication**: Paget disease
* **Vitamin D**
  * **Drugs**: Cholecalciferol
  * **Mechanism**: Increase Ca absorption and reabsorption
  * **Indication**: Osteomalacia
* **SERM**
  * **Drugs**: Raloxifene, estrogen
  * **Mechanism**: Inhibit osteoclast
  * **Indication**: Postmenopausal osteoporosis
{: .notice--info}

### Retinoic Acid / „É¨„ÉÅ„Éé„Ç§„É≥ÈÖ∏

* **Tretinoin**
  * **Drugs**: Tretinoin
  * **Mechanism**: Modify epithelial growth and turnover
  * **Indication**: Acne, photo-aged skin, acute promyelocytic leukemia
  * **Adverse effect**: Sunburn
* **Isotretinoin**
  * **Drugs**: Isotretinoin
  * **Mechanism**: Reduce sebaceous gland size
  * **Indication**: Severe cystic acne
  * **Adverse effect**: Teratogenic
* **Acitretin**
  * **Drugs**: Acitretin
  * **Mechanism**: Inhibit proinflammatory cytokine expression
  * **Indication**: Psoriases
  * **Adverse effect**: Skin and nail abnormality, teratogenic
{: .notice--info} -->

<!-- ## Hypothalamus and Pituitary Gland Disease / Ë¶ñÂ∫ä‰∏ãÈÉ®„Éª‰∏ãÂûÇ‰ΩìÁñæÊÇ£

### Hyperprolactinemia / È´ò„Éó„É≠„É©„ÇØ„ÉÅ„É≥Ë°ÄÁóá
### Acromegaly / ÂÖàÁ´ØËÇ•Â§ßÁóá
### Cushing's Disease / CushingÁóÖ
### Hypopituitarism / ‰∏ãÂûÇ‰ΩìÂâçËëâÊ©üËÉΩ‰Ωé‰∏ãÁóá
### Central Diabetes Insipidus / ‰∏≠Êû¢ÊÄßÂ∞øÂ¥©Áóá
### SIADH / „Éê„Çæ„Éó„É¨„Ç∑„É≥‰∏çÈÅ©ÂêàÂàÜÊ≥åÁóáÂÄôÁæ§

## Thyroid Gland Disease / Áî≤Áä∂ËÖ∫ÁñæÊÇ£

### Grave's Disease / BasedowÁóÖ
### Plummer Disease / PlummerÁóÖ
### Acute Thyroiditis / ÊÄ•ÊÄßÁî≤Áä∂ËÖ∫ÁÇé
### Subacute Thyroiditis / ‰∫úÊÄ•ÊÄßÁî≤Áä∂ËÖ∫ÁÇé
### Painless Thyroiditis / ÁÑ°ÁóõÊÄßÁî≤Áä∂ËÖ∫ÁÇé
### Chronic Thyroiditis / ÊÖ¢ÊÄßÁî≤Áä∂ËÖ∫ÁÇé
### Simple Goiter / ÂçòÁ¥îÊÄßÁî≤Áä∂ËÖ∫ËÖ´
### Multinodular Goiter / Â§öÁµêÁØÄÊÄßÁî≤Áä∂ËÖ∫ËÖ´
### Thyroid Cancer / Áî≤Áä∂ËÖ∫Áôå

## Parathyroid Gland Disease / ÂâØÁî≤Áä∂ËÖ∫ÁñæÊÇ£

### Primary Hyperparathyroidism / ÂéüÁô∫ÊÄßÂâØÁî≤Áä∂ËÖ∫Ê©üËÉΩ‰∫¢ÈÄ≤Áóá
### Renal Hyperparathyroidism / ËÖéÊÄßÂâØÁî≤Áä∂ËÖ∫Ê©üËÉΩ‰∫¢ÈÄ≤Áóá
### Malignancy-Related Hypercalcemia / ÊÇ™ÊÄßËÖ´ÁòçÈñ¢ÈÄ£È´ò„Ç´„É´„Ç∑„Ç¶„É†Ë°ÄÁóá
### Hypoparathyroidism / ÂâØÁî≤Áä∂ËÖ∫Ê©üËÉΩ‰Ωé‰∏ãÁóá
### Pseudohypoparathyroidism / ÂÅΩÊÄßÂâØÁî≤Áä∂ËÖ∫Ê©üËÉΩ‰Ωé‰∏ãÁóá

## Adrenal Gland Disease / ÂâØËÖéÁñæÊÇ£

### Cushing's Syndrome / CushingÁóáÂÄôÁæ§
### Primary Aldosteronism / ÂéüÁô∫ÊÄß„Ç¢„É´„Éâ„Çπ„ÉÜ„É≠„É≥Áóá
### Addison's Disease / AddisonÁóÖ
### Acute Adrenal Insufficiency / ÊÄ•ÊÄßÂâØËÖé‰∏çÂÖ®
### Pheochromocytoma / Ë§êËâ≤Á¥∞ËÉûËÖ´

## Other Endocrine Disease / „Åù„ÅÆ‰ªñ„ÅÆÂÜÖÂàÜÊ≥åÁñæÊÇ£

### MEN / Â§öÁô∫ÊÄßÂÜÖÂàÜÊ≥åËÖ∫ËÖ´Áóá
### Insulinoma / „Ç§„É≥„Çπ„É™„Éé„Éº„Éû
### Gastrinoma / „Ç¨„Çπ„Éà„É™„Éé„Éº„Éû
### Glucagonoma / „Ç∞„É´„Ç´„Ç¥„Éé„Éº„Éû
### VIPoma / VIPoma

## Glucose Metabolism Disorder / Á≥ñ‰ª£Ë¨ùÁï∞Â∏∏

### Type 1 Diabetes Mellitus / 1ÂûãÁ≥ñÂ∞øÁóÖ
### Type 2 Diabetes Mellitus / 2ÂûãÁ≥ñÂ∞øÁóÖ
### Maturity-Onset Diabetes of the Young / Ëã•Âπ¥Áô∫ÁóáÊàê‰∫∫ÂûãÁ≥ñÂ∞øÁóÖ
### Gestational Diabetes Mellitis / Â¶äÂ®†Á≥ñÂ∞øÁóÖ
### Diabetic Ketoacidosis / Á≥ñÂ∞øÁóÖÊÄß„Ç±„Éà„Ç¢„Ç∑„Éâ„Éº„Ç∑„Çπ
### Hyperosmolar Hyperglycemic Syndrome / È´òÊµ∏ÈÄèÂúßÈ´òË°ÄÁ≥ñÁóáÂÄôÁæ§
### Diabetic Foot / Á≥ñÂ∞øÁóÖË∂≥ÁóÖÂ§â
### Hypoglycemia / ‰ΩéË°ÄÁ≥ñÁóá

## Lipid and Nutrition Metabolism Disorder / ËÑÇË≥™„ÉªÊ†ÑÈ§ä‰ª£Ë¨ùÁï∞Â∏∏

### Dyslipidemia / ËÑÇË≥™Áï∞Â∏∏Áóá
### Familial Hypercholesterolemia / ÂÆ∂ÊóèÊÄßÈ´ò„Ç≥„É¨„Çπ„ÉÜ„É≠„Éº„É´Ë°ÄÁóá
### Obesity Disease / ËÇ•Ê∫ÄÁóá
### Metabolic Syndrome / „É°„Çø„Éú„É™„ÉÉ„ÇØ„Ç∑„É≥„Éâ„É≠„Éº„É†
### Vitamin A Deficiency / „Éì„Çø„Éü„É≥AÊ¨†‰πèÁóá
### Vitamin B1 Deficiency / „Éì„Çø„Éü„É≥B1Ê¨†‰πèÁóá
### Vitamin B3 Deficiency / „Éì„Çø„Éü„É≥B3Ê¨†‰πèÁóá
### Vitamin B6 Deficiency / „Éì„Çø„Éü„É≥B6Ê¨†‰πèÁóá
### Vitamin B12 Deficiency / „Éì„Çø„Éü„É≥B12Ê¨†‰πèÁóá
### Vitamin C Deficiency / „Éì„Çø„Éü„É≥CÊ¨†‰πèÁóá
### Vitamin D Deficiency / „Éì„Çø„Éü„É≥DÊ¨†‰πèÁóá
### Vitamin E Deficiency / „Éì„Çø„Éü„É≥EÊ¨†‰πèÁóá
### Vitamin K Deficiency / „Éì„Çø„Éü„É≥KÊ¨†‰πèÁóá
### Zinc Deficiency / ‰∫úÈâõÊ¨†‰πèÁóá
### Copper Deficiency / ÈäÖÊ¨†‰πèÁóá
### Malnutrition Syndrome / Ê†ÑÈ§ä‰∏çËâØÁóáÂÄôÁæ§

## Other Metabolism Disorder / „Åù„ÅÆ‰ªñ„ÅÆ‰ª£Ë¨ùÁï∞Â∏∏

### Hyperuricemia / È´òÂ∞øÈÖ∏Ë°ÄÁóá
### Gout / ÁóõÈ¢®
### Pseudogout / ÂÅΩÁóõÈ¢®
### Osteoporosis / È™®Á≤óÈ¨ÜÁóá
### Osteopetrosis / È™®Á°¨ÂåñÁóá
### Paget's Disease of Bone / È™®PagetÁóÖ
### Hemochromatosis / „Éò„É¢„ÇØ„É≠„Éû„Éà„Éº„Ç∑„Çπ
### Acute Intermittent Porphyria / ÊÄ•ÊÄßÈñìÊ¨†ÊÄß„Éù„É´„Éï„Ç£„É™„É≥Áóá
### Porphyria Cutanea Tarda / Êô©Áô∫ÊÄßÁöÆËÜö„Éù„É´„Éï„Ç£„É™„É≥Áóá
### Amyloidosis / „Ç¢„Éü„É≠„Ç§„Éâ„Éº„Ç∑„Çπ -->

# Nephrology / ËÖéËáìÁßë

## Electrolytes Metabolism Disorder / ÈõªËß£Ë≥™‰ª£Ë¨ùÁï∞Â∏∏

## Glomerular Disorder / Á≥∏ÁêÉ‰ΩìÁñæÊÇ£

## Tubulointerstitial Disorder / Â∞øÁ¥∞ÁÆ°„ÉªÈñìË≥™ÊÄßÁñæÊÇ£

## Renal Injury with Systemic Disorder / ÂÖ®Ë∫´ÊÄßÁñæÊÇ£„Å´‰º¥„ÅÜËÖéÈöúÂÆ≥

## Renal Vascular Disorder / ËÖéË°ÄÁÆ°ÊÄßÁñæÊÇ£

## Renal Failure / ËÖé‰∏çÂÖ®

<!-- ## Introduction /„ÄÄÁ∑èË´ñ

### Diuretics / Âà©Â∞øËñ¨

* **Carbonic anhydrase inhibitor**
  * **Drugs**: Acetazolamide
  * **Mechanism**: Inhibit carbonic anhydrase
  * **Indication**: Glaucoma, urine alkalinization
  * **Adverse effect**: Acidosis, renal calculi
* **Loop diuretics**
  * **Drugs**: Furosemide, bumetanide, torsemide, ethacrynic acid
  * **Mechanism**: Inhibit Na-K-2Cl contransporter
  * **Indication**: Acute pulmonary edema, congestive heart failure
  * **Adverse effect**: Hypokalemia, hypocalcemia, alkalosis, ototoxicity (with aminoglycoside)
* **Thiazide diuretics**
  * **Drugs**: Hydrochlorothiazide, chlorothiazide
  * **Mechanism**: Inhibit Na-Cl contransporter
  * **Indication**: Hypertension, nephrogenic diabetes insipidus
  * **Adverse effect**: Hypokalemia, hypercalcemia, alkalosis, hyperuricemia, hyperglycemia
* **Potassium-sparing diuretics**
  * **Drugs**: Spironolactone, eplerenone, amiloride, triamterene
  * **Mechanism**: Aldosterone antagonist (spironolactone, eplerenone), ENac blocker (amiloride, triamterene)
  * **Indication**: Hyperaldosteronism, prevent K+ loss
  * **Adverse effect**: Hyperkalemia, acidosis, gynecomastia (spironolactone)
* **Osmotic diuretics**
  * **Drugs**: Mannitol
  * **Mechanism**: Inhibit water reabsorption
  * **Indication**: Reduce intracranial and intraocular pressure 
* **ADH antagonist**
  * **Drugs**: Conivaptan, tolvaptan, demeclocycline
  * **Mechanism**: V1 and/or V2 antagonist
  * **Indication**: SIADH
{: .notice--info} -->

<!-- ## Water and Electrolytes Metabolism Disorder / Ê∞¥„ÉªÈõªËß£Ë≥™‰ª£Ë¨ùÁï∞Â∏∏

### Hyponatremia / ‰Ωé„Éä„Éà„É™„Ç¶„É†Ë°ÄÁóá
### Hypernatremia / È´ò„Éä„Éà„É™„Ç¶„É†Ë°ÄÁóá
### Hypokalemia / ‰Ωé„Ç´„É™„Ç¶„É†Ë°ÄÁóá
### Hyperkalemia / È´ò„Ç´„É™„Ç¶„É†Ë°ÄÁóá
### Hypocalcemia / ‰Ωé„Ç´„É´„Ç∑„Ç¶„É†Ë°ÄÁóá
### Hypercalcemia / È´ò„Ç´„É´„Ç∑„Ç¶„É†Ë°ÄÁóá
### Hypophosphatemia / ‰Ωé„É™„É≥Ë°ÄÁóá
### Hyperphosphatemia / È´ò„É™„É≥Ë°ÄÁóá
### Hypomagnesemia / ‰Ωé„Éû„Ç∞„Éç„Ç∑„Ç¶„É†Ë°ÄÁóá
### Hypermagnesemia / È´ò„Éû„Ç∞„Éç„Ç∑„Ç¶„É†Ë°ÄÁóá
### Metabolic Acidosis / ‰ª£Ë¨ùÊÄß„Ç¢„Ç∑„Éâ„Éº„Ç∑„Çπ
### Metabolic Alkalosis / ‰ª£Ë¨ùÊÄß„Ç¢„É´„Ç´„É≠„Éº„Ç∑„Çπ
### Respiratory Acidosis / ÂëºÂê∏ÊÄß„Ç¢„Ç∑„Éâ„Éº„Ç∑„Çπ
### Respiratory Alkalosis / ÂëºÂê∏ÊÄß„Ç¢„É´„Ç´„É≠„Éº„Ç∑„Çπ

## Glomerular Disease / Á≥∏ÁêÉ‰ΩìÁñæÊÇ£

### Acute Glomerulonephritis / ÊÄ•ÊÄßÁ≥∏ÁêÉ‰ΩìËÖéÁÇé
### Rapid Progressive Glomerulonephritis / ÊÄ•ÈÄüÈÄ≤Ë°åÊÄßÁ≥∏ÁêÉ‰ΩìËÖéÁÇé
### IgA Nephropathy / IgAËÖéÁóá
### Minimal Change Nephrotic Syndrome / ÂæÆÂ∞èÂ§âÂåñÂûã„Éç„Éï„É≠„Éº„ÇºÁóáÂÄôÁæ§
### Membranous Nephropathy / ËÜúÊÄßËÖéÁóá
### Focal Segmental Glomerulosclerosis / Â∑£Áä∂ÂàÜÁØÄÊÄßÁ≥∏ÁêÉ‰ΩìÁ°¨ÂåñÁóá
### Membranoproliferative Glomerulonephritis / ËÜúÊÄßÂ¢óÊÆñÊÄßÁ≥∏ÁêÉ‰ΩìËÖéÁÇé
### Alport's Syndrome / AlportÁóáÂÄôÁæ§
### Benign Familial Hematuria / ËâØÊÄßÂÆ∂ÊóèÊÄßË°ÄÂ∞ø

## Tubulointerstitial Disease / Â∞øÁ¥∞ÁÆ°„ÉªÈñìË≥™ÊÄßÁñæÊÇ£

### Fanconi Syndrome / FanconiÁóáÂÄôÁæ§
### Bartter's Syndrome / BartterÁóáÂÄôÁæ§
### Pseudo-Bartter's Syndrome / ÂÅΩÊÄßBartterÁóáÂÄôÁæ§
### Gitelman's Syndrome / GitelmanÁóáÂÄôÁæ§
### Liddle's Syndrome / LiddleÁóáÂÄôÁæ§
### Nephrogenic Diabetes Insipidus / ËÖéÊÄßÂ∞øÂ¥©Áóá
### Renal Tubular Acidosis / Â∞øÁ¥∞ÁÆ°ÊÄß„Ç¢„Ç∑„Éâ„Éº„Ç∑„Çπ
### Tubulointerstitial Nephritis / Â∞øÁ¥∞ÁÆ°ÈñìË≥™ÊÄßËÖéÁÇé

## Renal Injury with Systemic Disease / ÂÖ®Ë∫´ÊÄßÁñæÊÇ£„Å´‰º¥„ÅÜËÖéÈöúÂÆ≥

### Diabetic Nephropathy / Á≥ñÂ∞øÁóÖÊÄßËÖéÁóá
### Gouty Kidney / ÁóõÈ¢®ËÖé
### Myeloma Kidney / È™®È´ÑËÖ´ËÖé
### Cryoglobulin Nephropathy / „ÇØ„É™„Ç™„Ç∞„É≠„Éñ„É™„É≥Ë°ÄÁóáÊÄßËÖéÁóá
### Amyloid Nephropathy / „Ç¢„Éü„É≠„Ç§„ÉâËÖéÁóá
### Lupus Nephritis / „É´„Éº„Éó„ÇπËÖéÁÇé
### Scleroderma Kidney / Âº∑ÁöÆÁóáËÖé
### Drug-Induced Kidney Injury / Ëñ¨Ââ§ÊÄßËÖéÈöúÂÆ≥

## Renal Vascular Disease / ËÖéË°ÄÁÆ°ÊÄßÁñæÊÇ£

### Renovascular Hypertension / ËÖéË°ÄÁÆ°ÊÄßÈ´òË°ÄÂúß
### Benign Nephrosclerosis / ËâØÊÄßËÖéÁ°¨ÂåñÁóá
### Malignant Nephrosclerosis / ÊÇ™ÊÄßËÖéÁ°¨ÂåñÁóá
### Renal Infarction / ËÖéÊ¢óÂ°û
### Renal Papillary Necrosis / ËÖé‰π≥È†≠Â£äÊ≠ª
### Renal Cortical Necrosis / ËÖéÁöÆË≥™Â£äÊ≠ª
### Renal Vein Thrombosis / ËÖéÈùôËÑàË°ÄÊ†ìÁóá

## Renal Failure / ËÖé‰∏çÂÖ®

### Acute Kidney Injury / ÊÄ•ÊÄßËÖéÈöúÂÆ≥
### Chronic Kidney Disease / ÊÖ¢ÊÄßËÖéËáìÁóÖ
### Disequilibrium Syndrome / ‰∏çÂùáË°°ÁóáÂÄôÁæ§
### CKD Mineral and Bone Disorder / CKD„Å´‰º¥„ÅÜÈ™®„Éü„Éç„É©„É´‰ª£Ë¨ùÁï∞Â∏∏
### Dialysis Amyloidosis / ÈÄèÊûê„Ç¢„Éü„É≠„Ç§„Éâ„Éº„Ç∑„Çπ
### Renal Anemia / ËÖéÊÄßË≤ßË°Ä -->

# Hematology / Ë°ÄÊ∂≤Áßë

## Hemostasis Disorder (Primary) / Ê≠¢Ë°Ä„ÅÆÁï∞Â∏∏Ôºà‰∏ÄÊ¨°Ôºâ

## Hemostasis Disorder (Secondary) / Ê≠¢Ë°Ä„ÅÆÁï∞Â∏∏Ôºà‰∫åÊ¨°Ôºâ

## Red Blood Cell Disorder (Nonehemolysis) / Ëµ§Ë°ÄÁêÉ„ÅÆÁï∞Â∏∏ÔºàÈùûÊ∫∂Ë°ÄÔºâ

## Red Blood Cell Disorder (Hemolysis) / Ëµ§Ë°ÄÁêÉ„ÅÆÁï∞Â∏∏ÔºàÊ∫∂Ë°ÄÔºâ

## White Blood Cell Disorder / ÁôΩË°ÄÁêÉ„ÅÆÁï∞Â∏∏

## Myeloid Neoplasm / È™®È´ÑÁ≥ªËÖ´Áòç

## Lymphoid Neoplasm / „É™„É≥„ÉëÁ≥ªËÖ´Áòç

<!-- ## Introduction /„ÄÄÁ∑èË´ñ

### Alkylating Drug / „Ç¢„É´„Ç≠„É´ÂåñËñ¨

* **Nitrogen mustard**
  * **Drug**: Cyclophosphamide, ifosfamide
  * **Mechanism**: Directly damage DNA
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, hemorrhagic cystitis (due to acrolein, prevented by mesna)
* **Nitrosoureas**
  * **Drug**: Carmustine, lomustine
  * **Mechanism**: Directly damage DNA
  * **Indication**: Brain tumor (cross BBB)
  * **Adverse effect**: Myelosuppression, pulmonary toxicity
* **Alkyl sulfonate**
  * **Drug**: Busfulfan
  * **Mechanism**: Directly damage DNA
  * **Indication**: Before bone marrow transplantation
  * **Adverse effect**: Myelosuppression, pulmonary fibrosis, hyperpigmentation
* **Platinum analog**
  * **Drug**: Cisplatin, carboplatin, oxaliplatin
  * **Mechanism**: Directly damage DNA
  * **Indication**: Various tumor
  * **Adverse effect**: Myelosuppresion, nephrotoxicity, otoxicity, peripheral neuropathy
{: .notice--info}

### Antimetabolte / ‰ª£Ë¨ùÊãÆÊäóËñ¨

* **Folic acid analog**
  * **Drug**: Methotrexate, pemetrexed
  * **Mechanism**: Inhibit dihydrofolate reductase, inhibit thymidylate synthetase (pemetrexed)
  * **Indication**: Leukemia and lymphoma, autoimmune disease (methotrexate), mesothelioma, non-small cell lung cancer (pemetrexed)
  * **Adverse effect**: Myelosuppresion, mucositis, nephrotoxicity (rescued by leucovorin)
* **5-Fluorouracil**
  * **Drug**: 5-Fluorouracil, capecitabine
  * **Mechanism**:  Inhibit thymidylate synthetase (5F-dUMP)
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, hand-and-foot syndrome
* **Pyrimidine analog**
  * **Drug**: Cytarabine, gemticabine
  * **Mechanism**: Inhibit DNA polymerase
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression
* **Purine analog**
  * **Drug**: 6-Mercaptopurine, cladribine
  * **Mechanism**: Inhibit DNA polymerase
  * **Indication**: Leukemia
  * **Adverse effect**: Myelosuppression, interact with allopurinol
* **Hydroxyuria**
  * **Drug**: Hydroxyuria
  * **Mechanism**: Inhibit ribonucleoside diphosphate reductase
  * **Indication**: Leukemia, sickle cell anemia
  * **Adverse effect**: Myelosuppression, GI distress
{: .notice--info}

### Microtubule Damaging Drug / ÂæÆÂ∞èÁÆ°ÈòªÂÆ≥Ëñ¨

* **Vinca alkaloids**
  * **Drug**: Vinblastine, vincristine, vinorelbine
  * **Mechanism**: Inhibit microtubule polymerization
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, peripheral neuropathy
* **Taxanes**
  * **Drug**: Paclitaxel, docltaxel, cabazitaxel
  * **Mechanism**: Inhibit microtubule depolymerization
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, peripheral neuropathy, hypersensitivity (paclitaxel), fluid retention (docetaxel)
{: .notice--info}

### Topoisomerase Inhibitor / „Éà„Éù„Ç§„ÇΩ„É°„É©„Éº„ÇºÈòªÂÆ≥Ëñ¨

* **Topoisomerase I inhibitor**
  * **Drug**: Topotecan, irinotecan
  * **Mechanism**: Topoisomerase I inhibitor
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, diarrhea, secondary leukemia
* **Topoisomerase II inhibitor**
  * **Drug**: Etoposide
  * **Mechanism**: Topoisomerase II inhibitor
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression
{: .notice--info}

### Antitumor Antibiotics / ÊäóËÖ´ÁòçÊÄßÊäóÁîüÁâ©Ë≥™

* **Antrhacyclines**
  * **Drug**: Doxorubicin, daunorubicin, idarubicin, epirubicin
  * **Mechanism**: Inhibit topoisomerase II, intercalate between DNA base pairs, form oxygen free radical
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, cardiotoxicity (dexrazoxane protect)
* **Dactinomycin**
  * **Drug**: Dactinomycin
  * **Mechanism**: Intercalate between DNA base pairs
  * **Indication**: Pediatric cancer
  * **Adverse effect**: Myelosuppression
* **Bleomycin**
  * **Drug**: Bleomycin
  * **Mechanism**: Form oxygen free radical
  * **Indication**: Testicular cancer
  * **Adverse effect**: Pulmonary toxicity, hyperpigmentation
{: .notice--info}

### Target Therapy / ÂàÜÂ≠êÊ®ôÁöÑËñ¨

* **Monoclonal antibody (CD20)**
  * **Drug**: Rituximab
  * **Mechanism**: Anti-CD20
  * **Indication**: Non-Hodgkin lymphoma, chronic lymphocytic leukemia
* **Monoclonal antibody (CD30)**
  * **Drug**: Brentuximab vedotin
  * **Mechanism**: Anti-CD30
  * **Indication**: Hodgkin lymphoma
* **Monoclonal antibody (HER2)**
  * **Drug**: Trastuzumab, pertuzumab
  * **Mechanism**: Anti-HER2
  * **Indication**: Breast cancer, gastric cancer
* **Monoclonal antibody (EGFR)**
  * **Drug**: Cetuximab, panitumumab, necitumumab
  * **Mechanism**: Anti-EGFR
  * **Indication**: Metastatic colorectal cancer (KRAS wild-type)
* **Monoclonal antibody (VEGF)**
  * **Drug**: Bevacizumab, ramucirumab
  * **Mechanism**: Anti-VEGF (inhibit microvascular growth)
  * **Indication**: Various cancer
* **Tyrosine kinase inhibitor (BCR-ABL)**
  * **Drug**: Imatinib, dasatinib, nilotinib, and ponatinib
  * **Mechanism**: BCR-ABL inhibitor
  * **Indication**: Leukemia and lymphoma (Philadelphia chromosome-positive) 
* **Tyrosine kinase inhibitor (EGFR)**
  * **Drug**: Gatitinib, erlotinib
  * **Mechanism**: EFGR inhibitor
  * **Indication**: NSCLC
* **Tyrosine kinase inhibitor (BRAF)**
  * **Drug**: Vemurafenib
  * **Mechanism**: BRAF inhibitor
  * **Indication**: Melanoma (BRAF V600E)
* **Immune checkpoint inhibitor (CTLA-4)**
  * **Drug**: Ipilimumab
  * **Mechanism**: Anti-CTLA-4, enhance T-cell activation
  * **Indication**: Melanoma
* **Immune checkpoint inhibitor (PD-1)**
  * **Drug**: Pembrolizumab, nivolumab, cemiplimab
  * **Mechanism**: Anti-PD-1, enhance T-cell activation
  * **Indication**: Various cancer
* **Immune checkpoint inhibitor (PD-L1)**
  * **Drug**: Atezolizumab, durvalumab, avelumab
  * **Mechanism**: Anti-PD-L1, enhance T-cell activation
  * **Indication**: Various cancer
* **Immunomodulator**
  * **Drug**: Thalidomide, lenalidomide
  * **Mechanism**: Inhibit proinflammatory cytokines secretion, enhance call-mediated immunity
  * **Indication**: Multiple myeloma
  * **Adverse effect**: Birth defect
{: .notice--info} -->

<!-- ## Nonhemolytic Anemia / ÈùûÊ∫∂Ë°ÄÊÄßË≤ßË°Ä

### Iron Deficiency Anemia / ÈâÑÊ¨†‰πèÊÄßË≤ßË°Ä
### Sideroblastic Anemia / ÈâÑËäΩÁêÉÊÄßË≤ßË°Ä
### Secondary Anemia / ‰∫åÊ¨°ÊÄßË≤ßË°Ä
### Aplastic Anemia / ÂÜçÁîü‰∏çËâØÊÄßË≤ßË°Ä
### Pure Red Cell Aplasia / Ëµ§ËäΩÁêÉÁôÜ
### Megaloblastic Anemia / Â∑®Ëµ§ËäΩÁêÉÊÄßË≤ßË°Ä

## Hemolytic Anemia / Ê∫∂Ë°ÄÊÄßË≤ßË°Ä

### Hereditary Spherocytosis / ÈÅ∫‰ºùÊÄßÁêÉÁä∂Ëµ§Ë°ÄÁêÉÁóá
### Thalassemia / „Çµ„É©„Çª„Éü„Ç¢
### Sickle Cell Disease / ÈéåÁä∂Ëµ§Ë°ÄÁêÉÁóá
### G6PD Deficiency / G6PDÁï∞Â∏∏Áóá
### Pyruvate Kinase Deficiency / PKÁï∞Â∏∏Áóá
### Paroxysmal Nocturnal Hemoglobinuria / Áô∫‰ΩúÊÄßÂ§úÈñì„Éò„É¢„Ç∞„É≠„Éì„É≥Â∞øÁóá
### Autoimmune Hemolytic Anemia / Ëá™Â∑±ÂÖçÁñ´ÊÄßÊ∫∂Ë°ÄÊÄßË≤ßË°Ä
### Red Cell Fragmentation Syndrome / Ëµ§Ë°ÄÁêÉÁ†¥Á†ïÁóáÂÄôÁæ§

## Leukemia / ÁôΩË°ÄÁóÖ

### Acute Myeloid Leukemia / ÊÄ•ÊÄßÈ™®È´ÑÊÄßÁôΩË°ÄÁóÖ
### Acute Lymphoblastic Leukemia / ÊÄ•ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ
### Chronic Myeloid Leukemia / ÊÖ¢ÊÄßÈ™®È´ÑÊÄßÁôΩË°ÄÁóÖ
### Chronic Lymphocytic Leukemia / ÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ
### Hairy Cell Leukemia / ÊúâÊØõÁ¥∞ËÉûÁôΩË°ÄÁóÖ
### Adult T-cell Leukemia/Lymphoma / Êàê‰∫∫TÁ¥∞ËÉûÁôΩË°ÄÁóÖ„Éª„É™„É≥„ÉëËÖ´

## Malignant Lymphoma / ÊÇ™ÊÄß„É™„É≥„ÉëËÖ´

### Hodgkin Lymphoma / Hodgkin„É™„É≥„ÉëËÖ´
### Diffuse Large B-cell Lymphoma / „Å≥„Åæ„ÇìÊÄßÂ§ßÁ¥∞ËÉûÂûãBÁ¥∞ËÉû„É™„É≥„ÉëËÖ´
### Follicular Lymphoma / ÊøæËÉûÊÄß„É™„É≥„ÉëËÖ´
### MALT Lymphoma / MALT„É™„É≥„ÉëËÖ´
### Mantle Cell Lymphoma / „Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´
### Burkitt lymphoma / Burkitt„É™„É≥„ÉëËÖ´
### Peripheral T-cell Lymphoma / Êú´Ê¢¢ÊÄßTÁ¥∞ËÉû„É™„É≥„ÉëËÖ´
### Mycosis Fungoides and S√©zary Syndrome / ËèåÁä∂ÊÅØËÇâÁóá„ÉªS√©zaryÁóáÂÄôÁæ§

## Other Hematopoietic Tumors / „Åù„ÅÆ‰ªñ„ÅÆÈÄ†Ë°ÄÂô®ËÖ´Áòç

### Myelodysplastic Syndrome / È™®È´ÑÁï∞ÂΩ¢ÊàêÁóáÂÄôÁæ§
### Polycythemia Vera / ÁúüÊÄßËµ§Ë°ÄÁêÉÂ¢óÂä†Áóá
### Essential Thrombocythemia / Êú¨ÊÖãÊÄßË°ÄÂ∞èÊùøË°ÄÁóá
### Primary Myelofibrosis / ÂéüÁô∫ÊÄßÈ™®È´ÑÁ∑öÁ∂≠Áóá
### Multiple Myeloma / Â§öÁô∫ÊÄßÈ™®È´ÑËÖ´
### MGUS / MGUS
### Waldenstr√∂m's Macroglobulinemia / ÂéüÁô∫ÊÄß„Éû„ÇØ„É≠„Ç∞„É≠„Éñ„É™„É≥Ë°ÄÁóá
### Heavy-Chain Disease / HÈéñÁóÖ

## Other Blood Cell Disorder / „Åù„ÅÆ‰ªñ„ÅÆË°ÄÁêÉÁï∞Â∏∏

### Erythrocytosis / Ëµ§Ë°ÄÁêÉÂ¢óÂä†Áóá
### Leukemoid Reaction / È°ûÁôΩË°ÄÁóÖÂèçÂøú
### Agranulocytosis / ÁÑ°È°ÜÁ≤íÁêÉÁóá
### Infectious Mononucleosis / ‰ºùÊüìÊÄßÂçòÊ†∏Áóá
### Langerhans Cell Histiocytosis / LangerhansÁ¥∞ËÉûÁµÑÁπîÁêÉÁóá
### Hemophagocytic Syndrome / Ë°ÄÁêÉË≤™È£üÁóáÂÄôÁæ§

## Hemostasis and Coagulation Disorder / Ê≠¢Ë°Ä„ÉªÂáùÂõ∫Á≥ª„ÅÆÁï∞Â∏∏

### Immune Thrombocytopenic Purpura / ÂÖçÁñ´ÊÄßË°ÄÂ∞èÊùøÊ∏õÂ∞ëÊÄßÁ¥´ÊñëÁóÖ
### Thrombotic Thrombocytopenic Purpura / Ë°ÄÊ†ìÊÄßË°ÄÂ∞èÊùøÊ∏õÂ∞ëÊÄßÁ¥´ÊñëÁóÖ
### Hemolytic Uremic Syndrome / Ê∫∂Ë°ÄÊÄßÂ∞øÊØíÁóáÁóáÂÄôÁæ§
### Disseminated Intravascular Coagulation / Êí≠Á®ÆÊÄßË°ÄÁÆ°ÂÜÖÂáùÂõ∫
### Vitamin K Deficiency / „Éì„Çø„Éü„É≥KÊ¨†‰πèÁóá -->

# Rheumatology / „É™„Ç¶„Éû„ÉÅÁßë

## Immunodeficiency / ÂÖçÁñ´‰∏çÂÖ®

## Allergy / „Ç¢„É¨„É´„ÇÆ„Éº

## Collagen Disease (Arthritis) / ËÜ†ÂéüÁóÖÔºàÈñ¢ÁØÄÁÇéÔºâ

## Collagen Disease (Systemic) / ËÜ†ÂéüÁóÖÔºàÂÖ®Ë∫´ÊÄßÔºâ

## Collagen Disease (Vasculitis) / ËÜ†ÂéüÁóÖÔºàË°ÄÁÆ°ÁÇéÔºâ

<!-- ## Introduction /„ÄÄÁ∑èË´ñ

### Antiallergic Drug / Êäó„Ç¢„É¨„É´„ÇÆ„ÉºËñ¨

* **H1 antagonist (1st generation)**
  * **Drug**: Chlorpheniramine, dimenhydrinate, diphenhydramine, doxylamine, meclizine, promethazine
  * **Mechanism**: H1 receptor antagonist (pass BBB)
  * **Indication**: Allergic symptoms, insomnia, motion sickness, nausea and vomiting
  * **Adverse effect**: Sedation, anticholinergic
* **H1 antagonist (2st generation)**
  * **Drug**: Loratadine, cetirizine, clemastine, fexofenadine, desloratadine
  * **Mechanism**: H1 receptor antagonist (not pass BBB)
  * **Indication**: Allergic rhinitis
{: .notice--info}

### NSAID / Èùû„Çπ„ÉÜ„É≠„Ç§„ÉâÊÄßÊäóÁÇéÁóáËñ¨

* **Aspirin**
  * **Drug**: Aspirin
  * **Mechanism**: Inactivate COX-1 and COX-2 (irreversible)
  * **Indication**: Inflammation, pain, fever, reduce thrombi formation
  * **Adverse effect**: Gastrointestinal event, hypersensitivity, Reye syndrome (during viral infection)
* **NSAID**
  * **Drug**: Ibuprofen, naproxen, fenoprofen, ketoprofen / indomethacin, sulindac, ketorolac, diclofenac / peroxicam, mefenamate, meclofenamate, nabumetone / celecoxib (COX-2 selective)
  * **Mechanism**: Inactivate COX-1 and COX-2 (reversible)
  * **Indication**: Inflammation (indomethacin, diclofenac), pain (ketorolac), fever (ibuprogen, naproxen)
  * **Adverse effect**: Gastrointestinal event, hypersensitivity, cardiovascular event (COX-2 selective)
* **Acetaminophen**
  * **Drug**: Acetaminophen
  * **Mechanism**: Inactivate COX (centrally acting)
  * **Indication**: Pain, fever
  * **Adverse effect**: Hepatotoxicity (due to NAPQI, treat with N-acetylcystein)
* **PGE1 agonist**
  * **Drug**: Misoprostol, alprostadil
  * **Mechanism**: PGE1 agonist
  * **Indication**: NSAID-induced ulcer (misoprostol), erectile dysfunction (alprostadil), ductus arteriosus maintenance (alprostadil)
* **PGE2 agonist**
  * **Drug**: Dinoprostone
  * **Mechanism**: PGE2 agonist
  * **Indication**: Pregnancy termination
* **PGF2Œ± agonist**
  * **Drug**: Carboprost, latanoprost
  * **Mechanism**: PGF2Œ± agonist
  * **Indication**: Pregnancy termination (carboprost), glaucoma (latanoprost)
* **PGI2 agonist**
  * **Drug**: Epoprostenol, treprostinil, iloprost
  * **Mechanism**: PGI2 agonist
  * **Indication**: Pulmonary hypertension
{: .notice--info}

### Gout Drug / ÁóõÈ¢®„ÅÆËñ¨

* **Colchicine**
  * **Drug**: Colchicine
  * **Mechanism**: Prevent tubulin polymerization, interfere neutrophil migration
  * **Indication**: Acute gouty arthritis
  * **Adverse effect**: Gatrointestinal distress
* **Allopurinol**
  * **Drug**: Allopurinol, feboxostat
  * **Mechanism**: Xanthine oxidase inhibitor
  * **Indication**: Chronic gout
  * **Adverse effect**: Skin rash, GI distress
* **Porbenecid**
  * **Drug**: Compatitively inhibits reabaorption
of urate
  * **Mechanism**: Chronic gout
  * **Indication**: Urolithiasis
  * **Adverse effect**: Reduct other drugs excretion (penicillin)
* **Pegloticase**
  * **Drug**: Pegloticase
  * **Mechanism**: Recombinant uricase
  * **Indication**: Chronic gout
  * **Adverse effect**: Anaphylaxis
{: .notice--info}

### Immunosuppressive Drug / ÂÖçÁñ´ÊäëÂà∂Ëñ¨

* **Calcineurin inhibitor**
  * **Drug**: Cyclosporine, tacralimus
  * **Mechanism**: Calcineurin inhibitor
  * **Indication**: Solid-organ transplant, autoimmune disease
  * **Adverse effect**: Nephrotoxicity, gingival hyperplasia (cyclosporine)
* **mTOR inhibitor**
  * **Drug**: Sirolimus
  * **Mechanism**: mTOR inhibitor
  * **Indication**: Solid-organ transplant, autoimmune disease
  * **Adverse effect**: Anemia, increased cholesterol
* **Antimetabolite**
  * **Drug**: Azathioprine, mycophenolate mofetil, leflunomide
  * **Mechanism**: Inhibit DNA synthesis (Azathioprine: converted to 6-MP) (Mycophenolate mofetil: inhibit inosine monophosphate dehydrogenase) (Leflunomide: inhibit dihydroorotate dehydrogenase)
  * **Indication**: Solid-organ transplant, autoimmune disease
  * **Adverse effect**: GI distress, leukopenia, interact with allopurinol (azathioprine)
* **Biologic agent (TNF-Œ±)**
  * **Drug**: Infliximab, adalimumab, certolizumab, golimumab, etanercept
  * **Mechanism**: Block TNF-Œ± 
  * **Indication**: Autoimmune diseases
* **Biologic agent (IL-1)**
  * **Drug**: Anakinra
  * **Mechanism**: IL-1 receptor antagonist
  * **Indication**: Rheumatold arthritis
* **Biologic agent (IL-6 receptor)**
  * **Drug**: Tocilizumab
  * **Mechanism**: IL-6 receptor antagonist
  * **Indication**: Rheumatold arthritis
* **Biologic agent (JAK-STAT)**
  * **Drug**: Tofacitinib
  * **Mechanism**: Block JAK-STAT signaling
  * **Indication**: Rheumatold arthritis
* **Biologic agent (CD80/86)**
  * **Drug**: Abatacept
  * **Mechanism**: Block costimulatory signal
  * **Indication**: Rheumatold arthritis
* **Biologic agent (CD20)**
  * **Drug**: Rituximab
  * **Mechanism**: Anti-CD20 antibody
  * **Indication**: Rheumatoid arthritis, leukemia and lymphoma
* **Biologic agent (CD25)**
  * **Drug**: Basiliximab
  * **Mechanism**: Anti-CD25 antibody
  * **Indication**: Acute transplant rejection
* **Biologic agent (Œ±4 integrin)**
  * **Drug**: Natalizumab
  * **Mechanism**: Anti-Œ±4 integrin antibody
  * **Indication**: Multiple sclerosis, Crohn disease.
* **Antithymocyte globulin**
  * **Drug**: Antithymocyte globulin
  * **Mechanism**: Elimination of T lymphocyte
  * **Indication**: Aplastic anemia, graft-versus-host disease
{: .notice--info} -->

<!-- ## Allergy / „Ç¢„É¨„É´„ÇÆ„Éº

### Anaphylaxis / „Ç¢„Éä„Éï„Ç£„É©„Ç≠„Ç∑„Éº
### Food Allergy / È£üÁâ©„Ç¢„É¨„É´„ÇÆ„Éº
### Drug Allergy / Ëñ¨Áâ©„Ç¢„É¨„É´„ÇÆ„Éº
### Serem Sickness / Ë°ÄÊ∏ÖÁóÖ

## Collagen Disease (Arthritis) / ËÜ†ÂéüÁóÖÔºàÈñ¢ÁØÄÁÇéÔºâ

### Rheumatoid Arthritis / Èñ¢ÁØÄ„É™„Ç¶„Éû„ÉÅ
### Juvenile Idiopathic Arthritis / Ëã•Âπ¥ÊÄßÁâπÁô∫ÊÄßÈñ¢ÁØÄÁÇé
### Adult Still's Disease / Êàê‰∫∫StillÁóÖ
### Ankylosing Spondylitis / Âº∑Áõ¥ÊÄßËÑäÊ§éÁÇé
### Psoriatic Arthritis / ‰πæÁô¨ÊÄßÈñ¢ÁØÄÁÇé
### Reactive Arthritis / ÂèçÂøúÊÄßÈñ¢ÁØÄÁÇé

## Collagen Disease (Systemic) / ËÜ†ÂéüÁóÖÔºàÂÖ®Ë∫´ÊÄßÔºâ

### Systemic Lupus Erythematosus / ÂÖ®Ë∫´ÊÄß„Ç®„É™„ÉÜ„Éû„Éà„Éº„Éá„Çπ
### Scleroderma / Âº∑ÁöÆÁóá
### Polymyositis and Dermatomyositis / Â§öÁô∫ÊÄßÁ≠ãÁÇé„ÉªÁöÆËÜöÁ≠ãÁÇé
### Mixed Connective Tissue Disease / Ê∑∑ÂêàÊÄßÁµêÂêàÁµÑÁπîÁóÖ
### Polymyalgia Rheumatica / „É™„Ç¶„Éû„ÉÅÊÄßÂ§öÁô∫Á≠ãÁóõÁóá
### Fibromyalgia / Á∑öÁ∂≠Á≠ãÁóõÁóá
### Sj√∂gren's Syndrome / Sj√∂grenÁóáÂÄôÁæ§
### Behcet's Disease / BehcetÁóÖ
### Rheumatic Fever / „É™„Ç¶„Éû„ÉÅÁÜ±
### Antiphospholipid Syndrome / Êäó„É™„É≥ËÑÇË≥™Êäó‰ΩìÁóáÂÄôÁæ§
### IgG4-Related Disease / IgG4Èñ¢ÈÄ£ÁñæÊÇ£
### Goodpasture Syndrome / GoodpastureÁóáÂÄôÁæ§
### Sarcoidosis / „Çµ„É´„Ç≥„Ç§„Éâ„Éº„Ç∑„Çπ

## Collagen Disease (Vasculitis) / ËÜ†ÂéüÁóÖÔºàË°ÄÁÆ°ÁÇéÔºâ

### Giant Cell Arteritis / Â∑®Á¥∞ËÉûÊÄßÂãïËÑàÁÇé
### Takayasu's Arteritis / È´òÂÆâÂãïËÑàÁÇé
### Polyarteritis Nodosa / ÁµêÁØÄÊÄßÂ§öÁô∫ÂãïËÑàÁÇé
### Kawasaki Disease / Â∑ùÂ¥éÁóÖ
### Microscopic Polyangiitis / È°ïÂæÆÈè°ÁöÑÂ§öÁô∫Ë°ÄÁÆ°ÁÇé
### Granulomatosis with Polyangiitis / Â§öÁô∫Ë°ÄÁÆ°ÁÇéÊÄßËÇâËäΩËÖ´Áóá
### Eosinophilic Granulomatosis with Polyangiitis / Â•ΩÈÖ∏ÁêÉÊÄßÂ§öÁô∫Ë°ÄÁÆ°ÁÇéÊÄßËÇâËäΩËÖ´Áóá
### IgA Vasculitis / IgAË°ÄÁÆ°ÁÇé -->

# Infectious Diseases / ÊÑüÊüìÁóáÁßë

## Gram-Positive Bacteria Infection / „Ç∞„É©„É†ÈôΩÊÄßËèåÊÑüÊüìÁóá

## Gram-Negative Bacteria Infection / „Ç∞„É©„É†Èô∞ÊÄßËèåÊÑüÊüìÁóá

## Miscellaneous Bacteria Infection / „Åù„ÅÆ‰ªñ„ÅÆÁ¥∞ËèåÊÑüÊüìÁóá

## DNA Virus Infection / DNA„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá

## RNA Virus Infection / RNA„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá

## Fungus Infection / ÁúüËèåÊÑüÊüìÁóá

## Parasite Infection / ÂØÑÁîüËô´ÊÑüÊüìÁóá

<!-- ## Introduction /„ÄÄÁ∑èË´ñ

### Cell Wall Synthesis Inhibitor / Á¥∞ËÉûÂ£ÅÂêàÊàêÈòªÂÆ≥Ëñ¨

* **Penicillins**
  * **Drug**: (Original) penicillin G, penicillin V, benzathine penicillin / (Œ≤-lactamase resistant) oxacillin, dicloxacillin, methicillin, nafcillin / (Extended-spectrum) ampicillin, amoxicillin, piperacillin, ticarcillin / (Œ≤-lactamase inhibitor) clavulanate, sulbactam, tazobactam
  * **Mechanism**: Inhibit transpeptidase, resistance from Œ≤-lactamase, synergistic with aminoglycoside
  * **Indication**: Various bacteria, pseudomonas (piperacillin, ticarcillin)
  * **Adverse effect**: Hypersensitivity, GI disturbances
* **Cephalosporins**
  * **Drug**: (1st generation) cephalexin, cefazolin, cefadroxil / (2nd generation) cefoxitin, cefaclor, cefuroxime, cefotetan, cefprozil / (3rd generation)
  ceftazidime, cefperazone, ceftriazone, cefixime, cefdinir, cefotaxime / (4th generation) cefepime / (5th generation) ceftaroline
  * **Mechanism**: Inhibit transpeptidase, Œ≤-lactamase resistant, penetrate CSF (cefuroxime, 3rd generation)
  * **Indication**: Various bacteria, pseudomonas (cefoperazone, ceftazidime, cefepime), gonorrhea (ceftriaxone, cefixime), MRSA (ceftaroline)
  * **Adverse effect**: Hypersensitivity, GI disturbances
* **Carbapenems**
  * **Drug**: Imipenem (+ cilastatin), ertapenem, meropenem, doripenem
  * **Mechanism**: Inhibit transpeptidase, Œ≤-lactamase resistant, (cilastin: inhibit renal dehydropeptidase)
  * **Indication**: Various bacteria
  * **Adverse effect**: Hypersensitivity
* **Monobactam**
  * **Drug**: Aztreonam
  * **Mechanism**: Inhibit transpeptidase, Œ≤-lactamase resistant
  * **Indication**: Gram-negative (penicillin hypersensitivity)
* **Glycopeptides**
  * **Drug**: Vancomycin, telavancin, dalbavancin, oritavancin
  * **Mechanism**: Inhibit transglycosylase
  * **Indication**: Gram-positive (penicillin hypersensitivity), MRSA
  * **Adverse effect**: Red man syndrome, nephrotoxicity
* **Daptomycin**
  * **Drug**: Daptomycin
  * **Mechanism**: Disrupt cell membrane
  * **Indication**: Gram-positive, MRSA
  * **Adverse effect**: Myopathy
* **Polymyxin**
  * **Drug**: Polymyxin
  * **Mechanism**: Disrupt cell membrane
  * **Indication**: Gram-negative
  * **Adverse effect**: Nephrotoxicity, neurotoxicity
{: .notice--info}

### Protein Synthesis Inhibitor / „Çø„É≥„Éë„ÇØË≥™ÂêàÊàêÈòªÂÆ≥Ëñ¨

* **Aminoglycosides**
  * **Drug**: Streptomycin, gentamicin, tobramycin, neomycin, amikacin
  * **Mechanism**: Inhibit 30S ribosomal subunit, require active transport (anaerobe resistant), synergistic with Œ≤-lactam
  * **Indication**: Gram-negative, aerobe
  * **Adverse effect**: Nephrotoxic, ototoxic, neuromuscular blockade
* **Tetracyclines**
  * **Drug**: Tetracycline, demeclocycline, doxycycline, minocycline, tigecycline
  * **Mechanism**: Inhibit 30S ribosomal subunit
  * **Indication**: Rickatlsia, chlamydia, mycoplasma, acne vulgaris, MRSA (tigecycline)
  * **Adverse effect**: Tooth discoloration, growth inhibition, photosensitivity, calcium impair absorption
* **Macrolides**
  * **Drug**: Azithromycin, clarithromycin, erythromycin, telithromycin
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: Legionella, mycoplasma
  * **Adverse effect**: QT prolongation, inhibit CYP450
* **Lincosamide**
  * **Drug**: Clindamycin
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: Anaerobe, ance
  * **Adverse effect**: Pseudomembranous colitis
* **Oxazolidinones**
  * **Drug**: Linezolid
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: Gram-positive, VRE
  * **Adverse effect**: Thrombocytopenia, serotonin syndrome
* **Amphenicol**
  * **Drug**: Chloramphenicol
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: Various bacteria
  * **Adverse effect**: Aplastic anemia, hemolytic anemia (G6PD deficienct), gray baby syndrome
* **Streptogramins**
  * **Drug**: Quinupristin, dalfopristin
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: VRE, MRSA
{: .notice--info}

### DNA Synthesis Inhibitor / Ê†∏ÈÖ∏ÂêàÊàêÈòªÂÆ≥Ëñ¨

* **Antifolate drug**
  * **Drug**: Trimethoprim + sulfamethoxazole
  * **Mechanism**: Inhibit dihydropteroate synthase (sulfamethoxazole), inhibit dihydrofolate reductase (trimethoprim)
  * **Indication**: Urinary tract infections, pneumocystis pneumonia
  * **Adverse effect**: Hypenensitivity, Stevens-Johnson syndrome, hemolytic anemia (G6PD deficiency)
* **Fluoroquinolones**
  * **Drug**: Ciprofloxacin, norfloxacin, ofloxacin, levofloxacin, moxifloxacin, gemifloxacin
  * **Mechanism**: Inhibit DNA gyrase, inhibit topoisomerase IV
  * **Indication**: Urinary tract infections, respiratory tract infections
  * **Adverse effect**: QT prolongation, tendon rupture
* **Metronidazole**
  * **Drug**: Metronidazole
  * **Mechanism**: Form free radical
  * **Indication**: Trichomonas vaginalis, pseudomembranous colitis
  * **Adverse effect**: Peripheral neuropathy, ditulfiram-like reaction
{: .notice--info}

### Antimycobacterial Drug / ÊäóÁµêÊ†∏Ëñ¨

* **Isoniazid**
  * **Drug**: Isoniazid
  * **Mechanism**: Inhibit mycobactarial call wall synthesis
  * **Indication**: Tuberculosis (combination), prophylaxis
  * **Adverse effect**: Peripheral nauropathy (minimized by pyridoxine), hepatotoxicity
* **Rifampin**
  * **Drug**: Rifampin
  * **Mechanism**: Inhibits RNA polymerase
  * **Indication**: Tuberculosis (combination), atypical mycobactaria, meningitis
  * **Adverse effect**: Orange-color urine
* **Ethambutol**
  * **Drug**: Ethambutol
  * **Mechanism**: Inhibit arabinosyl transfarase
  * **Indication**: Tuberculosis (combination)
  * **Adverse effect**: Visual disturbance
* **Pyrazinamide**
  * **Drug**: Pyrazinamide
  * **Indication**: Tuberculosis (combination)
  * **Adverse effect**: Hepatotoxicity
* **Dapsone**
  * **Drug**: Dapsone
  * **Mechanism**: Inhibit dihydropteroate synthase
  * **Indication**: Leprosy, pneumocystis pneumonia
  * **Adverse effect**: Hemolysis, methemoglobinemia
{: .notice--info}

### Antifungal Drug / ÊäóÁúüËèåËñ¨

* **Polyene**
  * **Drug**: Amphotericin B, nystatin
  * **Mechanism**: Bind to ergosterol, form pores
  * **Indication**: Various fungus, cryptococcal meningitis (with flucytosine)
  * **Adverse effect**: Infusion-related reactions, nephrotoxicity
* **Azoles**
  * **Drug**: Itraconazole, ketoconazole, miconazole, fluconazole, clotrimazole, voriconazole, isavuconazole, posaconazole
  * **Mechanism**: Inhibit ergosterol synthesis (inhibit lanosterol methylation)
  * **Indication**: Various fungus, cryptococcal meningitis (fluconazole)
  * **Adverse effect**: Hepatotoxicity
* **Echinocandins**
  * **Drug**: Caspofungin, micafungin, anidulafungin
  * **Mechanism**: Inhibit cell wall synthesis
  * **Indication**: Candida, aspergillus
* **Flucytosine**
  * **Drug**: Flucytosine
  * **Mechanism**: Inhibit nucleic acid synthesis (converted to 5-fluorauracil)
  * **Indication**: Cryptococcal meningitis (with amphotericin B)
  * **Adverse effect**: Bone marrow supression
* **Griseofulvin**
  * **Drug**: Griseofulvin
  * **Mechanism**: Prevents spindle formation
  * **Indication**: Dermatophyte
{: .notice--info}

### Antiviral Drug / Êäó„Ç¶„Ç§„É´„ÇπËñ¨

* **Antiherpetic drug**
  * **Drug**: Acyclovir, valacyclovir, famiciclovir / ganciclovir, valganciclovir / foscarnet / cidofovir
  * **Mechanism**: Inhbit DNA polymerase (acyclovir, valacyclovir, famiciclovir: activated by viral thymidine kinase)
  * **Indication**: HSV, VZV, EBV, CMV
  * **Adverse effect**: Nephrotoxicity, neurotoxicity, bone marrow suppression
* **Anti-influenza drug**
  * **Drug**: Amantadine, rimantadine / zanamivir, neltamivir / baloxavir marboxil
  * **Mechanism**: M2 protein inhibitor / neuraminidase inhibitor / PA protein inhibitor
  * **Indication**: Influenza, prophylaxis
  * **Adverse effect**: CNS effect, GI dysfunction
* **Anti-HCV durg (direct-acting antiviral)**
  * **Drug**: Glecaprevir, grazoprevir, paritaprevir, simeprevir / daclatasvir, elbasvir, ledipasvir, ombitasvir, pibrentasvir, velpatasvir / sofosbubir, dasabuvir
  * **Mechanism**: NS3/4A inhibitor, NS5A inhibitor, NS5B inhibitor
  * **Indication**: HCV
* **Anti-HBV drug**
  * **Drug**: Lamivudine, adefovir, entecavir, tenofovir / interferon alpha
  * **Mechanism**: Inhibit DNA polymerase
  * **Indication**: HBV
{: .notice--info}

### Antiretroviral Drug / ÊäóHIVËñ¨

* **Nucleoside reverse transcriptase inhibitor**
  * **Drug**: Tenofovir, abacavir, zidovudine, emtricitabine, lamivudine, didanosine, stavudine
  * **Mechanism**: Competitively inhibit reverse transcriptase (require phosphorylation)
  * **Indication**: HIV
  * **Adverse effect**: Leukopenia, neuropathy, pancreatitis
* **Nonnucleoside reverse transcriptase inhibitor**
  * **Drug**: Efavirenz, nevirapine, rilpivirine, etravirine, delavirdine
  * **Mechanism**: Noncompetitively inhibit reverse transcriptase (not require phosphorylation)
  * **Indication**: HIV
  * **Adverse effect**: GI dysfunction, skin reaction
* **Protease inhibitor**
  * **Drug**: Ritonavir, darunavir, atazanavir, lopinavir
  * **Mechanism**: Inhibit polyprotein cleavage
  * **Indication**: HIV
  * **Adverse effect**: Hyperglycemia, hyparlipidemia lipodystrophy
* **Integrase inhibitor**
  * **Drug**: Raltegravir, elvitegravir, dolutegravir bictegravir.
  * **Mechanism**: Prevent viral DNA integration
  * **Indication**: HIV
* **Fusion inhibitor**
  * **Drug**: Enfuvirtida
  * **Mechanism**: Block viral entry (bind gp41)
  * **Indication**: HIV
* **CCR5 antagonist**
  * **Drug**: Maraviroc
  * **Mechanism**: Block viral entry (bind CCR5)
  * **Indication**: HIV
{: .notice--info}

### Antiparasitic Drug / ÊäóÂØÑÁîüËô´Ëñ¨

* **Anti-malaria drug**
  * **Drug**: Cloroquine, primaquine, quinine, atovaquone, artemether, mefloquine
  * **Indication**: Plasmodium vivax/ovale (chloroquine, primaquine), Plasmodium malaria (chloroquine), Plasmodium falciparum (quinine, atovaquone, artemther, mefloquine)
* **Anti-protozoa drug**
  * **Drug**: Metronidazole, stibogluconate sodium, nifurtimox, suramin
  * **Indication**: Entamoeba & Giardia & Trichomonas (metronidazole), Leishmania (stibogluconate sodium), trypanosoma (nifurtimox, suramin)
* **Anti-metazoa drug**
  * **Drug**: Albendazole, pyrantel pamoate, ivermectin, diethylcarbamazine, praziquantel, 
  * **Indication**: Nematode (albendazole, pyrantel pamoate, ivermectin), filaria (diethylcarbamazine), trematode & cestode (praziquantel)
{: .notice--info} -->

<!-- 

## Gram-Positive Bacterial Infection / „Ç∞„É©„É†ÈôΩÊÄßËèåÊÑüÊüìÁóá

### Staphylococcus Aureus Infection / ÈªÑËâ≤„Éñ„Éâ„Ç¶ÁêÉËèåÊÑüÊüìÁóá
### Staphylococcus Epidermidis Infection / Ë°®ÁöÆ„Éñ„Éâ„Ç¶ÁêÉËèåÊÑüÊüìÁóá
### Streptococcus Pyogenes Infection / ÂåñËÜø„É¨„É≥„ÇµÁêÉËèåÊÑüÊüìÁóá
### Streptococcus Agalactiae Infection / BÁæ§„É¨„É≥„ÇµÁêÉËèåÊÑüÊüìÁóá
### Streptococcus Pneumoniae Infection / ËÇ∫ÁÇéÁêÉËèåÊÑüÊüìÁóá
### Viridans Streptococci Infection / Á∑ëËâ≤„É¨„É≥„ÇµÁêÉËèåÊÑüÊüìÁóá
### Enterococcus Infection / ËÖ∏ÁêÉËèåÊÑüÊüìÁóá
### Diphtheria / „Ç∏„Éï„ÉÜ„É™„Ç¢
### Listeriosis / „É™„Çπ„ÉÜ„É™„Ç¢Áóá
### Anthrax / ÁÇ≠ÁñΩ
### Botulism / „Éú„ÉÑ„É™„Éå„ÇπÁóá
### Tetanus / Á†¥ÂÇ∑È¢®
### Clostridium Perfringens Infection / „Ç¶„Çß„É´„Ç∑„É•ËèåÊÑüÊüìÁóá
### Clostridioides Difficile Infection / „Éá„Ç£„Éï„Ç£„Ç∑„É´ËèåÊÑüÊüìÁóá
### Non-Sporeforming Anaerobe Infection / ÁÑ°ËäΩËÉûÂ´åÊ∞óÊÄßËèåÊÑüÊüìÁóá

## Gram-Negative Bacterial Infection / „Ç∞„É©„É†Èô∞ÊÄßËèåÊÑüÊüìÁóá

### Escherichia Coli Infection / Â§ßËÖ∏ËèåÊÑüÊüìÁóá
### Shigellosis / Á¥∞ËèåÊÄßËµ§Áó¢
### Typhoid Fever / ËÖ∏„ÉÅ„Éï„Çπ
### Salmonellosis / „Çµ„É´„É¢„Éç„É©Áóá
### Plague / „Éö„Çπ„Éà
### Yersinia Enterocolitica Infection / „Ç®„É´„Ç∑„Éã„Ç¢ÊÑüÊüìÁóá
### Klebsiella Pneumoniae Infection / „ÇØ„É¨„Éñ„Ç∑„Ç®„É©ÊÑüÊüìÁóá
### Serratia Marcescens Infection / „Çª„É©„ÉÅ„Ç¢ÊÑüÊüìÁóá
### Cholera / „Ç≥„É¨„É©
### Vibrio Parahaemolyticus Infection / ËÖ∏ÁÇé„Éì„Éñ„É™„Ç™ÊÑüÊüìÁóá
### Vibrio Vulnificus Infection / „Éê„É´„Éã„Éï„Ç£„Ç´„ÇπËèåÊÑüÊüìÁóá
### Campylobacter Jejuni Infection / „Ç´„É≥„Éî„É≠„Éê„ÇØ„Çø„ÉºÊÑüÊüìÁóá
### Helicobacter Pylori Infection / „Éî„É≠„É™ËèåÊÑüÊüìÁóá
### Haemophilus Influenzae Infection / „Ç§„É≥„Éï„É´„Ç®„É≥„Ç∂ËèåÊÑüÊüìÁóá
### Pertussis / ÁôæÊó•Âí≥
### Pseudomonas Aeruginosa Infection / Á∑ëËÜøËèåÊÑüÊüìÁóá
### Acinetobacter Baumannii Infection / „Ç¢„Ç∑„Éç„Éà„Éê„ÇØ„Çø„ÉºÊÑüÊüìÁóá
### Legionellosis / „É¨„Ç∏„Ç™„Éç„É©Áóá
### Brucellosis / „Éñ„É´„Çª„É©Áóá
### Tularemia / ÈáéÂÖéÁóÖ
### Cat-Scratch Disease / „Å≠„Åì„Å≤„Å£„Åã„ÅçÁóÖ
### Neisseria Gonorrhoeae Infection / Ê∑ãËèåÊÑüÊüìÁóá
### Neisseria Meningitidis Infection / È´ÑËÜúÁÇéËèåÊÑüÊüìÁóá
### Moraxella Catarrhalis Infection / „É¢„É©„ÇØ„Çª„É©ÊÑüÊüìÁóá

## Other Bacterial Infection / „Åù„ÅÆ‰ªñ„ÅÆÁ¥∞ËèåÊÑüÊüìÁóá

### Actinomycosis / ÊîæÁ∑öËèåÁóá
### Nocardiosis / „Éé„Ç´„É´„Ç∏„Ç¢Áóá
### Tuberculosis / ÁµêÊ†∏
### Nontuberculous Mycobacteriosis / ÈùûÁµêÊ†∏ÊÄßÊäóÈÖ∏ËèåÁóá
### Leprosy / HansenÁóÖ
### Syphilis / Ê¢ÖÊØí
### Borreliosis / „Éú„É¨„É™„Ç¢Áóá
### Leptospirosis / „É¨„Éó„Éà„Çπ„Éî„É©Áóá
### Chlamydia Infection / „ÇØ„É©„Éü„Ç∏„Ç¢ÊÑüÊüìÁóá
### Mycoplasma Infection / „Éû„Ç§„Ç≥„Éó„É©„Ç∫„ÉûÊÑüÊüìÁóá
### Rickettsia Infection / „É™„Ç±„ÉÉ„ÉÅ„Ç¢ÊÑüÊüìÁóá

## DNA Viral Infection / DNA„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá

### Herpes Simplex Virus Infection / ÂçòÁ¥î„Éò„É´„Éö„Çπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Varicella-Zoster Virus Infection / Ê∞¥ÁóòÂ∏ØÁä∂Áñ±Áñπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Epstein-Barr Virus Infection / EB„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Cytomegalovirus Infection / „Çµ„Ç§„Éà„É°„Ç¨„É≠„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Human Herpesvirus 6 & 7 Infection / „Éí„Éà„Éò„É´„Éö„Çπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Human Papillomavirus Infection / „Éí„Éà„Éë„Éî„É≠„Éº„Éû„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Poxvirus Infection / „Éù„ÉÉ„ÇØ„Çπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Parvovirus Infection / „Éë„É´„Éú„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Adenovirus Infection / „Ç¢„Éá„Éé„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Hepatitis B / BÂûãËÇùÁÇé

## RNA Viral Infection / RNA„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá

### Influenza / „Ç§„É≥„Éï„É´„Ç®„É≥„Ç∂
### COVID-19 / Êñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### SARS / ÈáçÁóáÊÄ•ÊÄßÂëºÂê∏Âô®ÁóáÂÄôÁæ§
### MERS / ‰∏≠Êù±ÂëºÂê∏Âô®ÁóáÂÄôÁæ§
### Norovirus Infection / „Éé„É≠„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Rotavirus Infection / „É≠„Çø„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Enterovirus Infection / „Ç®„É≥„ÉÜ„É≠„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Measles Virus Infection / È∫ªÁñπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Rubella Virus Infection / È¢®Áñπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Mumps Virus Infection / „É†„É≥„Éó„Çπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Japanese Encephalitis / Êó•Êú¨ËÑ≥ÁÇé
### West Nile Encephalitis / „Ç¶„Ç®„Çπ„Éà„Éä„Ç§„É´ËÑ≥ÁÇé
### Rabies / ÁãÇÁä¨ÁóÖ
### Dengue Fever / „Éá„É≥„Ç∞ÁÜ±
### Chikungunya Fever / „ÉÅ„ÇØ„É≥„Ç∞„Éã„Ç¢ÁÜ±
### Zika Fever / „Ç∏„Ç´ÁÜ±
### Ebola Hemorrhagic Fever / „Ç®„Éú„É©Âá∫Ë°ÄÁÜ±
### SFTS / ÈáçÁóáÁÜ±ÊÄßË°ÄÂ∞èÊùøÊ∏õÂ∞ëÁóáÂÄôÁæ§
### HIV Infection / HIVÊÑüÊüìÁóá
### HTLV-1 Infection / HTLV-1ÊÑüÊüìÁóá
### Hepatitis A / AÂûãËÇùÁÇé
### Hepatitis C / CÂûãËÇùÁÇé
### Hepatitis D / DÂûãËÇùÁÇé
### Hepatitis E / EÂûãËÇùÁÇé

## Fungal Infection / ÁúüËèåÊÑüÊüìÁóá

### Candidiasis / „Ç´„É≥„Ç∏„ÉÄÁóá
### Aspergillosis / „Ç¢„Çπ„Éö„É´„ÇÆ„É´„ÇπÁóá
### Mucormycosis / „É†„Éº„Ç≥„É´Áóá
### Cryptococcosis / „ÇØ„É™„Éó„Éà„Ç≥„ÉÉ„ÇØ„ÇπÁóá
### Pneumocystis Infection / „Éã„É•„Éº„É¢„Ç∑„Çπ„ÉÅ„ÇπÊÑüÊüìÁóá
### Histoplasmosis / „Éí„Çπ„Éà„Éó„É©„Çπ„ÉûÁóá
### Coccidioidomycosis / „Ç≥„ÇØ„Ç∑„Ç∏„Ç™„Ç§„Éá„ÇπÁóá
### Blastomycosis / „Éñ„É©„Çπ„Éà„Éü„Çª„ÇπÁóá

## Protozoal Infection / ÂéüËô´ÊÑüÊüìÁóá

### Amebiasis / „Ç¢„É°„Éº„ÉêËµ§Áó¢
### Giardiasis / „É©„É≥„Éñ„É´Èû≠ÊØõËô´Áóá
### Cryptosporidiosis / „ÇØ„É™„Éó„Éà„Çπ„Éù„É™„Ç∏„Ç¶„É†Áóá
### Malaria / „Éû„É©„É™„Ç¢
### Babesiosis / „Éê„Éô„Ç∑„Ç¢Áóá
### Toxoplasmosis / „Éà„Ç≠„ÇΩ„Éó„É©„Ç∫„ÉûÁóá
### Leishmaniasis / „É™„Éº„Ç∑„É•„Éû„Éã„Ç¢Áóá
### African Sleeping Sickness / „Ç¢„Éï„É™„Ç´Áù°Áú†ÁóÖ
### Chagas Disease / „Ç∑„É£„Éº„Ç¨„ÇπÁóÖ
### Trichomoniasis / „Éà„É™„Ç≥„É¢„Éä„ÇπÁóá

## Helminthic Infection / Ë†ïËô´ÊÑüÊüìÁóá

### Ascariasis / ÂõûËô´Áóá
### Enterobiasis / ËüØËô´Áóá
### Trichuriasis / Èû≠Ëô´Áóá
### Hookworm Infection / Èâ§Ëô´Áóá
### Strongyloidiasis / Á≥ûÁ∑öËô´Áóá
### Anisakiasis / „Ç¢„Éã„Çµ„Ç≠„Çπ
### Filariasis / „Éï„Ç£„É©„É™„Ç¢Áóá
### Onchocerciasis / „Ç™„É≥„Ç≥„Çª„É´„Ç´Áóá
### Loiasis / „É≠„Ç¢Á≥∏Áä∂Ëô´Áóá
### Gnathostomiasis / È°éÂè£Ëô´Áóá
### Angiostrongyliasis / Â∫ÉÊù±‰ΩèË°ÄÁ∑öËô´Áóá
### Trichinellosis / ÊóãÊØõËô´Áóá
### Schistosomiasis / ‰ΩèË°ÄÂê∏Ëô´Áóá
### Clonorchiasis / ËÇùÂê∏Ëô´Áóá
### Metagonimiasis / Ê®™Â∑ùÂê∏Ëô´Áóá
### Paragonimiasis / ËÇ∫Âê∏Ëô´Áóá
### Diphyllobothriasis / Ë£ÇÈ†≠Êù°Ëô´Áóá
### Taeniasis Saginata / ÁÑ°Èâ§Êù°Ëô´Áóá
### Taeniasis Solium / ÊúâÈâ§Êù°Ëô´Áóá
### Echinococcosis / ÂåÖËô´Áóá

-->

# Neurology / Á•ûÁµåÁßë

## Cerebrovascular Disorder / ËÑ≥Ë°ÄÁÆ°ÈöúÂÆ≥

### Atherothrombotic Infarction / „Ç¢„ÉÜ„É≠„Éº„É†Ë°ÄÊ†ìÊÄßËÑ≥Ê¢óÂ°û

* **Overview**
  * Cerebral infarction caused by atherosclerosis in intra/extracranial major arteries, leading to cerebral ischemia and necrosis
  * Common in middle-aged and elderly, risk factors include hypertension, diabetes, dyslipidemia, smoking, heavy drinking
* **Presentation**
  * **Transient weakness, hemiplegia, numbness, amaurosis fugax**: TIA as prodromal symptoms
  * **Progressive hemiplegia, dysarthria**: Gradual onset during rest due to progressive vessel occlusion
* **Examination**
  * **[CT] Normal or early CT sign (hyperacute), low-density area (acute to chronic)**: Infarct evolution
  * **[MRI] DWI high intensity (hyperacute), T1 low/T2 & FLAIR high intensity (acute to chronic)**: Infarct evolution
  * **[CTA, MRA, Angiography] Arterial stenosis/occlusion**: Atherosclerotic changes
* **Management**
  * **[Acute] rt-PA (within 4.5h), mechanical thrombectomy (within 8h)**: Recanalization
  * **[Acute] Edaravone, antiplatelet drugs, anticoagulants, glycerol**: Neuroprotection and antithrombotic
  * **[Chronic] Risk factor management, antiplatelet therapy**: Prevention of recurrence
{: .notice--info}

### Cardioembolic Infarction / ÂøÉÂéüÊÄßËÑ≥Â°ûÊ†ìÁóá

* **Overview**
  * Cerebral infarction caused by embolism from cardiac thrombus, leading to cerebral ischemia and necrosis
  * Common in patients with atrial fibrillation, recent myocardial infarction, valvular disease, infectious endocarditis
* **Presentation**
  * **Sudden hemiplegia, dysarthria, aphasia, consciousness disturbance**: Abrupt onset during daytime activity
* **Examination**
  * **[CT] Normal or early CT sign (hyperacute), low-density area (acute to chronic)**: Infarct evolution
  * **[MRI] DWI high intensity (hyperacute), T1 low/T2 & FLAIR high intensity (acute to chronic)**: Infarct evolution
  * **[CTA, MRA, Angiography] Vessel occlusion without significant atherosclerosis**: Embolic nature
  * **[Echocardiography] Cardiac thrombus**: Source of embolism
* **Management**
  * **[Acute] rt-PA (within 4.5h), mechanical thrombectomy (within 8h)**: Recanalization
  * **[Acute] Edaravone, glycerol, heparin**: Neuroprotection and anticoagulation
  * **[Chronic] DOACs or warfarin**: Prevention of recurrence
{: .notice--info}

### Lacunar Infarction / „É©„ÇØ„ÉäÊ¢óÂ°û

* **Overview**
  * Small infarction in penetrating arteries of brain, leading to cerebral ischemia and necrosis
  * Common in elderly with hypertension
* **Presentation**
  * **Mild motor weakness, sensory disturbance, dysarthria**: Small vessel occlusion in penetrating artery territory
* **Examination**
  * **[CT] Small low-density area**: Small infarct in penetrating artery territory
  * **[MRI] Small DWI high intensity (hyperacute), T1 low/T2 & FLAIR high intensity (acute to chronic)**: Small infarct in penetrating artery territory
* **Management**
  * **[Acute] rt-PA (within 4.5h), edaravone, antiplatelet drugs**: Early treatment
  * **[Chronic] Antiplatelet therapy, blood pressure control**: Prevention of recurrence
{: .notice--info}

### Transient Ischemic Attack / ‰∏ÄÈÅéÊÄßËÑ≥ËôöË°ÄÁô∫‰Ωú

* **Overview**
  * Temporary neurological symptoms due to focal brain ischemia without infarction, important warning sign for future stroke
  * Common in patients with atherosclerosis risk factors or cardiac diseases
* **Presentation**
  * **Sudden amaurosis fugax, weakness, hemiplegia, numbness, aphasia, dizziness (resolve in 2-15 minutes)**: Temporary brain or retinal ischemia
* **Examination**
  * **[CT, MRI] No acute infarction**: Differentiates from stroke
* **Management**
  * **Antiplatelet therapy, anticooagulation**: Prevention of atherothrombotic events or cardiac embolism
  * **Risk factor management**: Prevent recurrence
{: .notice--info}

### Wallenberg Syndrome / WallenbergÁóáÂÄôÁæ§

* **Overview**
  * Lateral medullary infarction due to vertebrobasilar artery occlusion
  * Common in patients with atherosclerosis risk factors or cardiac diseases
* **Presentation**
  * **Nystagmus, vertigo, ataxia**: Vestibular and cerebellar involvement
  * **Ipsilateral facial sensory loss, dysphagia, hoarseness, Horner's syndrome**: Cranial nerve and sympathetic pathway involvement
  * **Contralateral body temperature and pain sensory loss**: Lateral spinothalamic tract involvement
  * **No motor weakness or deep sensory loss**: Sparing of pyramidal tract and dorsal column
* **Examination**
  * **[CT, MRI] Stroke lesion in lateral medulla**: Lateral medullary infarction
* **Management**
  * **Treatments of atherothrombotic or cardioembolic stroke**: Based on underlying cause
{: .notice--info}

### Cerebellar Infarction / Â∞èËÑ≥Ê¢óÂ°û

* **Overview**
  * Infarction in cerebellar territory (mainly PICA)
  * Common in patients with atherosclerosis risk factors or cardiac diseases
* **Presentation**
  * **Sudden vertigo, nausea, vomiting, ataxia, dysarthria**: Cerebellar dysfunction
  * **Consciousness disturbance**: Indicates brain stem compression
* **Examination**
  * **[CT, MRI] Stroke lesion in cerebellar region**: Cerebellar infarction
* **Management**
  * **[No compression] Conservative treatment**: Standard stroke care
  * **[Hydrocephalus] Ventricular drainage**: Relieve CSF pressure
  * **[Brain stem compression] Decompressive surgery**: Prevent herniation
{: .notice--info}

### Carotid Artery Stenosis / È†∏ÂãïËÑàÁã≠Á™ÑÁóá

* **Overview**
  * Atherosclerotic stenosis of carotid artery, risk for cerebral infarction
  * Risk factors include hypertension, diabetes, dyslipidemia, smoking, heavy drinking
* **Presentation**
  * **Asymptomatic**: Incidental finding
  * **Transient motor weakness, amaurosis fugax, hemiplegia**: TIA symptoms
* **Examination**
  * **[Ultrasound, MRI/MRA, CTA, Angiography] Carotid artery stenosis**: Confirm diagnosis and assess severity
* **Management**
  * **Risk factor control, antiplatelet drugs**: Prevent strokes
  * **Carotid endarterectomy (CEA), carotid artery stenting (CAS)**: Based on symptoms and stenosis severity
{: .notice--info}

### Cerebral Artery Dissection / ËÑ≥ÂãïËÑàËß£Èõ¢

* **Overview**
  * Bleeding within walls of cerebral artery, most common in intracranial vertebral artery
  * Important cause of stroke in 40-50s
* **Presentation**
  * **Sudden posterior neck/occipital pain**: Characteristic initial symptom
  * **Stroke symptoms**: Due to ischemia or subarachnoid hemorrhage
* **Examination**
  * **[MRI/MRA, DSA] Pearl and string sign, double lumen, intimal flap**: Confirms diagnosis
* **Management**
  * **[Ischemic] Anticoagulation or antiplatelet therapy**: Recanalization
  * **[Hemorrhagic] Trapping, proximal clipping, coil embolization**: Prevent rebleeding
{: .notice--info}

### Putaminal Hemorrhage / Ë¢´ÊÆªÂá∫Ë°Ä

* **Overview**
  * Rupture and bleeding of lenticulostriate arteries
  * Common in patients with hypertension history
* **Presentation**
  * **Sudden headache, consciousness disturbance**: Increased intracranial pressure
  * **Contralateral hemiplegia, sensory disturbance**: Damage to adjacent internal capsule
  * **Conjugate deviation towards lesion side**: Damage to PPRF
* **Examination**
  * **[CT] High-density area in putamen**: Blood in putamen
* **Management**
  * **Conservative treatment**: For hematoma ‚â§30mL
  * **Hematoma removal surgery**: For hematoma >30mL
{: .notice--info}

### Thalamic Hemorrhage / Ë¶ñÂ∫äÂá∫Ë°Ä

* **Overview**
  * Rupture and bleeding of thalamoperforating and thalamogeniculate arteries, poor prognosis in severe cases
  * Common in patients with hypertension history
* **Presentation**
  * **Sudden headache, consciousness disturbance**: Increased intracranial pressure
  * **Hemiplegia, sensory disturbance**: Damage to thalamus and internal capsule
  * **Downward and medial deviation of eyes**: Damage to superior colliculus 
* **Examination**
  * **[CT] High-density area in thalamus**: Blood in thalamus
* **Management**
  * **Conservative treatment**: Surgical intervention contraindicated due to critical location
  * **Ventricular drainage**: For intraventricular hemorrhage with impending herniation
{: .notice--info}

### Pontine Hemorrhage / Ê©ãÂá∫Ë°Ä

* **Overview**
  * Rupture and bleeding of pontine arteries, poor prognosis in severe cases
  * Common in patients with hypertension history
* **Presentation**
  * **Consciousness disturbance, respiratory disturbance**: Direct brainstem compression
  * **Quadriplegia, bilateral decerebrate rigidity**: Damage to motor pathways
  * **Fixed midline gaze, pinpoint pupils**: Damage to PPRF and sympathetic tract
* **Examination**
  * **[CT] High-density area in pons**: Blood in pons
* **Management**
  * **Conservative treatment**: Surgical intervention contraindicated due to critical location
{: .notice--info}

### Cerebellar Hemorrhage / Â∞èËÑ≥Âá∫Ë°Ä

* **Overview**
  * Rupture and bleeding of cerebellar artery (mainly SCA)
  * Common in patients with hypertension history
* **Presentation**
  * **Sudden severe occipital headache**: Direct cerebellar compression
  * **Rotatory vertigo, repeated vomiting , nystagmus**: Damage to cerebellar vestibular system
  * **Gait disturbance without quadriplegia**: Cerebellar ataxia
* **Examination**
  * **[CT] High-density area in cerebellum**: Blood in cerebellum
* **Management**
  * **Conservative treatment**: For hematoma ‚â§30mL
  * **Hematoma removal surgery**: For hematoma >30mL
{: .notice--info}

### Subcortical Hemorrhage / ÁöÆË≥™‰∏ãÂá∫Ë°Ä

* **Overview**
  * Rupture and bleeding of cortical branches of cerebral arteries
  * Common in patients with arteriovenous malformation (young) or cerebral amyloid angiopathy (elderly)
* **Presentation**
  * **Sudden headache, seizures**: Increased intracranial pressure
  * **Contralateral sensory disturbance**: Damage to parietal lobe
  * **Homonymous hemianopia**: Damage to occipital lobe
  * **Sensory aphasia, visual field defect**: Damage to temporal lobe
  * **Contralateral motor paralysis**: Damage to frontal lobe
* **Examination**
  * **[CT] High-density area in subcortical region**: Blood in affected lobe
* **Management**
  * **Conservative treatment**: For hematoma with depth >1cm from surface
  * **Hematoma removal surgery**: For hematoma with depth ‚â§1cm from surface
{: .notice--info}

### Cerebral Aneurysm / ËÑ≥ÂãïËÑàÁò§

* **Overview**
  * Bulging of cerebral arteries due to medial defects and acquired factors, causes subarachnoid hemorrhage when ruptured
  * More common in 40-60 years adults
* **Presentation**
  * **Asymptomatic**: Found incidentally
  * **Pupil dilation, diplopia, ptosis**: IC-PC aneurysm compressing cranial nerve III
  * **Visual disturbance**: IC-Oph aneurysm compressing cranial nerve II
* **Examination**
  * **[MRA, 3D-CTA, DSA] Visible aneurysm**: Confirms diagnosis and location
* **Management**
  * **Surgical neck clipping, endovascular coil embolization**: For symptomatic or high risk aneurysm
  * **Observation, blood pressure control, lifestyle modification**: For asymptomatic and small aneurysm 
{: .notice--info}

### Subarachnoid Hemorrhage / „Åè„ÇÇËÜú‰∏ãÂá∫Ë°Ä

* **Overview**
  * Bleeding into subarachnoid space from ruptured cerebral aneurysm or AVM, rapid progression and high mortality
  * More common in 40-60 years adults
* **Presentation**
  * **Thunderclap headache**: Rupture of cerebral aneurysm
  * **Nausea, vomiting, altered consciousness, seizures**: Increased intracranial pressure
  * **Neck stiffness, Kernig's sign**: Meningeal irritation
* **Examination**
  * **[CT] Starfish-shaped high density in suprasellar region**: Bleeding in subarachnoid space
  * **[MRI] FLAIR high signal in subarachnoid space**: When CT is negative
  * **[CSF] Bloody or xanthochromic**: When CT, MRI are negative
  * **[DSA, 3D-CTA, MRA] Identify bleeding source**: Pre-surgical planning
* **Management**
  * **[Pre-op] Blood pressure control, anti-edema drugs, sedation, anticonvulsants**: Prevent rebleeding and herniation
  * **[Definitive] Surgical neck clipping, endovascular coil embolization**: Repair ruptured cerebral arteries
  * **[Post-op] Fasudil, ozagrel sodium, Triple-H therapy**: Prevent/treat vasospasm
{: .notice--info}

### Arteriovenous Malformation / ËÑ≥ÂãïÈùôËÑàÂ•áÂΩ¢

* **Overview**
  * Congenital vascular malformation with direct arteriovenous shunting and abnormal vessel cluster (nidus)
  * More common children and young adults
* **Presentation**
  * **Headache, seizures, progressive hemiparesis**: Cerebral ischemia due to steal phenomenon
  * **Sudden headache, hemiparesis, altered consciousness**: Intracerebral hemorrhage
  * **Neck stiffness, Kernig's sign**: Subarachnoid hemorrhage
* **Examination**
  * **[DSA, MRA] Dilated and tortuous vessels with nidus**: Abnormal vascular connections
  * **[MRI] Multiple flow voids**: Rapid flow rate in nidus
* **Management**
  * **Surgical excision, endovascular embolization, stereotactic radiosurgery**: For hemorrhagic or progressive cases
  * **Conservative treatment**: For non-hemorrhagic or inoperable cases
{: .notice--info}

### Moyamoya Disease / „ÇÇ„ÇÑ„ÇÇ„ÇÑÁóÖ

* **Overview**
  * Progressive stenosis/occlusion of bilateral ICA terminus, causing formation of fragile collateral vessels
  * Common in children <10y and adults 30-40y
* **Presentation**
  * **Transient hemiparesis, altered consciousness, speech disturbance after hyperventilation (in children)**: Cerebral ischemia
  * **Focal neurological deficits (in adults)**: Intracerebral hemorrhage or ischemia
* **Examination**
  * **[MRA, DSA] Bilateral stenosis of ICA terminus and proximal ACA/MCA, abnormal vessel network**: Characteristic moyamoya vessels
  * **[MRI] Flow voids in bilateral basal ganglia**: Rapid flow rate in collateral vessels
* **Management**
  * **STA-MCA anastomosis, EMS, EDAS**: Improve blood flow by direct and indirect bypass
  * **Antiplatelet drugs, anticonvulsants**: Conservative treatment
{: .notice--info}

### Carotid-Cavernous Fistula / ÂÜÖÈ†∏ÂãïËÑà-Êµ∑Á∂øÈùôËÑàÊ¥ûÁòª

* **Overview**
  * Abnormal connection between internal carotid artery and cavernous sinus
  * Due to trauma or aneurysm rupture
* **Presentation**
  * **Pulsatile exophthalmos, conjunctival congestion/edema, orbital bruit**: High pressure in cavernous sinus causing venous congestion
  * **Diplopia, visual disturbance**: Extraocular muscle palsy due to cranial nerve compression
* **Examination**
  * **[DSA] Early visualization of cavernous sinus in arterial phase**: Direct arteriovenous shunting
* **Management**
  * **Endovascular surgery**: Close fistula
{: .notice--info}

### Cerebral Venous Sinus Thrombosis / ËÑ≥ÈùôËÑàÊ¥ûË°ÄÊ†ìÁóá

* **Overview**
  * Thrombosis in cerebral venous sinuses leading to venous congestion
  * Associated with pregnancy/puerperium, oral contraceptives, autoimmune diseases, blood disorders, infections
* **Presentation**
  * **Severe headache, vomiting**: Increased intracranial pressure
  * **Seizures, weakness, paralysis, altered consciousness**: Brain edema or hemorrhage
* **Examination**
  * **[MRI] Brain hemorrhage, edema**: Due to venous congestion
  * **[MRV] Venous sinus occlusion**: Direct visualization of thrombus
* **Management**
  * **Heparin**: Prevent thrombus progression
{: .notice--info}

### Normal Pressure Hydrocephalus / Ê≠£Â∏∏ÂúßÊ∞¥È†≠Áóá

* **Overview**
  * Chronic hydrocephalus with normal CSF pressure due to circulation disturbance in subarachnoid space
  * Idiopathic (60-70s) or secondary to SAH, trauma, meningitis 
* **Presentation**
  * **Gait disturbance, cognitive decline, urinary incontinence**: Due to enlarged ventricles compressing brain tissue
* **Examination**
  * **[CT/MRI] Symmetrical ventricular enlargement, dilated Sylvian fissures and basal cisterns**: Hydrocephalus involving ventricles and subarachnoid space
  * **[Lumbar puncture] Normal CSF pressure**: Distinguishes from other types of hydrocephalus
* **Management**
  * **Lumboperitoneal (L-P) or ventriculoperitoneal (V-P) shunt**: Divert excess CSF
{: .notice--info}

<!-- ### Cerebral Infarction / ËÑ≥Ê¢óÂ°û

* **Overview**
  * Thrombus or embolus obstruct cerebral artery, ischemia and necrosis in the supplied areas, various neurological symptoms and permanent disabilities 
  * [Atherothrombotic infarction] Thrombus forms due to atherosclerosis of carotid or cerebral arteries; hypertension, diabetes, dyslipidemia, smoking, and heavy drinking increase the risk
  * [Cardioembolic infarction] Embolus forms in heart due to heart diseases (atrial fibrillation, valvular heart disease, myocardial infarction)
  * [Lacunar infarction] Lipohyalinosis (blood vessel degeneration due to prolonged hypertension) or microatheroma block small penetrating arteries (to basal ganglia, internal capsule, thalamus)
* **Presentation**
  * **Contralateral hemiplegia, sensory disturbances, dysarthria**: Damage to primary motor or somatosensory cortex
  * **Aphasia, agnosia**: Damage to association cortex
  * **Consciousness disorder**: Widespread cortical damage
  * **Dizziness, nausea, vomiting, cerebellar ataxia, dysarthria (in case of cerebellar infarction)**: Damage to cerebellar balancing and coordinating functions
  * **Temperature and pain sensation impairment of ipsilateral face and contralateral limbs, nystagmus, hoarseness, dysarthria (in case of brainstem infarction, particularly Wallenberg syndrome)**: Damage to spinothalamic tract and cranial nerve nucleus at lateral medulla
  * **Motor disturbance, sensory disturbance, bladder and rectal disturbance, with proprioception preserved (in case of spinal cord infarction, particularly anterior spinal artery syndrome)**
  * **[Atherothrombotic infarction] Occur at rest (often sleeping) and gradually worsen; sometimes preceded by transient ischemic attack**: Stasis of blood flow promotes thrombus formation, thrombus gradually enlarge and progressively block the blood flow
  * **[Cardioembolic infarction] Occur suddenly during activity and develop rapidly, often with large infarct area and severe symptoms**: Increased blood flow during activity dislodge the thrombus,  thrombus rapidly block a major cerebral artery
  * **[Lacunar infarction] Mild motor disturbances, sensory disturbances or dysarthria, without cortical symptoms**: Blockage of small penetrating artery resulting in small infarction area in deep brain
* **Examination**
  * **[CT] No obvious abnormalities in hyperacute phase, low-density region in acute and chronic phase**: No enough structural changes in hyperacute phase, edema in acute phase, liquefactive necrosis in chronic phase
  * **[MRI] High-signal on DWI in hyperacute phase, high signal on T2 and FLAIR in acute and chronic phase**: Water accumulate in cells with restricted diffusion in hyperacute phase, edema in acute phase, liquefactive necrosis in chronic phase
  * **[CTA, MRA, cerebral angiography] Vascular stenosis or occlusion**
* **Management**
  * **[Acute phase] Respiration management (intubation as needed), circulation management (avoid aggressively lowering BP), metabolism management (fluid, glucose)**: Control respiration, circulation, metabolism
  * **[Acute phase] Thrombolytics (rt-PA) or thrombectomy**: Activate plasminogen and dissolve clot, or directly remove clot endovascularly
  * **[Acute phase] Antiplatelet drugs (ozagrel, aspirin) and anticoagulants (heparin, argatroban), neuroprotective drugs (edaravone), anti-cerebral adema drugs (glycerol)**: Prevent thrombus enlargement, prevent free radical damage, prevent brain herniation
  * **[Chronic phase] Control hypertension, diabetes, dyslipidemia, obesity**: Control risk factors
  * **[Chronic phase] Antiplatelet drugs (clopidogrel, cilostazol, aspirin) for atherothrombotic and lacunar infarction, anticoagulants (dabigatran, rivaroxaban, warfarin) for cardioembolic infarction**: Prevent thrombus or embolus formation
  * **[Chronic phase] Rehabilitation**
{: .notice--info}

### Transient Ischemic Attack / ‰∏ÄÈÅéÊÄßËÑ≥ËôöË°ÄÁô∫‰Ωú

* **Overview**
  * Thrombus or embolus obstruct peripheral arteries, transient neurological symptoms, thrombus dissolves and vessels reopen soon after, may precede cerebral infarction due to larger thrombus formation
* **Presentation**
  * **Temporary loss of vision, weakness and hemiplegia, numbness, aphasia (resolve within 2 ~ 15 minutes)**: Temporary ischemia of eye, motor cortex, sensory cortex, language cortex
  * **May develop to cerebral infarction**
* **Examination**
  * **[CT, MRI] No findings of cerebral infarction**
* **Management**
  * **[Preventive] Antiplatelet drugs (clopidogrel, cilostazol, aspirin), anticoagulants (dabigatran, rivaroxaban, warfarin), carotid edarterectomy or carotid artery stenting, control risk factors**: Prevent thrombus or embolus formation
{: .notice--info}

### Carotid Artery Stenosis / È†∏ÂãïËÑàÁã≠Á™ÑÁóá

* **Overview**
  * Narrowing of carotid artery due to atherosclerosis, may lead to TIA or cerebral infarction due to dislodged thrombus
* **Presentation**
  * **Asymptomatic**
  * **May cause TIA or cerebral infarction**
* **Examination**
  * **[Carotid ultrasound] Stenosis of internal carotid artery**
  * **[MRA, CTA, cerebral angiography] Stenosis of internal carotid artery**
* **Management**
  * **[Preventive] Antiplatelet drugs (clopidogrel, cilostazol, aspirin), control hypertension, diabetes, dyslipidemia**: Prevent thrombus formation
  * **[Surgical] Carotid edarterectomy, carotid artery stenting**: Directly remove plaque or prevent plaque breaking off
{: .notice--info}

### Cerebral Hemorrhage / ËÑ≥Âá∫Ë°Ä

* **Overview**
  * Prolonged hypertension weakens vessels walls, leading to rupture and bleeding
  * [Putaminal hemorrhage] Rupture of lenticulostriate artery
  * [Thalamic hemorrhage] Rupture of thalamoperforating or thalamogeniculate artery
  * [Brainstem hemorrhage] Rupture of pontine arteries
  * [Cerebellar hemorrhage] Rupture of superior cerebellar artery
  * [Subcortical hemorrhage] Rupture of cortical branches
* **Presentation**
  * **Headache, impaired consciousness**: Increased intracranial pressure lead to pain and brain herniation
  * **Contralateral hemiplegia, sensory disturbances**: Damage to descending or ascending fibers in internal capsule
  * **[Putaminal hemorrhage] Conjugate deviation of eyes towards affected side**: Damage to corticobulbar fibers to contralateral PPRF (horizontal gaze center)
  * **[Thalamic hemorrhage] Downward and inward deviation of eyes**: Damage to superior colliculus (vertical gaze center)
  * **[Brainstem hemorrhage] Respiratory distress,quadriplegia, fixed midline eyes, pinpoint pupils**: Damage to respiratory center, bilateral corticospinal tract, PPRF and superior colliculus, sympathetic tract
  * **[Cerebellar hemorrhage] Rotational vertigo and repeated vomiting, standing and walking difficulty**: Damage to cerebellar balancing function and coordination function
  * **[Subcortical hemorrhage] Motor disturbances, sensory disturbances, visual field defects, sensory aphasia**: Damage to frontal lobe, parietal lobe, occipital lobe, temporal lobe
* **Examination**
  * **[CT] High-density region**: Fresh blood has higher density
* **Management**
  * **[Clear consciousness] Respiration management (intubation as needed),  circulation management (systolic pressure < 140 mmHg), metabolism management (fluid), anti-cerebral adema drugs (glycerol, mannitol)**: Control respiration, circulation, metabolism, cerebral edema
  * **[Impaired consciousness] Hematoma removal surgery, ventricular drainage**: Relieve brain herniation due to hematoma or hydrocephalus
  * **[Chronic phase] Control hypertension, rehabilitation**
{: .notice--info}

### Arteriovenous Malformation / ËÑ≥ÂãïÈùôËÑàÂ•áÂΩ¢

* **Overview**
  * Congenital cerebrovascular abnormality where arteries and veins directly connect without capillaries, result in a cluster of dilated and tortuous vessels (nidus), may lead to cerebral hemorrhage and secondary subarachnoid hemorrhage due to rupture
  * More common in children and young adults
* **Presentation**
  * **Headache, seizures, progressive hemiplegia**: Abnormal connection bypass capillaries and cause ischemia
  * **Motor disturbance, sensory disturbance, bladder and rectal disturbance (in case of spinal AVM)**
  * **May cause cerebral hemorrhage and secondary subarachnoid hemorrhage**
* **Examination**
  * **[Cerebral angiography, MRA] Cluster of dilated and tortuous vessels**
  * **[MRI] Multiple flow void (no signal) region**: MRI cannot capture fast-moving blood in abnormal vessels
* **Management**
  * **[Hemorrhage or symptomatic] Resection of nidus, embolization of nidus, gamma knife**: Prevent hemorrhage
  * **[Non-hemorrhage] Anticonvulsants**: Symptomatic treatment
{: .notice--info}

### Subarachnoid Hemorrhage / „Åè„ÇÇËÜú‰∏ãÂá∫Ë°Ä

* **Overview**
  * Bleeding into subarachnoid space due to rupture of vascular lesions, underlying diseases include cerebral aneurysm (80%) and arteriovenous malformations
* **Presentation**
  * **Sudden severe pain**: Increased intracranial pressure trigger pain
  * **Nausea, vomiting, impaired consciousness**: Increased intracranial pressure irritates brainstem
  * **Neck stiffness, Kernig sign, Brudzinski sign, positive neck flexion test**: Blood in subarachnoid space irritates meninges
  * **[Complication] Rebleeding**: Dislodge of the initial clot due to fluctuation of blood pressure
  * **[Complication] Cerebral vasospasm**: Blood breakdown products irritate and trigger contractions of vessels
  * **[Complication] Normal pressure hydrocephalus**: Blood breakdown products obstruct CSF absorption pathway
* **Examination**
  * **[CT] Star-shaped high-density area around suprasellar region**: Fresh blood pooling in subarachnoid space (which has star-shaped anatomy around suprasellar region)
  * **[MRI] High signal on FLAIR**: FLAIR suppress CSF signal but highlight abnormal fluid (blood)
  * **[CSF analysis] Blood-stained CSF or xanthochromia (yellowish CSF)**: RBC or bilirubin in CSF
  * **[DSA (4-vessel study), MRA, 3D-CTA] Cerebral aneurysm (preoperative)**
* **Management**
  * **[Preoperative] Blood pressure management (antihypertensive drugs), intracranial pressure management (anti-cerebral edema drugs), pain relief and sedation (diazepam, pentazocine)**: Prevent rebleeding and brain herniation
  * **[Surgical] Aneurysm neck clipping, aneurysm coil embolization**: Prevent rebleeding
  * **[Postoperative] Vasodilator (fasudil), antiplatelet drug (ozagrel)**: Prevent vasospasm
{: .notice--info}

### Cerebral Aneurysm / ËÑ≥ÂãïËÑàÁò§

* **Overview**
  * Bulge in brain vessels (particularly in branching points) due to congenital defects in tunica media and acquired factors such as hypertension and arteriosclerosis; usually asymptomatic but may lead to subarachnoid hemorrhage due to rupture
  * More common in middle age adults
* **Presentation**
  * **Asymptomatic in most cases**
  * **Mydriasis, diplopia, ptosis**: Compression of oculomotor nerve by aneurysm
  * **Vision and visual field defects**: Compression of optic nerve by aneurysm
  * **May cause subarchnoid hemorrhage** 
* **Examination**
  * **[MRA, 3D-CTA, DSA] Cerebral aneurysm**
* **Management**
  * **[Observation]**: If asymptomatic 
  * **[Surgical] Aneurysm neck clipping, aneurysm coil embolization**: If symptomatic or high risk of rupture
{: .notice--info}

### Moyamoya Disease / „ÇÇ„ÇÑ„ÇÇ„ÇÑÁóÖ

* **Overview**
  * Narrowing or occlusion of arteries in circle of Willis lead to ischemia, fragility of compensating collateral circulation lead to hemorrhage
  * More common in children under 10s and adults in 30s ~ 40s
* **Presentation**
  * **[Childhood] Temporary hemiplegia, sensory disturbances, altered consciousness, seizures after cooling hot food by blowing, playing wind instruments, intense crying**: Hypoventilation cause decreased CO2 levels, lead to cerebral vasoconstriction and ischemia
  * **[Adulthood] May lead to cerebral hemorrhage**
* **Examination**
  * **[DSA, MRA] Narrowing or occlusion near terminal portion of internal carotid artery, presence of moyamoya vessles near basal ganglia**
  * **[MRI] Punctate or linear flow void (no signal) region near basal ganglia**: MRI cannot capture fast-moving blood in abnormal vessels
* **Management**
  * **[Surgical] STA-MCA bypass**: Revascularization by connecting superficial temporal artery and middle cerebral artery
  * **[Medical] Antiplatelet drugs, anticonvulsants**: Infarction prevention and symptomatic treatment 
{: .notice--info}

### Carotid-Cavernous Fistula / ÂÜÖÈ†∏ÂãïËÑà-Êµ∑Á∂øÈùôËÑàÊ¥ûÁòª

* **Overview**
  * Arteriovenous fistula forms between internal carotid artery and cavernous sinus due to trauma or rupture of aneurysm, lead to increased pressure in cavernous sinus and ophthalmic veins
  * [Dural arteriovenous fistula] Arteriovenous fistula can also form in transverse sinus and sigmoid sinus
* **Presentation**
  * **Pulsatile exophthalmos, conjunctival congestion and edema**: Increased pressure in ophthalmic veins in a pulsatile fashion 
  * **Pulsatile bruit in orbital region, extraocular muscle paralysis**: Increased pressure in cavernous sinus in a pulsatile fashion 
* **Examination**
  * **[Cerebral angiography ] Visualization of cavernous sinus during arterial phase**: Arterial blood flows directly into cavernous sinus
* **Management**
  * **Endovascular embolization using coil**: Occlusion of the fistula
{: .notice--info}

### Sinus Thrombosis / ÈùôËÑàÊ¥ûË°ÄÊ†ìÁóá

* **Overview**
  * Thrombus forms in venous sinus and obstructs blood return, due to dural arteriovenous fistula or hypercoagulability
* **Presentation**
  * **Headache, vomiting**: Increased intracranial pressure
* **Examination**
  * **[MRV] Narrowing or occlusion of venous sinus**
* **Management**
  * **Anticoagulants (heparin)**: Prevent further thrombus formation
{: .notice--info}

### Hypertensive Encephalopathy / È´òË°ÄÂúßÊÄßËÑ≥Áóá

* **Overview**
  * Sudden or severe increase in blood pressure impairs brain‚Äôs autoregulation and blood-brain barrier, lead to cerebral edema and neurological symptoms 
* **Presentation**
  * **Headache, nausea, vomiting, consciousness disturbances**: Increased intracranial pressure
* **Examination**
  * **[MRI] High signal in localized area**: Edema
  * **[CT] Low-density in localized area**: Edema
* **Management**
  * **Calcium channel blockers (nicardipine), anti-cerebral edema drugs (glycerol, mannitol)**: Reduce blood pressure, relieve cerebral edema
{: .notice--info} -->

## Dementia / Ë™çÁü•Áóá

### Alzheimer's Disease / AlzheimerÂûãË™çÁü•Áóá

* **Overview**
  * Most common type of dementia, neurodegenerative disease characterized by brain atrophy and presence of senile plaques and neurofibrillary tangles
  * Common in elderly 
* **Presentation**
  * **Memory loss, disorientation, impaired judgment**: Hippocampal and temporal lobe atrophy
  * **Apraxia, agnosia, aphasia, executive dysfunction**: Parietal lobe atrophy
  * **Delusions (theft), behavioral changes**: Progressive cognitive decline
* **Examination**
  * **[CT/MRI] Cortical atrophy (hippocampus), enlarged sulci and ventricles**: General brain atrophy
  * **[SPECT/PET] Decreased blood flow in parietal and temporal lobes**: Reduced brain function
  * **[Cognitive tests] Decline in memory and cognitive function**: Progressive cognitive decline
* **Management**
  * **Cholinesterase inhibitors (donepezil), NMDA receptor antagonist (memantine)**: Improve cognitive function or reduce cognitive decline
  * **Atypical antipsychotics, yokukansan**: Manage psychiatric symptoms
  * **Exercise, reminiscence therapy, recreation, music therapy**: Non-pharmacological therapy
{: .notice--info}

### Dementia with Lewy Bodies / LewyÂ∞è‰ΩìÂûãË™çÁü•Áóá

* **Overview**
  * Neurodegenerative disease characterized by cognitive impairment, visual hallucinations, and parkinsonism
  * Common in elderly
* **Presentation**
  * **Fluctuating cognitive impairment**: Progressive neurodegeneration
  * **Recurrent visual hallucinations**: May due to occipital lobe dysfunction
  * **Parkinsonism**: Due to dopaminergic neuron loss
  * **REM sleep behavior disorder**: Disruption of muscle tone in sleep
* **Examination**
  * **[SPECT/PET] Decreased occipital blood flow**: Reduced brain function
  * **[MIBG myocardial scintigraphy] Decreased MIBG uptake**: Sympathetic denervation
  * **[DAT-SPECT] Reduced striatal uptake**: Loss of dopaminergic neurons
* **Management**
  * **Cholinesterase inhibitors (donepezil)**: Improve cognitive function
  * **Yokukansan, atypical antipsychotics**: Manage hallucinations (antipsychotics may worsen parkinsonism)
  * **L-dopa**: Treat parkinsonism
  * **Clonazepam**: Treat REM sleep behavior disorder
{: .notice--info}

### Frontotemporal Dementia / ÂâçÈ†≠ÂÅ¥È†≠ÂûãË™çÁü•Áóá

* **Overview**
  * Neurodegenerative disease characterized by personality changes and behavioral abnormalities
  * Common in middle-aged adults (40-60s)
* **Presentation**
  * **Decreased initiative, emotional blunting**: Frontal lobe atrophy
  * **Disinhibition, stereotypical behaviors, lack of disease awareness**: Behavioral changes
* **Examination**
  * **[CT/MRI] Frontal and temporal lobe atrophy**: Localized brain degeneration
  * **[SPECT/PET] Decreased blood flow in frontal and temporal lobes**: Reduced brain function
* **Management**
  * **Symptomatic treatment**: No curative treatment
{: .notice--info}

### Vascular Dementia / Ë°ÄÁÆ°ÊÄßË™çÁü•Áóá

* **Overview**
  * Second most common type of dementia, caused by cerebrovascular disorders including infarctions and hemorrhages
  * Risk factors: hypertension, diabetes, dyslipidemia, atrial fibrillation, smoking
* **Presentation**
  * **Depression, reduced spontaneity, executive dysfunction, delirium, emotional incontinence**: Damage to various brain regions
  * **Patchy cognitive decline**: Specific cognitive decline based on lesion area
  * **Motor/sensory deficits, pseudobulbar palsy, parkinsonian gait**: Focal neurological symptoms based on lesion area
* **Examination**
  * **[CT/MRI] Infarcts, hemorrhages**: Evidence of cerebrovascular disease
* **Management**
  * **Blood pressure control, antiplatelet/anticoagulation therapy**: Prevent stroke recurrence
  * **Rehabilitation, lifestyle modification**: Improve functional status
{: .notice--info}

<!-- ### Alzheimer‚Äôs Dementia / AlzheimerÂûãË™çÁü•Áóá

* **Overview**
  * Degeneration of cerebral cortex due to accumulation of amyloid Œ≤ and phosphorylated tau protein, leading to cognitive impairment
  * Common in elderly individuals, most common type of dementia
  * Pathology shows cerebral atrophy grossly, senile plaques and neurofibrillary tangles microscopically 
* **Presentation**
  * **[Core symptoms] Memory impairment, disorientation, executive dysfunction, aphasia, apraxia, agnosia**: Degeneration of cerebral cortex, mainly temporal lobe (hippocampus) and parietal lobe 
  * **[BPSD] Insomnia, hallucinations/delusions, depressive states, anxiety/agitation, excitement/violence, unclean behavior, wandering, pica/overeating, dependency**: Disruption of normal brain functions
* **Examination**
  * **[Cognitive function test] HDS-R score <= 20, MMSE <= 23**: Cognitive impairment
  * **[CT, MRI] Atrophy, mainly temporal lobe and hippocampus**: Degeneration of temporal lobe
  * **[SPECT, PET] Reduced blood flow, mainly temporal lobe and parietal lobe**: Reduced neuronal activity leads to reduced blood flow
* **Management**
  * **Cholinesterase inhibitor (donepezil, galantamine, rivastigmine)**: Reduce breakdown and increase level of acetylcholine, improve signal transduction
  * **NMDA receptor antagonist (memantin)**: Inhibit excessive glutamate activity, reduce neuronal damage 
{: .notice--info}

### Dementia With Lewy Bodies / LewyÂ∞è‰ΩìÂûãË™çÁü•Áóá

* **Overview**
  * Degeneration of cerebral cortex due to accumulation of Œ±-synuclein, leading to cognitive impairment and Parkinsonism
Pathology shows Lewy bodies
* **Presentation**
  * **Cognitive impairment, visual hallucinations (with daily or weekly fluctuation)**: Degeneration of cerebral cortex, mainly occipital lobe
  * **Parkinsonism, REM sleep behavior disorder**: Degeneration of basal ganglia and brainstem
* **Examination**
  * **[SPECT, PET] Reduced blood flow, mainly occipital lobe**: Degeneration of occipital lobe
  * **[MIBG myocardial scintigraphy] Decreased uptake**: Degeneration of postganglionic sympathetic nerve fiber
  * **[Dopamine reuptake test] Loss of dopamine neuron in basal ganglia**
* **Management**
  * **Cholinesterase inhibitor (donepezil)**: For cognitive impairment
  * **Levodopa**: For Parkinsonism
  * **Benzodiazepine (clonazepam)**: For REM sleep behavior disorder
{: .notice--info}

### Frontotemporal Dementia / ÂâçÈ†≠ÂÅ¥È†≠ÂûãË™çÁü•Áóá

* **Overview**
  * Degeneration of cerebral cortex (mainly frontal and temporal lobe), leading to cognitive impairment, personality changes and behavioral abnormalities 
* **Presentation**
  * **Decreased spontaneity, emotional blunting, disinhibition, stereotyped behaviors**: Degeneration of cerebral cortex, mainly frontal lobe and temporal lobe 
* **Examination**
  * **[CT, MRI] Atrophy, mainly frontal lobe and temporal lobe**: Degeneration of frontal lobe and temporal lobe
  * **[SPECT, PET] Reduced blood flow, mainly frontal lobe and temporal lobe**: Degeneration of frontal lobe and temporal lobe
* **Management**
  * **Symptomatic treatment**
{: .notice--info}

### Vascular Dementia / Ë°ÄÁÆ°ÊÄßË™çÁü•Áóá

* **Overview**
  * Cerebrovascular diseases damage the brain, leading to cognitive impairment
* **Presentation**
  * **Gradual and patchy decline in cognitive function**: Gradual and partial damage to cerebral cortex
  * **Motor and sensory disturbances**: Other symptoms of cerebral infarction or hemorrhage
* **Examination**
  * **[CT, MRI] Cerebral infarction or hemorrhage**
* **Management**
  * **Control hypertension, antiplatelet drugs, anticoagulants**: Prevent relapse of infarction
{: .notice--info} -->

## Neurodegenerative Disorder / Á•ûÁµåÂ§âÊÄßÁñæÊÇ£

### Parkinson's Disease / ParkinsonÁóÖ

* **Overview**
  * Neurodegenerative disorder due to loss of dopamine-producing cells in substantia nigra
  * Common in middle-aged and elderly
* **Presentation**
  * **Resting tremor (4-6 Hz)**: Reduced dopamine transmission
  * **Bradykinesia, micrographia, mask-like face**: Impaired movement initiation
  * **Muscle rigidity (cogwheel or lead-pipe)**: Increased muscle tone
  * **Postural instability, forward-leaning posture**: Impaired balance control
  * **Freezing gait, small steps, festination**: Combined effect of bradykinesia and postural instability
  * **Constipation, urinary dysfunction, orthostatic hypotension, seborrhea**: Autonomic dysfunction
* **Examination**
  * **[MIBG myocardial scintigraphy] Reduced MIBG uptake**: Sympathetic denervation
  * **[DAT-SPECT] Reduced striatal uptake**: Loss of dopaminergic neurons
* **Management**
  * **L-dopa**: Replaces dopamine
  * **Dopamine agonists**: Stimulates dopamine receptors
  * **Anticholinergics, amantadine, MAO-B inhibitors, COMT inhibitors**: Various mechanisms to improve dopamine function
  * **Deep brain stimulation**: For medication-resistant cases
{: .notice--info}

### Progressive Supranuclear Palsy / ÈÄ≤Ë°åÊÄßÊ†∏‰∏äÊÄßÈ∫ªÁó∫

* **Overview**
  * Progressive neurodegenerative disease with tau protein accumulation in basal ganglia and brainstem
  * Common in males aged 50-70 years
* **Presentation**
  * **Vertical gaze palsy (especially downward)**: Supranuclear impairment of vertical eye movements
  * **Early falls, postural instability, neck extension**: Increased axial muscle tone
  * **Bradykinesia, masked face, small voice, freezing gait**: Parkinsonism (rare resting tremor)
  * **Dysarthria, dysphagia**: Pseudobulbar palsy
  * **Subcortical dementia**: Cognitive decline
* **Examination**
  * **[CT/MRI] Midbrain tegmentum atrophy (hummingbird sign)**: Characteristic neurodegeneration pattern
* **Management**
  * **Supportive care**: No established treatment
  * **Levodopa, other antiparkinsonian drugs**: Limited effectiveness
 {: .notice--info}

### Corticobasal Degeneration / Â§ßËÑ≥ÁöÆË≥™Âü∫Â∫ïÊ†∏Â§âÊÄßÁóá

* **Overview**
  * Progressive neurodegenerative disease with tau protein accumulation in cerebral cortex and basal ganglia
  * Common in ages 50-70 years
* **Presentation**
  * **Limb-kinetic apraxia, ideomotor apraxia, alien hand syndrome , cortical sensory loss**: Cortical symptoms
  * **Rigidity, bradykinesia, postural instability**: Parkinsonism (rare resting tremor)
  * **Myoclonus, dystonia, cognitive decline**: Other brain involvement
  * **Symptoms show marked asymmetry**: Characteristic feature
* **Examination**
  * **[CT/MRI] Asymmetric cerebral atrophy**: Underlying neurodegeneration
* **Management**
  * **Supportive care**: No established treatment
  * **Levodopa, other antiparkinsonian drugs**: Limited effectiveness
{: .notice--info}

### Huntington‚Äôs Disease / HuntingtonÁóÖ

* **Overview**
  * Progressive neurodegenerative disease due to CAG repeat expansion in Huntington gene
  * Autosomal dominant , onset typically 30-50 years
* **Presentation**
  * **Quick, dance-like involuntary movements of limbs**: Chorea due to striatal degeneration
  * **Personality changes, dementia, delusions, hallucinations**: Progressive psychiatric symptoms
* **Examination**
  * **[CT/MRI] Caudate nucleus atrophy, enlarged anterior horn of lateral ventricles**: Characteristic brain changes
  * **[Genetic test] CAG repeat expansion in Huntington gene**: Confirms diagnosis
* **Management**
  * **Haloperidol, tiapride, tetrabenazine**: Control chorea (levodopa worsens symptoms)
  * **Haloperidol, chlorpromazine**: Manage psychiatric symptoms
{: .notice--info}

### MSA-C / Â§öÁ≥ªÁµ±ËêéÁ∏ÆÁóáÂ∞èËÑ≥Âûã

* **Overview**
  * Progressive degeneration of inferior olive nucleus, pons, and cerebellum
  * Common in middle-aged and elderly, non-hereditary
* **Presentation**
  * **Truncal ataxia, drunken gait, limb incoordination, dysarthria**: Cerebellar dysfunction (initial symptoms)
  * **Abnormal finger-nose, heel-knee, diadochokinesis tests**: Cerebellar dysfunction
  * **Parkinsonism, autonomic symptoms, pyramidal signs**: Disease progression affecting multiple systems
* **Examination**
  * **[CT/MRI] Cerebellar and brainstem atrophy**: Neurodegeneration
  * **[MRI T2] Hot cross bun sign in ventral pons**: Characteristic finding of MSA-C
* **Management**
  * **TRH/TRH derivatives**: For cerebellar symptoms
  * **Levodopa**: For parkinsonism
  * **Droxidopa, midodrine, Œ±-blockers**: For autonomic symptoms (orthostatic hypotension, urinary dysfunction)
{: .notice--info}

### MSA-P / Â§öÁ≥ªÁµ±ËêéÁ∏ÆÁóá„Éë„Éº„Ç≠„É≥„ÇΩ„É≥Âûã

* **Overview**
  * Progressive degeneration of striatum and substantia nigra
  * Common in middle-aged and elderly, non-hereditary
* **Presentation**
  * **Akinesia, rigidity, small-step gait**: Parkinsonian symptoms (rare resting tremor)
  * **Cerebellar symptoms, autonomic symptoms, pyramidal signs**: Disease progression affecting multiple systems
* **Examination**
  * **[MRI] Putaminal atrophy**: Striatal degeneration
  * **[MRI T2/FLAIR] Linear hyperintensity in lateral putamen**: Characteristic finding of MSA-P
* **Management**
  * **Levodopa**: For parkinsonism
  * **TRH/TRH derivatives**: For cerebellar symptoms
  * **Droxidopa, midodrine, Œ±-blockers**: For autonomic symptoms (orthostatic hypotension, urinary dysfunction)
{: .notice--info}

### Shy-Drager Syndrome / Shy-DragerÁóáÂÄôÁæ§

* **Overview**
  * Part of multiple system atrophy characterized by primary autonomic dysfunction
  * Common in middle-aged and elderly, non-hereditary
* **Presentation**
  * **Orthostatic hypotension, postprandial hypotension, urinary dysfunction, constipation, erectile dysfunction, anhidrosis, Horner's syndrome**: Autonomic dysfunction
  * **Cerebellar symptoms, parkinsonism, pyramidal signs**: Disease progression affecting multiple systems
* **Examination**
  * **[CT/MRI] Various combinations of MSA-C and MSA-P findings**: Multiple system involvement
* **Management**
  * **Droxidopa, midodrine, Œ±-blockers**: For autonomic symptoms (orthostatic hypotension, urinary dysfunction)
  * **TRH/TRH derivatives**: For cerebellar symptoms
  * **Levodopa**: For parkinsonism
{: .notice--info}

### Amyotrophic Lateral Sclerosis / Á≠ãËêéÁ∏ÆÊÄßÂÅ¥Á¥¢Á°¨ÂåñÁóá

* **Overview**
  * Progressive degeneration of both upper and lower motor neurons leads to muscle atrophy
  * Common in 60-70s, mainly sporadic but some familial
* **Presentation**
  * **Muscle weakness, atrophy, fasciculation (mainly upper limbs)**: Lower motor neuron damage
  * **Hyperreflexia, Babinski sign (mainly lower limbs)**: Upper motor neuron damage
  * **Dysphagia, dysarthria, tongue atrophy**: Bulbar palsy
  * **No eye movement disorder, sensory disturbance, bladder/bowel dysfunction, pressure sores**: Four negative symptoms characteristic of ALS
* **Examination**
  * **[EMG] Denervation potentials at rest, high amplitude potentials during voluntary contraction**: Neurogenic changes
  * **[Muscle ultrasound] Fasciculation**: Lower motor neuron damage
* **Management**
  * **Supportive care, rehabilitation**: No curative treatment , mean survival 3-5 years
  * **Riluzole, edaravone**: Limited effectiveness
{: .notice--info}

### Spinal Muscular Atrophy / ËÑäÈ´ÑÊÄßÁ≠ãËêéÁ∏ÆÁóá

* **Overview**
  * Degeneration of lower motor neurons due to SMN gene deletion/mutation, four types based on age of onset and severity
* **Presentation**
  * **[Type I] Severe hypotonia (floppy infant)**: Onset at birth
  * **[Type II] Intermediate severity**: Onset by age 2
  * **[Type III] Proximal muscle weakness, Gowers' sign**: Onset age 2-18
  * **[Type IV] Very slow progression**: Adult onset
  * **Normal intelligence**: Only motor function affected
* **Examination**
  * **[Genetic testing] SMN gene deletion/mutation**: Confirms diagnosis in many cases
* **Management**
  * **Supportive care**: No curative treatment, variable progression based on types
{: .notice--info}

### Bulbospinal Muscular Atrophy / ÁêÉËÑäÈ´ÑÊÄßÁ≠ãËêéÁ∏ÆÁóá

* **Overview**
  * Degeneration of lower motor neurons due to CAG repeat expansion in androgen receptor gene
  * X-linked recessive, common in  20-50 years males
* **Presentation**
  * **Bulbar palsy, widespread fasciculations**: Lower motor neuron degeneration
  * **Gynecomastia, hypogonadism**: Androgen receptor dysfunction
  * **Normal intelligence**: Only motor and endocrine systems affected
* **Examination**
  * **[Genetic testing] CAG repeat expansion in androgen receptor gene**: Definitive diagnosis
* **Management**
  * **Supportive care**: No curative treatment, slow progression
{: .notice--info}

<!-- ### Parkinson‚Äôs Disease / ParkinsonÁóÖ

* **Overview**
  * Degeneration of dopamine neuron in substantia nigra pars compacta lead to dopamine deficiency, the direct pathway of basal ganglia (striatum - globus pallidus internum - thalamus) cannot be excited and making movement difficult
  * More common in middle-aged to elderly individuals 
  * Pathology reveals loss of neuromelanin-containing cells in substantia nigra and appearance of Lewy bodies in nerve cells (due to accumulation of Œ±-synuclein)
* **Presentation**
  * **Akinesia (slow movement, difficulty initiating walking and short-step gait, masked face)**: Dopamine depletion disrupts movement control
  * **Resting tremor  (pill-rolling tremor, tapping tremor)**: Dopamine depletion disrupts movement control
  * **Muscle rigidity (cogwheel or lead-pipe)**: Dopamine depletion disrupts muscle tone control
  * **Postural instability (increased tendency to fall when pushed)**: Dopamine depletion disrupts balance maintenance 
  * **Depression, dementia, sleep disorder**: Dopamine depletion disrupts mood and cognition
  * **Orthostatic hypotension, urinary dysfunction, chronic constipation**: Dopamine depletion disrupts autonomic system
* **Examination**
  * **[CT, MRI] No specific findings**
  * **[MIBG myocardial scintigraphy] Decreased uptake**: Degeneration of postganglionic sympathetic nerve fibers
  * **[Dopamine transporter imaging] Loss of dopamine neuron in basal ganglia**
* **Management**
  * **Dopamine precursor (levodopa) + dopamine decarboxylase inhibitor (carbidopa)**: Levodopa cross blood-brain barrier and convert to dopamine (carbidopa inhibit the conversion in peripheral tissue)
  * **Dopamine agonist (bromocriptine, pergolide, cabergoline, pramipexole, ropinirole, rotigotine, apomorphine)**: Stimulate dopamine receptor
  * **Anticholinergic drugs (trihexyphenidyl, biperiden, prophenamine)**: Balance acetylcholine and dopamine level
  * **Dopamine release promoter (amantadine)**: Increase dopamine release
  * **Monoamine oxidase B inhibitor (selegiline, rasagiline)**: Inhibit breakdown of dopamine
  * **COMT inhibitor (Entacapone)**: Inhibit breakdown of levodopa
  * **Deep brain stimulation (subthalamic nucleus or globus pallidus)**: Modulate abnormal neural activity caused by dopamine deficiency 
{: .notice--info}

### Progressive Supranuclear Palsy / ÈÄ≤Ë°åÊÄßÊ†∏‰∏äÊÄßÈ∫ªÁó∫

* **Overview**
  * Degeneration of basal ganglia and brainstem due to abnormal accumulation of tau protein
* **Presentation**
  * **Increased neck muscle tone, akinesia, muscle rigidity, postural instability, (resting tremor is absent)**: Degeneration of basal ganglia
  * **Vertical gaze palsy, speech and swallowing impairment**: Degeneration of brain stem
  * **Mental disturbances**: Degeneration of frontal lobe
* **Examination**
  * **[CT, MRI] Atrophy of midbrain tegmentum (hummingbird sign)**
* **Management**
  * **No established treatment, similar to medication for Parkinson‚Äôs disease**: Limited response
{: .notice--info}

### Corticobasal Degeneration / Â§ßËÑ≥ÁöÆË≥™Âü∫Â∫ïÊ†∏Â§âÊÄßÁóá

* **Overview**
  * Degeneration of cerebral cortex and basal ganglia due to abnormal accumulation of tau protein
* **Presentation**
  * **Motor clumsiness, apraxia, alien hand syndrome, dementia, involuntary movements (asymmetry between two sides)**: Degeneration of cerebral cortex
  * **Akinesia, muscle rigidity, postural instability, (resting tremor is absent)**: Degeneration of basal ganglia
* **Examination**
  * **[CT, MRI] Asymmetric cortical atrophy**
* **Management**
  * **No established treatment, similar to medication for Parkinson‚Äôs disease**: Limited response
{: .notice--info}

### Huntington‚Äôs Disease / HuntingtonÁóÖ

* **Overview**
  * Degeneration of striatum lead to overactivity of dopaminergic neurons, causing involuntary movements
Autosomal dominant inheritance, due to abnormal expansion of CAG repeats
* **Presentation**
  * **Rapid involuntary movements of limbs**: Degeneration of striatum disruptions inhibition of involuntary movements
  * **Personality change, dementia**: Degeneration of cerebral cortex
* **Examination**
  * **[CT, MRI] Atrophy of caudate nucleus, enlargement of anterior horns of lateral ventricles**
  * **[Genetic test] Abnormal expansion of CAG repeats**
* **Management**
  * **Tetrabenazine**: For involuntary movements
  * **Antipsychotics (haloperidol)**: For psychiatric symptoms
{: .notice--info}

### Amyotrophic Lateral Sclerosis / Á≠ãËêéÁ∏ÆÊÄßÂÅ¥Á¥¢Á°¨ÂåñÁóá

* **Overview**: 
  * Degeneration of upper and lower motor neurons leads to progressive muscular atrophy; mostly sporadic but sometimes hereditary 
  * More common in middle-aged to elderly individuals 
  * Pathology shows atrophy of pyramidal tract and anterior horn, with TDP-43 positive inclusions
* **Presentation**
  * **Muscle weakness, muscle atrophy, fasciculations**: Degeneration of lower motor neurons lead to reduced stimulation on muscles
  * **Increased tendon reflexes, positive Babinski sign**: Degeneration of upper motor neurons lead to reduced inhibition on lower motor neurons
  * **Dysphagia, dysarthria, tongue atrophy**: Degeneration of cranial nerves lead to bulbar palsy
  * **No eye movement disorders, sensory impairments, bladder or rectal dysfunction, pressure sores**: Cranial nerves III IV VI, sensory neurons, autonomic neurons are spared
* **Examination**
  * **[EMG] Denervation potentials at rest**: Denervation from lower motor neurons leads to spontaneous electrical activity
  * **[EMG] High-amplitude potentials during voluntary contraction**: Degeneration of lower motor neurons leads to formation of larger motor units by remaining neurons
  * **[Muscle biopsy] Grouped atrophy**: Denervation of motor units
* **Management**
  * **No cure**: Progress to requiring mechanical ventilation or death in 3~5 years
  * **[Medication] Riluzole, edaravone**: Protect neurons by reducing glutamate activity or scavenging free radicals
{: .notice--info}

### Spinal Muscular Atrophy / ËÑäÈ´ÑÊÄßÁ≠ãËêéÁ∏ÆÁóá

* **Overview**
  * Degeneration of lower motor neurons leads to progressive muscular atrophy; autosomal recessive inheritance
  * Type I onset at birth and die within one year, type III onset at 2~18 years and have good prognosis
* **Presentation**
  * **Muscle weakness (floppy infant, Gowers‚Äô sign), fasciculations, absent tendon reflexes**: Degeneration of lower motor neurons cause reduced stimulation on muscles
* **Examination**
  * **[Genetic test] SMN gene mutation**
* **Management**
  * **Symptomatic treatment**: Type I die within one year, type III and IV have good prognosis
{: .notice--info}

### Bulbospinal Muscular Atrophy / ÁêÉËÑäÈ´ÑÊÄßÁ≠ãËêéÁ∏ÆÁóá

* **Overview**
  * Degeneration of lower motor neurons leads to progressive muscular atrophy; X-linked recessive inheritance, due to abnormal expansion of CAG repeats in androgen receptor gene
* **Presentation**
  * **Muscle weakness, muscle atrophy (primarily proximal muscles), fasciculations, tremors**: Degeneration of lower motor neurons cause reduced stimulation on muscles
  * **Dysphagia, dysarthria, tongue atrophy**: Degeneration of cranial nerves cause bulbar palsy
  * **Gynecomastia, impotence, testicular atrophy**: Abnormal androgen receptor lead to reduced sensitivity to androgen
* **Examination**
  * **[Genetic test] Abnormal expansion of CAG repeats**
* **Management**
  * **Symptomatic treatment**: Prognosis depends on CAG repeats number
{: .notice--info}

### Multiple System Atrophy / Â§öÁ≥ªÁµ±ËêéÁ∏ÆÁóá

* **Overview**
  * Degeneration of olivo-ponto-cerebellar system, striatonigral system, and autonomic nervous system; sporadic
  * More common in middle-aged to elderly individuals 
  * Pathology shows glial cytoplasmic inclusion (due to accumulation of Œ±-synuclein)
  * [MSA-C] Cerebellar ataxia as predominant early symptom, but other symptoms present later
  * [MSA-P] Parkinsonism as predominant early symptom, but other symptoms present later
  * [Shy-Drager syndrome] Autonomic dysfunction as predominant early symptom, but other symptoms present later
* **Presentation**
  * **[Cerebellar ataxia] Truncal ataxia (staggering gait), limb coordination problems (abnormal finger-to-nose test), dysarthria**: Degeneration of olivo-ponto-cerebellar system
  * **[Parkinsonism] Bradykinesia, muscle rigidity, shuffling gait (resting tremor are rare)**: Degeneration of striatonigral system
  * **[Autonomic dysfunction] Orthostatic hypotension, bladder and rectal dysfunction, erectile dysfunction, sweating abnormalities, horner syndrome**: Degeneration of autonomic nervous system
* **Examination**
  * **[CT, MRI] Atrophy of cerebellum and brainstem, cross sign in pons**: Degeneration of olivo-ponto-cerebellar system, degeneration of transverse and longitudinal pontocerebellar fibers
  * **[CT, MRI] Atrophy of putamen, linear area of high-signal on lateral side of putamen**: Degeneration of striatonigral system, gliosis of lateral side of putamen
* **Management**
  * **[Cerebellar ataxia] TRH analog (protirelin, taltirelin)**: Stimulate neurotransmission and enhance motor control
  * **[Parkinsonism] Dopamine precursor (levodopa)**: Converted to dopamine and alleviate Parkinsonism
  * **[Autonomic dysfunction] Alpha-agonists (midodrine, droxidopa), alpha-blockers**: For orthostatic hypotension or urinary retention 
{: .notice--info}

### Spinocerebellar Ataxia / ËÑäÈ´ÑÂ∞èËÑ≥Â§±Ë™øÁóá

* **Overview**
  * Degeneration of cerebellum or spinal cord; hereditary
  * [SCA-3] Abnormal expansion of CAG repeats in ataxia-3 gene, autosomal dominant
  * [SCA-6] Abnormal expansion of CAG repeats in CACNA1A gene, autosomal dominant
  * [Dentato-rubro-pallido-luysian atrophy] Abnormal expansion of atrophin-1 gene, autosomal dominant
  * [Friedreich ataxia] Abnormal expansion of GAA repeats in frataxin genes, autosomal recessive
* **Presentation**
  * **Cerebellar ataxia, startled expression (SCA-3)**: Degeneration of cerebellum 
  * **Spinal ataxia, deep sensory loss (Friedreich ataxia)**: Degeneration of spinal cord
* **Examination**
  * **[CT. MRI] Degeneration of cerebellum and spinal cord**
* **Management**
  * **Symptomatic treatment**
{: .notice--info}

### Wernicke Encephalopathy / WernickeËÑ≥Áóá

* **Overview**
  * Vitamin B1 deficiency (chronic alcoholism, malnutrition, inappropriate IV infusion) damage neurons and cause necrosis (mainly around cerebral ventricles)
* **Presentation**
  * **Consciousness disturbances (somnolence, delirium)**: Impairment of thalamus
  * **Ocular movement disorders (abducens nerve palsy, nystagmus)**: Impairment of brainstem (cranial nerve nucleus)
  * **Cerebellar dysfunction (ataxic gait)**: Impairment of cerebellum 
  * **Korsakoff syndrome (memory impairment, confabulation, disorientation)**: Irreversible damage to brain if untreated
* **Examination**
  * **[MRI] High signal in third ventricle, cerebral aqueduct, fourth ventricle, mammillary body**: Neuronal damage around cerebral ventricles
  * **[Blood test] Vitamin B1 decrease**: Vitamin B1 deficiency
* **Management**
  * **Large intravenous administration of Vitamin B1**
  * **[Don‚Äôt] Glucose administration alone during Vitamin B1 deficiency is contraindicated**: Further consume Vitamin B12
{: .notice--info}

### Subacute Combined Degeneration of Spinal Cord / ‰∫úÊÄ•ÊÄßËÑäÈ´ÑÈÄ£ÂêàÂ§âÊÄßÁóá

* **Overview**
  * Vitamin B12 deficiency (total gastrectomy, autoimmune atrophic gastritis) cause degeneration of posterior column, lateral column and peripheral nerve
* **Presentation**
  * **Deep sensory impairment, positive Romberg‚Äôs sign**: Impairment of posterior column
  * **Increased tendon reflexes, positive Babinski sign, spastic paralysis**: Impairment of lateral column
  * **Numbness, muscle weakness**: Impairment of peripheral nerves
  * **Anemia, Hunter‚Äôs glossitis**: Impairment of DNA synthesis 
* **Examination**
  * **[Blood test] Megaloblastic anemia, vitamin B12 decrease, methylmalonic acid increase, homocysteine increase**: Vitamin B12 is crucial for DNA synthesis (RBC production), conversion of methylmalonyl-CoA to succinyl-CoA, conversion of homocysteine to methionine
  * **[MRI] High-signal in posterior column and lateral column**
* **Management**
  * **IV and oral administration of Vitamin B12**
  * **[Don‚Äôt] Folic acid administration alone is contraindicated**: Mask the neurological symptoms and further consume Vitamin B12
{: .notice--info} -->

## Demyelinating Disorder / ËÑ±È´ÑÊÄßÁñæÊÇ£

### Multiple Sclerosis / Â§öÁô∫ÊÄßÁ°¨ÂåñÁóá

* **Overview**
  * Autoimmune demyelinating disease affecting central nervous system white matter
  * Multiple lesions occur in space and time with relapsing-remitting course
  * Common in women aged 15-50
* **Presentation**
  * **Sudden visual impairment, central scotoma**: Retrobulbar optic neuritis
  * **Double vision, MLF syndrome**: Brainstem involvement
  * **Muscle weakness, hyperreflexia, Babinski sign**: Pyramidal tract involvement
  * **Numbness, trigeminal neuralgia, Lhermitte's sign**: Sensory tract involvement
  * **Ataxia, tremor, nystagmus, dysarthria**: Cerebellar involvement
  * **Neurogenic bladder**: Autonomic system involvement
  * **Euphoria, depression**: Mental symptoms
* **Examination**
  * **[MRI] Multiple white matter lesions**: Spatial dissemination
  * **[CSF] IgG‚Üë, oligoclonal bands, MBP‚Üë**: Psychiatric destruction
* **Management**
  * **[Acute] Steroid pulse therapy, plasmapheresis**: Reduce inflammation
  * **[Prevention] IFN-Œ≤, glatiramer acetate, fingolimod, natalizumab**: Prevent relapses
  * **[Symptomatic] Gabapentin/pregabalin (pain), carbamazepine (spasm), baclofen (spasticity)**: Manage symptoms
{: .notice--info}

### Neuromyelitis Optica / Ë¶ñÁ•ûÁµåËÑäÈ´ÑÁÇé

* **Overview**
  * Autoimmune disease with antibodies against aquaporin-4 (AQP4) in astrocytes
  * Common in 30s women, often associated with other autoimmune diseases
* **Presentation**
  * **Visual loss, blindness, horizontal hemianopia**: Severe optic neuritis
  * **Quadriparesis, sensory disturbance, bladder/bowel dysfunction**: Transverse myelitis
* **Examination**
  * **[MRI] Extensive spinal cord lesions (‚â•3 vertebral segments)**: Extensive transverse myelitis
  * **[Blood] Anti-AQP4 antibody positive**: Confirms diagnosis
  * **[CSF] Oligoclonal bands usually negative**: Differentiate from MS
* **Management**
  * **[Acute] Steroid pulse therapy, plasmapheresis**: Reduce inflammation
  * **[Prevention] Steroids, immunosuppressants, rituximab**: Prevent relapses
{: .notice--info}

### Acute Disseminated Encephalomyelitis / ÊÄ•ÊÄßÊï£Âú®ÊÄßËÑ≥ËÑäÈ´ÑÁÇé

* **Overview**
  * Inflammatory demyelinating disease of central nervous system, similar to MS but with rapid onset and remission
  * Common in children, triggered by viral infections or vaccines
* **Presentation**
  * **Sudden onset of headache, vomiting, consciousness disturbances, seizures**: Acute disseminated demyelination of central nervous system
* **Examination**
  * **[MRI] Multiple demyelinating lesions**: Similar to MS but typically monophasic
* **Management**
  * **High-dose steroids, immunoglobulin**: Reduce inflammation
  * **Good prognosis**: Usually monophasic
{: .notice--info}

## Miscellaneous CNS Disorder / „Åù„ÅÆ‰ªñ„ÅÆ‰∏≠Êû¢Á•ûÁµåÁñæÊÇ£

### Anti-NMDA Receptor Encephalitis / ÊäóNMDAÂèóÂÆπ‰ΩìÊäó‰ΩìËÑ≥ÁÇé

* **Overview**
  * Autoimmune encephalitis mainly affecting limbic system through anti-NMDA receptor antibodies
  * Common in young females, associated with tumors especially ovarian teratoma
* **Presentation**
  * **Fever, headache**: Prodromal phase
  * **Agitation, hallucinations, delusions**: Psychiatric phase
  * **Decreased consciousness, reduced movement, respiratory depression**: Unresponsive phase
  * **Dystonia, orofacial dyskinesia, myoclonus, seizures**: Movement disorder phase
* **Examination**
  * **[Blood/CSF] Anti-NMDA receptor antibodies**: Confirms diagnosis
  * **[MRI] Abnormal signals in limbic system**: Inflammation in limbic system
* **Management**
  * **Tumor removal**: If present
  * **Steroid pulse therapy, IVIg, plasmapheresis**: Suppress immune response
{: .notice--info}

### Wernicke's Encephalopathy / WernickeËÑ≥Áóá

* **Overview**
  * Acute/subacute inflammation and necrosis in periventricular areas due to vitamin B1 deficiency
  * Often seen in alcoholism, post-gastrointestinal surgery, hyperemesis gravidarum
* **Presentation**
  * **Altered consciousness, delirium, confusion**: Thalamus involvement
  * **Eye movement disorders, nystagmus**: Brainstem involvement
  * **Trunk ataxia, unsteady gait**: Cerebellar dysfunction
* **Examination**
  * **[MRI] T2/FLAIR high signal in periventricular areas**: Periventricular inflammation and necrosis
  * **[Blood] Low vitamin B1, lactic acidosis**: Thiamine deficiency and metabolic derangement
* **Management**
  * **Immediate high-dose IV thiamine (before glucose administration)**: Replace deficiency
  * **May progress to Korsakoff syndrome**: Amnesia, disorientation, confabulation
{: .notice--info}

### Subacute Combined Degeneration of Spinal Cord / ‰∫úÊÄ•ÊÄßËÑäÈ´ÑÈÄ£ÂêàÂ§âÊÄßÁóá

* **Overview**
  * Vitamin B12 deficiency causing degeneration of peripheral and central nervous system
  * Common after total gastrectomy due to malabsorption of B12
* **Presentation**
  * **Macrocytic anemia, Hunter glossitis**: Vitamin B12 deficiency
  * **Romberg sign, impaired proprioception**: Posterior column damage
  * **Hyperreflexia, Babinski sign, spastic paralysis**: Lateral column (pyramidal tract) damage
  * **Numbness and weakness in extremities**: Peripheral nerve damage
* **Examination**
  * **[Blood] Vitamin B12‚Üì, methylmalonic acid‚Üë, homocysteine‚Üë**: B12 deficiency disrupts folate and fatty acid metabolism
  * **[Urine] Methylmalonic acid excretion‚Üë**: Same
* **Management**
  * **Intramuscular vitamin B12**: Replace deficiency
  * **Avoid folic acid alone**: Can worsen neurological symptoms
{: .notice--info}

### Spinal Cord Infarction / ËÑäÈ´ÑÊ¢óÂ°û

* **Overview**
  * Infarction of anterior 2/3 of spinal cord due to anterior spinal artery occlusion
  * Common causes: Aortic dissection, aortic surgery, atherosclerosis
* **Presentation**
  * **Motor weakness, sensory loss (pain, temperature)**: Anterior and lateral columns involvement
  * **Preserved position/vibration sense**: Posterior column sparing
* **Examination**
  * **[MRI] T2 high signal in anterior spinal cord**: Anterior spinal cord infarction
* **Management**
  * **Edaravone, anti-edema drugs, corticosteroids**: Neuroprotection
{: .notice--info}

### Spinal Arteriovenous Malformation / ËÑäÈ´ÑÂãïÈùôËÑàÂ•áÂΩ¢

* **Overview**
  * Abnormal arteriovenous shunts in spinal cord vasculature, classified as intramedullary AVM, perimedullary AVF, dural AVF
* **Presentation**
  * **Acute motor and sensory disturbances, headache, vomiting, consciousness disturbances**: Acute intramedullary or subarachnoid hemorrhage
  * **Gradual motor and sensory disturbances**: Venous hypertension causes congestion and edema in spinal cord
* **Examination**
  * **[MRI] Flow void lesions of nidus or shunt, T2 high signal in spinal cord**: Arteriovenous malformation, spinal edema
  * **[Angiography] Nidus, shunt**: Definitive diagnosis
* **Management**
  * **[Surgical treatment]**: Direct removal of AVM/AVF
  * **[Endovascular treatment]**: Catheter-based embolization
{: .notice--info}

### Syringomyelia / ËÑäÈ´ÑÁ©∫Ê¥ûÁóá

* **Overview**
  * Fluid-filled cavity formation within spinal cord causing neurological deficits
  * Common in 20-40s, often associated with Chiari malformation
* **Presentation**
  * **Upper limb temperature and pain sensory loss (unilateral first and bilateral cape-like later)**: Damage to spinothalamic tract (central spinal cord)
  * **Upper limb muscle atrophy, lower limb spastic paralysis**: Progress to involve anterior horn and lateral column
  * **Bulbar palsy, Horner‚Äôs syndrome**: Progress to involve upper and lower levels of spinal cord
* **Examination**
  * **[MRI] Cavity formation within spinal cord**: Confirm diagnosis
* **Management**
  * **Foramen magnum decompression**: Primary treatment for Chiari-associated cases
  * **Syrinx-subarachnoid shunt**: Direct treatment of syrinx
{: .notice--info} 

### Brown-S√©quard Syndrome / Brown-S√©quardÁóáÂÄôÁæ§

* **Overview**
  * Hemisection of spinal cord resulting in distinct neurological deficits
  * Causes include trauma, tumor, infection
* **Presentation**
  * **[At level of injury] Ipsilateral all sensory loss**: Damage to dorsal root entry
  * **[At level of injury] Ipsilateral muscle weakness**: Damage to anterior horn exit
  * **[Below level of injury] Ipsilateral proprioceptive loss**: Damage to dorsal column before crossing
  * **[Below level of injury] Ipsilateral spastic paralysis**: Damage to pyramidal tract after crossing
  * **[Below level of injury] Contralateral pain and temperature loss**: Damage to lateral spinothalamic tract after crossing
* **Examination**
  * **[Physical] Characteristic sensory and motor loss**
* **Management**
  * **Treat underlying cause**
{: .notice--info} 

<!-- ### Multiple Sclerosis / Â§öÁô∫ÊÄßÁ°¨ÂåñÁóá

* **Overview**
  * Autoimmune-related Inflammatory demyelination throughout white matter of CNS (spatial dissemination), leading to various neurological symptoms that recur and remit (temporal dissemination); PNS usually spared
  * Relapsing-remitting type (more) characterized by relapse and remission at first and progress without remission later; primary progressive type (less) progress without remission from onset
  * More common in young women (autoimmune) and high latitude region
* **Presentation**
  * **Vision loss, central scotomas (recover in 1-2 weeks, relapse latter)**: Impairment of optic nerve (optic neuritis)
  * **Internuclear ophthalmoplegia**: Impairment of medial longitudinal fasciculus
  * **Ataxia, tremor, nystagmus, dysarthria**: Impairment of cerebellum
  * **Weakness of extremities, spasticity, hyperreflexia, clonus**: Impairment of motor pathway
  * **Numbness, electric shock-like sensation during neck movement (Lhermitte‚Äôs sign), trigeminal neuralgia**: Impairment of sensory pathway
  * **Bladder and bowel dysfunction**: Impairment of autonomic nervous system
* **Examination**
  * **[MRI] Multiple high-signal plaque lesion in brain and spinal cord**: Demyelination of CNS white matter
  * **[CSF analysis] Lymphocytes increased, IgG increased, oligoclonal band present, myelin binding protein present**: Autoimmune destruction of myelin in CNS
  * **Abnormal evoked potential (especially visual)**: Demyelination of the corresponding pathway
* **Management**
  * **[Acute exacerbation] Steroid pulse therapy, plasmapheresis**: Suppress acute inflammation
  * **[Relapse prevention] Interferon-beta, glatiramer (MBP-mimicking peptide), natalizumab (anti-Œ±4 integrin antibody), fingolimod (S1PR modulator)**: Immunomodulatory or immunosuppressive drugs
  * **[Symptomatic treatment] Muscle relaxant, anticonvulsant (gabapentin, pregabalin), anticholinergic drugs or alpha-blockers**: For spasticity, neuropathic pain, urinary symptoms
{: .notice--info}

### Neuromyelitis Optica / Ë¶ñÁ•ûÁµåËÑäÈ´ÑÁÇé

* **Overview**
  * Anti-AQP4 autoantibody damage astrocytes, lead to inflammatory demyelination causing relapsing optic neuritis and myelitis
More common in middle age women (autoimmune)
* **Presentation**
  * **Vision loss, visual field defects**: Impairment of optic nerve (optic neuritis)
  * **Motor disturbances, sensory disturbances, bladder and bowel dysfunction**: Impairment of spinal cord (myelitis)
* **Examination**
  * **[MRI] High-signal lesion in brain and spinal cord (>3 vertebral segments)**: Demyelination of optic nerve and spinal cord
  * **[Blood] Anti-AQP4 antibody positive**: Autoimmune nature
* **Management**
  * **[Acute exacerbation] Steroid pulse therapy, plasmapheresis**: Suppress acute inflammation
  * **[Relapse prevention] Steroid, immunosuppressant, rituximab (anti -CD20 antibody)**
{: .notice--info}

### Acute Disseminated Encephalomyelitis / ÊÄ•ÊÄßÊï£Âú®ÊÄßËÑ≥ËÑäÈ´ÑÁÇé

* **Overview**
  * Inflammatory demyelination of throughout CNS (spatial dissemination) with acute and monophasic course (compared to multiple sclerosis), preceded by viral infection or vaccination (hypersensitivity)
* **Presentation**
  * **Fever, headache, vomiting (acute onset and rapid remission)**: Inflammation of brain
* **Examination**
  * **[Blood] WBC increase, ESR increase, CRP increase**: Inflammation
  * **[MRI] Scattered high-signal lesions in brain**: Disseminated demyelination of CNS
* **Management**
  * **Steroid pulse therapy, plasmapheresis, high-dose immunoglobulin therapy**: Suppress acute inflammation
{: .notice--info}

### Adrenoleukodystrophy / ÂâØËÖéÁôΩË≥™„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº

* **Overview**
  * X-linked recessive disorder, defects of peroxisome prevent breakdown of very long-chain fatty acids, which accumulate in white matter of brain (progressive demyelination) and adrenal gland (adrenal insufficiency)
* **Presentation**
  * **Personality and behavioral abnormalities (aggression), intellectual disability**: Impairment of commissural fibers of brain
  * **Gait disturbances (ataxic gait)**: Impairment of spinal cord
  * **Vision and hearing impairment**: Impairment of visual and auditory pathway
* **Examination**
  * **[Blood] Cortisol decrease, very long-chain fatty acids increase**: Adrenal insufficiency, fatty acid metabolism defect
  * **[MRI] High-signal lesion in brain**: Demyelination of CNS
  * **[Genetic test] ABCD1 mutation**
* **Management**
  * **Steroid hormone**: For adrenal insufficiency 
  * **No cure, dead in 1~5 years**
{: .notice--info} -->

## Peripheral Nerve Disorder / Êú´Ê¢¢Á•ûÁµåÈöúÂÆ≥

### Guillain-Barr√© Syndrome / Guillain-Barr√©ÁóáÂÄôÁæ§

* **Overview**
  * Acute immune-mediated polyneuropathy affecting myelin/axons of peripheral nerves, generally self-limiting but can be severe
  * Usually preceded by respiratory or gastrointestinal infection
* **Presentation**
  * **Ascending symmetric flaccid paralysis, respiratory difficulty (severe cases)**: Lower motor neuron damage
  * **Sensory disturbances in limbs, decreased tendon reflexes**: Peripheral nerve dysfunction
  * **Facial paralysis, bulbar palsy, diplopia**: Cranial nerve involvement
* **Examination**
  * **[Blood] Anti-ganglioside antibodies (anti-GM1)**: Autoimmune nature
  * **[CSF] Protein‚Üë, cell‚Üí**: Inflammation but no infection
  * **[Nerve conduction] Decreased conduction velocity, conduction block**: Demyelination/axonal damage
* **Management**
  * **[Mild] Conservative treatment**: Self-limiting nature
  * **[Moderate] IV immunoglobulin, plasma exchange**: Modulate immune response
  * **[Severe] Respiratory support**: For respiratory muscle paralysis
{: .notice--info}

### Chronic Inflammatory Demyelinating Polyradiculoneuropathy / ÊÖ¢ÊÄßÁÇéÁóáÊÄßËÑ±È´ÑÊÄßÂ§öÁô∫Ê†π„Éã„É•„Éº„É≠„Éë„ÉÅ„Éº

* **Overview**
  * Chronic autoimmune demyelinating peripheral neuropathy
  * Progress over >2 months, 	no preceding infection
* **Presentation**
  * **Progressive weakness and sensory disturbances in limbs, decreased tendon reflexes**: Demyelination of peripheral nerves
* **Examination**
  * **[Nerve conduction] Decreased conduction velocity, conduction block**: Demyelination
  * **[CSF] Protein‚Üë, cell‚Üí**: Inflammation but no infection
  * **[MRI] Thickening and enhancement of nerve roots and plexus**: Chronic inflammation of nerve roots
  * **[Nerve biopsy] Demyelination, remyelination, inflammatory cell infiltration**: Confirms diagnosis
* **Management**
  * **Corticosteroids, IV immunoglobulin, plasma exchange**: Modulate immune response
{: .notice--info}

### Charcot-Marie-Tooth Disease / Charcot-Marie-ToothÁóÖ

* **Overview**
  * Hereditary progressive peripheral neuropathy caused by mutations in myelin-related genes 
  * Autosomal dominant inheritance, onset in 10-30s
* **Presentation**
  * **Distal leg weakness, calf atrophy (drop foot), gait disturbance (steppage gait)**: Progressive motor neuropathy
  * **Mild sensory disturbance, decreased tendon reflexes**: Peripheral nerve dysfunction
* **Examination**
  * **[Nerve conduction] Decreased conduction velocity**: Demyelination
  * **[Genetic testing] Myelin-related genes mutation**: Confirms diagnosis
  * **[Nerve biopsy] Onion bulb formation**: Chronic demyelination and remyelination
* **Management**
  * **Supportive care**: No specific treatment available
  * **Good life prognosis**: Very slow progression
{: .notice--info}

### Familial Amyloid Polyneuropathy / ÂÆ∂ÊóèÊÄß„Ç¢„Éü„É≠„Ç§„Éâ„Éù„É™„Éã„É•„Éº„É≠„Éë„ÉÅ„Éº

* **Overview**
  * Hereditary amyloid deposition in multiple organs, caused by mutant transthyretin produced in liver
  * Autosomal dominant inheritance, onset in 20-40s
* **Presentation**
  * **Progressive sensory disturbances**: Sensory nerve involvement
  * **Diarrhea, constipation, erectile dysfunction, orthostatic hypotension**: Autonomic nerve involvement
  * **Progressive muscle weakness and atrophy**: Motor nerve involvement
  * **Heart failure, arrhythmia, kidney dysfunction, eye dysfunction**: Systemic amyloid deposition
* **Examination**
  * **[Blood] Abnormal transthyretin**: Genetic mutation
  * **[Nerve conduction] Decreased amplitude, reduced conduction velocity**: Axonal and myelin damage
  * **[Biopsy] Congo red positive amyloid deposits**: Confirmation of amyloid
  * **[Genetic testing] Transthyretin gene mutation**: Definitive diagnosis
* **Management**
  * **Liver transplantation**: Limited indication
  * **Poor prognosis**
{: .notice--info}

### Diabetic Neuropathy / Á≥ñÂ∞øÁóÖÊÄß„Éã„É•„Éº„É≠„Éë„ÉÅ„Éº

* **Overview**
  * Complication of diabetes, caused by metabolic disorders and vascular damage to nerves
  * Usually occurs after 5-10 years of diabetes
* **Presentation**
  * **Symmetric glove-stocking sensory disturbance, decreased vibration sense, absent Achilles reflex**: Sensory nerve involvement
  * **Orthostatic hypotension, urinary dysfunction, erectile dysfunction, GI symptoms**: Autonomic nerve involvement
  * **Eye movement disorders, carpal tunnel syndrome, proximal muscle atrophy**: Mononeuropathy
* **Examination**
  * **[Clinical] History of diabetes**: Essential for diagnosis
* **Management**
  * **Blood glucose control**: Prevent disease progression
  * **NSAIDs, antidepressants, pregabalin**: Pain control
  * **Aldose reductase inhibitors, vitamin B12**: Metabolic improvement
{: .notice--info}

### Trigeminal Neuralgia / ‰∏âÂèâÁ•ûÁµåÁóõ

* **Overview**
  * Paroxysmal severe pain along trigeminal nerve distribution, mainly caused by vascular compression
  * Common in middle-aged females
* **Presentation**
  * **Sudden severe stabbing pain in unilateral face (seconds to minutes)**: Compressed trigeminal nerve irritation
  * **Pain triggered by touching or moving face**: Hypersensitivity of affected nerve
* **Examination**
  * **[MRI] Vascular compression of trigeminal nerve**: Cause of idiopathic trigeminal neuralgia
* **Management**
  * **Anticonvulsants (carbamazepine, pheytoin, valproic acid), pregabalin**: Stabilize neuronal activity
  * **Trigeminal nerve block, microvascular decompression surgery**: For medication-resistant cases
{: .notice--info}

### Bell's Palsy and Ramsay Hunt Syndrome / BellÈ∫ªÁó∫„ÉªRamsay HuntÁóáÂÄôÁæ§

* **Overview**
  * **[Bell's Palsy]** HSV-1 reactivation causing CN VII inflammation, good prognosis (95% recovery)
  * **[Ramsay Hunt]** VZV reactivation causing CN VII/VIII inflammation, worse prognosis (60-70% recovery)
  * Common in 50s adults (Bell), 20s and 50s adults (Ramsay Hunt)
* **Presentation**
  * **Unable to close eye, wrinkle forehead, raise mouth (sudden unilateral facial weakness)**: CN VII Motor component involvement
  * **Ear pain, hyperacusis, decreased taste, decreased tear/saliva production**: CN VII sensory and autonomic component involvement
  * **[Ramsay Hunt] Painful vesicles in ear/oral cavity**: VZV reactivation
  * **[Ramsay Hunt] Hearing loss, tinnitus, vertigo**: CN VIII involvement
* **Examination**
  * **[Bell's] Exclusion of other causes**: Diagnosis of exclusion
  * **[Ramsay Hunt] Vesicles in ear/oral cavity**: Herpes zoster
* **Management**
  * **Corticosteroids**: Reduce inflammation and edema
  * **Antiviral drugs (acyclovir)**: Suppress viral replication
  * **Vitamin B**: Promote nerve regeneration
  * **Facial nerve decompression**: For severe cases
{: .notice--info}

## Muscular Disorder / Á≠ãÁñæÊÇ£

### Duchenne and Becker Muscular Dystrophy / DuchenneÂûã„ÉªBeckerÂûãÁ≠ã„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº

* **Overview**
  * Congenital progressive muscle weakness due to deficiency of dystrophin protein, Duchenne is severe form and Becker is milder form
  * X-linked recessive inheritance, mainly affects boys
* **Presentation**
  * **Delayed walking, abnormal gait (waddling)**: Progressive muscle weakness
  * **Gowers' sign, calf pseudohypertrophy**: Proximal muscle weakness
* **Examination**
  * **[Blood] CK‚Üë, aldolase‚Üë, AST‚Üë, ALT‚Üë, LDH‚Üë**: Muscle cell damage
  * **[Urine] Creatine/creatinine ratio‚Üë**: Decreased utilization of creatine by muscle cells
  * **[EMG] Myogenic changes**: Muscle fiber degeneration
  * **[Genetic test] Dystrophin gene mutation**: Confirms diagnosis
* **Management**
  * **Corticosteroids**: Slow disease progression
  * **Physical therapy**: Maintain function
  * **Ventilatory support**: For respiratory failure
 {: .notice--info}

### Myotonic Dystrophy / Á≠ãÂº∑Áõ¥ÊÄß„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº

* **Overview**
  * Hereditary myopathy with delayed muscle relaxation and muscle weakness
  * Autosomal dominant disorder, common in 20-30s adults
* **Presentation**
  * **Grip myotonia, tongue deformation**: Delayed muscle relaxation
  * **Distal muscle weakness and atrophy, dysphagia, dysarthria**: Progressive muscle degeneration
  * **Hatchet face**: Facial, temporal, and masseter muscle atrophy
  * **Frontal baldness, cataracts, diabetes, cardiac conduction defects**: Multi-system involvement
* **Examination**
  * **[Blood] CK‚Üë, IgG‚Üì**: Muscle damage and immune changes
  * **[EMG] Myotonic discharge (dive bomber sound)**: Characteristic electrical activity
  * **[Genetic test] Abnormal expansion in DMPK gene**: Confirms diagnosis
* **Management**
  * **Supportive care**: No definitive treatment
  * **Phenytoin**: For severe myotonia
{: .notice--info}

### Mitochondrial Encephalomyopathy (MELAS) / „Éü„Éà„Ç≥„É≥„Éâ„É™„Ç¢ËÑ≥Á≠ãÁóá

* **Overview**
  * CNS and muscular disorder caused by mitochondrial DNA mutations
  * Maternal inheritance, common in 5-15 years old
* **Presentation**
  * **Headache, vomiting, seizures, altered consciousness, hemiparesis**: Characteristic of MELAS
  * **Cognitive decline, sensorineural hearing loss, muscle weakness, fatigue**: Mitochondrial dysfunction
  * **Short stature, diabetes, cardiomyopathy**: Multi-system involvement
* **Examination**
  * **[Blood/CSF] Lactate‚Üë, pyruvate‚Üë, L/P ratio‚Üë**: Impaired mitochondrial energy production
  * **[Muscle biopsy] Ragged-red fibers**: Abnormal mitochondrial accumulation
  * **[Genetic test] Mitochondrial DNA mutation**: Confirms diagnosis
* **Management**
  * **Vitamins, Coenzyme Q, L-arginine, pyruvate**: Support mitochondrial function and metabolism
{: .notice--info}

### Periodic Paralysis / Âë®ÊúüÊÄßÂõõËÇ¢È∫ªÁó∫

* **Overview**
  * Periodic episodes of flaccid paralysis due to serum potassium abnormalities
  * Common in children to 30s males, often secondary to hyperthyroidism or primary aldosteronism
* **Presentation**
  * **Flaccid paralysis of limbs, often after intense exercise**: Hypokalemia causes flaccid paralysis
  * **Episodes fully reversible but often relapse**: Recurrent potassium imbalance
* **Examination**
  * **[Blood] K‚Üì or ‚Üë during attacks**: Hypokalemia or hyperkalemia
  * **[Blood] Thyroid hormone‚Üë, aldosterone‚Üë**: Hyperthyroidism or primary aldosteronism
* **Management**
  * **Potassium correction, avoid triggers**: Prevent episode
  * **Treat underlying condition**: Especially thyroid disease
{: .notice--info}

### Myasthenia Gravis / ÈáçÁóáÁ≠ãÁÑ°ÂäõÁóá

* **Overview**
  * Autoimmune disease affecting neuromuscular junction with anti-AChR (acetylcholine receptor) antibodies
  * Common in children, women 20-40s, men 50-60s
* **Presentation**
  * **Ptosis, diplopia**: Early symptoms due to external ocular muscle weakness
  * **Muscle weakness worsening throughout day**: Neuromuscular junction fatigue without muscle atrophy
  * **Dysarthria, dysphagia, tongue weakness**: Bulbar symptoms in generalized type
* **Examination**
  * **[Edrophonium test] Temporary improvement**: ACh increases in neuromuscular junction
  * **[EMG] Waning phenomenon**: Decremental response to repetitive nerve stimulation
  * **[Blood] Anti-AChR antibodies or anti-MuSK antibodies (+)**: Autoimmune nature
  * **[Chest X-ray, CT] Thymoma or thymic hyperplasia**: Associated thymic abnormalities
* **Management**
  * **[Ocular type] Anticholinesterase drugs, steroids**: Symptomatic treatment
  * **[Generalized type] Extended thymectomy, steroids, immunosuppressants**: Radical treatment
  * **[Myasthenic crisis] Plasmapheresis**: Emergency treatment
{: .notice--info}

### Lambert-Eaton Myasthenic Syndrome / Lambert-EatonÁóáÂÄôÁæ§

* **Overview**
  * Autoimmune disease affecting neuromuscular junction with anti-VGCC (voltage-gated calcium channel) antibodies
  * Paraneoplastic syndrome, commonly in middle-aged men with small cell lung cancer
* **Presentation**
  * **Muscle weakness (predominantly proximal lower limbs), decreased reflexes**: Reduced acetylcholine release
  * **Diurnal variation in muscle weakness, temporary improvement with repetitive movement**: Variation in Ca2+ in muscle cells
* **Examination**
  * **[EMG] Waxing phenomenon**: Increased response with repeated stimulation
  * **[Blood] Anti-VGCC antibodies**: Autoimmune nature
* **Management**
  * **[With malignancy] Treatment of underlying cancer**: Primary treatment
  * **[Without malignancy] Steroids, immunosuppressants, anticholinesterase drugs, plasmapheresis**: Symptomatic treatment
{: .notice--info}

## Infectious Disorder / ÊÑüÊüìÊÄßÁñæÊÇ£

### Bacterial Meningitis / Á¥∞ËèåÊÄßÈ´ÑËÜúÁÇé

* **Overview**
  * Acute bacterial infection of meninges, medical emergency with high mortality
* **Presentation**
  * **Fever, headache, vomiting (within 1 week)**: Meningeal inflammation
  * **Altered consciousness**: Severe inflammation affecting brain function
  * **Neck stiffness, Kernig's sign**: Meningeal irritation
* **Examination**
  * **[CSF] Pressure‚Üë, WBC‚Üë (neutrophils) , protein‚Üë, glucose‚Üì**: Bacterial infection and inflammation
  * **[CSF] Culture, antigen detection, PCR**: Identify causative bacteria
* **Management**
  * **Empiric antibiotics**: Immediate treatment based on age
  * **Targeted antibiotics**: Switch to narrow-spectrum after pathogen identification
  * **Corticosteroids**: Reduce inflammation
{: .notice--info}

### Tuberculous Meningitis / ÁµêÊ†∏ÊÄßÈ´ÑËÜúÁÇé

* **Overview**
  * Subacute meningitis caused by M. tuberculosis
  * Common in children 1-6 years
* **Presentation**
  * **Fever, headache, vomiting (over 2-4 weeks)**: Meningeal inflammation
  * **Altered consciousness**: Severe inflammation affecting brain function
  * **Neck stiffness, Kernig's sign**: Meningeal irritation
  * **Cranial nerve palsies (III, VI, VII, VIII)**: Basilar inflammation
* **Examination**
  * **[CSF] Pressure‚Üë, lymphocytes‚Üë, protein‚Üë, glucose‚Üì, Cl‚Üì, fibrin formation, ADA‚Üë**: TB infection
  * **[CSF] PCR, acid-fast stain, culture**: Identify TB bacteria
  * **[Contrast CT/MRI] Basilar enhancement, hydrocephalus**: Characteristic findings
* **Management**
  * **Anti-TB drugs (INH, RFP, PZA, EB)**: Multiple drug combination
  * **Corticosteroids**: Reduce inflammation
{: .notice--info}


### Fungal Meningitis / ÁúüËèåÊÄßÈ´ÑËÜúÁÇé

* **Overview**
  * Fungal infection of meninges, mainly by Cryptococcus neoformans
  * Common in AIDS and immunocompromised patients
* **Presentation**
  * **Fever, headache, altered consciousness (over 2-4 weeks)**: Meningeal inflammation
  * **Neck stiffness, Kernig's sign**: Meningeal irritation
* **Examination**
  * **[CSF] Pressure‚Üë, lymphocytes‚Üë, protein‚Üë, glucose‚Üì**: Inflammatory response
  * **[CSF] India ink stain, latex agglutination, PCR, culture**: Identify fungal pathogen
* **Management**
  * **IV Amphotericin B + oral Flucytosine**: Standard combination therapy
  * **Fluconazole**: For maintenance or in renal dysfunction
{: .notice--info}

### Viral Meningitis / „Ç¶„Ç§„É´„ÇπÊÄßÈ´ÑËÜúÁÇé

* **Overview**
  * Viral infection of meninges, mainly by enteroviruses
  * Common in children
* **Presentation**
  * **Fever, headache, vomiting (within 1 week)**: Meningeal inflammation
  * **Mild neck stiffness, photophobia**: Meningeal irritation
* **Examination**
  * **[CSF] Pressure‚Üë, lymphocytes‚Üë, protein‚Üë, glucose‚Üí**: Viral inflammation
  * **[CSF] Negative stain and culture, PCR, antibody titer**: Rules out bacterial infection, Identify viral pathogen
* **Management**
  * **Bed rest**: Self-limiting
  * **Anti-edema drugs**: If increased intracranial pressure
  * **Acyclovir**: For HSV or VZV infections
{: .notice--info}

### Brain Abscess / ËÑ≥ËÜøÁòç

* **Overview**
  * Pus collection in brain parenchyma, commonly in fronto-temporal lobes
  * Secondary to adjacent infections (middle ear, sinuses) or hematogenous spread (heart infection)
* **Presentation**
  * **Fever, headache**: Infection and increased intracranial pressure
  * **Seizures, focal neurological deficits**: Local brain tissue damage
* **Examination**
  * **[Blood] WBC‚Üë, ESR‚Üë, CRP‚Üë**: Infection and inflammation
  * **[CT/MRI] Ring-enhancing lesion with low-density center**: Pus surrounded by capsule
* **Management**
  * **High-dose systemic antibiotics + metronidazole**: Target aerobic and anaerobic bacteria
  * **Anti-edema drugs (corticosteroids, glycerol)**: Reduce brain swelling
  * **Surgical drainage**: For large (>2cm) or expanding abscesses
{: .notice--info}

### Herpes Simplex Encephalitis / ÂçòÁ¥î„Éò„É´„Éö„ÇπËÑ≥ÁÇé

* **Overview**
  * Most common sporadic encephalitis caused by HSV, predilection for temporal lobe, poor prognosis and often with sequela
* **Presentation**
  * **Fever, headache, vomiting, neck stiffness**: Meningeal irritation
  * **Mental symptoms, memory disturbance**: Temporal lobe involvement
  * **Consciousness disturbance, seizures**: Severe brain inflammation
* **Examination**
  * **[CSF] Pressure‚Üë, lymphocytes‚Üë, protein‚Üë, glucose‚Üí**: Viral inflammation
  * **[MRI] High signal in temporal lobe on T2/FLAIR**: Brain inflammation and edema
  * **[EEG] Periodic lateralized epileptiform discharges (PLEDs)**: Abnormal brain activity
  * **[CSV] HSV-DNA detection, anti-HSV antibody‚Üë**: Confirmatory tests
* **Management**
  * **Antiviral drugs (acyclovir, vidarabine)**: Antiviral therapy
  * **Anti-edema drugs (glycerol)**: Reduce brain edema
  * **Antiepileptic drugs (diazepam, phenobarbital)**: Control seizures
  * **Corticosteroids**: Reduce inflammation
{: .notice--info}

### Influenza-Associated Encephalopathy / „Ç§„É≥„Éï„É´„Ç®„É≥„Ç∂ËÑ≥Áóá

* **Overview**
  * Acute encephalopathy due to influenza infection, with rapid progression and poor prognosis
  * Primarily affects children under 5 years
* **Presentation**
  * **Rapid onset of consciousness disturbance**: Primary manifestation
  * **Seizures, abnormal behavior**: Brain dysfunction
* **Examination**
  * **[CT/MRI] Various patterns of brain edema**: Brain damage
* **Management**
  * **Oxygen, fluid therapy, temperature control**: Maintain vital functions
  * **Antiepileptic drugs (diazepam, midazolam)**: Control seizures
  * **Anti-edema drugs (D-mannitol)**: Reduce brain edema
  * **Antiviral drugs (oseltamivir, zanamivir)**: Target influenza virus
  * **Steroid pulse therapy, high-dose Œ≥-globulin therapy**: Reduce inflammation
{: .notice--info}

### Reye Syndrome / ReyeÁóáÂÄôÁæ§

* **Overview**
  * Acute encephalopathy with diffuse microvesicular fatty liver
  * Primarily affects children and adolescents
* **Presentation**
  * **Vomiting, consciousness disturbances, seizures**: Brain damage
* **Examination**
  * **[Blood] AST‚Üë, ALT‚Üë, ammonia‚Üë**: Impaired liver dysfunction
* **Management**
  * **D-mannitol**: Reduce brain edema
  * **Glucose infusion**: Correct hypoglycemia
  * **Aspirin contraindicated**: May cause Reye syndrome in children with viral infections
{: .notice--info}

### Subacute Sclerosing Panencephalitis / ‰∫úÊÄ•ÊÄßÁ°¨ÂåñÊÄßÂÖ®ËÑ≥ÁÇé

* **Overview**
  * Progressive CNS disease occurring years after measles infection or vaccination
  * Commonly affects children with measles/vaccination history before age 1
* **Presentation**
  * **Cognitive decline, personality changes**: Progressive brain degeneration
  * **Myoclonus, seizures**: Neurological manifestation of brain inflammation
  * **Akinetic mutism**: Terminal stage of disease
* **Examination**
  * **[CSF] Elevated IgG, oligoclonal bands, high measles antibody titer**: Immune response to measles virus
  * **[EEG] Periodic synchronous discharge with high-amplitude slow waves**: Characteristic finding
* **Management**
  * **Inosine pranobex (oral), interferon or ribavirin (intrathecal)**: Antiviral and immunomodulatory effect
  * **Anticonvulsants**: Control myoclonus and seizures
  * **Poor prognosis**: Death within few years
{: .notice--info}

### Progressive Multifocal Leukoencephalopathy / ÈÄ≤Ë°åÊÄßÂ§öÂ∑£ÊÄßÁôΩË≥™ËÑ≥Áóá

* **Overview**
  * Demyelinating CNS disease caused by JC virus reactivation in immunocompromised patients
* **Presentation**
  * **Cognitive dysfunction, hemiplegia, aphasia**: Demyelinating diseases of brain
  * **Akinetic mutism**: Terminal stage of disease
* **Examination**
  * **[MRI] Multiple demyelinating lesions in white matter**: Characteristic finding
  * **[CSF] JC virus PCR positive**: Confirms diagnosis
* **Management**
  * **No curative treatment**: Supportive care only
  * **Poor prognosis**: Fatal within months of onset
{: .notice--info}

### Creutzfeldt-Jakob Disease / Creutzfeldt-JakobÁóÖ

* **Overview**
  * Caused by accumulation of abnormal prion protein (PrPSc) in brain
  * More common in elderly adults, usually sporadic but can be hereditary or acquired
* **Presentation**
  * **Gait disturbance, visual problems**: Early neurological manifestations
  * **Rapidly progressive dementia, myoclonus**: Progressive brain degeneration
  * **Akinetic mutism**: Terminal stage of disease
* **Examination**
  * **[MRI] Progressive cerebral atrophy, high signals in DWI**: Brain tissue changes
  * **[EEG] Periodic synchronous discharge with high-amplitude sharp waves**: Characteristic finding
  * **[CSF] Elevated neuron-specific enolase, 14-3-3 protein, total tau protein**: Markers of neuronal damage
* **Management**
  * **No currative treatment**: Supportive care only
  * **Poor prognosis**: Death within 1-2 years
{: .notice--info}

## Functional Disorder / Ê©üËÉΩÊÄßÁñæÊÇ£

### Migraine / ÁâáÈ†≠Áóõ

* **Overview**
  * Moderate to severe throbbing headache mainly in temporal region, related to trigeminal nerve excitation and cerebral vasodilation
  * Common in women aged 20-40s
* **Presentation**
  * **Visual aura**: Precedes headache
  * **Throbbing temporal headache (1-5 attacks per month)**: Due to cerebral vasodilation, worsens with daily activities
  * **Photophobia, phonophobia, osmophobia, nausea, vomiting**: Associated symptoms due to sensory hypersensitivity
* **Examination**
  * **Clinical diagnosis**
* **Management**
  * **[Attack] Triptans, NSAIDs, acetaminophen, rest in dark**: Vasoconstriction, pain relief (triptans contraindicated in MI/stroke)
  * **[Prevention] Ca channel blockers, antiepileptics, antidepressants, Œ≤-blockers, lifestyle modification**: Reduce frequency and severity of attacks
{: .notice--info}

### Tension-type Headache / Á∑äÂºµÂûãÈ†≠Áóõ

* **Overview**
  * Mild to moderate non-throbbing headache mainly in neck and occipital regions, due to muscle tension
  * Most common primary headache
* **Presentation**
  * **Band-like pressure or heavy sensation around head**: Non-pulsatile, bilateral pain due to muscle tension
  * **No photophobia, phonophobia, nausea, vomiting, not aggravated by activity**: Distinguishes from migraine
* **Examination**
  * **Clinical diagnosis**
  * **[Physical] Tenderness around skull**: Due to muscle tension
* **Management**
  * **Stretching, head exercises, cognitive behavioral therapy**: Reduce muscle tension and stress
  * **NSAIDs, antidepressants**: Pain relief, attack prevention
{: .notice--info}

### Cluster Headache / Áæ§Áô∫È†≠Áóõ

* **Overview**
  * Severe unilateral pain in orbital and temporal region
  * More common in men aged 20-40s
* **Presentation**
  * **Sudden severe unilateral orbital pain (at night, ~1 hour)**: Unknown cause
  * **Attacks occur at same time daily (clustering ~1 month)**: Circadian rhythm involvement
  * **Lacrimation, conjunctival injection, nasal congestion/discharge, Horner syndrome**: Autonomic symptoms
* **Examination**
  * **Clinical diagnosis**
* **Management**
  * **[Attack] Subcutaneous triptan injection, 100% oxygen inhalation**: Rapid pain relief
  * **[Prevention] Calcium channel blockers (verapamil)**: Reduce frequency of attacks
{: .notice--info}

### Rolandic Epilepsy / „É≠„Éº„É©„É≥„Éâ„Å¶„Çì„Åã„Çì

* **Overview**
  * Childhood partial epilepsy characterized by centrotemporal spikes
  * Common in boys aged 2-12 years, spontaneous remission in adolescence
* **Presentation**
  * **Facial and limb convulsions during sleep**: Simple partial seizures
  * **Speech arrest and drooling during awakening**: Focal seizures without impairment of consciousness
* **Examination**
  * **[EEG] High-amplitude centrotemporal spikes during interictal period**: Characteristic finding for diagnosis
* **Management**
  * **Observation**: For seizures not affecting daily life
  * **Carbamazepine**: For seizure needing control
{: .notice--info}

### Temporal Lobe Epilepsy / ÂÅ¥È†≠Ëëâ„Å¶„Çì„Åã„Çì

* **Overview**
  * Symptomatic partial epilepsy originating in temporal lobe, commonly caused by hippocampal sclerosis
  * One of the most common epilepsy
* **Presentation**
  * **Epigastric discomfort, d√©j√† vu/jamais vu, anxiety, phantom smells**: Simple partial seizures with autonomic and psychic symptoms
  * **Staring, lip smacking, chewing movements, wandering, loss of consciousness**: Complex partial seizures with automatisms
* **Examination**
  * **[EEG] Unilateral anterior temporal spikes during interictal period**: Localizes epileptic focus
  * **[MRI] Hippocampal sclerosis**: Common structural cause
* **Management**
  * **Ccarbamazepine, lamotrigine, levetiracetam**: For partial epilepsy
  * **Amygdalohippocampectomy, temporal lobectomy, vagus nerve stimulation**: For drug-resistant cases
{: .notice--info}

### Childhood Absence Epilepsy / Â∞èÂÖêÊ¨†Á•û„Å¶„Çì„Åã„Çì

* **Overview**
  * Idiopathic generalized epilepsy characterized by absence seizures
  * More common in girls aged 4-10 years
* **Presentation**
  * **Brief interruption of activity and consciousness (~10 seconds per episode, multiple episodes per day)**: Absence seizures
* **Examination**
  * **[EEG] 3 Hz spike-and-wave complexes during ictal and interictal periods**: Diagnostic finding
* **Management**
  * **Valproic acid**: First-line treatment
  * **Ethosuximide, lamotrigine**: Second-line treatment
  * **Good prognosis**: 95% remission rate
{: .notice--info}

### Juvenile Myoclonic Epilepsy / Ëã•Âπ¥„Éü„Ç™„ÇØ„É≠„Éã„Éº„Å¶„Çì„Åã„Çì

* **Overview**
  * Idiopathic generalized epilepsy characterized by myoclonic seizures
  * More common in adolescence
* **Presentation**
  * **Sudden bilateral upper limb jerks**: Myoclonic seizures
  * **Generalized tonic-clonic seizures**: Present in almost all cases
  * **Photosensitivity**: Sensory hypersensitivity
* **Examination**
  * **[EEG] Polyspike-wave complexes during ictal and interictal periods**: Diagnostic finding
* **Management**
  * **Valproic acid**: First-line treatment
  * **Levetiracetam, lamotrigine, topiramate, clonazepam**: Second-line treatments
  * **Generally good prognosis**
{: .notice--info}

### West Syndrome / WestÁóáÂÄôÁæ§

* **Overview**
  * Generalized epilepsy in infants, mostly due to perinatal problems, congenital malformations, metabolic disorders, or tuberous sclerosis
  * More common in infants under 1 year 
* **Presentation**
  * **Head drops, sudden limb elevation**: Epileptic spasms occurring in clusters
  * **Developmental delay or regression**: Impact on psychomotor development
* **Examination**
  * **[EEG] Chaotic high-amplitude slow waves with spikes during interictal period**: Characteristic hypsarrhythmia
* **Management**
  * **ACTH therapy**: First-line treatment
  * **Vigabatrin**: Second-line treatment
  * **Poor prognosis**: 10-50% progress to Lennox-Gastaut syndrome
{: .notice--info}

### Lennox-Gastaut Syndrome / Lennox-GastautÁóáÂÄôÁæ§

* **Overview**
  * Symptomatic generalized epilepsy in early childhood, may develop from West syndrome or organic brain disorders
  * More common in children 1-8 years
* **Presentation**
  * **Neck/trunk flexion, atypical absence, sudden falls**: Multiple seizure types
  * **Developmental delay**: Impact on psychomotor development
* **Examination**
  * **[EEG] Slow spike-wave complexes during interictal period**: Diagnostic finding
* **Management**
  * **Valproic acid, lamotrigine, clonazepam, rufinamide**: Multiple antiepileptic drugs
  * **Ketogenic diet, corpus callosotomy**: Alternative treatments
  * **Poor prognosis**: <20% remission rate
{: .notice--info}

### Dravet Syndrome / DravetÁóáÂÄôÁæ§

* **Overview**
  * Severe epilepsy caused by ion channel gene mutations
  * Onset in infancy
* **Presentation**
  * **Generalized tonic-clonic seizures**: Triggered by fever or bathing
  * **Multiple seizure types develop**: Treatment-resistant epilepsy
* **Examination**
  * **[Genetic testing] SCN1A gene mutation**: Common finding
* **Management**
  * **Multiple antiepileptic drugs**: Often refractory to treatment
  * **Poor prognosis**: High mortality in early childhood
{: .notice--info}

### Febrile Seizures / ÁÜ±ÊÄß„Åë„ÅÑ„Çå„Çì

* **Overview**
  * Seizures occurring with fever ‚â•38¬∞C, due to increased brain excitability during fever
  * Common in infants/toddlers 6 months-6 years
* **Presentation**
  * **Symmetric tonic-clonic seizures (1-2 minutes)**: Brief episodes
* **Examination**
  * **Clinical diagnosis**
* **Management**
  * **Temperature control, observation**: Mostly self-limiting
 {: .notice--info}

### Status Epilepticus / „Å¶„Çì„Åã„ÇìÈáçÁ©ç

* **Overview**
  * Continuous or recurring seizures without recovery, can cause irreversible brain damage after 30 minutes
  * Various causes: epilepsy, stroke, head trauma, encephalitis, toxicity
* **Presentation**
  * **Generalized tonic-clonic seizures**: Convulsive status epilepticus
  * **Impaired consciousness, automatisms**: Non-convulsive status epilepticus
* **Examination**
  * **Seizures >5 minutes**: Key diagnostic criterion
* **Management**
  * **Immediate airway management, oxygen**: Basic life support
  * **IV diazepam**: First-line emergency treatment
{: .notice--info}

### Cerebral Palsy / ËÑ≥ÊÄßÈ∫ªÁó∫

* **Overview**
  * Non-progressive brain damage during developmental period, commonly due to perinatal injury (premature birth, asphyxia)
* **Presentation**
  * **Abnormal posture, increased/decreased muscle tone**: Impaired coordination between flexor and extensor muscles
  * **Developmental delay, epilepsy, joint contracture**: Complication during development
* **Examination**
  * **Clinical diagnosis**
* **Management**
  * **Rehabilitation**: Improve motor function
{: .notice--info}

## Neurocutaneous Syndrome / ÊØçÊñëÁóá

### Tuberous Sclerosis / ÁµêÁØÄÊÄßÁ°¨ÂåñÁóá

* **Overview**
  * Autosomal dominant genetic disorder causing multiple nodular lesions (hamartomas) in various organs
* **Presentation**
  * **Hypopigmented macules (ash-leaf spots), facial angiofibromas , shagreen patches**: Characteristic skin lesions
  * **Seizures, developmental delay**: Cortical tubers in brain
* **Examination**
  * **[CT] Multiple calcifications around lateral ventricles**: Brain hamartomas (subependymal giant cell astrocytoma, subependymal nodule)
  * **[MRI] Nodular lesions in cortex/subependymal areas**: Brain hamartomas (subependymal giant cell astrocytoma, subependymal nodule)
* **Management**
  * **Symptomatic treatment**: Tailored to individual manifestations
{: .notice--info}

### Neurofibromatosis Type 1 / Á•ûÁµåÁ∑öÁ∂≠ËÖ´ÁóáÔºëÂûã

* **Overview**
  * Autosomal dominant genetic disorder (50-70% due to new mutations) causing multiple neurofibroma
* **Presentation**
  * **Multiple caf√©-au-lait spots (by age 2)**: Light to dark brown patches
  * **Axillary/inguinal freckling (age 3-5)**: Clustered small brown spots
  * **Cutaneous neurofibromas**: Soft and hemispherical nodules on skin
  * **Lisch nodules**: Gray-brown nodules on iris
* **Examination**
  * **Based on clinical presentation**
* **Management**
  * **Symptomatic treatment**: Tailored to individual manifestations
{: .notice--info}

### Neurofibromatosis Type 2 / Á•ûÁµåÁ∑öÁ∂≠ËÖ´ÁóáÔºíÂûã

* **Overview**
  * Autosomal dominant genetic disorder causing acoustic schwannomas
  * Typically onset in 20-30s
* **Presentation**
  * **Bilateral hearing loss, tinnitus**: Due to acoustic schwannomas
  * **Vertigo, facial nerve palsy**: Involvement of other cranial nerves
  * **Early-onset cataracts**: Ocular manifestation
* **Examination**
  * **[MRI] Bilateral acoustic schwannomas**: Characteristic finding
* **Management**
  * **Surgical removal of tumors**: Challenging to improve neurological symptoms
{: .notice--info}

### Sturge-Weber Syndrome / Sturge-WeberÁóáÂÄôÁæ§

* **Overview**
  * Non-hereditary neurocutaneous disorder characterized by facial angioma simplex, leptomeningeal angioma, and choroidal vascular lesions
* **Presentation**
  * **Unilateral facial port-wine stain**: Facial angioma simplex (present at birth, following trigeminal nerve distribution)
  * **Seizures, hemiparesis, intellectual disability**: Leptomeningeal angioma  (contralateral to port-wine stain)
  * **Glaucoma**: Choroidal vascular lesions (Ipsilateral to port-wine stain)
* **Examination**
  * **[Contrast MRI] Enhanced leptomeningeal angioma**: Vascularized angioma
  * **[Skull X-ray] Gyriform calcifications**: Leptomeningeal involvement
* **Management**
  * **Laser therapy**: For facial port-wine stain
  * **Anticonvulsants,**: For seizure control
  * **Intraocular pressure reduction (trabeculotomy, trabeculectomy)**: For glaucoma treatment
{: .notice--info}

### von Hippel-Lindau Disease / von Hippel-LindauÁóÖ

* **Overview**
  * Autosomal dominant genetic disorder causing hemangioblastomas in CNS and cystic tumors in multiple organs
  * Typically onset in 20-40s
* **Presentation**
  * **Dizziness, nystagmus, ataxia**: Cerebellar hemangioblastomas
  * **Headache, vomiting**: Increased intracranial pressure
  * **Visual disturbances, eye pain**: Hemangioblastomas in retina
  * **Tumors or cysts in kidneys, adrenal glands, pancreas, spleen**: Multi-organ involvement
* **Examination**
  * **[CT, MRI] Multiple cystic tumors with mural nodules in cerebellum**: Hemangioblastomas
* **Management**
  * **Surgical resection or radiotherapy**:  For hemangioblastomas
{: .notice--info}

## Brain Tumor / ËÑ≥ËÖ´Áòç

### Diffuse Astrocytoma / „Å≥„Åæ„ÇìÊÄßÊòüÁ¥∞ËÉûËÖ´

* **Overview**
  * Low-grade (Grade II) astrocytoma with high differentiation
  * Common in young adults, usually in cerebral hemispheres
* **Presentation**
  * **Epileptic seizures, paralysis, aphasia**: Focal brain symptoms
  * **Headache, vomiting**: Increased intracranial pressure
* **Examination**
  * **[CT] Ill-defined low-density mass**: Infiltrative nature of tumor
  * **[MRI] T1: ill-defined low signal, T2: high signal**: Tumor characteristics
  * **[Contrast CT/MRI] No enhancement**: Low-grade nature
  * **[Genetic testing] IDH1 mutation**: Associated with better prognosis
* **Management**
  * **Surgical resection**: Aim for maximal safe resection
  * **Radiation therapy**: Additional treatment post-surgery
{: .notice--info}

### Pilocytic Astrocytoma / ÊØõÊßòÁ¥∞ËÉûÊÄßÊòüÁ¥∞ËÉûËÖ´

* **Overview**
  * Most benign (Grade I) astrocytoma, non-invasive and rare malignant transformation
  * Common in childhood to adolescence, often in cerebellum or optic nerve/chiasm
* **Presentation**
  * **Cerebellar ataxia**: Cerebellar involvement
  * **Headache, vomiting**: Increased intracranial pressure
  * **Visual impairment, visual field defects**: Optic nerve/chiasm involvement
* **Examination**
  * **[Imaging] Well-defined tumor in cerebellum or optic pathway**: Characteristic locations
  * **[Genetic testing] NF1 gene mutation**: Association with neurofibromatosis type 1
* **Management**
  * **Surgical resection**: Curative for accessible tumors
  * **Chemotherapy**: For optic pathway tumors where resection is difficult
{: .notice--info}

### Glioblastoma / ËÜ†ËäΩËÖ´

* **Overview**
  * Highest grade (Grade IV) astrocytoma with low differentiation, rapidly progressing with extremely poor prognosis
  * Common in middle-aged and older adults, often in cerebral hemispheres
* **Presentation**
  * **Rapidly progressing headache, vomiting**: Increased intracranial pressure
  * **Personality changes, epileptic seizures, paralysis, aphasia**: Focal brain symptoms
* **Examination**
  * **[MRI] T1: ill-defined low signal, T2: heterogeneous high signal**: Tumor characteristics
  * **[Contrast MRI] Ring-like enhancement**: Typical pattern
  * **[Pathology] Microvascular proliferation, necrosis, pseudopalisading**: Characteristic histological features
  * **[Genetic testing] IDH mutation**: For further classification
* **Management**
  * **Surgical resection**: Primary treatment
  * **Postoperative radiotherapy and chemotherapy**: Adjuvant treatment
  * **Prognosis**: Usually fatal within 2 years
{: .notice--info}

### Oligodendroglioma / ‰πèÁ™ÅËµ∑ËÜ†ËÖ´

* **Overview**
  * Low-grade (Grade II) glioma originating from oligodendroglia, slow growth
  * Common in adults aged 20-50 years, often in cerebral white matter
* **Presentation**
  * **Epileptic seizures**: Focal brain irritation
  * **Headache**: Increased intracranial pressure
* **Examination**
  * **[CT] Low to iso-density mass, often with calcification**: Characteristic finding
  * **[MRI] T1: low signal, T2: high signal, well-defined mass**: Tumor characteristics
  * **[Genetic testing] 1p/19q co-deletion**: Diagnostic and prognostic marker
  * **[Pathology] Honeycomb structure, fried egg appearance**: Characteristic histological features
* **Management**
  * **Surgical resection**: Aim for total removal
  * **Postoperative radiotherapy**: High sensitivity to radiation
{: .notice--info}

### Ependymoma / ‰∏äË°£ËÖ´

* **Overview**
  * Grade II brain tumor originating from ependymal cells
  * Peak incidence at 5-9 years, often near ventricles (especially 4th ventricle)
* **Presentation**
  * **Headache, vomiting**: Increased intracranial pressure due to non-communicating hydrocephalus
* **Examination**
  * **[CT] Iso to high-density mass, often with cysts/calcification**: Characteristic findings
  * **[MRI] T1: low signal, T2: high signal, well-defined mass**: Tumor characteristics
  * **[Pathology] Perivascular pseudorosettes, ependymal rosettes**: Diagnostic histological features
* **Management**
  * **Surgical resection**: Aim for total removal
  * **Postoperative radiotherapy**: Additional treatment
{: .notice--info}

### Medulloblastoma / È´ÑËäΩËÖ´

* **Overview**
  * Malignant embryonal tumor (Grade IV) derived from undifferentiated neuroepithelial cells
  * Most common malignant brain tumor in children, predilection for cerebellar vermis
* **Presentation**
  * **Headache, projectile vomiting, papilledema**: Increased intracranial pressure due to non-communicating hydrocephalus
  * **Inability to maintain sitting, gait instability, falls**: Cerebellar symptoms
* **Examination**
  * **[CT] Iso to high-density mass , often calcified**: Tumor characteristics
  * **[MRI] T1: low signal, T2: high signal**: Tumor characteristics
  * **[Contrast MRI] Homogeneous enhancement**: Tumor vascularity
  * **[Pathology] Tumor cells with scant cytoplasm, Homer Wright rosettes**: Diagnostic features
  * **[Genetic testing] WNT, SHH, MYC abnormalities**: For subclassification
* **Management**
  * **Surgical resection**: Primary treatment
  * **Postoperative radiotherapy and chemotherapy**: Adjuvant treatment
{: .notice--info}

### Germ Cell Tumor / ËÉöÁ¥∞ËÉûËÖ´Áòç

* **Overview**
  * Tumors derived from germ cells, mainly germinomas and teratomas
  * Common in male children, mostly in suprasellar and pineal regions
* **Presentation**
  * **Polyuria, growth retardation, delayed puberty**: Hypothalamic-pituitary dysfunction (suprasellar tumor)
  * **Visual disturbances**: Optic nerve/chiasm compression (suprasellar tumor)
  * **Headache, vomiting**: Increased intracranial pressure due to hydrocephalus (pineal tumor)
  * **Upward gaze palsy (Parinaud syndrome), light-near dissociation (Argyll Robertson pupils)**: Midbrain involvement (pineal tumor)
* **Examination**
  * **[CT/MRI] Mass in suprasellar region**: Suprasellar tumor
  * **[CT/MRI] Mass in pineal region , calcification, ventricular enlargement**: Pineal tumor
* **Management**
  * **Radiotherapy + chemotherapy**: For germinoma
  * **Surgical resection + radiotherapy/chemotherapy**: For teratoma
{: .notice--info}

### Malignant Lymphoma / ÊÇ™ÊÄß„É™„É≥„ÉëËÖ´

* **Overview**
  * Intracranial lymphoid tumor, mostly primary non-Hodgkin's lymphoma
  * More common in 50-70s adults and males
* **Presentation**
  * **Headache, vomiting, papilledema**: Increased intracranial pressure
  * **Paralysis, aphasia, memory impairment**: Focal brain symptoms
* **Examination**
  * **[CT] Iso to high-density lesions**: Tumor characteristics
  * **[MRI] T1: iso to slow signal, T2: high signal**: Tumor characteristics
  * **[Contrast CT/MRI] Homogeneous enhancement**: Highly vascular tumor
  * **[Blood, CSF] Soluble IL-2 receptor‚Üë (blood), Œ≤2-microglobulin‚Üë (CSF)**: Tumor marker
* **Management**
  * **High-dose methotrexate + radiotherapy**: Standard treatment
{: .notice--info}

### Hemangioblastoma / Ë°ÄÁÆ°ËäΩËÖ´

* **Overview**
  * Benign tumor rich in capillaries with intratumoral cysts, associated with von Hippel-Lindau disease
  * More common in 20-70s adults, mostly in cerebellar hemisphere
* **Presentation**
  * **Headache, vomiting**: Increased intracranial pressure
  * **Dizziness, nystagmus, ataxia**: Cerebellar symptoms
  * **Polycythemia**: Due to erythropoietin production by tumor
* **Examination**
  * **[MRI] T1: iso to low signal, T2: high signal, cystic lesion**: Tumor characteristics
  * **[Contrast MRI] Enhancing mural nodule**: Highly vascular tumor component
* **Management**
  * **Surgical resection**: Primary treatment
  * **Radiation therapy**: For inoperable cases or residual
{: .notice--info}

### Meningioma / È´ÑËÜúËÖ´

* **Overview**
  * Benign tumor (Grade I) originating from arachnoid cells, grows slowly and compresses surrounding brain tissue
  * More common in 40-70s women
* **Presentation**
  * **Headache, epileptic seizures**: Due to compression of brain tissue
* **Examination**
  * **[X-ray/CT] Bone thickening, destruction, calcification**: Tumor effects on adjacent bone
  * **[MRI] T1: iso to low signal, T2: iso to high signal**: Tumor characteristics
  * **[Contrast CT/MRI] Well-defined homogeneous enhancement, dural tail sign**: Highly vascular nature
  * **[External carotid angiography] Sunburst appearance**: Tumor vasculature
* **Management**
  * **Surgical resection**: Primary treatment
  * **Stereotactic radiosurgery**: For small or residual tumors
  * **Observation**: For small asymptomatic tumors
{: .notice--info}

### Schwannoma / Á•ûÁµåÈûòËÖ´

* **Overview**
  * Benign tumor (Grade I) originating from Schwann cells, 90% of intracranial cases occur on vestibulocochlear nerve
  * More common in 40-60s adults
* **Presentation**
  * **Unilateral high-frequency hearing loss, tinnitus**: Cochlear nerve involvement
  * **Horizontal nystagmus towards healthy side, Bruns nystagmus, vertigo**: Vestibular nerve involvement
* **Examination**
  * **[CT] Internal auditory canal enlargement, low to iso-density mass in cerebellopontine angle**: Tumor growth and characteristics
  * **[MRI] T1: low signal, T2: iso signal**: Tumor characteristics
  * **[Contrast CT/MRI] Marked enhancement**: Highly vascular nature
* **Management**
  * **Surgery**: For large symptomatic tumors
  * **Radiation therapy**: For tumors <3 cm or residual tumors
  * **Observation**: For small asymptomatic tumors
{: .notice--info}

### Pituitary Adenoma / ‰∏ãÂûÇ‰ΩìËÖ∫ËÖ´

* **Overview**
  * Benign tumor originating from anterior pituitary cells, classified as functional or non-functional
  * Common in adults
* **Presentation**
  * **Acromegaly, hyperprolactinemia, Cushing disease**: Hormone overproduction (functional adenoma)
  * **Visual field defects (bitemporal hemianopsia), headache, pituitary hormone deficiency**: Compression of optic chiasm/normal pituitary
* **Examination**
  * **[X-ray] Ballooning/double floor of sella turcica**: Bone shadows changes due to tumor growth
  * **[CT/MRI] Mass in suprasellar cistern, T1: iso to low signal, T2: iso to high signal**: Microadenoma or macroadenoma in sella turcica
* **Management**
  * **Dopamine agonists**: For prolactin-secreting tumors
  * **Transsphenoidal surgery (TSS)**: For other types of tumors
  * **Radiotherapy**: For inoperable cases or residual tumors
  * **Observation**: For small asymptomatic tumors
{: .notice--info}

### Craniopharyngioma / È†≠ËìãÂíΩÈ†≠ËÖ´

* **Overview**
  * Benign tumor (Grade I) originating from craniopharyngeal duct remnants (Rathke's pouch)
  * Bimodal age distribution of children and adults , common in suprasellar region
* **Presentation**
  * **Visual field defects (bitemporal hemianopsia), optic atrophy**: Optic chiasm compression
  * **Short stature, delayed puberty, hypogonadism, amenorrhea**: Anterior pituitary dysfunction
  * **Hypothermia, consciousness disturbance, memory loss, depression**: Hypothalamic dysfunction
* **Examination**
  * **[X-ray] Flattened sella turcica**: Tumor effect on surrounding bone
  * **[CT] Scattered calcifications, cystic components in suprasellar region**: Characteristic tumor features
  * **[Contrast CT/MRI] Enhancement of cyst wall and solid components**: Tumor vascularity
* **Management**
  * **Surgery**: Primary treatment
  * **Radiation therapy**: For residual tumor or recurrence
{: .notice--info}

### Metastatic Brain Tumor / Ëª¢ÁßªÊÄßËÑ≥ËÖ´Áòç

* **Overview**
  * Malignant tumors from extracranial sites metastasizing to the brain
* **Presentation**
  * **Headache, neurological deficits, seizures**: Symptoms vary based on location and size
* **Examination**
  * **[CT/MRI] Multiple lesions, ring-like enhancement with contrast**: Characteristic imaging features
* **Management**
  * **Whole-brain radiation therapy**: Primary treatment
  * **Stereotactic radiosurgery**: For selected cases
  * **Surgery**: For large and accessible single lesions
{: .notice--info}

## Congenital Anomaly / ÂÖàÂ§©Â•áÂΩ¢

### Myelomeningocele / ËÑäÈ´ÑÈ´ÑËÜúÁò§

* **Overview**
  * Severe form of spinal bifida with exposed spinal cord, due to failure of caudal neural tube closure
  * Often associated with Chiari II malformation and hydrocephalus
* **Presentation**
  * **Skin defect, exposed spinal cord (in lumbosacral region)**: Failed neural tube closure
  * **Lower limb motor/sensory disorders, deformities, bladder/bowel dysfunction**: Spinal cord dysfunction
* **Examination**
  * **[Prenatal] Maternal serum AFP‚Üë, amniotic fluid AFP‚Üë**: Neural tube defect
  * **[Prenatal US/MRI] Ventricle enlargement, lumbosacral mass**: Hydrocephalus and spinal defect
  * **[MRI] Herniation of medulla/cerebellar vermis/fourth ventricle, enlarged ventricles**: Chiari II malformation, hydrocephalus
* **Management**
  * **Early closure surgery (within 48h after birth)**: Prevent CSF infection and spinal cord degeneration
  * **Post-operative care**: Management of urinary dysfunction, limb deformities
{: .notice--info}

### Spina Bifida Occulta / ÊΩúÂú®ÊÄß‰∫åÂàÜËÑäÊ§é

* **Overview**
  * Hidden form of spina bifida often with spinal lipoma, can develop tethered cord syndrome with growth
  * More common in females
* **Presentation**
  * **Subcutaneous mass, dimpling, nevus, localized hypertrichosis (in lumbosacral region)**: Associated skin findings
  * **Lower limb motor/sensory disorders, deformities, scoliosis, bladder/bowel dysfunction (with growth)**: Due to tethered spinal cord
* **Examination**
  * **[MRI] Spinal lipoma, tethered spinal cord**: Confirms diagnosis
* **Management**
  * **Surgical untethering**: Removal of lipoma
{: .notice--info}

### Cranium Bifidum / ‰∫åÂàÜÈ†≠Ëìã

* **Overview**
  * Defect in cranial midline due to failure of rostral neural pore closure, complete failure leads to anencephaly (incompatible with life)
* **Presentation**
  * **Midline cranial swelling**: Herniation of intracranial contents through skull defect
* **Examination**
  * **[MRI] Herniation of meninges (+ brain tissue)**: Meningocele, encephalomeningocele
* **Management**
  * **Surgical repair**: Removal of herniated sac and closure of skull defect
{: .notice--info}

### Chiari Malformation Type I / Chiari I ÂûãÂ•áÂΩ¢

* **Overview**
  * Herniation of cerebellar tonsils into spinal canal, often associated with syringomyelia
  * Can occur in adults and children
* **Presentation**
  * **Headache, neck and shoulder pain (worsen with coughing)**: Pressure from herniated cerebellar tonsils
* **Examination**
  * **[MRI] Herniated cerebellar tonsils into spinal canal**: Confirms diagnosis
  * **[MRI] Syringomyelia**: Common associated finding
* **Management**
  * **Observation**: For asymptomatic cases
  * **Foramen magnum decompression**: Removal of occipital bone and C1 lamina
{: .notice--info}

### Chiari Malformation Type II / Chiari II ÂûãÂ•áÂΩ¢

* **Overview**
  * Herniation of lower brainstem, fourth ventricle, and cerebellar vermis into spinal canal
  * Associated with myelomeningocele and hydrocephalus
* **Presentation**
  * **Myelomeningocele, hydrocephalus**: Present at birth
  * **Inspiratory stridor, apnea, dysphagia**: Brainstem compression
* **Examination**
  * **[MRI] Herniated medulla, fourth ventricle, cerebellar vermis**: Confirms diagnosis
  * **[MRI] Enlarged ventricles**: Associated hydrocephalus
* **Management**
  * **[0-2 days] Myelomeningocele closure**: Primary repair
  * **[1-2 weeks] CSF drainage or VP shunt**: Treat hydrocephalus
  * **[1-2 months] Foramen magnum decompression**: For brainstem symptoms
{: .notice--info}

### Dandy-Walker Syndrome / Dandy-WalkerÁóáÂÄôÁæ§

* **Overview**
  * Malformation characterized by cerebellar vermis hypoplasia and cystic dilation of fourth ventricle
  * Often associated with multiple congenital anomalies (corpus callosum agenesis, occipital encephalocele, VSD, PDA)
* **Presentation**
  * **Hydrocephalus symptoms**: Increased intracranial pressure
  * **Developmental delay**: Brain malformation effects
* **Examination**
  * **[MRI] Hypoplastic cerebellar vermis, cystic dilation of fourth ventricle**: Primary findings
* **Management**
  * **Ventriculoperitoneal (VP) shunt, cystoperitoneal (CP) shunt**: Treat hydrocephalus and fourth ventricle cyst
{: .notice--info}

### Craniosynostosis / È†≠ËìãÁ∏´ÂêàÊó©ÊúüÁôíÂêàÁóá

* **Overview**
  * Premature fusion of cranial sutures causing skull deformity and restriction
* **Presentation**
  * **Skull and facial deformity, bony ridge at suture**: Abnormal growth due to premature suture fusion
  * **Signs of increased intracranial pressure**: Compression of brain tissue
* **Examination**
  * **[X-ray, 3D-CT] Absent suture lines, skull deformity, thickened/sclerotic bone at fusion site, copper-beaten appearance**: Confirms diagnosis
* **Management**
  * **Fronto-orbital advancement, cranial vault remodeling**: Relieve brain compression, correct cosmetic deformity
{: .notice--info}

## Head Injury / È†≠ÈÉ®Â§ñÂÇ∑

### Skull Fracture / È†≠ËìãÈ™®È™®Êäò

* **Overview**
  * Fracture of skull, classified by location (vault/base) and type (open/closed)
* **Presentation**
  * **[Vault] Variable symptoms**: Depends on open/closed status
  * **[Anterior Base] Raccoon eyes, CSF rhinorrhea, anosmia, visual disturbance**: Injury to frontal base and CN I/II
  * **[Middle Base] Battle's sign, CSF otorrhea, facial paralysis, hearing loss**: Injury to temporal bone and CN VII/VIII
  * **[Posterior Base] Dysphasia, dysarthria, respiratory inhibitions**: Injury to occipital bone and CN IX~XII/brainstem
* **Examination**
  * **[X-ray, CT] Linear or depressed fracture lines**: Direct visualization of bone injury
  * **[CT] Pneumocephalus**: Indicates communication with exterior
* **Management**
  * **[Closed fracture] Conservative treatment**: Observation
  * **[Open fracture] Emergency surgery**: Debridement and closure
  * **[CSF leak] Head elevation, antibiotics**: Prevent infection
{: .notice--info}

### Acute Epidural Hematoma / ÊÄ•ÊÄßÁ°¨ËÜúÂ§ñË°ÄËÖ´

* **Overview**
  * Bleeding between skull and dura mater due to skull fracture, most commonly from middle meningeal artery (temporal region)
* **Presentation**
  * **Trauma followed by lucid interval**: Time before blood accumulates
  * **Sudden deterioration of consciousness**: Increased intracranial pressure from expanding hematoma
* **Examination**
  * **[X-ray] Skull fracture**: Trauma
  * **[CT] Lens-shaped high-density area (at trauma site)**: Blood collection between skull and dura
  * **[CT] Compressed ventricles, midline shift**: Mass effect from expanding hematoma
* **Management**
  * **Emergency craniotomy**: Remove hematoma and achieve hemostasis
{: .notice--info}

### Acute Subdural Hematoma / ÊÄ•ÊÄßÁ°¨ËÜú‰∏ãË°ÄËÖ´

* **Overview**
  * Bleeding in subdural space due to head trauma, most commonly from cortical vessels or bridging veins
* **Presentation**
  * **Trauma followed by immediate loss of consciousness**: Severe brain injury with contusion
* **Examination**
  * **[CT] Crescent-shaped high-density area (at opposite site)**: Blood collection in subdural space
* **Management**
  * **Emergency craniotomy**: Remove hematoma and achieve hemostasis
  * **Poor prognosis**: High mortality even with early surgery
{: .notice--info}

### Cerebral Contusion / ËÑ≥Êå´ÂÇ∑

* **Overview**
  * Brain tissue damage with localized contusion, small hemorrhages, and edema from head trauma
* **Presentation**
  * **Trauma followed by progressive deterioration of consciousness**: Due to increasing edema and mass effect
* **Examination**
  * **[CT] High density spots**: Punctate hemorrhages
  * **[CT] Low-density areas around hemorrhage**: Surrounding edema
* **Management**
  * **Conservative or surgical treatment**: Based on mass effect severity
{: .notice--info}

### Chronic Subdural Hematoma / ÊÖ¢ÊÄßÁ°¨ËÜú‰∏ãË°ÄËÖ´

* **Overview**
  * Gradual expansion of encapsulated blood in subdural space, develops 2-3 months after minor head trauma
  * Common in elderly and alcoholics
* **Presentation**
  * **Headache, cognitive decline, gait disturbance, hemiparesis**: Gradual brain compression
* **Examination**
  * **[CT] Crescent-shaped low to high-density area**: Varying blood density due to chronicity
  * **[MRI] High signal on T1 and T2**: Chronic blood products
* **Management**
  * **Burr hole drainage**: Remove hematoma
{: .notice--info}

### Diffuse Axonal Injury / „Å≥„Åæ„ÇìÊÄßËª∏Á¥¢ÊêçÂÇ∑

* **Overview**
  * Widespread axonal damage due to rotational acceleration forces
* **Presentation**
  * **Trauma followed by prolonged unconsciousness**: Due to widespread neural damage
  * **Higher brain dysfunction**: Due to extensive white matter damage
* **Examination**
  * **[CT] No significant findings**: Microscopic nature of damage
  * **[MRI] High signal areas at tissue boundaries**: Displacement between tissues during acceleration
* **Management**
  * **Conservative treatment**: No direct treatment
{: .notice--info}

<!-- ## Cerebral Infarction / ËÑ≥Ê¢óÂ°û

### Atherothrombotic Infarction / „Ç¢„ÉÜ„É≠„Éº„É†Ë°ÄÊ†ìÊÄßËÑ≥Ê¢óÂ°û
### Cardioembolic Infarction / ÂøÉÂéüÊÄßËÑ≥Â°ûÊ†ìÁóá
### Lacunar Infarction / „É©„ÇØ„ÉäÊ¢óÂ°û
### Transient Ischemic Attack / ‰∏ÄÈÅéÊÄßËÑ≥ËôöË°ÄÁô∫‰Ωú
### Carotid Artery Stenosis / È†∏ÂãïËÑàÁã≠Á™ÑÁóá
### Cerebellar Infarction / Â∞èËÑ≥Ê¢óÂ°û
### Wallenberg Syndrome / WallenbergÁóáÂÄôÁæ§

## Cerebral Hemorrhage / ËÑ≥Âá∫Ë°Ä

### Putaminal Hemorrhage / Ë¢´ÊÆªÂá∫Ë°Ä
### Thalamic Hemorrhage / Ë¶ñÂ∫äÂá∫Ë°Ä
### Brainstem Hemorrhage / ËÑ≥ÂππÂá∫Ë°Ä
### Cerebellar Hemorrhage / Â∞èËÑ≥Âá∫Ë°Ä
### Subcortical Hemorrhage / ÁöÆË≥™‰∏ãÂá∫Ë°Ä
### Subarachnoid Hemorrhage / „Åè„ÇÇËÜú‰∏ãÂá∫Ë°Ä

## Other Cerebrovascular Disease / „Åù„ÅÆ‰ªñ„ÅÆËÑ≥Ë°ÄÁÆ°ÁñæÊÇ£

### Cerebral Aneurysm / ËÑ≥ÂãïËÑàÁò§
### Arteriovenous Malformation / ËÑ≥ÂãïÈùôËÑàÂ•áÂΩ¢
### Moyamoya Disease / „ÇÇ„ÇÑ„ÇÇ„ÇÑÁóÖ
### Carotid-Cavernous Fistula / ÂÜÖÈ†∏ÂãïËÑàÊµ∑Á∂øÈùôËÑàÊ¥ûÁòª
### Dural Arteriovenous Fistula / Á°¨ËÜúÂãïÈùôËÑàÁòª
### Sinus Thrombosis / ÈùôËÑàÊ¥ûË°ÄÊ†ìÁóá
### Hypertensive Encephalopathy / È´òË°ÄÂúßÊÄßËÑ≥Áóá
### Spinal Arteriovenous Malformation / ËÑäÈ´ÑÂãïÈùôËÑàÂ•áÂΩ¢
### Spinal Cord Infarction / ËÑäÈ´ÑÊ¢óÂ°û

## Dementia / Ë™çÁü•Áóá

### Alzheimer Type Dementia / AlzheimerÂûãË™çÁü•Áóá
### Vascular Dementia / Ë°ÄÁÆ°ÊÄßË™çÁü•Áóá
### Dementia with Lewy Bodies / LewyÂ∞è‰ΩìÂûãË™çÁü•Áóá
### Frontotemporal Lobar Degeneration / ÂâçÈ†≠ÂÅ¥È†≠ËëâÂ§âÊÄßÁóá

## Neurodegenerative Disease / Á•ûÁµåÂ§âÊÄßÁñæÊÇ£

### Parkinson's Disease / ParkinsonÁóÖ
### Progressive Supranuclear Palsy / ÈÄ≤Ë°åÊÄßÊ†∏‰∏äÊÄßÈ∫ªÁó∫
### Corticobasal Degeneration / Â§ßËÑ≥ÁöÆË≥™Âü∫Â∫ïÊ†∏Â§âÊÄßÁóá
### Huntington's Disease / HuntingtonÁóÖ
### MSA-C / MSA-C
### MSA-P / MSA-P
### Shy-Drager Syndrome / Shy-DragerÁóáÂÄôÁæ§
### Cortical Cerebellar Atrophy / ÁöÆË≥™ÊÄßÂ∞èËÑ≥ËêéÁ∏ÆÁóá
### SCA-3 / SCA-3
### SCA-6 / SCA-6
### Dentato-Rubro-Pallido-Luysian Atrophy / Ê≠ØÁä∂Ê†∏Ëµ§Ê†∏Ê∑°ËíºÁêÉ„É´„Ç§‰ΩìËêéÁ∏ÆÁóá
### Friedreich Ataxia / FriedreichÈÅãÂãïÂ§±Ë™øÁóá
### Syringomyelia / ËÑäÈ´ÑÁ©∫Ê¥ûÁóá
### Subacute Combined Degeneration of Spinal Cord / ‰∫úÊÄ•ÊÄßÈÄ£ÂêàÊÄßËÑäÈ´ÑÂ§âÊÄßÁóá
### Amyotrophic Lateral Sclerosis / Á≠ãËêéÁ∏ÆÊÄßÂÅ¥Á¥¢Á°¨ÂåñÁóá
### Spinal Muscular Atrophy / ËÑäÈ´ÑÊÄßÁ≠ãËêéÁ∏ÆÁóá
### Spinal and Bulbar Muscular Atrophy / ÁêÉËÑäÈ´ÑÊÄßÁ≠ãËêéÁ∏ÆÁóá

## Demyelinating Disease / ËÑ±È´ÑÊÄßÁñæÊÇ£

### Multiple Sclerosis / Â§öÁô∫ÊÄßÁ°¨ÂåñÁóá
### Neuromyelitis Optica / Ë¶ñÁ•ûÁµåËÑäÈ´ÑÁÇé
### Acute Disseminated Encephalomyelitis / ÊÄ•ÊÄßÊï£Âú®ÊÄßËÑ≥ËÑäÈ´ÑÁÇé
### Adrenoleukodystrophy / ÂâØËÖéÁôΩË≥™„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Metachromatic Leukodystrophy / Áï∞ÊüìÊÄßÁôΩË≥™„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº

## Peripheral Neuropathy / Êú´Ê¢¢Á•ûÁµåÈöúÂÆ≥

### Guillain-Barr√© Syndrome / Guillain-Barr√©ÁóáÂÄôÁæ§
### Chronic Inflammatory Demyelinating Polyneuropathy / ÊÖ¢ÊÄßÁÇéÁóáÊÄßËÑ±È´ÑÊÄßÂ§öÁô∫Á•ûÁµåÁÇé
### Charcot-Marie-Tooth Disease / Charcot-Marie-ToothÁóÖ
### Familial Amyloid Polyneuropathy / ÂÆ∂ÊóèÊÄß„Ç¢„Éü„É≠„Ç§„Éâ„Éù„É™„Éã„É•„Éº„É≠„Éë„ÉÅ„Éº
### Diabetic Neuropathy / Á≥ñÂ∞øÁóÖÊÄßÁ•ûÁµåÈöúÂÆ≥
### Wernicke Encephalopathy / WernickeËÑ≥Áóá
### Carcinomatous Neuropathy / ÁôåÊÄß„Éã„É•„É≠„Éë„ÉÅ„Éº
### Crow-Fukase Syndrome / Crow-FukaseÁóáÂÄôÁæ§
### Trigeminal Neuralgia / ‰∏âÂèâÁ•ûÁµåÁóõ
### Bell's Palsy / BellÈ∫ªÁó∫
### Ramsay Hunt Syndrome / Ramsay HuntÁóáÂÄôÁæ§

## Muscular Disease / Á≠ãÁñæÊÇ£

### Duchenne Muscular Dystrophy / DuchenneÂûãÁ≠ã„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Becker Muscular Dystrophy / BeckerÂûãÁ≠ã„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Limb-Girdle Muscular Dystrophy / LGÂûãÁ≠ã„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Fascioscapulohumeral Muscular Dystrophy / FSHÂûãÁ≠ã„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Congenital Muscular Dystrophy / ÂÖàÂ§©ÊÄßÁ≠ã„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Myotonic Dystrophy / Á≠ãÂº∑Áõ¥ÊÄß„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Mitochondrial Encephalomyopathy / „Éü„Éà„Ç≥„É≥„Éâ„É™„Ç¢ËÑ≥Á≠ãÁóá
### Periodic Paralysis / Âë®ÊúüÊÄßÂõõËÇ¢È∫ªÁó∫
### Myasthenia Gravis / ÈáçÁóáÁ≠ãÁÑ°ÂäõÁóá
### Lambert-Eaton Myasthenic Syndrome / Lambert-EatonÁóáÂÄôÁæ§

## Phacomatosis / ÊØçÊñëÁóá

### Neurofibromatosis Type 1 / Á•ûÁµåÁ∑öÁ∂≠ËÖ´ÁóáÔºëÂûã
### Neurofibromatosis Type 2 / Á•ûÁµåÁ∑öÁ∂≠ËÖ´ÁóáÔºíÂûã
### Tuberous Sclerosis / ÁµêÁØÄÊÄßÁ°¨ÂåñÁóá
### Von Hippel-Lindau Disease / Von Hippel-LindauÁóÖ
### Sturge-Weber Syndrome / Sturge-WeberÁóáÂÄôÁæ§

## Infectious Disease / ÊÑüÊüìÊÄßÁñæÊÇ£

### Bacterial Meningitis / Á¥∞ËèåÊÄßÈ´ÑËÜúÁÇé
### Tuberculous Meningitis / ÁµêÊ†∏ÊÄßÈ´ÑËÜúÁÇé
### Fungal Meningitis / ÁúüËèåÊÄßÈ´ÑËÜúÁÇé
### Viral Meningitis / „Ç¶„Ç§„É´„ÇπÊÄßÈ´ÑËÜúÁÇé
### Herpes Simplex Encephalitis / ÂçòÁ¥î„Éò„É´„Éö„ÇπËÑ≥ÁÇéÁóá
### HIV-Associated Neurocognitive Disorder / HIV Èñ¢ÈÄ£Á•ûÁµåË™çÁü•ÈöúÂÆ≥
### HTLV-1 Associated Myelopathy / HTLV-1 Èñ¢ÈÄ£ËÑäÈ´ÑÁóá
### Subacute Sclerosing Panencephalitis / ‰∫úÊÄ•ÊÄßÁ°¨ÂåñÊÄßÂÖ®ËÑ≥ÁÇé
### Progressive Multifocal Leukoencephalopathy / ÈÄ≤Ë°åÊÄßÂ§öÂ∑£ÊÄßÁôΩË≥™ËÑ≥Áóá
### Creutzfeldt-Jakob Disease / Creutzfeldt-JakobÁóÖ
### Brain Abscess / ËÑ≥ËÜøÁòç
### Neurosyphilis / Á•ûÁµåÊ¢ÖÊØí
### Acute Encephalopathy / ÊÄ•ÊÄßËÑ≥Áóá
### Reye Syndrome / ReyeÁóáÂÄôÁæ§
### Acute Cerebellar Ataxia / ÊÄ•ÊÄßÂ∞èËÑ≥Â§±Ë™øÁóá

## Brain Tumor / ËÑ≥ËÖ´Áòç

### Diffuse Astrocytoma / „Å≥„Åæ„ÇìÊÄßÊòüÁ¥∞ËÉûËÖ´
### Glioblastoma / ËÜ†ËäΩËÖ´
### Oligodendroglioma / ‰πèÁ™ÅËµ∑ËÜ†ËÖ´
### Ependymoma / ‰∏äË°£ËÖ´
### Medulloblastoma / È´ÑËäΩËÖ´
### Meningioma / È´ÑËÜúËÖ´
### Schwannoma / Á•ûÁµåÈûòËÖ´
### Pituitary Adenoma / ‰∏ãÂûÇ‰ΩìËÖ∫ËÖ´
### Craniopharyngioma / È†≠ËìãÂíΩÈ†≠ËÖ´
### Germ Cell Tumor / ËÉöÁ¥∞ËÉûËÖ´Áòç
### Hemangioblastoma / Ë°ÄÁÆ°ËäΩËÖ´
### Malignant Lymphoma / ÊÇ™ÊÄß„É™„É≥„ÉëËÖ´
### Metastatic Brain Tumor / Ëª¢ÁßªÊÄßËÑ≥ËÖ´Áòç
### Spinal Cord Tumor / ËÑäÈ´ÑËÖ´Áòç

## Functional Disease / Ê©üËÉΩÊÄßÁñæÊÇ£

### Rolandic Epilepsy / Roland„Å¶„Çì„Åã„Çì
### Temporal Lobe Epilepsy / ÂÅ¥È†≠Ëëâ„Å¶„Çì„Åã„Çì
### Childhood Absence Epilepsy / Â∞èÂÖêÊ¨†Á•û„Å¶„Çì„Åã„Çì
### Juvenile Myoclonic Epilepsy / Ëã•Âπ¥„Éü„Ç™„ÇØ„É≠„Éã„Éº„Å¶„Çì„Åã„Çì
### West Syndrome / WestÁóáÂÄôÁæ§
### Lennox-Gastaut Syndrome / Lennox-GastautÁóáÂÄôÁæ§
### Dravet Syndrome / DravetÁóáÂÄôÁæ§
### Febrile Seizure / ÁÜ±ÊÄß„Åë„ÅÑ„Çå„Çì
### Cerebral Palsy / ËÑ≥ÊÄßÈ∫ªÁó∫
### Migraine / ÁâáÈ†≠Áóõ
### Tension-Type Headache / Á∑äÂºµÊÄßÈ†≠Áóõ
### Cluster Headache / Áæ§Áô∫È†≠Áóõ
### Restless Legs Syndrome / „ÇÄ„Åö„ÇÄ„ÅöËÑöÁóáÂÄôÁæ§

## Head Injury / È†≠ÈÉ®Â§ñÂÇ∑

### Skull Base Fracture / È†≠ËìãÂ∫ïÈ™®Êäò
### Cranial Vault Fracture / ÂÜÜËìãÈÉ®È™®Êäò
### Acute Epidural Hematoma / ÊÄ•ÊÄßÁ°¨ËÜúÂ§ñË°ÄËÖ´
### Acute Subdural Hematoma / ÊÄ•ÊÄßÁ°¨ËÜú‰∏ãË°ÄËÖ´
### Chronic Subdural Hematoma / ÊÖ¢ÊÄßÁ°¨ËÜú‰∏ãË°ÄËÖ´
### Cerebral Contusion / ËÑ≥Êå´ÂÇ∑
### Diffuse Axonal Injury / „Å≥„Åæ„ÇìÊÄßËª∏Á¥¢ÊêçÂÇ∑
### Spinal Cord Injury / ËÑäÈ´ÑÊêçÂÇ∑
### Normal Pressure Hydrocephalus / Ê≠£Â∏∏ÂúßÊ∞¥È†≠Áóá -->

# Psychiatry / Á≤æÁ•ûÁßë

## Schizophrenia / Áµ±ÂêàÂ§±Ë™øÁóá

## Mood Disorder / Ê∞óÂàÜÈöúÂÆ≥

## Neurotic Disorder / Á•ûÁµåÁóáÊÄßÈöúÂÆ≥

## Physiologic Disorder / ÁîüÁêÜÁöÑÈöúÂÆ≥

## Personality Disorder / ‰∫∫Ê†ºÈöúÂÆ≥

## Developmental Disorder / Áô∫ÈÅîÈöúÂÆ≥

## Organic Mental Disorder / Âô®Ë≥™ÊÄßÁ≤æÁ•ûÈöúÂÆ≥

## Substance Related Disorder / Áâ©Ë≥™Èñ¢ÈÄ£ÈöúÂÆ≥

# Ophthalmology / ÁúºÁßë

## Functional Disorder / Ê©üËÉΩÈöúÂÆ≥

## Conjunctiva Disorder / ÁµêËÜúÁñæÊÇ£

## Cornea Disorder / ËßíËÜúÁñæÊÇ£

## Uvea Disorder / „Å∂„Å©„ÅÜËÜúÁñæÊÇ£

## Retina Disorder / Á∂≤ËÜúÁñæÊÇ£

## Cataract / ÁôΩÂÜÖÈöú

## Glaucoma / Á∑ëÂÜÖÈöú

## Optic Nerve Disorder / Ë¶ñÁ•ûÁµåÁñæÊÇ£

## Eyelid and Lacrimal Apparatus Disorder / ÁúºÁûº„ÉªÊ∂ôÂô®ÁñæÊÇ£

## Miscellaneous Ophthalmic Disorder / „Åù„ÅÆ‰ªñ„ÅÆÁúºÁßëÁñæÊÇ£

# Otolaryngology / ËÄ≥ÈºªÂíΩÂñâÁßë

## External and Middle Ear Disorder / Â§ñËÄ≥„Éª‰∏≠ËÄ≥ÁñæÊÇ£

## Inner Ear Disorder / ÂÜÖËÄ≥ÁñæÊÇ£

## Nose and Paranasal Sinus Disorder / Èºª„ÉªÂâØÈºªËÖîÁñæÊÇ£

## Oral Cavity and Tonsil Disorder / Âè£ËÖî„ÉªÊâÅÊ°ÉÁñæÊÇ£

## Pharynx and Larynx Disorder / ÂíΩÈ†≠„ÉªÂñâÈ†≠ÁñæÊÇ£

## Cervical and Facial Disorder / È†∏ÈÉ®„ÉªÈ°îÈù¢ÁñæÊÇ£

<!-- ### Upper Respiratory Tract / ‰∏äÊ∞óÈÅì -->

<!-- * **Nose**
  * **Structure**: Palatine, nasal septum (medial), ethmoid, 3 nasal choncha
  * **Histology**: Pseudostratified columnar epithelium, olfactory mucosa (olfactory cell, subtentacular cell, basal cell)
  * **Artery**: Anterior and posterior ethmoidal artery (ophthalmic artery), inferior labial artery (facial artery), sphenopalatine artery (maxillary artery)
  * **Nerve**: Olfactory nerve (CN I), anterior ethmoidal nerve (CN V2), nasopalatine nerve (CN V3)
  * **Nasal meatus**: Sphenoethmoidal recess (sphenoid sinus), superior meatus (posterior ethmoid sinus), middle meatus (other paranasal sinus), inferior meatus (nasolacrimal duct)
  * **Paranasal sinus**: Frontal sinus, sphenoid sinus, ethmoid sinus, sphenoid sinus
* **Pharynx**
  * **Structure**: Nasopharynx (nasal cavity), oropharynx (oral cavity), laryngopharynx (trachea, esophagus)
  * **Histology**: Pseudostratified columnar (nasopharynx), stratified squamous (oropharynx, laryngopharynx)
  * **Nerve**: CN V2 (nasopharynx), CN IX (oropharynx), CN X (laryngopharynx)
* **Larynx**
  * **Structure**: Thyroid cartilage, cricoid cartilage (C6), arytenoid cartilage, vestibular fold, vocal fold
  * **Muscle**: Cricothyroideus (tense), lateral cricoarytenoideus (close), posterior cricoarytenoideus (open), thyroarytenoideus (relax), transverse arytenoideus (close), oblique arytenoideus (constrict), vocalis (control)
  * **Nerve**: External laryngeal nerve (CN X, cricothyroideus), internal laryngeal nerve (CN X, sensation above vocal fold), recurrent laryngeal nerve (CN X, other muscle, left loop aoric arch, right loop subclavian artery)
{: .notice--info} -->

# Dermatology / ÁöÆËÜöÁßë

## Eczema / ÊπøÁñπ

## Urticaria / ËïÅÈ∫ªÁñπ

## Erythema / Á¥ÖÊñëÁóá

## Bullous Dermatoses / Ê∞¥Áñ±Áóá

## Keratosis / ËßíÂåñÁóá

## Pigmentary Disorder / Ëâ≤Á¥†Áï∞Â∏∏Áóá

## Nevus / ÊØçÊñë

## Skin Tumor / ÁöÆËÜöËÖ´Áòç

## Skin Infection / ÁöÆËÜöÊÑüÊüìÁóá

## Epidermal Appendage Disorder / ÁöÆËÜöÈôÑÂ±ûÂô®ÁñæÊÇ£

## Dermis Disorder / ÁúüÁöÆÁñæÊÇ£

## Collagen Disease / ËÜ†ÂéüÁóÖ

## Metabolism Disorder / ‰ª£Ë¨ùÁï∞Â∏∏Áóá

## Physical Disorder / Áâ©ÁêÜÁöÑÈöúÂÆ≥


<!-- ## Eczema and Dermatitis / ÊπøÁñπ„ÉªÁöÆËÜöÁÇé

### Contact Dermatitis /  Êé•Ëß¶ÁöÆËÜöÁÇé
### Atopic Dermatitis / „Ç¢„Éà„Éî„ÉºÊÄßÁöÆËÜöÁÇé
### Asteatotic Eczema / ÁöÆËÑÇÊ¨†‰πèÊÄßÊπøÁñπ
### Seborrheic Dermatitis / ËÑÇÊºèÊÄßÁöÆËÜöÁÇé
### Nummular Eczema / Ë≤®Âπ£Áä∂ÊπøÁñπ
### Autosensitization Dermatitis / Ëá™ÂÆ∂ÊÑü‰ΩúÊÄßÁöÆËÜöÁÇé
### Stasis Dermatitis / „ÅÜ„Å£ÊªûÊÄßÁöÆËÜöÁÇé
### Lichen Vidal / VidalËãîÁô¨
### Pompholyx / Ê±óÁñ±

## Urticaria and Pruritis / ËïÅÈ∫ªÁñπ„ÉªÊéªÁóí

### Urticaria / ËïÅÈ∫ªÁñπ
### Angioedema / Ë°ÄÁÆ°ÊÄßÊµÆËÖ´
### Prurigo / ÁóíÁñπ
### Pruritus Cutaneous / ÁöÆËÜöÁòôÁóíÁóá

## Erythema and Drug Eruption / Á¥ÖÊñëÁóá„ÉªËñ¨Áñπ

### Erythema Exsudativum Multiforme / Â§öÂΩ¢Êª≤Âá∫ÊÄßÁ¥ÖÊñë
### Erythema Nodosum / ÁµêÁØÄÊÄßÁ¥ÖÊñë
### Erythema Induratum / Á°¨ÁµêÊÄßÁ¥ÖÊñë
### Sweet's Disease / SweetÁóÖ
### Drug Eruption / Ëñ¨Áñπ
### Fixed Drug Eruption / Âõ∫ÂÆöËñ¨Áñπ
### Stevens-Johnson Syndrome / Stevens-JohnsonÁóáÂÄôÁæ§
### Toxic Epidermal Necrolysis / ‰∏≠ÊØíÊÄßË°®ÁöÆÂ£äÊ≠ªÁóá
### Drug-Induced Hypersensitivity Syndrome / Ëñ¨Ââ§ÊÄßÈÅéÊïèÁóáÁóáÂÄôÁæ§
### Skin Disorders Caused by Anticancer Drugs / Êäó„Åå„ÇìËñ¨„Å´„Çà„ÇãÁöÆËÜöÈöúÂÆ≥
### Erythroderma / Á¥ÖÁöÆÁóá
### Graft-Versus-Host Disease / ÁßªÊ§çÁâáÂØæÂÆø‰∏ªÁóÖ

## Bullous Dermatoses and Pustulosis / Ê∞¥Áñ±Áóá„ÉªËÜøÁñ±Áóá

### Pemphigus Vulgaris / Â∞ãÂ∏∏ÊÄßÂ§©Áñ±Áò°
### Pemphigus Foliaceus / ËêΩËëâÁä∂Â§©Áñ±Áò°
### Bullous Pemphigoid / Ê∞¥Áñ±ÊÄßÈ°ûÂ§©Áñ±Áò°
### Dermatitis Herpetiformis Duhring / DuhringÁñ±ÁñπÁä∂ÁöÆËÜöÁÇé
### Epidermolysis Bullosa Acquisita / ÂæåÂ§©ÊÄßË°®ÁöÆÊ∞¥Áñ±Áóá
### Epidermolysis Bullosa Hereditaria / ÂÖàÂ§©ÊÄßË°®ÁöÆÊ∞¥Áñ±Áóá
### Palmoplantar Pustulosis / ÊéåËπ†ËÜøÁñ±Áóá

## Keratosis / ËßíÂåñÁóá

### Psoriasis Vulgaris / Â∞ãÂ∏∏ÊÄß‰πæÁô¨
### Guttate Psoriasis / Êª¥Áä∂‰πæÁô¨
### Pustular Psoriasis / ËÜøÁñ±ÊÄß‰πæÁô¨
### Psoriatic Erythroderma / ‰πæÁô¨ÊÄßÁ¥ÖÁöÆÁóá
### Parapsoriasis En Plaques / Â±ÄÈù¢Áä∂È°û‰πæÁô¨
### Pityriasis Lichenoides / ËãîÁô¨Áä∂Á≤ÉÁ≥†Áñπ
### Lichen Planus / ÊâÅÂπ≥ËãîÁô¨
### Pityriasis Rosea Gibert / Gibert„Å∞„ÇâËâ≤Á≤ÉÁ≥†Áñπ
### Pityriasis Rubra Pilaris / ÊØõÂ≠îÊÄßÁ¥ÖËâ≤Á≤ÉÁ≥†Áñπ
### Keratosis Pilaris / ÊØõÂ≠îÊÄßËßíÂåñÁóá
### Clavus and Callus / È∂èÁúº„ÉªËÉºËÉù
### Acanthosis Nigricans / ÈªíËâ≤Ë°®ÁöÆËÖ´
### Ichthyosis Vulgaris / Â∞ãÂ∏∏ÊÄßÈ≠öÈ±óÁô¨
### X-Linked Ichthyosis / XÈÄ£ÈéñÊÄßÈ≠öÈ±óÁô¨
### Congenital Ichthyosiform Erythroderma / ÂÖàÂ§©ÊÄßÈ≠öÈ±óÁô¨ÊßòÁ¥ÖÁöÆÁóá
### Epidermolytic Ichthyosis / Ë°®ÁöÆËûçËß£ÊÄßÈ≠öÈ±óÁô¨
### Palmoplantar Keratoderma / ÊéåËπ†ËßíÂåñÁóá
### Darier's Disease / DarierÁóÖ

## Pigmentary Disorder / Ëâ≤Á¥†Áï∞Â∏∏Áóá

### Oculocutaneous Albinism / ÁúºÁöÆËÜöÁôΩÁöÆÁóá
### Vitiligo Vulgaris / Â∞ãÂ∏∏ÊÄßÁôΩÊñë
### Nevus Depigmentosus / ËÑ±Ëâ≤Á¥†ÊÄßÊØçÊñë
### Vogt-Koyanagi-Harada Disease / Vogt-Â∞èÊü≥-ÂéüÁî∞ÁóÖ
### Leucoderma Sutton / SuttonÁôΩÊñë
### Ephelides / ÈõÄÂçµÊñë
### Melasma / ËÇùÊñë
### Senile Lentigo / ËÄÅ‰∫∫ÊÄßËâ≤Á¥†Êñë

## Nevus / ÊØçÊñë

### Epidermal Nevus / Ë°®ÁöÆÊØçÊñë
### Sebaceous Nevus / ËÑÇËÖ∫ÊØçÊñë
### Melanocytic Nevus / Ëâ≤Á¥†ÊÄßÊØçÊñë
### Spitz Nevus / SpitzÊØçÊñë
### Nevus Spilus / ÊâÅÂπ≥ÊØçÊñë
### Nevus of Ota / Â§™Áî∞ÊØçÊñë
### Mongolian Spot / ËíôÂè§Êñë
### Blue Nevus / ÈùíËâ≤ÊØçÊñë

## Skin Tumor / ÁöÆËÜöËÖ´Áòç

### Seborrheic Keratosis / ËÑÇÊºèÊÄßËßíÂåñÁóá
### Porokeratosis / Ê±óÂ≠îËßíÂåñÁóá
### Epidermal Cyst / Ë°®ÁöÆÂö¢ËÖ´
### Hypertrophic Scar and Keloid / ËÇ•ÂéöÊÄßÁò¢Áóï„Éª„Ç±„É≠„Ç§„Éâ
### Mastocytoma / ËÇ•Ê∫ÄÁ¥∞ËÉûÁóá
### Infantile Hamangioma / ‰π≥ÂÖêË°ÄÁÆ°ËÖ´
### Glomus Tumor / „Ç∞„É≠„É†„ÇπËÖ´Áòç
### Kasabach-Merritt Syndrome / Kasabach-MerrittÁóáÂÄôÁæ§
### Capillary Malformation / ÊØõÁ¥∞Ë°ÄÁÆ°Â•áÂΩ¢
### Basal Cell Carcinoma / Âü∫Â∫ïÁ¥∞ËÉûÁôå
### Squamous Cell Carcinoma / ÊúâÊ£òÁ¥∞ËÉûÁôå
### Keratoacanthoma / „Ç±„É©„Éà„Ç¢„Ç´„É≥„Éà„Éº„Éû
### Solar Keratosis / Êó•ÂÖâËßíÂåñÁóá
### Bowen's Disease / BowenÁóÖ
### Extramammary Paget's Disease / ‰π≥ÊàøÂ§ñPagetÁóÖ
### Merkel Cell Carcinoma / MerkelÁ¥∞ËÉûÁôå
### Malignant Melanoma / ÊÇ™ÊÄßÈªíËâ≤ËÖ´
### Angiosarcoma / Ë°ÄÁÆ°ËÇâËÖ´
### Kaposi's Sarcoma / KaposiËÇâËÖ´
### Mycosis Fungoides / ËèåÁä∂ÊÅØËÇâÁóá
### S√©zary Syndrome / S√©zaryÁóáÂÄôÁæ§

## Skin Infection / ÁöÆËÜöÊÑüÊüìÁóá

### Folliculitis / ÊØõÂåÖÁÇé
### Furuncle and Carbuncle / Áô§„ÉªÁô∞
### Paronychia / Áà™Âõ≤ÁÇé
### Erysipelas / ‰∏πÊØí
### Cellulitis / ËúÇÂ∑£ÁÇé
### Necrotizing Fasciitis / Â£äÊ≠ªÊÄßÁ≠ãËÜúÁÇé
### Gas Gangrene / „Ç¨„ÇπÂ£äÁñΩ
### Impetigo Contagiosa / ‰ºùÊüìÊÄßËÜøÁóÇÁñπ
### Staphylococcal Scalded Skin Syndrome / „Éñ„Éâ„Ç¶ÁêÉËèåÊÄßÁÜ±ÂÇ∑ÊßòÁöÆËÜöÁóáÂÄôÁæ§
### Toxic Shock Syndrome / „Éà„Ç≠„Ç∑„ÉÉ„ÇØ„Ç∑„Éß„ÉÉ„ÇØÁóáÂÄôÁæ§
### Scarlet Fever / Áå©Á¥ÖÁÜ±
### Tuberculosis Cutis / ÁöÆËÜöÁµêÊ†∏
### Nontuberculous Mycobacteriosis / ÈùûÁµêÊ†∏ÊÄßÊäóÈÖ∏ËèåÁóá
### Leprosy / HansenÁóÖ
### Herpes Simplex / ÂçòÁ¥îÁñ±Áñπ
### Varicella / Ê∞¥Áóò
### Herpes Zoster / Â∏ØÁä∂Áñ±Áñπ
### Hand Foot and Mouth Disease / ÊâãË∂≥Âè£ÁóÖ
### Measles / È∫ªÁñπ
### Rubella / È¢®Áñπ
### Exanthema Subitum / Á™ÅÁô∫ÊÄßÁô∫Áñπ
### Erythema Infectiosum / ‰ºùÊüìÊÄßÁ¥ÖÊñë
### Gianotti Disease / GianottiÁóÖ
### Verruca Vulgaris / Â∞ãÂ∏∏ÊÄßÁñ£Ë¥Ö
### Verruca Plana / ÊâÅÂπ≥Áñ£Ë¥Ö
### Molluscum Contagiosum / ‰ºùÊüìÊÄßËªüÂ±ûËÖ´
### Dermatophytosis / ÁôΩÁô¨
### Cutaneous Candidiasis / ÁöÆËÜö„Ç´„É≥„Ç∏„ÉÄÁóá
### Malassezia Infection / „Éû„É©„Çª„ÉÅ„Ç¢ÊÑüÊüìÁóá
### Sporotrichosis / „Çπ„Éù„É≠„Éà„É™„Ç≥„Éº„Ç∑„Çπ
### Dematiaceous Fungal Infection / ÈªíËâ≤ÁúüËèåÁóá
### Scabies / Áñ•Áô¨
### Pediculosis / „Ç∑„É©„ÉüÁóá
### Lyme Disease / „É©„Ç§„É†ÁóÖ
### Scrub Typhus / „ÉÑ„ÉÑ„Ç¨„É†„Ç∑ÁóÖ 

## Epidermal Appendage Disease / ÁöÆËÜöÈôÑÂ±ûÂô®„ÅÆÁñæÊÇ£

### Miliaria / Ê±óÁñπ
### Hyperhidrosis / Â§öÊ±óÁóá
### Anhidrosis / ÁÑ°Ê±óÁóá
### Bromidrosis / Ëá≠Ê±óÁóá
### Acne Valgaris / Â∞ãÂ∏∏ÊÄßÁó§Áò°
### Acneiform Eruption / Áó§Áò°ÊßòÁô∫Áñπ
### Rosacea / ÈÖíÁö∂
### Rosacea-Like Dermatitis / ÈÖíÁö∂ÊßòÁöÆËÜöÁÇé
### Androgenetic Alopecia / Áî∑ÊÄßÂûãËÑ±ÊØõÁóá
### Alopecia Areata / ÂÜÜÂΩ¢ËÑ±ÊØõÁóá
### Trichotillomania / ÊäúÊØõÁóá
### Ingrown Nail / Èô•ÂÖ•Áà™
-->

# Orthopedic Surgery / Êï¥ÂΩ¢Â§ñÁßë

## Upper Limb Disorder / ‰∏äËÇ¢ÁñæÊÇ£

## Lower Limb Disorder / ‰∏ãËÇ¢ÁñæÊÇ£

## Trunk Disorder / ‰ΩìÂππÁñæÊÇ£

## Joint Disorder / Èñ¢ÁØÄÁñæÊÇ£

## Peripheral Nerve Disorder / Êú´Ê¢¢Á•ûÁµåÁñæÊÇ£

## Trauma / Â§ñÂÇ∑

## Metabolic Disorder / ‰ª£Ë¨ùÊÄßÁñæÊÇ£

## Infectious Disorder / ÊÑüÊüìÊÄßÁñæÊÇ£

## Bone Tumor / È™®ËÖ´Áòç

# Urology / Ê≥åÂ∞øÂô®Áßë

## Urinary Tract Infection and Stone / Â∞øË∑ØÊÑüÊüìÁóá„ÉªÁµêÁü≥

## Urinary Tract Tumor / Â∞øË∑ØËÖ´Áòç

## Urinary Tract Dysfunction / Â∞øË∑ØÊ©üËÉΩÈöúÂÆ≥

## Urinary Tract Congenital Anomaly / Â∞øË∑ØÂÖàÂ§©Áï∞Â∏∏

## Penis Disorder / Èô∞ËåéÁñæÊÇ£

## Testicle Disorder / Áùæ‰∏∏ÁñæÊÇ£

## Prostate Disorder / ÂâçÁ´ãËÖ∫ÁñæÊÇ£


<!-- ### Male Genital Organ / Áî∑ÊÄßÂô®

* **Scrotum**
  * **Structure**: Skin, smooth muscle (dartos)
  * **Artery**: Anterior scrotal artery (external pudendal artery), posterior scrotal artery (perineal artery)
  * **Nerve**: Scrotal nerve (perineal nerve)
  * **Spermatic cord**: Ductus deferens, tesicular artery, pampiniform plexus, genitofemoral nerve
* **Testis**
  * **Structure**: External fascia (external oblique), middle fascia (internal oblique), internal fascia (fascia transversalis), tunica vaginalis (peritoneum), tunica albuginea, lobule, seminoferous tube
  * **Artery**: Testicular artery (abdominal aorta)
  * **Vein**: Right testicular vein (inferior vena cava), left testicular vein (left renal vein)
  * **Spermatogenesis**: Spermatogonia, 1st spermatocyte, 2nd spermatocyte, spermatid, sperm
  * **Cell**: Sertoli cell (blood-testis barrier, activin, inhibin, MIF), Leydig cell (testosterone)
  * **Genital tracty**: Seminoferous tubule (spermatogenic cell, Sertoli cell), tubuli recti (Sertoli cell), rete testis (simple cuboidal), ductuli efferentes (simple columnar), epididymis (pseudostratified columnar, steriocelia), vas deferens (pseudostratified columnar, steriocelia)
* **Gland**
  * **Siminal vesicle**: Into prostate seminal coliculus
  * **Prostate**: Into prostatic sinus, central zone, peripheral zone (adenocarcinoma), transitional zone (BPH)
  * **Bulbourethral gland**: Into uretra
* **Penis**
  * **Structure**: 2 corpus cavernosa (crura, with tunica albuginea), 1 corpus spongisum (blub, glans)
  * **Artery**: Deep artery of penis (corpus cavernosa, perineal artery), artery of bulb (corpus spongiosum, perineal artery), dorsal artery of penis (glans, perineal artery)
  * **Nerve**: Dorsal nerve of penis (perineal nerve)
  * **Function**: Erection (parasympathetic, inferior hypogastric ganglion), ejaculation (sympathetic, superior hypogastric ganglion)
{: .notice--info} -->

<!-- ## Urinary Tract Dysfunction / Â∞øË∑ØÊ©üËÉΩÈöúÂÆ≥

### Hydronephrosis / Ê∞¥ËÖéÁóá
### Neurogenic Bladder / Á•ûÁµåÂõ†ÊÄßËÜÄËÉ±
### Overactive Bladder / ÈÅéÊ¥ªÂãïËÜÄËÉ±
### Stress Incontinence / ËÖπÂúßÊÄßÂ∞øÂ§±Á¶Å

## Urinary Tract and Genital Infection / Â∞øË∑Ø„ÉªÊÄßÂô®ÊÑüÊüìÁóá

### Pyelonephritis / ËÖéÁõÇËÖéÁÇé
### Renal Abscess / ËÖéËÜøÁòç
### Cystitis / ËÜÄËÉ±ÁÇé
### Urinary Tuberculosis / Â∞øË∑ØÁµêÊ†∏
### Urethritis / Â∞øÈÅìÁÇé
### Prostatitis / ÂâçÁ´ãËÖ∫ÁÇé
### Epididymitis / Á≤æÂ∑£‰∏ä‰ΩìÁÇé
### Orchitis / Á≤æÂ∑£ÁÇé

## Urinary Tract and Genital Tumor / Â∞øË∑Ø„ÉªÊÄßÂô®ËÖ´Áòç

### Urinary Stone / Â∞øË∑ØÁµêÁü≥
### Renal Cell Carcinoma / ËÖéÁ¥∞ËÉûÁôå
### Renal Pelvic and Ureteral Cancer / ËÖéÁõÇ„ÉªÂ∞øÁÆ°Áôå
### Bladder Cancer / ËÜÄËÉ±Áôå
### Penile Cancer / Èô∞ËåéÁôå
### Benign Prostatic Hyperplasia / ÂâçÁ´ãËÖ∫ËÇ•Â§ßÁóá
### Prostatic Cancer / ÂâçÁ´ãËÖ∫Áôå
### Testicular Tumor / Á≤æÂ∑£ËÖ´Áòç

## Genital Dysfunction / ÊÄßÂô®Ê©üËÉΩÁï∞Â∏∏
### Varicocele / Á≤æÁ¥¢ÈùôËÑàÁò§
### Testicular Torsion / Á≤æÂ∑£ÊçªËª¢Áóá
### Phimosis / ÂåÖËåé
### Erectile Dysfunction / ÂãÉËµ∑ÈöúÂÆ≥
### Priapism / ÊåÅÁ∂öÂãÉËµ∑Áóá
### Male Infertility / Áî∑ÊÄß‰∏çÂ¶äÁóá -->

# Gynecology / Â©¶‰∫∫Áßë

## Sexuel Development Disorder / ÊÄßÂàÜÂåñÁñæÊÇ£

## Endocrine Disorder / ÂÜÖÂàÜÊ≥å„ÅÆÁï∞Â∏∏

## Aging-Related Disorder / Âä†ÈΩ¢„Å´„Çà„ÇãÁñæÊÇ£

## Genital Infection / ÊÄßÂô®ÊÑüÊüìÁóá

## Valvar and Vaginal Disorder / Â§ñÈô∞„ÉªËÖüÁñæÊÇ£

## Uterine Disorder / Â≠êÂÆÆÁñæÊÇ£

## Ovarian Disorder / ÂçµÂ∑£ÁñæÊÇ£

## Breast Disorder / ‰π≥ËÖ∫ÁñæÊÇ£

## Infertility / ‰∏çÂ¶äÁóá

<!-- ## Endocrine Disorder / ÂÜÖÂàÜÊ≥å„ÅÆÁï∞Â∏∏

### Anovulatory Cycle / ÁÑ°ÊéíÂçµÂë®ÊúüÁóá

### Luteal Insufficiency / ÈªÑ‰ΩìÊ©üËÉΩ‰∏çÂÖ®

### Premenstrual Syndrome / ÊúàÁµåÂâçÁóáÂÄôÁæ§

### Dysmenorrhea / ÊúàÁµåÂõ∞Èõ£Áóá

### Hyperprolactinemia / È´ò„Éó„É≠„É©„ÇØ„ÉÅ„É≥Ë°ÄÁóá

### Anorexia Nervosa / Á•ûÁµåÊÄß„ÇÑ„ÅõÁóá

### Amenorrhea Due to Weight Loss / ÂçòÁ¥îÊÄß‰ΩìÈáçÊ∏õÂ∞ëÊÄßÁÑ°ÊúàÁµå

### Sheehan Syndrome / SheehanÁóáÂÄôÁæ§

### Polycystic Ovary Syndrome / Â§öÂö¢ËÉûÊÄßÂçµÂ∑£ÁóáÂÄôÁæ§

## Sex Development Disorder / ÊÄßÂàÜÂåñÁñæÊÇ£

### Congenital Adrenocortical Hyperplasia / ÂÖàÂ§©ÊÄßÂâØËÖéÁöÆË≥™ÈÅéÂΩ¢ÊàêÁóá

### Androgen Insensitivity Syndrome / „Ç¢„É≥„Éâ„É≠„Ç≤„É≥‰∏çÂøúÁóá

### Turner Syndrome / TurnerÁóáÂÄôÁæ§

### Klinefelter Syndrome / KlinefelterÁóáÂÄôÁæ§ -->

# Obstetrics / Áî£Áßë

## Early Pregnancy Disorder / Â¶äÂ®†ÂàùÊúü„ÅÆÁï∞Â∏∏

## Later Pregnancy Disorder / Â¶äÂ®†‰∏≠„ÉªÂæåÊúü„ÅÆÁï∞Â∏∏

## Complicated Pregnancy / Âêà‰ΩµÁóáÂ¶äÂ®†

## Mother to Children Infection / ÊØçÂ≠êÊÑüÊüìÁóá

## Delivery Disorder / ÂàÜÂ®©„ÅÆÁï∞Â∏∏

## Puerperium Disorder / Áî£Ë§•„ÅÆÁï∞Â∏∏

# Pediatrics / Â∞èÂÖêÁßë

## Neonate Disorder / Êñ∞ÁîüÂÖêÁñæÊÇ£

## Congenital Disorder / ÂÖàÂ§©Áï∞Â∏∏

## Cardiovascular Disorder / Âæ™Áí∞Âô®ÁñæÊÇ£

## Respiratory Disorder / ÂëºÂê∏Âô®ÁñæÊÇ£

## Gastrointestinal Disorder / Ê∂àÂåñÂô®ÁñæÊÇ£

## Endocrine and Metabolism Disorder / ÂÜÖÂàÜÊ≥å„Éª‰ª£Ë¨ùÁñæÊÇ£

## Renal and Urologic Disorder / ËÖé„ÉªÊ≥åÂ∞øÂô®ÁñæÊÇ£

## Hematologic Disorder / Ë°ÄÊ∂≤ÁñæÊÇ£

## Immunologic Disorder / ÂÖçÁñ´ÁñæÊÇ£

## Infectious Disorder / ÊÑüÊüìÊÄßÁñæÊÇ£

## Neurologic Disorder / Á•ûÁµåÁñæÊÇ£

## Mental Disorder / Á≤æÁ•ûÁñæÊÇ£

## Neoplasm / Êñ∞ÁîüÁâ©

<!-- ## Cardiovascular Disease / Âæ™Áí∞Âô®ÁñæÊÇ£

### Atrial Septal Defect / ÂøÉÊàø‰∏≠ÈöîÊ¨†ÊêçÁóá
### Ventricular Septal Defect / ÂøÉÂÆ§‰∏≠ÈöîÊ¨†ÊêçÁóá
### Atrioventricular Septal Defect / ÊàøÂÆ§‰∏≠ÈöîÊ¨†ÊêçÁóá
### Patent Ductus Arteriosus / ÂãïËÑàÁÆ°ÈñãÂ≠òÁóá
### Coarctation of the Aorta / Â§ßÂãïËÑàÁ∏ÆÁ™ÑÁóá
### Eisenmenger Syndrome / EisenmengerÁóáÂÄôÁæ§
### Tetralogy of Fallot / FallotÂõõÂæ¥Áóá
### Complete Transposition of Great Arteries / ÂÆåÂÖ®Â§ßË°ÄÁÆ°Ëª¢‰ΩçÁóá
### Total Anomalous Pulmonary Venous Return / Á∑èËÇ∫ÈùôËÑàÈÇÑÊµÅÁï∞Â∏∏Áóá
### Double Outlet Right Ventricle / ‰∏°Â§ßË°ÄÁÆ°Âè≥ÂÆ§Ëµ∑ÂßãÁóá
### Hypoplastic Left Heart Syndrome / Â∑¶ÂøÉ‰ΩéÂΩ¢ÊàêÁóáÂÄôÁæ§
### Pulmonary Stenosis / ËÇ∫ÂãïËÑàÁã≠Á™ÑÁóá
### Pure Pulmonary Atresia / Á¥îÂûãËÇ∫ÂãïËÑàÈñâÈéñ
### Truncus Arteriosus Communis / Á∑èÂãïËÑàÂππÁóá
### Ruptured Aneurysm of the sinus of Valsalva / ValsalvaÊ¥ûÂãïËÑàÁò§Á†¥Ë£Ç
### Tricuspid Atresia / ‰∏âÂ∞ñÂºÅÈñâÈéñÁóá
### Ebstein's Disease / EbsteinÁóÖ
### Single Ventricle / ÂçòÂøÉÂÆ§Áóá

## Gastrointestinal Disease / Ê∂àÂåñÂô®ÁñæÊÇ£

### Congenital Esophageal Atresia / ÂÖàÂ§©ÊÄßÈ£üÈÅìÈñâÈéñ
### Hypertrophic Pyloric Stenosis / ËÇ•ÂéöÊÄßÂπΩÈñÄÁã≠Á™ÑÁóá
### Congenital Duodenal Atresia or Stenosis / ÂÖàÂ§©ÊÄßÂçÅ‰∫åÊåáËÖ∏ÈñâÈéñ„ÉªÁã≠Á™ÑÁóá
### Congenital Intestinal Atresia or Stenosis / ÂÖàÂ§©ÊÄßÂ∞èËÖ∏ÈñâÈéñ„ÉªÁã≠Á™ÑÁóá
### Intestinal Malrotation / ËÖ∏ÂõûËª¢Áï∞Â∏∏Áóá
### Meckel Diverticulum / MeckelÊÜ©ÂÆ§
### Intussusception / ËÖ∏ÈáçÁ©çÁóá
### Hirschsprung Disease / HirschsprungÁóÖ
### Necrotizing Enterocolitis / Â£äÊ≠ªÊÄßËÖ∏ÁÇé
### Anal Atresia / ÈéñËÇõ 
### Bochdalek Hernia / BochdalekÂ≠î„Éò„É´„Éã„Ç¢
### Omphalocele / ËáçÂ∏Ø„Éò„É´„Éã„Ç¢
### Gastroschisis / ËÖπÂ£ÅÁ†¥Ë£Ç
### Gilbert Syndrome / GilbertÁóáÂÄôÁæ§
### Crigler-Najjar Syndrome / Cirgler-NajjarÁóáÂÄôÁæ§
### Dubin-Johnson Syndrome / Dubin-JohnsonÁóáÂÄôÁæ§
### Rotor Syndrome / RotorÁóáÂÄôÁæ§
### Biliary Atresia / ËÉÜÈÅìÈñâÈéñÁóá
### Congenital Biliary Dilatation / ÂÖàÂ§©ÊÄßËÉÜÈÅìÊã°ÂºµÁóá

## Metabolism Disease / ‰ª£Ë¨ùÁñæÊÇ£

### Phenylketonuria / „Éï„Çß„Éã„É´„Ç±„Éà„É≥Â∞øÁóá
### Maple Syrup Urine Disease / „É°„Éº„Éó„É´„Ç∑„É≠„ÉÉ„ÉóÂ∞øÁóá
### Homocystinurea / „Éõ„É¢„Ç∑„Çπ„ÉÅ„É≥Â∞øÁóá
### Urea Cycle Defect / Â∞øÁ¥†„Çµ„Ç§„ÇØ„É´Áï∞Â∏∏Áóá
### Von Gierke Disease / Von GierkeÁóÖ
### Pompe Disease / PompeÁóÖ
### Galactosemia / „Ç¨„É©„ÇØ„Éà„Éº„ÇπË°ÄÁóá
### Lactose Intolerance / ‰π≥Á≥ñ‰∏çËÄêÁóá
### Mucopolysaccharidoses / „É†„Ç≥Â§öÁ≥ñÁóá
### Tay-Sachs Disease / Tay-SachsÁóÖ
### Fabry Disease / FabryÁóÖ
### Gaucher Disease / GaucherÁóÖ
### Nieman-Pick Disease / Nieman-PickÁóÖ
### Lesch-Nyhan Syndrome / Lesch-NyhanÁóáÂÄôÁæ§
### Wilson's Disease / WilsonÁóÖ
### Menkes Disease / MenkesÁóÖ
### Marfan Syndrome / MarfanÁóáÂÄôÁæ§
### Ehlers-Danlos Syndrome / Ehlers-DanlosÁóáÂÄôÁæ§
### Ketotic Hypoglycemia / „Ç±„Éà„É≥ÊÄß‰ΩéË°ÄÁ≥ñÁóá
### Acetonic Vomiting / „Ç¢„Çª„Éà„É≥Ë°ÄÊÄßÂòîÂêêÁóá
### Osteomalacia / È™®ËªüÂåñÁóá
### Osteogenesis Imperfecta / È™®ÂΩ¢Êàê‰∏çÂÖ®Áóá
### Chondrodysplasia / ËªüÈ™®Áï∞ÂΩ¢ÊàêÁóá

## Endocrine Disease / ÂÜÖÂàÜÊ≥åÁñæÊÇ£

### Growth Hormone Deficiency / ÊàêÈï∑„Éõ„É´„É¢„É≥Ê¨†‰πèÁóá
### Congenital Hypothyroidism / ÂÖàÂ§©ÊÄßÁî≤Áä∂ËÖ∫Ê©üËÉΩ‰Ωé‰∏ãÁóá
### Precocious Puberty / Êó©Áô∫ÊÄßÊÄùÊò•Êúü
### McCune-Albright Syndrome / McCune-AlbrightÁóáÂÄôÁæ§
### Turner Syndrome / TurnerÁóáÂÄôÁæ§
### Klinefelter Syndrome / KlinefelterÁóáÂÄôÁæ§
### Kallman Syndrome / KallmanÁóáÂÄôÁæ§
### Prader-Willi Syndrome / Prader-WilliÁóáÂÄôÁæ§
### Congenital Adrenocortical Hyperplasia / ÂÖàÂ§©ÊÄßÂâØËÖéÁöÆË≥™ÈÅéÂΩ¢Êàê
### Androgen Insensitivity Syndrome / „Ç¢„É≥„Éâ„É≠„Ç≤„É≥‰∏çÂøúÁóá

## Renal and Urologic Disease / ËÖé„ÉªÊ≥åÂ∞øÂô®ÁñæÊÇ£

### Polycystic Kidney Disease / Â§öÁô∫ÊÄßÂö¢ËÉûËÖé
### Sponge Kidney / Êµ∑Á∂øËÖé
### Horseshoe Kidney / È¶¨ËπÑËÖé
### Congenital Hydronephrosis / ÂÖàÂ§©ÊÄßÊ∞¥ËÖéÁóá
### Duplicated Renal Pelvis and Ureter / ÈáçË§áËÖéÂ≠üÂ∞øÁÆ°
### Ectopic Ureter / Â∞øÁÆ°Áï∞ÊâÄÈñãÂè£
### Ureterocele / Â∞øÁÆ°Áò§
### Vesicourethral Reflux / ËÜÄËÉ±Â∞øÁÆ°ÈÄÜÊµÅ
### Hypospadias / Â∞øÈÅì‰∏ãË£Ç
### Cryptorchidism / ÂÅúÁïôÁ≤æÂ∑£
### Hydrocele Testis / Èô∞Âö¢Ê∞¥ËÖ´

## Hematologic Disease / Ë°ÄÊ∂≤ÁñæÊÇ£

### Hemophilia / Ë°ÄÂèãÁóÖ
### Von Willebrand Disease / Von WillebrandÁóÖ
### Bernard-Soulier Syndrome / Bernard-SoulierÁóáÂÄôÁæ§
### Glanzmann Thrombasthenia / Ë°ÄÂ∞èÊùøÁÑ°ÂäõÁóá

## Immune Disease / ÂÖçÁñ´ÁñæÊÇ£

### Severe Combined Immunodeficiency / ÈáçÁóáË§áÂêàÂÖçÁñ´‰∏çÂÖ®Áóá
### X-linked Agammaglobulinemia / XÈÄ£ÈéñÁÑ°Œ≥-„Ç∞„É≠„Éñ„É™„É≥Ë°ÄÁóá
### Hyper-IgM Syndrome / È´òIgMÁóáÂÄôÁæ§
### Wiskott-Aldrich Syndrome / Wiskott-AldrichÁóáÂÄôÁæ§
### Ataxia Telangiectasia / ÊØõÁ¥∞Ë°ÄÁÆ°Êã°ÂºµÊÄßÈÅãÂãïÂ§±Ë™øÁóá
### DiGeorge Syndrome / DiGeorgeÁóáÂÄôÁæ§
### Ch√©diak-Higashi Syndrome / Ch√©diak-HigashiÁóáÂÄôÁæ§
### Chronic Granulomatous Disease / ÊÖ¢ÊÄßËÇâËäΩËÖ´Áóá

## Neurological Disease / Á•ûÁµåÁñæÊÇ£

### Craniosynostosis / È†≠ËìãÁ∏´ÂêàÊó©ÊúüÁôíÂêàÁóá
### Spina Bifida / ‰∫åÂàÜËÑäÊ§é
### Cranium Bifidum / ‰∫åÂàÜÈ†≠Ëìã
### Congenital Hydrocephalus / ÂÖàÂ§©ÊÄßÊ∞¥È†≠Áóá
### Chiari Malformation / ChiariÂ•áÂΩ¢
### Dandy-Walker Syndrome / Dandy-WalkerÁóáÂÄôÁæ§
### Arachnoid Cyst / „Åè„ÇÇËÜúÂö¢ËÉû

## Neoplasm / Êñ∞ÁîüÁâ©

### Hepatoblastoma / ËÇùËäΩËÖ´
### Wilms' Tumor / WilmsËÖ´Áòç -->

<!-- # Emergency Medicine / ÊïëÊÄ•Áßë

## Shock / „Ç∑„Éß„ÉÉ„ÇØ

### Cardiopulmonary Arrest / ÂøÉËÇ∫ÂÅúÊ≠¢
### Hypovolemic Shock / Âæ™Áí∞Ë°ÄÊ∂≤ÈáèÊ∏õÂ∞ëÊÄß„Ç∑„Éß„ÉÉ„ÇØ
### Anaphylactic Shock / „Ç¢„Éä„Éï„Ç£„É©„Ç≠„Ç∑„Éº„Ç∑„Éß„ÉÉ„ÇØ
### Neurogenic Shock / Á•ûÁµåÂéüÊÄß„Ç∑„Éß„ÉÉ„ÇØ
### Septic Shock / ÊïóË°ÄÁóáÊÄß„Ç∑„Éß„ÉÉ„ÇØ
### Cardiogenic Shock / ÂøÉÂéüÊÄß„Ç∑„Éß„ÉÉ„ÇØ
### Extracardiac Obstructive Shock / ÂøÉÂ§ñÈñâÂ°ûÊÄß„Ç∑„Éß„ÉÉ„ÇØ

## Emergency Disease / ÊïëÊÄ•ÁñæÊÇ£

### Airway Foreign Body / Ê∞óÈÅìÁï∞Áâ©
### Gastrointestinal Foreign Body / Ê∂àÂåñÁÆ°Áï∞Áâ©
### Status Epilepticus / „Å¶„Çì„Åã„ÇìÈáçÁ©çÁä∂ÊÖã
### Acute Abdomen / ÊÄ•ÊÄßËÖπÁóá
### Multiple Organ Dysfunction Syndrome / Â§öËáìÂô®‰∏çÂÖ®

## Thoracic Injury / ËÉ∏ÈÉ®Â§ñÂÇ∑

### Tracheobronchial Injury / Ê∞óÁÆ°„ÉªÊ∞óÁÆ°ÊîØÊêçÂÇ∑
### Pulmonary Contusion / ËÇ∫Êå´ÂÇ∑
### Flail Chest / ËÉ∏ÈÉ≠ÂãïÊè∫
### Open Pneumothorax / ÈñãÊîæÊÄßÊ∞óËÉ∏
### Tension Pneumothorax / Á∑äÂºµÊÄßÊ∞óËÉ∏
### Aortic Injury / Â§ßÂãïËÑàÊêçÂÇ∑
### Massive Hemothorax / Â§ßÈáèË°ÄËÉ∏

## Abdominal Injury / ËÖπÈÉ®Â§ñÂÇ∑

### Liver Injury / ËÇùÊêçÂÇ∑
### Splenic Rupture / ËÑæÁ†¥Ë£Ç
### Kidney Injury / ËÖéÂ§ñÂÇ∑
### Urethral Injury / Â∞øÈÅìÂ§ñÂÇ∑
### Bladder Injury / ËÜÄËÉ±Â§ñÂÇ∑
### Testicular Injury / Á≤æÂ∑£Â§ñÂÇ∑

## Other Injury / „Åù„ÅÆ‰ªñ„ÅÆÂ§ñÂÇ∑

### High Energy Trauma / È´ò„Ç®„Éç„É´„ÇÆ„ÉºÂ§ñÂÇ∑
### Crush Syndrome / ÂúßÊå´ÁóáÂÄôÁæ§
### Compartment Syndrome / „Ç≥„É≥„Éë„Éº„Éà„É°„É≥„ÉàÁóáÂÄôÁæ§
### Fat Embolism Syndrome / ËÑÇËÇ™Â°ûÊ†ìÁóáÂÄôÁæ§
### Burns / ÁÜ±ÂÇ∑
### Smoke Inhalation Injury / Ê∞óÈÅìÁÜ±ÂÇ∑

## Diseases due to Physical Factors / Áâ©ÁêÜÁöÑË¶ÅÂõ†„Å´„Çà„ÇãÁñæÊÇ£

### Heat Illness / ÁÜ±‰∏≠Áóá
### Accidental Hypothermia / ÂÅ∂Áô∫ÊÄß‰Ωé‰ΩìÊ∏©Áóá
### Altitude Sickness / È´òÂ±±ÁóÖ
### Decompression Sickness / Ê∏õÂúßÁóá

## Poisoning / ‰∏≠ÊØí

### Food Poisoning / È£ü‰∏≠ÊØí
### Drug Poisoning / Ëñ¨Áâ©‰∏≠ÊØí
### Organic Solvent Poisoning / ÊúâÊ©üÊ∫∂Ââ§‰∏≠ÊØí
### Toxic Gas Poisoning / ÊúâÊØí„Ç¨„Çπ‰∏≠ÊØí
### Metal Poisoning / ÈáëÂ±û‰∏≠ÊØí
### Pesticide Poisoning / Ëæ≤Ëñ¨‰∏≠ÊØí -->
